data_2hir_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hir _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 32.8 m-85 -120.12 -110.46 0.34 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.268 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 173.15 178.71 0.09 Allowed 'General case' 0 C--N 1.258 -3.395 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -76.47 130.18 37.6 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.644 -1.223 . . . . 0.0 111.175 -176.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 96.2 m -40.6 168.06 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.15 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -143.66 11.85 1.67 Allowed 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 113.066 -1.879 . . . . 0.0 107.626 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -173.9 125.76 0.36 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.433 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -47.1 158.06 0.15 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.224 178.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 95.57 -28.26 12.88 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.588 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.89 176.92 0.49 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.938 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -156.49 20.18 0.34 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 116.947 -1.901 . . . . 0.0 114.863 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -134.14 16.0 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -102.04 -179.62 4.05 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.025 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.1 mt -77.85 72.69 4.4 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.003 1.383 . . . . 0.0 108.003 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.4 t -77.68 -82.85 0.08 Allowed 'General case' 0 C--N 1.25 -3.733 0 CA-C-N 112.051 -2.341 . . . . 0.0 110.356 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.81 110.86 9.46 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.859 -1.536 . . . . 0.0 108.505 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.3 -154.56 33.52 Favored Glycine 0 N--CA 1.479 1.528 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -82.8 5.56 21.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.52 1.153 . . . . 0.0 109.324 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.42 149.01 25.3 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.657 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.1 t -82.65 144.56 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.027 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -144.67 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.965 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -141.3 82.91 0.23 Allowed Glycine 0 C--N 1.282 -2.464 1 N-CA-C 128.17 6.028 . . . . 0.0 128.17 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.1 tm0? -19.22 126.0 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 124.595 0.82 . . . . 0.0 111.483 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.48 56.95 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 106.551 -2.619 . . . . 0.0 106.551 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.0 m-20 -110.12 -169.74 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.188 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -144.36 130.9 19.95 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.043 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.612 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 52.6 t -99.58 168.29 10.05 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.586 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.434 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 28.1 mm -145.95 119.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 C-N-CA 118.298 -1.361 . . . . 0.0 112.508 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 9' ' ' SER . 12.0 mt . . . . . 0 N--CA 1.494 1.754 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.49 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.612 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 120.864 0.364 . . . . 0.0 110.909 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.549 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 35.2 tt0 -127.6 161.21 29.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.02 71.13 1.04 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -174.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -101.79 113.12 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 118.161 -1.416 . . . . 0.0 113.27 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' VAL . 7.5 t -31.11 158.69 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.421 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.64 159.51 8.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -78.12 102.59 7.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.37 -104.65 2.93 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.64 137.86 6.77 Favored Pre-proline 0 C--N 1.303 -1.418 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.908 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.9 Cg_endo -68.87 91.68 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.735 0.957 . . . . 0.0 109.681 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 47.7 tttp . . . . . 0 N--CA 1.503 2.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.262 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.446 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 33.1 m-85 -114.27 -116.74 0.32 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.719 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 1.3 p -165.59 176.62 7.96 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.909 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.66 125.57 35.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.191 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' ' NE2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -59.84 165.59 3.09 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-O 123.594 1.664 . . . . 0.0 111.897 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -142.31 13.32 1.99 Allowed 'General case' 1 C--N 1.239 -4.197 0 CA-C-N 110.595 -3.002 . . . . 0.0 105.338 174.198 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 16.1 mt-10 -160.31 139.47 10.73 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.584 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.525 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.65 -175.62 0.06 Allowed 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 123.236 1.493 . . . . 0.0 111.15 177.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 69.47 -36.87 0.34 Allowed Glycine 1 C--N 1.231 -5.294 0 CA-C-N 111.278 -2.692 . . . . 0.0 112.524 177.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.553 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -59.74 -171.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.555 -175.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.596 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -171.77 40.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.659 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 72.9 mt -143.02 1.32 1.26 Allowed 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.3 p -100.48 171.45 7.73 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.604 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -81.48 78.83 8.19 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 123.664 1.697 . . . . 0.0 107.998 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.568 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -79.76 -61.32 2.03 Favored 'General case' 1 C--N 1.235 -4.382 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.845 -178.724 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 11.4 mm-40 -73.99 72.17 1.61 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.66 -1.616 . . . . 0.0 108.284 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -113.4 4.07 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.3 p -99.91 -11.75 20.42 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-O 124.048 1.88 . . . . 0.0 109.197 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.04 119.39 19.14 Favored 'General case' 1 C--N 1.207 -5.628 0 CA-C-N 110.709 -2.95 . . . . 0.0 110.216 178.944 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 25.4 t -63.41 147.11 12.39 Favored 'Isoleucine or valine' 1 C--N 1.215 -5.279 0 CA-C-N 110.956 -2.838 . . . . 0.0 107.713 175.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -77.93 -132.16 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.77 89.75 0.1 OUTLIER Glycine 1 C--N 1.224 -5.677 0 C-N-CA 115.942 -3.028 . . . . 0.0 112.36 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' ASN . 36.2 tt0 -23.67 142.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 113.782 -1.209 . . . . 0.0 110.743 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -7.42 63.4 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -173.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.2 m-20 -111.11 -166.89 1.11 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.607 -1.297 . . . . 0.0 108.91 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -147.48 98.01 2.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 10' ' ' GLY . 51.1 t -75.68 154.84 36.26 Favored 'General case' 0 CA--C 1.435 -3.448 0 C-N-CA 116.55 -2.06 . . . . 0.0 109.918 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 37' ' ' ASN . 32.3 mm -139.08 120.97 16.67 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.246 0 CA-C-N 112.769 -2.014 . . . . 0.0 109.633 175.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.525 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.4 mt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -95.48 -173.36 2.88 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.56 -1.655 . . . . 0.0 108.629 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 85.6 m -133.59 67.12 1.53 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -91.17 136.02 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 117.011 -1.876 . . . . 0.0 114.829 -171.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.631 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 t -17.83 144.5 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 110.008 -3.269 . . . . 0.0 113.127 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.26 -137.03 6.6 Favored Glycine 0 N--CA 1.484 1.878 1 N-CA-C 130.2 6.84 . . . . 0.0 130.2 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.73 98.5 0.88 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.601 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.61 -104.86 2.85 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.745 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.41 138.44 10.09 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.9 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.24 104.33 1.53 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.325 1.35 . . . . 0.0 110.715 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.905 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.961 0.41 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 22.0 m-85 -137.34 -111.15 0.18 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.655 0.741 . . . . 0.0 109.777 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 179.16 177.56 0.52 Allowed 'General case' 0 C--N 1.262 -3.229 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.64 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.07 131.68 37.4 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.387 -177.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 93.7 m -43.01 172.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.122 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -146.08 11.06 1.18 Allowed 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.727 172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -168.86 123.73 0.88 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.461 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.95 149.71 1.77 Allowed 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.152 173.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 93.08 -0.58 69.28 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.17 -1.49 . . . . 0.0 111.613 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -81.84 -173.6 4.55 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.695 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -167.69 30.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 116.689 -2.004 . . . . 0.0 115.348 -178.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 34.7 mt -146.07 14.56 1.32 Allowed 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -109.43 -179.98 3.98 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.725 -175.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.661 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 mt -76.27 70.22 2.87 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.142 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.535 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 4.1 m -75.89 -83.06 0.07 Allowed 'General case' 0 C--N 1.249 -3.761 0 CA-C-N 112.44 -2.164 . . . . 0.0 110.387 -176.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.73 107.01 6.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.108 -1.837 . . . . 0.0 108.75 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.12 -137.54 33.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.148 -1.501 . . . . 0.0 109.901 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -98.65 5.06 47.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.585 1.183 . . . . 0.0 109.223 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -85.74 145.38 27.28 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.147 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 17.7 t -79.3 143.15 12.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.94 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -75.27 -165.27 0.39 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -152.5 98.0 0.18 Allowed Glycine 0 C--N 1.288 -2.098 0 C-N-CA 116.02 -2.991 . . . . 0.0 112.261 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.0 tt0 -27.42 148.07 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 112.207 -1.997 . . . . 0.0 111.008 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.47 53.94 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 104.795 -3.322 . . . . 0.0 104.795 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 41' ' ' THR . 2.1 t-20 -105.16 -162.28 0.87 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 112.716 -1.742 . . . . 0.0 108.536 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' N ' HD22 ' A' ' 12' ' ' ASN . 0.7 OUTLIER -149.41 104.6 3.39 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 10' ' ' GLY . 36.1 t -77.5 149.88 34.94 Favored 'General case' 0 C--N 1.269 -2.918 0 C-N-CA 117.095 -1.842 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 37' ' ' ASN . 7.5 mm -137.14 118.72 18.5 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.194 0 CA-C-N 112.695 -2.048 . . . . 0.0 109.859 177.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.449 ' H ' ' HB3' ' A' ' 9' ' ' SER . 93.1 mt . . . . . 0 N--CA 1.505 2.3 0 C-N-CA 118.769 -1.172 . . . . 0.0 113.757 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.663 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 1.9 tt0 -102.42 -164.33 1.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.615 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.663 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -135.62 73.26 1.46 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -92.21 120.07 40.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.986 -173.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.615 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -6.17 141.89 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 112.668 -2.06 . . . . 0.0 114.437 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.96 -177.95 19.32 Favored Glycine 0 N--CA 1.488 2.166 1 N-CA-C 130.907 7.123 . . . . 0.0 130.907 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -108.78 90.78 3.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.799 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.63 -107.05 2.66 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.175 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.36 134.91 4.82 Favored Pre-proline 0 C--N 1.301 -1.53 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' LYS . 9.2 Cg_endo -75.87 97.23 1.09 Allowed 'Trans proline' 0 C--O 1.211 -0.855 0 C-N-CA 121.41 1.407 . . . . 0.0 110.648 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.0 tttm . . . . . 0 N--CA 1.512 2.632 0 O-C-N 123.543 0.527 . . . . 0.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 98.6 t . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.512 0.672 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -139.4 -117.88 0.13 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 179.52 177.33 0.59 Allowed 'General case' 0 C--N 1.253 -3.588 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.443 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.569 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.14 131.57 34.22 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.325 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -48.08 155.43 0.46 Allowed 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.939 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -134.18 7.15 3.65 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.021 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.539 ' N ' HE22 ' A' ' 11' ' ' GLN . 0.2 OUTLIER -163.29 138.64 6.58 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.898 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -55.47 146.43 20.06 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.579 ' CA ' ' HZ3' ' A' ' 27' ' ' LYS . . . 97.84 -16.05 60.87 Favored Glycine 0 N--CA 1.497 2.715 1 N-CA-C 127.634 5.814 . . . . 0.0 127.634 -172.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.539 HE22 ' N ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -78.8 -171.47 2.58 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 118.896 -1.121 . . . . 0.0 109.069 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.564 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.4 m120 -148.23 -53.29 0.19 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 117.562 -1.655 . . . . 0.0 115.413 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.2 mt -73.22 14.29 0.33 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.094 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.6 p -102.58 173.88 6.14 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.42 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.19 72.58 5.76 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.885 1.326 . . . . 0.0 108.283 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 88.1 m -75.29 -71.82 0.34 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 112.254 -2.248 . . . . 0.0 109.224 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 90.88 2.99 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 117.987 -1.485 . . . . 0.0 109.448 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.48 -138.31 40.53 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.413 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -0.02 50.76 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.309 1.052 . . . . 0.0 109.996 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -88.98 144.16 26.36 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.668 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.0 t -85.46 143.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.743 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -75.93 -152.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.484 173.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -150.82 98.69 0.19 Allowed Glycine 0 C--N 1.27 -3.113 0 C-N-CA 116.738 -2.648 . . . . 0.0 111.122 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.4 tt0 -27.94 147.92 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 112.413 -1.893 . . . . 0.0 110.379 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -12.22 70.32 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 43' ' ' GLU . 28.0 t30 -111.64 -159.6 0.69 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.982 -1.109 . . . . 0.0 108.989 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 40' ' ' VAL . 30.7 tttp -157.2 111.81 2.72 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 118.656 -1.217 . . . . 0.0 111.723 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 11' ' ' GLN . 5.3 m -78.62 157.77 28.61 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 117.871 -1.532 . . . . 0.0 110.409 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.7 mm -133.52 110.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.321 173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' H ' ' HB3' ' A' ' 9' ' ' SER . 46.8 mt . . . . . 0 N--CA 1.514 2.746 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.784 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.886 0.374 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.471 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 8.3 tt0 -78.0 175.33 10.17 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 117.687 -1.605 . . . . 0.0 106.884 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.77 74.51 1.48 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.071 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.615 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -120.12 138.91 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.355 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 3.5 t -50.4 160.89 0.35 Allowed 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.22 -23.34 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.992 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -162.99 -150.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.485 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.543 ' H ' ' CD ' ' A' ' 43' ' ' GLU . . . 176.8 85.74 0.06 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.189 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.84 139.3 29.93 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.032 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.0 Cg_endo -75.8 117.36 4.7 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.146 1.231 . . . . 0.0 110.203 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.1 tmtt? . . . . . 0 N--CA 1.498 1.937 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 2.4 m-85 -130.83 -99.48 0.32 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.538 0.685 . . . . 0.0 110.204 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 178.07 -178.92 0.26 Allowed 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.027 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.58 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -94.91 134.99 36.96 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.103 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -55.89 158.77 3.54 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.476 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -146.65 14.87 1.23 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.003 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -166.37 137.16 3.44 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.715 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -54.64 152.33 7.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.838 176.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.39 -1.99 73.61 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.088 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.27 -165.98 0.76 Allowed 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.265 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.4 m-20 -164.04 -56.88 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 18.3 mt -74.87 12.99 0.72 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.592 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.573 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.2 p -105.13 178.98 4.4 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.841 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 15' ' ' LEU . 7.1 mt -78.99 76.83 5.47 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-O 123.082 1.42 . . . . 0.0 108.936 -176.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 84.9 m -75.44 -84.83 0.05 OUTLIER 'General case' 1 C--N 1.243 -4.034 0 CA-C-N 112.027 -2.352 . . . . 0.0 111.123 -177.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.58 104.46 6.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.174 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.36 -111.38 3.46 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.916 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.28 3.99 7.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.472 1.129 . . . . 0.0 109.463 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -87.24 145.19 26.48 Favored 'General case' 0 C--N 1.257 -3.424 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.9 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.8 t -82.92 143.24 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.328 -1.349 . . . . 0.0 109.956 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.84 -178.22 4.16 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.028 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.716 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -121.24 116.78 3.25 Favored Glycine 0 C--N 1.278 -2.645 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.072 -169.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -41.8 3.28 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.048 0 CA-C-N 111.345 -2.427 . . . . 0.0 114.11 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -102.62 16.01 55.23 Favored Glycine 0 C--N 1.262 -3.53 0 N-CA-C 105.935 -2.866 . . . . 0.0 105.935 172.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.584 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.7 t-20 -138.61 -154.53 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.619 -1.29 . . . . 0.0 108.748 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG3' ' H ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -163.0 109.3 1.17 Allowed 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.084 177.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -84.64 139.36 32.1 Favored 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.435 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.7 mm -125.77 119.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.713 -1.585 . . . . 0.0 112.123 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 9' ' ' SER . 21.6 mt . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 118.606 -1.238 . . . . 0.0 109.98 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.541 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.746 0 CA-C-O 120.823 0.344 . . . . 0.0 110.138 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 10.4 tt0 -89.05 -169.26 2.45 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.337 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.537 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -158.57 46.17 0.31 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.872 -174.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.5 m -114.39 158.44 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -12.65 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.084 0 CA-C-N 110.883 -2.871 . . . . 0.0 114.009 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.77 -99.11 0.12 Allowed Glycine 0 N--CA 1.496 2.652 1 N-CA-C 132.148 7.619 . . . . 0.0 132.148 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -161.17 28.37 0.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.003 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 13.64 73.29 0.01 OUTLIER Glycine 0 C--N 1.3 -1.462 1 N-CA-C 129.598 6.599 . . . . 0.0 129.598 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.92 130.31 64.07 Favored Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.188 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -76.23 106.13 2.21 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 121.392 1.394 . . . . 0.0 110.748 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 118.746 -1.181 . . . . 0.0 109.607 -179.68 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.443 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 9.3 m-85 -104.18 -112.57 0.24 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.419 0.628 . . . . 0.0 110.335 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.94 169.18 19.71 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.661 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.4 127.24 35.8 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.103 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.7 m -46.86 155.37 0.26 Allowed 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.723 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -147.97 16.68 1.09 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.822 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -163.06 131.82 3.97 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.08 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.41 153.3 7.54 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.4 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.42 -23.79 20.16 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 118.359 -1.877 . . . . 0.0 111.295 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' GLY . 13.1 mm-40 -54.76 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.254 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.626 ' C ' ' H ' ' A' ' 14' ' ' CYS . 5.0 m-20 -176.67 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.166 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.443 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 6.0 mt -73.68 8.03 2.13 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.626 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.5 p -102.44 -179.97 4.13 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.622 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mt -79.41 71.61 5.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.739 1.257 . . . . 0.0 108.371 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 34.1 t -70.82 -77.58 0.09 Allowed 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.428 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 89.61 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 117.76 -1.576 . . . . 0.0 109.019 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.21 -142.47 44.64 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.631 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -0.05 30.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.124 0.964 . . . . 0.0 110.35 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -87.63 143.59 27.1 Favored 'General case' 0 C--N 1.26 -3.317 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.849 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 8.0 t -88.75 142.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.095 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -77.69 -160.56 0.19 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.015 175.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -143.83 96.43 0.19 Allowed Glycine 0 C--O 1.186 -2.895 0 C-N-CA 117.904 -2.093 . . . . 0.0 108.862 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -30.59 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -82.51 7.09 66.06 Favored Glycine 1 C--N 1.238 -4.903 0 N-CA-C 105.741 -2.944 . . . . 0.0 105.741 172.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.631 ' N ' ' O ' ' A' ' 23' ' ' GLY . 64.6 m-20 -121.97 -156.44 0.69 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.477 -1.362 . . . . 0.0 108.6 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -152.31 103.29 2.83 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.645 176.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 42.1 t -78.31 162.75 26.27 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 117.521 -1.672 . . . . 0.0 108.876 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.2 mm -149.88 121.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.386 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.506 2.33 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.988 178.446 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.597 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.141 0.496 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.9 tt0 -122.08 159.77 26.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -122.69 66.58 0.95 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -176.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -90.41 121.59 40.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.425 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -37.55 173.47 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.89 177.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' HA ' ' A' ' 26' ' ' ASN . . . 126.44 -105.54 0.79 Allowed Glycine 0 N--CA 1.484 1.871 1 N-CA-C 128.411 6.124 . . . . 0.0 128.411 -176.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -165.01 88.9 0.47 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.49 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' ASN . . . -102.23 -123.02 5.17 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.682 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.42 134.52 10.2 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.938 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -70.1 98.83 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 N-CA-C 109.683 -0.93 . . . . 0.0 109.683 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' NZ ' HE22 ' A' ' 11' ' ' GLN . 26.3 tttp . . . . . 0 N--CA 1.491 1.607 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.025 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.097 0.475 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 58.3 m-85 -102.93 -116.53 0.2 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 p -160.13 165.78 31.03 Favored 'General case' 0 C--N 1.257 -3.429 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.928 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.21 129.54 34.56 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.992 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' OE1' ' A' ' 11' ' ' GLN . 13.7 m -46.58 169.8 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 CA-C-O 122.639 1.209 . . . . 0.0 110.436 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -150.08 14.36 0.8 Allowed 'General case' 0 C--N 1.258 -3.388 0 CA-C-N 112.415 -2.175 . . . . 0.0 106.783 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -164.96 123.13 1.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.196 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.37 153.92 1.95 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.626 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 10.2 85.51 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' OE1' ' CB ' ' A' ' 6' ' ' CYS . 3.4 mt-30 -82.62 -166.45 1.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 14' ' ' CYS . 6.2 t-20 -135.64 -93.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.199 -1.8 . . . . 0.0 115.323 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 2.5 mt -75.13 40.32 0.15 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.804 -173.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -94.59 -160.94 0.81 Allowed 'General case' 0 C--O 1.18 -2.593 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.016 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.1 mt -109.04 81.2 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 m -76.35 -81.71 0.08 Allowed 'General case' 0 C--N 1.249 -3.768 0 CA-C-N 112.944 -1.934 . . . . 0.0 111.209 -174.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 4.0 mm-40 -78.36 107.22 10.83 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.86 -1.536 . . . . 0.0 109.238 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.93 11.86 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 2.15 15.25 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.26 1.029 . . . . 0.0 110.056 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.61 149.32 25.94 Favored 'General case' 0 C--N 1.259 -3.353 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.931 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 35.5 t -88.2 148.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 118.491 -1.283 . . . . 0.0 111.049 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.2 m -136.62 -166.64 1.93 Allowed 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 93.21 -43.39 2.54 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 117.336 -2.364 . . . . 0.0 111.748 175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.572 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.8 tt0 -59.04 105.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.081 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.06 -10.16 28.47 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -118.89 -165.23 1.11 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.428 -0.886 . . . . 0.0 111.653 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -156.69 112.76 2.98 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.004 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.58 152.01 28.8 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 118.304 -1.359 . . . . 0.0 110.857 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.8 mm -139.53 104.7 2.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.455 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.509 2.477 0 C-N-CA 118.676 -1.21 . . . . 0.0 110.146 -177.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.423 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 30.0 m-80 . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -87.37 166.37 14.9 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.842 -1.543 . . . . 0.0 107.6 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.3 m -133.34 71.31 1.46 Allowed 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -91.37 137.71 21.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.507 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.8 t -34.83 168.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.815 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 122.48 -146.14 16.65 Favored Glycine 0 N--CA 1.482 1.706 1 N-CA-C 130.014 6.766 . . . . 0.0 130.014 -178.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -161.89 119.55 2.21 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.553 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.84 -91.3 1.11 Allowed Glycine 0 N--CA 1.486 2.032 1 N-CA-C 129.742 6.657 . . . . 0.0 129.742 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.8 122.14 4.25 Favored Pre-proline 0 C--N 1.302 -1.5 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.356 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.2 Cg_endo -66.71 95.26 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.07 1.18 . . . . 0.0 109.638 177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' PRO . 11.9 tttt . . . . . 0 N--CA 1.497 1.918 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.211 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 5.8 m-85 -141.84 -114.01 0.12 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.967 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 2.0 p -163.79 176.51 9.46 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.272 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.48 132.48 35.01 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.584 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.33 149.26 7.62 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.975 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -148.69 18.34 1.02 Allowed 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -161.54 109.37 1.46 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.287 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -47.83 147.1 2.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.471 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 100.92 -5.82 56.59 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.791 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -85.57 -164.96 1.1 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.285 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 14' ' ' CYS . 35.5 m-20 -164.28 -43.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.806 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 51.7 mt -76.91 17.26 0.44 Allowed 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.051 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.541 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.2 p -108.43 176.93 4.94 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.457 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 15' ' ' LEU . 5.2 mt -78.59 73.57 5.14 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 123.0 1.381 . . . . 0.0 108.16 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 32.1 t -67.79 -82.96 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.936 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 16' ' ' CYS . 4.0 mm-40 -84.25 120.98 26.86 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.9 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.27 -115.94 6.36 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.036 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.93 5.59 5.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.753 1.263 . . . . 0.0 108.819 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -88.29 144.46 26.41 Favored 'General case' 0 C--N 1.262 -3.204 0 CA-C-N 112.342 -2.208 . . . . 0.0 112.256 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 22.1 t -80.0 139.08 18.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.744 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.4 -140.64 0.08 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 118.416 -1.314 . . . . 0.0 109.371 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -157.65 111.89 0.5 Allowed Glycine 0 C--N 1.286 -2.233 0 C-N-CA 116.339 -2.839 . . . . 0.0 112.574 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.5 tt0 -36.21 152.06 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 113.482 -1.359 . . . . 0.0 108.448 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.88 -18.11 57.3 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.3 t-20 -106.33 -161.83 0.82 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.989 -1.605 . . . . 0.0 107.081 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -160.35 101.96 1.39 Allowed 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.901 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 22.2 m -78.64 155.71 29.4 Favored 'General case' 0 CA--C 1.46 -2.487 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.424 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -136.3 108.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.649 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.405 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.0 mt . . . . . 0 N--CA 1.507 2.424 0 C-N-CA 118.155 -1.418 . . . . 0.0 108.394 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.481 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 14.3 tt0 -83.46 -176.1 6.14 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -136.68 75.16 1.52 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -109.25 127.54 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.156 -1.418 . . . . 0.0 114.363 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.559 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 t -27.37 148.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 112.579 -2.1 . . . . 0.0 113.566 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.48 -101.37 0.19 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.551 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -98.61 -139.54 0.31 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.346 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.551 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 179.95 88.66 0.07 OUTLIER Glycine 0 C--N 1.28 -2.539 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.9 139.56 25.12 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.527 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -77.14 136.62 16.39 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.199 1.266 . . . . 0.0 109.16 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tttp . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 117.791 -1.564 . . . . 0.0 111.021 -179.487 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 21.9 t . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 5.8 m-85 -137.99 -112.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.069 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.714 ' HG1' ' H ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -172.08 176.5 3.47 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.036 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.714 ' H ' ' HG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.27 131.0 34.37 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.168 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -53.44 158.46 1.73 Allowed 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.734 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -140.16 8.99 2.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.125 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -161.0 143.98 12.84 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.52 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.453 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.03 147.92 45.64 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.658 175.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 94.61 -7.44 71.14 Favored Glycine 0 N--CA 1.503 3.154 1 N-CA-C 126.736 5.454 . . . . 0.0 126.736 -172.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 75.9 mt-30 -83.67 -167.41 1.71 Allowed 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 114.283 -0.959 . . . . 0.0 111.09 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.2 m-80 -156.38 -51.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.985 -1.486 . . . . 0.0 114.553 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 59.5 mt -76.09 13.69 0.84 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.618 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.5 p -110.13 177.8 4.6 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.73 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 mt -77.77 75.92 4.31 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-O 122.811 1.291 . . . . 0.0 108.552 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.62 -80.43 0.08 Allowed 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.647 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.32 107.62 12.22 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.156 -1.418 . . . . 0.0 109.502 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.46 -144.02 48.74 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.176 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -90.26 5.06 48.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.38 1.086 . . . . 0.0 109.778 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -88.6 143.59 26.85 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.941 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.76 139.28 17.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.277 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -146.14 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.735 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.99 117.54 0.77 Allowed Glycine 0 C--N 1.278 -2.664 0 C-N-CA 117.451 -2.309 . . . . 0.0 110.67 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.5 tt0 -33.23 154.17 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.054 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.42 -6.31 82.36 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 41' ' ' THR . 8.7 t30 -122.25 -164.16 1.14 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.929 -1.136 . . . . 0.0 108.493 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 40' ' ' VAL . 36.2 tttp -162.22 112.35 1.53 Allowed 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.9 m -83.04 153.63 24.83 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.64 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.58 117.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.284 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.1 mt . . . . . 0 N--CA 1.518 2.959 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 122.448 1.118 . . . . 0.0 113.92 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.431 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 12.7 tt0 -153.46 170.89 19.62 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.052 -1.885 . . . . 0.0 107.206 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.431 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -145.31 79.12 1.57 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.429 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.77 146.25 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 C-N-CA 117.776 -1.57 . . . . 0.0 114.879 -176.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -18.14 146.6 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 113.059 -1.882 . . . . 0.0 114.176 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.24 -120.94 1.02 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 7.4 mm-40 -78.67 -135.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.48 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.03 97.44 0.12 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 144.83 55.16 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.422 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.23 126.07 8.93 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.356 1.371 . . . . 0.0 109.469 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 N--CA 1.489 1.505 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.992 -179.096 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.477 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 3.5 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 120.941 0.4 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.477 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 61.5 m-85 -106.06 -115.82 0.25 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.73 0.776 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -178.1 175.35 1.26 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.77 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 134.68 36.4 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.653 -176.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.43 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 92.7 m -47.8 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.662 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -138.05 3.14 2.4 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.725 -1.58 . . . . 0.0 107.992 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -171.16 136.55 1.07 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.424 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.499 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -51.27 157.88 0.89 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.468 178.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -20.97 46.7 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.663 -1.732 . . . . 0.0 112.629 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.15 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -161.65 21.9 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 115.668 -2.413 . . . . 0.0 115.285 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.2 mt -146.71 25.88 1.16 Allowed 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -104.81 179.8 4.17 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.227 -176.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.635 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 mt -84.06 75.55 10.14 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.661 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 2.3 t -73.58 -68.99 0.46 Allowed 'General case' 0 C--N 1.254 -3.572 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.472 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -84.32 89.32 7.34 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.52 -133.22 25.47 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.045 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 -1.66 58.21 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.144 0.973 . . . . 0.0 110.412 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -81.49 137.88 35.55 Favored 'General case' 0 C--N 1.26 -3.301 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.48 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 52.4 t -83.03 155.15 3.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.231 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.521 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.9 m -145.19 -173.21 4.04 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.687 ' N ' HD21 ' A' ' 26' ' ' ASN . . . 99.31 -45.55 1.54 Allowed Glycine 0 C--O 1.206 -1.6 0 C-N-CA 117.547 -2.264 . . . . 0.0 114.611 173.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.56 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -63.48 115.89 5.07 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.586 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.92 -10.56 39.41 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.687 HD21 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -125.96 -158.24 0.84 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.919 -1.141 . . . . 0.0 111.417 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -154.82 124.36 6.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.527 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -78.82 155.13 29.35 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 117.54 -1.664 . . . . 0.0 109.5 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 38' ' ' GLN . 15.2 mm -150.77 122.43 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.619 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.716 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.499 ' H ' ' HB3' ' A' ' 9' ' ' SER . 7.7 mt . . . . . 0 N--CA 1.495 1.808 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.186 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.672 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.809 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.606 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 40.2 tt0 -150.71 155.85 40.12 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.2 m -116.94 65.1 0.72 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -77.78 130.34 36.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 117.709 -1.597 . . . . 0.0 111.515 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.4 t -35.77 167.45 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.057 -1.883 . . . . 0.0 112.395 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 123.04 -133.93 9.28 Favored Glycine 0 N--CA 1.488 2.108 1 N-CA-C 130.387 6.915 . . . . 0.0 130.387 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -161.99 116.2 1.88 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.595 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.95 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.42 -1.372 . . . . 0.0 111.511 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.85 152.58 19.32 Favored Pre-proline 0 C--N 1.31 -1.136 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.404 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -72.3 116.29 4.65 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 121.212 1.275 . . . . 0.0 109.733 170.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tttp . . . . . 0 C--N 1.303 -1.441 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.702 -178.739 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 2.3 m-85 -132.06 -111.84 0.24 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.813 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 2.7 p -162.34 177.31 9.69 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.809 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.55 134.02 34.32 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.678 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 m -52.54 155.48 2.16 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.052 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -140.54 9.73 2.24 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.688 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -163.33 139.85 7.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.838 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.87 156.92 6.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.496 176.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 85.18 0.66 88.67 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.086 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.417 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 27.2 mt-30 -84.4 -177.37 6.61 Favored 'General case' 0 N--CA 1.514 2.768 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.175 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.3 m-20 -151.81 -50.88 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 117.978 -1.489 . . . . 0.0 114.394 -177.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 87.1 mt -75.99 17.99 0.3 Allowed 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.299 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.558 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.7 p -110.35 178.92 4.23 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.94 73.0 6.72 Favored 'General case' 0 CA--C 1.465 -2.289 0 CA-C-O 122.843 1.306 . . . . 0.0 108.552 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 94.4 m -69.94 -93.41 0.01 OUTLIER 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.28 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.09 116.55 13.76 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.394 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.28 -139.63 42.28 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.796 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -99.93 6.31 45.21 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.526 1.155 . . . . 0.0 108.992 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.88 144.7 28.23 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.305 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 6.9 t -85.12 138.93 18.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 118.154 -1.418 . . . . 0.0 109.556 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -140.18 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.954 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.45 122.19 1.03 Allowed Glycine 0 C--N 1.275 -2.837 0 C-N-CA 117.303 -2.379 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.4 tt0 -34.41 157.17 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.579 -1.31 . . . . 0.0 110.028 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -18.35 21.52 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 24' ' ' GLN . 13.0 t30 -104.19 -164.39 1.05 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.915 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -161.67 102.77 1.19 Allowed 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.046 -1.461 . . . . 0.0 111.65 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -79.84 153.6 28.97 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.45 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.4 mm -134.71 115.58 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.893 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.441 ' H ' ' HB3' ' A' ' 9' ' ' SER . 10.6 mt . . . . . 0 N--CA 1.504 2.233 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.642 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.694 HD21 ' N ' ' A' ' 38' ' ' GLN . 1.2 t-20 . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.571 0.701 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.694 ' N ' HD21 ' A' ' 37' ' ' ASN . 38.6 tt0 -144.1 171.0 14.89 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -132.58 73.21 1.52 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -113.11 130.3 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -172.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.9 t -22.71 155.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.573 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.35 -123.56 1.93 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.609 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -76.85 -131.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.393 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.609 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 157.2 80.09 0.03 OUTLIER Glycine 0 C--N 1.282 -2.431 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.933 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.36 131.52 42.08 Favored Pre-proline 0 CA--C 1.559 1.29 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.871 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.65 119.56 6.5 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.123 1.215 . . . . 0.0 110.928 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.406 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.539 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.415 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 20.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.937 0.399 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 26.8 m-85 -103.82 -113.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -159.0 169.17 24.91 Favored 'General case' 0 C--N 1.261 -3.28 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.992 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.47 130.2 34.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.69 -1.204 . . . . 0.0 111.103 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.7 m -47.4 171.61 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.331 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -144.33 8.1 1.37 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.704 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -170.49 139.24 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.4 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.459 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -52.97 159.31 1.19 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.79 176.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.61 50.01 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.037 -1.554 . . . . 0.0 112.461 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.47 -173.06 3.88 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.496 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 14' ' ' CYS . 69.6 m-80 -155.77 -45.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.72 -1.592 . . . . 0.0 113.937 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 45.5 mt -76.59 16.24 0.52 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.163 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -100.4 -170.1 1.82 Allowed 'General case' 0 C--O 1.181 -2.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.64 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 mt -91.52 71.38 5.94 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.8 t -64.2 -84.4 0.02 OUTLIER 'General case' 0 C--N 1.254 -3.554 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.929 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.451 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 tm-20 -69.88 88.0 0.55 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.067 -1.453 . . . . 0.0 109.227 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.49 -130.9 18.76 Favored Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.399 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.96 0.75 57.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.184 0.992 . . . . 0.0 110.38 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -90.41 147.18 23.59 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.065 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 23.6 t -85.99 147.16 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 117.979 -1.488 . . . . 0.0 110.813 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.4 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -76.29 -129.91 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.36 115.45 0.57 Allowed Glycine 0 C--N 1.276 -2.751 0 C-N-CA 117.871 -2.109 . . . . 0.0 110.892 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 12.4 tt0 -34.44 149.22 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.279 -0.96 . . . . 0.0 109.905 177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.39 -10.89 65.07 Favored Glycine 0 C--N 1.292 -1.906 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 20.4 t30 -108.09 -162.9 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 40' ' ' VAL . 50.4 tttp -154.24 104.26 2.59 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.74 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 52.6 t -77.4 159.57 29.36 Favored 'General case' 0 CA--C 1.462 -2.425 0 C-N-CA 117.01 -1.876 . . . . 0.0 109.284 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.415 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 8.9 mm -137.23 115.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.132 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.557 ' CD2' ' ND2' ' A' ' 37' ' ' ASN . 18.9 mt . . . . . 0 N--CA 1.497 1.898 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.575 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.742 0 CA-C-O 121.75 0.785 . . . . 0.0 112.603 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 15.7 tt0 -155.02 164.35 39.01 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -130.11 75.72 1.67 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.572 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -119.32 130.42 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.569 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 42' ' ' GLY . 8.1 t -51.09 154.56 1.52 Allowed 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.388 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' N ' ' HG1' ' A' ' 41' ' ' THR . . . 170.06 -24.32 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.117 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.507 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 3.3 tt0 -162.89 -143.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.367 0.603 . . . . 0.0 110.265 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -179.2 85.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.757 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.484 ' H ' ' HG1' ' A' ' 45' ' ' THR . 0.1 OUTLIER -105.72 107.1 58.67 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.667 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 Cg_endo -68.68 92.9 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.7 tmtm? . . . . . 0 N--CA 1.491 1.607 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.668 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.924 0.392 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 69.4 m-85 -139.68 -121.95 0.12 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.64 0.733 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 3.0 t 177.99 -177.77 0.22 Allowed 'General case' 0 C--N 1.259 -3.332 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.823 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.32 133.09 36.61 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.521 -177.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.461 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 86.7 m -46.14 169.1 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.089 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -155.27 17.3 0.41 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.921 172.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 2.0 tt0 -167.31 124.14 1.18 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.905 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -55.78 151.64 10.9 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.646 177.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.86 -16.53 59.19 Favored Glycine 0 C--N 1.282 -2.439 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.25 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 17.5 mt-30 -60.23 179.21 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' HB3' ' H ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -161.3 25.55 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 115.523 -2.471 . . . . 0.0 115.352 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 34.6 mt -147.61 26.74 1.02 Allowed 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.46 177.74 4.7 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.373 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.644 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 mt -80.38 70.86 7.13 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.054 -1.884 . . . . 0.0 107.408 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 41.4 m -73.28 -61.9 1.66 Allowed 'General case' 1 C--N 1.239 -4.211 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.541 -173.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.6 88.92 7.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.075 -1.45 . . . . 0.0 109.526 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.47 -105.37 1.77 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.112 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.42 -2.5 11.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.229 1.014 . . . . 0.0 110.485 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.77 139.99 30.17 Favored 'General case' 0 C--N 1.254 -3.583 0 CA-C-N 113.326 -1.761 . . . . 0.0 111.419 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 42.6 t -79.25 151.15 4.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 117.723 -1.591 . . . . 0.0 109.314 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 86.4 m -140.49 -173.75 3.77 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 102.74 -49.87 0.95 Allowed Glycine 0 C--O 1.2 -2.002 0 C-N-CA 117.496 -2.287 . . . . 0.0 114.263 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 26' ' ' ASN . 9.7 tm0? -63.78 115.14 4.52 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.493 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.42 52.59 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.98 -163.7 1.33 Allowed 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.156 -1.022 . . . . 0.0 111.623 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HZ3' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -158.21 133.08 8.44 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.092 175.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.9 m -90.2 149.97 22.18 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.005 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.433 ' CD1' ' HZ3' ' A' ' 27' ' ' LYS . 32.1 mm -140.35 111.86 4.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.795 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' H ' ' HB3' ' A' ' 9' ' ' SER . 8.9 mt . . . . . 0 N--CA 1.499 1.977 0 C-N-CA 118.341 -1.343 . . . . 0.0 109.208 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.484 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.747 0 CA-C-O 121.383 0.611 . . . . 0.0 109.62 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.43 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 9.6 tt0 -79.3 172.93 13.12 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.486 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 90.0 m -134.03 62.46 1.65 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -79.45 135.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 117.913 -1.515 . . . . 0.0 111.931 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.7 t -38.8 165.13 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.332 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.02 -151.73 17.83 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -143.07 124.48 14.72 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.524 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.3 -113.02 3.75 Favored Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.775 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.484 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -151.83 149.1 22.95 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.056 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.33 115.25 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.333 1.355 . . . . 0.0 110.546 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.408 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.632 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.504 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -142.59 -113.75 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.914 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -159.31 173.42 16.31 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.506 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.56 132.18 34.14 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.564 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.1 155.12 2.0 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.218 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -148.13 14.92 1.03 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.007 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 19.9 mt-10 -161.52 127.04 3.63 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.619 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.453 ' CB ' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -53.5 158.24 1.84 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.088 177.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 79.67 11.21 84.96 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.582 -1.77 . . . . 0.0 110.435 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.46 HE21 ' CG ' ' A' ' 47' ' ' LYS . 1.8 tp60 -74.71 -164.63 0.29 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.269 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 14' ' ' CYS . 9.8 m-20 -162.86 -69.36 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 117.914 -1.515 . . . . 0.0 113.93 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 72.0 mt -76.3 19.72 0.24 Allowed 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.538 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.562 ' H ' ' C ' ' A' ' 12' ' ' ASN . 22.7 p -103.55 177.99 4.68 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.372 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -79.85 70.74 6.46 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 122.829 1.299 . . . . 0.0 107.765 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.625 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 39.5 t -69.21 -74.45 0.13 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.583 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.72 130.5 40.65 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.411 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 23.61 -91.26 0.01 OUTLIER Glycine 0 N--CA 1.503 3.155 1 N-CA-C 127.198 5.639 . . . . 0.0 127.198 -174.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.09 2.56 10.42 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.926 1.346 . . . . 0.0 107.864 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -89.73 143.01 27.15 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.882 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 6.7 t -84.35 143.5 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.241 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.486 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -71.85 -142.43 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.06 115.44 0.57 Allowed Glycine 0 C--N 1.279 -2.619 0 C-N-CA 117.314 -2.374 . . . . 0.0 110.844 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.46 ' C ' ' H ' ' A' ' 26' ' ' ASN . 11.3 tt0 -34.87 155.21 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.39 -0.905 . . . . 0.0 109.478 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.81 -16.33 55.02 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 106.452 -2.659 . . . . 0.0 106.452 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.517 HD22 ' C ' ' A' ' 39' ' ' CYS . 14.2 t30 -106.72 -156.55 0.58 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.081 -1.06 . . . . 0.0 108.776 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' H ' ' CG ' ' A' ' 26' ' ' ASN . 1.2 ttpp -159.63 103.54 1.56 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.57 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 42.7 t -78.28 156.98 29.38 Favored 'General case' 0 CA--C 1.462 -2.41 0 C-N-CA 116.808 -1.957 . . . . 0.0 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.3 mm -145.62 118.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.772 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.078 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' H ' ' CB ' ' A' ' 9' ' ' SER . 12.8 mt . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.673 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.716 0 CA-C-O 121.2 0.524 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.529 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.0 tt0 -119.95 164.08 16.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -123.57 71.48 1.09 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -101.3 124.72 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -171.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 11.3 t -18.69 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 112.416 -2.174 . . . . 0.0 113.168 171.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.75 -155.73 20.74 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.54 98.32 5.18 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.93 -115.79 2.12 Favored Glycine 0 C--O 1.215 -1.042 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.653 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -164.84 150.96 9.03 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.565 -177.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -76.97 132.87 13.21 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.751 1.634 . . . . 0.0 110.057 170.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' CG ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.191 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.775 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.476 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 15.5 t . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.476 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 16.9 m-85 -140.3 -114.73 0.14 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.688 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 p -158.13 175.25 14.03 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.211 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.18 132.05 36.94 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.273 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.07 151.09 2.81 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.082 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -138.13 8.03 2.69 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.994 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -166.79 132.88 2.29 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.409 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.94 154.38 0.74 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.568 177.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 87.87 11.23 68.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.41 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -82.99 -170.09 2.85 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.786 177.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.6 m120 -151.94 -73.51 0.15 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 118.406 -1.318 . . . . 0.0 113.365 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 51.8 mt -74.57 27.85 0.08 Allowed 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.176 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 20.9 p -105.55 177.29 4.89 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.598 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 15' ' ' LEU . 7.4 mt -79.91 73.23 6.69 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.992 1.377 . . . . 0.0 107.629 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 76.2 m -69.52 -78.82 0.07 Allowed 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 111.864 -2.426 . . . . 0.0 110.869 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.22 107.36 9.55 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.544 -1.263 . . . . 0.0 109.867 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -115.05 6.83 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.95 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.93 0.6 11.93 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.361 1.077 . . . . 0.0 110.033 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.67 146.51 25.67 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.856 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.75 140.29 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 C-N-CA 118.367 -1.333 . . . . 0.0 110.014 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -138.8 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.95 175.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -166.31 121.25 0.97 Allowed Glycine 0 C--N 1.272 -3.008 0 C-N-CA 117.839 -2.124 . . . . 0.0 110.008 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.9 tt0 -34.65 159.44 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.081 -1.06 . . . . 0.0 110.251 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.0 -16.4 58.67 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.6 t30 -105.91 -161.22 0.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.873 -1.163 . . . . 0.0 108.864 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -160.95 96.42 1.11 Allowed 'General case' 0 C--N 1.28 -2.453 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.24 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.78 133.9 37.05 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 117.642 -1.623 . . . . 0.0 109.635 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -122.98 120.46 60.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.646 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.441 ' H ' ' HB3' ' A' ' 9' ' ' SER . 22.6 mt . . . . . 0 N--CA 1.504 2.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.162 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.545 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.648 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 5.5 tt0 -117.2 -179.93 3.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.446 ' C ' HD22 ' A' ' 26' ' ' ASN . 0.5 OUTLIER -145.55 78.85 1.56 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.508 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -114.74 131.51 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 C-N-CA 118.331 -1.347 . . . . 0.0 114.635 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.563 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -9.41 143.77 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.263 171.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.03 -145.71 15.3 Favored Glycine 0 N--CA 1.489 2.225 1 N-CA-C 131.067 7.187 . . . . 0.0 131.067 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -146.87 84.77 1.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.719 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -107.88 2.43 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.232 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -161.64 145.56 9.69 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.99 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.09 105.5 2.08 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.52 1.48 . . . . 0.0 110.496 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 N--CA 1.497 1.888 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.714 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.451 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 60.0 m-85 -130.23 -118.29 0.23 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.67 0.748 . . . . 0.0 110.478 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.584 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -179.17 178.06 0.75 Allowed 'General case' 0 C--N 1.259 -3.367 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.643 -178.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.584 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.94 132.95 35.27 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.986 0.898 . . . . 0.0 112.119 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -52.96 154.49 2.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.843 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -139.38 11.27 2.54 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.979 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 13.6 tt0 -166.34 125.39 1.54 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.272 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -45.14 155.58 0.12 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.819 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.08 -18.71 56.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 22.4 mt-30 -79.71 -175.66 4.97 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.91 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 14' ' ' CYS . 65.8 m-80 -152.2 -48.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 117.68 -1.608 . . . . 0.0 114.126 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 29.0 mt -75.35 17.73 0.25 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.557 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.8 p -103.25 175.73 5.38 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.962 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.1 mt -78.88 73.19 5.43 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 122.959 1.362 . . . . 0.0 108.284 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.61 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 35.8 t -72.8 -82.24 0.05 Allowed 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 112.11 -2.314 . . . . 0.0 109.816 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.71 97.76 3.3 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 117.452 -1.699 . . . . 0.0 109.129 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 20' ' ' ASN . . . 64.65 -148.78 51.38 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.217 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -78.86 3.54 16.61 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.358 1.075 . . . . 0.0 109.553 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -87.14 143.07 27.47 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.79 -178.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 t -84.49 144.91 8.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.51 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.09 -137.33 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.13 109.11 0.35 Allowed Glycine 0 C--N 1.282 -2.457 0 C-N-CA 117.414 -2.327 . . . . 0.0 111.128 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.9 tm0? -34.36 150.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.36 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.95 57.37 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 16.3 t30 -106.5 -161.34 0.79 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 40' ' ' VAL . 49.0 tttp -155.42 105.82 2.5 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.357 175.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.609 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 51.9 t -76.34 158.17 31.72 Favored 'General case' 0 CA--C 1.462 -2.408 0 C-N-CA 116.845 -1.942 . . . . 0.0 108.718 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.1 mm -138.13 115.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.082 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.679 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.483 ' H ' ' HB3' ' A' ' 9' ' ' SER . 13.7 mt . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.215 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.679 0 CA-C-O 121.008 0.432 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.2 tt0 -128.78 166.43 19.02 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -126.04 72.24 1.29 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -115.45 130.68 69.63 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.167 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.117 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 t -42.58 159.72 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.844 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.4 -103.26 0.22 Allowed Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.854 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -79.15 -148.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.022 0.439 . . . . 0.0 109.949 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.57 80.57 0.06 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.54 126.72 28.27 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.934 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -73.39 115.67 4.42 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 121.409 1.406 . . . . 0.0 111.734 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.5 tptp . . . . . 0 CA--C 1.565 1.529 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.105 177.643 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 12.1 m-85 -115.77 -116.46 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.388 0.614 . . . . 0.0 110.709 -177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -152.1 172.74 15.86 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.534 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 131.08 34.88 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.96 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -49.08 150.77 1.49 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.771 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -141.24 12.94 2.19 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -165.25 125.59 1.89 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.572 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.77 159.8 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.237 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.77 -5.91 72.65 Favored Glycine 0 N--CA 1.505 3.288 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.327 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -70.43 -176.48 1.24 Allowed 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.573 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 14' ' ' CYS . 5.2 m120 -148.29 -64.22 0.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.562 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 9.6 mt -73.06 22.53 0.07 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.899 -177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 12' ' ' ASN . 17.2 p -104.96 176.76 5.05 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.28 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -82.65 70.82 9.7 Favored 'General case' 0 C--N 1.27 -2.884 0 CA-C-O 122.703 1.239 . . . . 0.0 107.859 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.9 t -67.51 -88.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.258 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -73.43 109.2 6.77 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.064 -1.854 . . . . 0.0 109.849 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.43 -132.19 24.96 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -103.51 4.91 36.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.741 1.258 . . . . 0.0 108.549 178.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -87.69 149.81 24.02 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.374 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 5.4 t -87.51 141.2 14.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.123 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -141.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.636 ' N ' ' ND2' ' A' ' 26' ' ' ASN . . . -164.23 101.98 0.19 Allowed Glycine 0 N--CA 1.504 3.175 0 C-N-CA 115.608 -3.187 . . . . 0.0 112.98 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLY . 13.6 tm0? -27.45 114.63 0.07 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.519 1.152 . . . . 0.0 110.558 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.497 ' H ' HD21 ' A' ' 12' ' ' ASN . . . 130.03 -16.82 5.48 Favored Glycine 0 C--N 1.28 -2.561 0 N-CA-C 105.263 -3.135 . . . . 0.0 105.263 -171.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.636 ' ND2' ' N ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.63 -171.41 1.98 Allowed 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 20.5 tttp -143.93 99.64 3.43 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.605 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 48.6 t -76.93 163.63 26.55 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.361 -1.736 . . . . 0.0 108.716 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.3 mm -147.36 118.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.102 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.503 2.216 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.297 177.677 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.605 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 11.6 tt0 -124.76 163.36 22.27 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -124.05 65.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 t -89.44 131.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.914 -1.514 . . . . 0.0 111.816 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 42' ' ' GLY . 1.9 t -44.83 170.45 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.55 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 131.89 -111.64 1.08 Allowed Glycine 0 N--CA 1.494 2.502 1 N-CA-C 130.141 6.816 . . . . 0.0 130.141 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASN . 37.1 mt-10 -77.14 -144.53 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.092 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.2 96.3 0.1 Allowed Glycine 0 C--N 1.288 -2.123 0 C-N-CA 118.263 -1.922 . . . . 0.0 112.236 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.72 123.44 34.73 Favored Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.82 176.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.67 118.09 4.73 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.489 1.46 . . . . 0.0 110.561 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 tttp . . . . . 0 CA--C 1.562 1.425 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.686 179.148 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.417 ' HB3' HD22 ' A' ' 37' ' ' ASN . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 2.4 t30 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.675 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 9' ' ' SER . 11.3 mt . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.543 ' C ' HD21 ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.543 ' N ' HD21 ' A' ' 37' ' ' ASN . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' C ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.483 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 22.8 t . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 19.6 m-85 -147.61 -114.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.461 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p -162.55 172.92 14.69 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.436 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.26 126.81 33.07 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.581 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 178.33 0.09 Allowed 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 122.781 1.277 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -151.96 18.32 0.68 Allowed 'General case' 0 C--N 1.258 -3.412 0 CA-C-N 111.923 -2.399 . . . . 0.0 106.311 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -161.43 134.27 6.17 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 117.73 -1.588 . . . . 0.0 114.789 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.479 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -63.59 154.23 33.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.507 172.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.25 -20.9 40.61 Favored Glycine 0 C--N 1.287 -2.143 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.953 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -82.59 -174.03 4.97 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.908 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.6 -36.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.609 -176.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 61.0 mt -76.11 11.5 1.46 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.501 -1.28 . . . . 0.0 110.187 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.537 ' H ' ' C ' ' A' ' 12' ' ' ASN . 5.1 p -104.08 174.58 5.81 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.07 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -78.07 74.77 4.61 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 122.855 1.312 . . . . 0.0 108.208 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -71.02 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 111.803 -2.453 . . . . 0.0 110.076 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 3.9 mm-40 -76.04 121.46 22.79 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.709 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.33 -144.93 23.79 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.482 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -91.24 4.16 53.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.589 1.185 . . . . 0.0 109.139 178.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -83.31 146.55 28.45 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.742 -2.026 . . . . 0.0 111.403 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.32 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.529 -1.268 . . . . 0.0 110.342 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -130.43 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -168.37 109.93 0.36 Allowed Glycine 0 C--N 1.276 -2.793 0 C-N-CA 118.315 -1.898 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 26' ' ' ASN . 10.8 tt0 -35.11 154.38 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.032 178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -17.25 27.36 Favored Glycine 0 C--N 1.29 -1.987 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.521 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 27.6 t30 -96.56 -157.96 0.62 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.549 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -159.07 98.67 1.47 Allowed 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.702 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 53.2 t -78.23 166.03 23.21 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.199 -1.8 . . . . 0.0 110.541 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.489 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 7.6 mm -137.89 108.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.003 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' H ' ' HB3' ' A' ' 9' ' ' SER . 96.1 mt . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.121 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 tt0 -79.88 164.53 23.49 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.211 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.78 65.65 1.03 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -105.3 127.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 118.226 -1.39 . . . . 0.0 113.121 -172.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.469 ' HG1' ' N ' ' A' ' 42' ' ' GLY . 5.5 t -53.98 156.41 2.96 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.505 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' N ' ' HG1' ' A' ' 41' ' ' THR . . . 171.63 -62.89 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.763 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.61 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -121.93 -141.32 0.33 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.639 0.733 . . . . 0.0 110.728 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.61 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -172.66 70.53 0.1 Allowed Glycine 0 N--CA 1.493 2.456 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.81 109.29 60.86 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.737 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.12 121.79 7.54 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.201 1.267 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.614 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.268 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.883 0.373 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.435 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 45.1 m-85 -131.54 -117.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 3.0 p -161.45 166.54 27.1 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.821 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.74 127.74 33.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.029 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' HA ' HE22 ' A' ' 11' ' ' GLN . 2.9 m -44.91 154.09 0.15 Allowed 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.986 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.774 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -149.78 18.8 0.9 Allowed 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.591 174.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -164.73 120.07 1.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.967 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -49.21 154.15 0.87 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.147 178.143 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.93 -1.89 85.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.367 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.774 HE22 ' H ' ' A' ' 7' ' ' THR . 6.1 mt-30 -73.95 -172.29 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.115 -1.434 . . . . 0.0 108.28 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.702 HD22 ' H ' ' A' ' 44' ' ' GLY . 5.1 m-20 -136.77 -82.04 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 117.516 -1.674 . . . . 0.0 115.282 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 19.9 mt -73.16 34.64 0.08 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.347 -172.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.585 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.1 p -103.07 174.42 5.88 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.26 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.81 77.69 10.03 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.839 1.304 . . . . 0.0 108.505 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.9 m -73.5 -87.45 0.03 OUTLIER 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.442 -176.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.93 107.51 7.05 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.668 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.4 -147.29 50.62 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.909 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -87.52 4.69 42.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.278 1.037 . . . . 0.0 110.1 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.46 140.25 32.45 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 113.268 -1.787 . . . . 0.0 111.642 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 36.7 t -82.91 155.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.334 -1.347 . . . . 0.0 109.91 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.535 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.5 m -141.41 -163.79 1.63 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.673 ' N ' ' ND2' ' A' ' 26' ' ' ASN . . . 105.61 -60.32 0.39 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 118.094 -2.003 . . . . 0.0 112.973 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 8.7 tt0 -66.8 110.32 3.24 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.131 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 -7.34 76.32 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.673 ' ND2' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.01 -171.19 2.56 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.919 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -155.4 114.01 3.5 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.028 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.1 m -82.96 149.8 26.79 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.064 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.5 mm -138.5 118.3 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.858 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' SER . 13.7 mt . . . . . 0 N--CA 1.502 2.173 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.799 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.676 ' ND2' ' N ' ' A' ' 38' ' ' GLN . 1.3 t-20 . . . . . 0 C--O 1.215 -0.749 0 CA-C-O 121.247 0.546 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.676 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 8.2 tt0 -146.45 174.19 11.62 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.66 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.79 61.54 1.65 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -80.05 129.88 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.309 -172.064 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.9 t -25.91 156.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.875 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.97 -139.6 11.56 Favored Glycine 0 N--CA 1.492 2.423 1 N-CA-C 131.506 7.362 . . . . 0.0 131.506 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.56 109.51 3.28 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.702 ' H ' HD22 ' A' ' 12' ' ' ASN . . . -107.07 -110.25 3.45 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.858 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.02 139.41 7.31 Favored Pre-proline 0 C--N 1.299 -1.596 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.473 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.0 Cg_exo -58.63 125.76 19.29 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 N-CA-C 109.41 -1.035 . . . . 0.0 109.41 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.5 tmtt? . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.827 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.506 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 43.4 t . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.506 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 24.9 m-85 -108.66 -117.74 0.27 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.681 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 6.7 p -161.21 174.29 13.84 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.897 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.33 131.74 35.68 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -48.85 158.81 0.29 Allowed 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.902 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -145.8 13.74 1.34 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.991 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -166.96 121.23 1.04 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.815 -177.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.55 156.6 0.43 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.266 176.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.27 -23.26 28.11 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.057 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' GLY . 11.1 mm-40 -54.07 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.568 -179.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.21 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.519 -1.672 . . . . 0.0 114.28 177.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 19.9 mt -130.52 11.56 5.33 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' A' ' 16' ' ' CYS . 26.5 p -102.78 178.23 4.62 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.319 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mt -77.09 73.09 3.68 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 123.057 1.408 . . . . 0.0 107.656 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 31.7 t -77.14 -75.86 0.19 Allowed 'General case' 0 C--N 1.254 -3.558 0 CA-C-N 111.863 -2.426 . . . . 0.0 110.507 -175.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.415 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.94 -126.25 26.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -1.74 24.13 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.678 1.227 . . . . 0.0 108.703 178.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -83.26 151.7 25.5 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.865 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 43.3 t -81.21 149.21 5.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.301 -1.359 . . . . 0.0 111.273 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -73.74 -140.78 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 175.288 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.24 110.48 0.4 Allowed Glycine 0 C--N 1.281 -2.501 0 C-N-CA 117.488 -2.291 . . . . 0.0 111.135 176.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -32.69 145.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.489 -0.856 . . . . 0.0 110.515 177.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.17 -2.79 63.77 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 -174.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.5 ' ND2' ' C ' ' A' ' 39' ' ' CYS . 8.9 t30 -117.1 -157.91 0.68 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.952 -1.124 . . . . 0.0 109.188 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HZ3' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -160.68 102.85 1.35 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.665 176.55 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 10' ' ' GLY . 43.9 t -78.35 165.9 23.29 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 117.7 -1.6 . . . . 0.0 110.146 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 11.8 mm -149.12 120.25 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.409 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.7 mt . . . . . 0 N--CA 1.497 1.876 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.442 177.465 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.512 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.7 0 CA-C-O 121.407 0.622 . . . . 0.0 110.595 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.534 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -105.76 164.83 11.62 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.233 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -121.2 71.67 0.96 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -177.304 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -96.55 120.85 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 118.194 -1.402 . . . . 0.0 114.78 -171.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.1 t -19.75 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 112.456 -2.156 . . . . 0.0 113.781 171.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.24 -151.01 20.15 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.25 122.86 7.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.187 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 -95.56 0.19 Allowed Glycine 0 N--CA 1.478 1.493 1 N-CA-C 131.52 7.368 . . . . 0.0 131.52 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.0 104.48 20.59 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.529 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -70.41 103.36 1.26 Allowed 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.003 1.135 . . . . 0.0 110.484 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.571 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -140.63 -112.93 0.14 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.886 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.54 171.85 17.48 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.003 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -94.46 133.67 37.81 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.283 -177.55 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -56.4 156.59 5.79 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.84 176.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.453 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -143.08 9.38 1.69 Allowed 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.71 173.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 7' ' ' THR . 12.3 mt-10 -164.95 145.96 7.58 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.502 -179.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.494 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -59.67 152.72 21.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.532 176.448 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 97.7 -17.65 58.55 Favored Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.137 -1.506 . . . . 0.0 112.376 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.437 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 10.3 mm-40 -61.41 -166.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.022 -179.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.592 HD22 ' H ' ' A' ' 26' ' ' ASN . 1.7 m-20 -158.48 -68.18 0.09 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.748 -178.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.63 18.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.277 -176.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.4 p -100.39 175.96 5.52 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.731 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mt -79.87 73.53 6.62 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.793 1.282 . . . . 0.0 108.417 -177.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 43.4 t -72.32 -83.41 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 112.39 -2.186 . . . . 0.0 110.226 -177.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -75.2 110.82 9.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.341 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.04 -139.91 43.1 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -95.68 3.7 53.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.54 1.162 . . . . 0.0 109.276 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-N 112.898 -1.956 . . . . 0.0 111.467 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.8 t -80.18 144.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -78.67 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.429 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -146.31 96.01 0.18 Allowed Glycine 0 C--N 1.282 -2.463 1 N-CA-C 129.618 6.607 . . . . 0.0 129.618 179.074 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' GLY . 35.2 tp60 -33.88 121.48 0.44 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.658 178.024 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.06 -6.77 34.95 Favored Glycine 0 C--N 1.291 -1.968 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 -172.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.592 ' H ' HD22 ' A' ' 12' ' ' ASN . 13.5 t30 -118.22 -167.61 1.38 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.316 -0.942 . . . . 0.0 109.292 177.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -142.1 106.41 4.8 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.267 176.206 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLY . 7.9 t -76.11 158.55 31.65 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 116.413 -2.115 . . . . 0.0 108.262 177.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.483 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 14.6 mm -147.11 124.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.274 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.494 ' H ' ' HB3' ' A' ' 9' ' ' SER . 8.3 mt . . . . . 0 N--CA 1.499 1.997 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.402 175.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 C--O 1.214 -0.792 0 CA-C-O 121.185 0.517 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 24.0 tt0 -151.57 165.46 34.21 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.532 ' C ' HD22 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -125.38 66.75 1.14 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -100.71 117.75 46.4 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 118.281 -1.368 . . . . 0.0 110.685 -175.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.2 150.48 3.29 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.25 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.23 -37.56 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.268 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 22.4 tt0 -157.29 -129.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.821 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.75 97.41 0.13 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.616 -1.278 . . . . 0.0 111.314 176.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.23 107.96 60.7 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.492 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.25 101.54 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.785 0.99 . . . . 0.0 110.262 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.276 -178.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.417 ' HB3' HD22 ' A' ' 37' ' ' ASN . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 2.4 t30 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.675 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 9' ' ' SER . 11.3 mt . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.543 ' C ' HD21 ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.543 ' N ' HD21 ' A' ' 37' ' ' ASN . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' C ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.557 0.694 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 4' ' ' THR . 65.0 m-85 -132.76 -130.28 0.18 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.651 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 6.9 p -165.23 177.71 7.44 Favored 'General case' 0 C--N 1.256 -3.459 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.622 -176.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.76 129.93 34.76 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.422 178.13 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -43.69 158.16 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.594 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -138.31 10.7 2.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.541 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -165.43 130.04 2.42 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.42 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.45 153.02 0.39 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.608 -0.837 . . . . 0.0 108.754 172.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 80.35 19.38 69.2 Favored Glycine 0 C--N 1.278 -2.666 0 C-N-CA 119.994 -1.098 . . . . 0.0 112.45 -178.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 11.1 mm-40 -89.95 -166.32 1.56 Allowed 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.919 178.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.611 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.0 m120 -153.5 -72.46 0.13 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 37.5 mt -71.82 17.16 0.1 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.566 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.611 ' H ' ' C ' ' A' ' 12' ' ' ASN . 26.7 p -103.93 176.48 5.14 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.218 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 15' ' ' LEU . 5.1 mt -80.77 72.72 7.75 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 122.676 1.227 . . . . 0.0 108.156 -177.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 99.6 m -70.93 -79.51 0.06 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 112.555 -2.112 . . . . 0.0 110.315 -176.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.532 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 3.2 mp0 -74.36 91.97 2.26 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.061 -1.456 . . . . 0.0 108.788 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.78 -140.36 31.48 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.188 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -86.76 4.09 42.33 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.016 0.912 . . . . 0.0 110.65 -178.916 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -90.87 140.01 30.21 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.235 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 22' ' ' CYS . 12.6 t -80.48 146.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.73 177.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.532 ' SG ' ' OE1' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -100.0 -146.96 0.34 Allowed 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.327 176.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -157.18 123.05 1.24 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 116.721 -2.656 . . . . 0.0 111.885 -177.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.616 HE22 ' CA ' ' A' ' 46' ' ' PRO . 5.2 tp-100 -35.25 160.76 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.036 -1.582 . . . . 0.0 110.052 175.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.78 52.73 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 -174.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' A' ' 41' ' ' THR . 18.1 t30 -109.15 -163.43 0.87 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.249 -0.976 . . . . 0.0 109.23 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.39 96.75 1.19 Allowed 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.241 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -84.1 126.08 32.75 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 117.896 -1.522 . . . . 0.0 112.306 -178.413 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 37' ' ' ASN . 11.4 mm -99.32 116.56 42.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.275 -176.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.296 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 29' ' ' ILE . 1.6 t-20 . . . . . 0 CA--C 1.502 -0.881 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 5.1 tt0 -103.03 -165.28 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.029 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -147.98 89.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.268 -177.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -105.62 123.68 60.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 112.982 -1.917 . . . . 0.0 113.169 -176.7 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.3 t -6.35 144.05 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 112.534 -2.121 . . . . 0.0 113.824 171.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 136.07 172.15 12.54 Favored Glycine 0 N--CA 1.487 2.095 1 N-CA-C 130.979 7.151 . . . . 0.0 130.979 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.47 94.76 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.953 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.17 -113.33 3.52 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -164.07 134.18 3.18 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.725 -179.898 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.616 ' CA ' HE22 ' A' ' 24' ' ' GLN . 9.5 Cg_endo -76.81 98.62 1.23 Allowed 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.458 1.439 . . . . 0.0 110.481 173.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.4 tttp . . . . . 0 N--CA 1.493 1.684 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.203 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.561 0.696 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.83 -121.8 0.21 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.709 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 1.8 t -170.71 178.86 3.42 Favored 'General case' 0 C--N 1.254 -3.56 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.251 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.555 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -95.12 131.22 41.37 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.155 -178.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.406 ' HA ' HE22 ' A' ' 11' ' ' GLN . 1.9 m -47.65 153.88 0.53 Allowed 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.8 177.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -148.57 18.03 1.03 Allowed 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.87 174.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.11 122.84 1.89 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.709 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -52.55 146.73 9.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.575 0.703 . . . . 0.0 110.663 178.835 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 98.96 -0.34 57.55 Favored Glycine 0 C--N 1.277 -2.749 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.66 178.112 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.4 mt-30 -88.39 179.17 6.38 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.653 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -148.0 -42.16 0.16 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.423 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.76 22.88 0.13 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.608 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.559 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.2 p -121.8 177.21 5.37 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.602 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.5 74.73 6.14 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 122.672 1.225 . . . . 0.0 108.915 -176.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.8 m -69.89 -77.77 0.08 Allowed 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.03 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.77 114.99 17.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.785 -179.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.42 -120.76 24.13 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.255 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -111.71 4.59 18.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.486 1.136 . . . . 0.0 109.821 -179.327 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -88.72 143.9 26.62 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.911 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 12.8 t -83.03 136.73 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.342 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -140.2 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.541 174.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.86 123.77 1.18 Allowed Glycine 0 C--N 1.27 -3.103 0 C-N-CA 116.58 -2.724 . . . . 0.0 111.58 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -33.94 150.78 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 113.009 -1.596 . . . . 0.0 109.078 175.687 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 96.99 -12.7 65.55 Favored Glycine 0 C--N 1.29 -2.007 0 N-CA-C 106.359 -2.696 . . . . 0.0 106.359 -173.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.5 t-20 -114.15 -163.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.904 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -157.36 99.28 1.76 Allowed 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.395 176.148 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 10' ' ' GLY . 3.6 m -78.38 149.78 33.3 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.6 -1.64 . . . . 0.0 109.848 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.38 115.68 38.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.598 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.419 ' H ' ' HB3' ' A' ' 9' ' ' SER . 29.0 mt . . . . . 0 N--CA 1.498 1.955 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.57 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 5.3 tt0 -78.77 -179.0 6.26 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -135.47 68.81 1.45 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.878 -1.129 . . . . 0.0 107.954 178.952 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -104.22 124.51 58.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.517 -175.692 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.546 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 10.2 t -55.03 154.59 5.28 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.53 -24.05 0.15 Allowed Glycine 0 N--CA 1.494 2.505 0 CA-C-N 113.744 -1.571 . . . . 0.0 109.762 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 5.4 tt0 -159.46 -140.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA3' ' H ' ' A' ' 25' ' ' GLY . . . 163.8 102.06 0.16 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.196 -1.478 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.6 139.98 32.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.633 178.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -76.86 102.13 1.58 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.773 1.649 . . . . 0.0 109.273 172.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 tptt . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 118.3 -1.36 . . . . 0.0 111.732 -177.122 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 120.672 0.273 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -114.08 -110.25 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.559 0.695 . . . . 0.0 110.683 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 177.2 179.22 0.24 Allowed 'General case' 0 C--N 1.261 -3.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.784 -179.097 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.572 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -82.84 130.88 35.19 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.459 -176.992 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 m -47.56 160.72 0.11 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.729 175.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 t -141.78 9.43 1.96 Allowed 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.786 175.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -168.18 154.13 7.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.218 178.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 157.16 14.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.898 176.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 91.85 -22.56 30.61 Favored Glycine 0 N--CA 1.51 3.604 0 C-N-CA 119.336 -1.411 . . . . 0.0 114.147 177.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -78.52 160.95 27.39 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.719 -177.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 28' ' ' CYS . 6.8 m-80 -151.21 21.33 0.75 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 115.535 1.679 . . . . 0.0 115.535 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.639 ' CD1' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -123.65 8.29 8.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.159 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.9 p -102.53 179.97 4.14 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.226 -178.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 mt -79.75 74.88 6.44 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.95 1.357 . . . . 0.0 108.476 -177.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.0 t -72.14 -80.77 0.06 Allowed 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 112.098 -2.319 . . . . 0.0 110.116 -177.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.31 106.86 10.51 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.957 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.58 -151.79 46.05 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.06 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -81.17 5.36 17.12 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.1 0.952 . . . . 0.0 110.332 -179.468 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -89.63 142.2 27.9 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.679 -1.601 . . . . 0.0 112.588 -176.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 43.0 t -82.56 151.2 4.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.72 178.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -103.69 -143.26 0.36 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.71 176.26 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ASN . . . -159.44 118.81 0.85 Allowed Glycine 0 C--O 1.203 -1.792 0 C-N-CA 116.782 -2.627 . . . . 0.0 112.469 -176.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.556 ' C ' ' H ' ' A' ' 26' ' ' ASN . 52.3 tt0 -35.3 162.02 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.699 -1.25 . . . . 0.0 110.179 174.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' GLN . . . 87.91 -24.29 11.33 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 106.006 -2.837 . . . . 0.0 106.006 -172.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.7 t30 -96.42 -167.17 1.53 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.35 102.88 1.24 Allowed 'General case' 0 C--N 1.265 -3.103 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.61 177.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 97.3 m -78.29 158.98 28.71 Favored 'General case' 0 CA--C 1.442 -3.184 0 C-N-CA 117.372 -1.731 . . . . 0.0 108.86 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.6 mm -142.72 114.3 3.01 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.355 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.027 174.237 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.507 2.409 0 C-N-CA 118.132 -1.427 . . . . 0.0 109.09 177.949 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -81.09 171.96 14.29 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -137.5 75.58 1.54 Allowed 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.644 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -110.97 131.02 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 117.997 -1.481 . . . . 0.0 114.88 -174.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.572 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -9.15 153.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 112.296 -2.229 . . . . 0.0 115.233 172.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.38 -136.21 8.53 Favored Glycine 0 N--CA 1.495 2.616 1 N-CA-C 129.937 6.735 . . . . 0.0 129.937 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.636 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -76.55 -131.13 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.46 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.636 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 140.13 107.54 0.71 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.471 176.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.82 135.06 36.01 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.037 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -68.07 100.72 0.65 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 120.512 0.808 . . . . 0.0 110.196 173.882 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.639 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 12.4 tptm . . . . . 0 N--CA 1.492 1.627 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.003 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 33.4 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.201 0.524 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.479 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 2.8 m-85 -118.4 -96.72 0.47 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.441 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -178.34 178.56 0.86 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.9 178.346 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.554 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.44 132.11 34.02 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.559 -175.683 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 m -48.88 160.13 0.21 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.362 176.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -152.8 14.77 0.55 Allowed 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.533 173.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 6.5 tt0 -166.2 117.97 1.03 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.982 -178.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.81 160.99 0.05 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.709 177.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.99 -29.34 8.81 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 118.839 -1.648 . . . . 0.0 112.482 -179.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 33.2 mt-30 -67.6 -168.84 0.1 Allowed 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.615 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.5 m-20 -166.0 -28.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 117.716 -1.594 . . . . 0.0 113.998 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.53 15.04 5.89 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.706 -178.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.5 p -105.63 177.11 4.95 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.992 -178.055 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.74 75.76 4.28 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.76 1.266 . . . . 0.0 108.726 -176.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 14.3 m -82.24 -72.68 0.43 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.265 -2.243 . . . . 0.0 111.251 -177.215 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.03 87.88 1.87 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.505 179.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -142.16 37.38 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.176 -1.487 . . . . 0.0 109.682 -178.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 0.98 43.34 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.187 0.994 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -90.64 150.39 21.71 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.413 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.2 t -81.3 150.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.335 -178.303 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -72.91 -136.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.542 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -169.67 111.46 0.42 Allowed Glycine 0 C--N 1.283 -2.395 0 C-N-CA 117.429 -2.32 . . . . 0.0 110.785 174.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 23' ' ' GLY . 34.9 tt0 -34.76 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.778 177.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.12 -12.46 62.23 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 -174.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 34.9 t30 -108.0 -162.09 0.81 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 40' ' ' VAL . 23.0 tttt -147.74 103.32 3.5 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.132 173.536 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.0 t -75.93 156.92 33.77 Favored 'General case' 0 C--N 1.272 -2.77 0 C-N-CA 117.692 -1.603 . . . . 0.0 109.752 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.0 mm -139.05 116.05 10.85 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.099 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.506 2.361 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.577 179.284 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.411 HD21 ' N ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HG3' ' H ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -133.25 175.48 9.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.669 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 1.3 m -137.93 67.96 1.41 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.561 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -107.19 128.18 62.34 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.809 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.04 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.461 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -52.94 151.35 4.71 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.6 -27.19 0.12 Allowed Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.404 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 26' ' ' ASN . 69.2 mt-10 -154.18 -135.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.432 0.634 . . . . 0.0 109.546 -178.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.71 97.93 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.684 177.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.15 144.45 52.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.249 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -78.85 130.19 9.45 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.726 1.617 . . . . 0.0 110.678 173.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp . . . . . 0 CA--C 1.564 1.503 0 C-N-CA 118.401 -1.32 . . . . 0.0 108.673 177.362 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.996 0.427 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -106.36 -114.17 0.26 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.304 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -176.63 174.3 1.87 Allowed 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.532 178.856 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.538 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.43 133.77 36.54 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.888 -175.882 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.9 m -47.35 170.26 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.458 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.457 176.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.38 10.23 1.45 Allowed 'General case' 0 C--N 1.262 -3.207 0 CA-C-N 113.406 -1.725 . . . . 0.0 107.276 172.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -169.94 128.82 0.92 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.512 -179.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -46.81 163.21 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.442 177.645 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.64 -15.46 24.96 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.011 -2.042 . . . . 0.0 111.597 178.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -58.64 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.763 -1.175 . . . . 0.0 108.613 177.95 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -145.68 -81.48 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.345 -1.742 . . . . 0.0 114.348 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.32 36.72 0.12 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.831 -173.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -101.39 -176.69 3.22 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.337 179.758 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.615 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 11.3 mt -90.99 80.61 5.72 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.925 -176.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.59 -78.64 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 CA-C-N 112.862 -1.972 . . . . 0.0 110.709 -177.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 79.7 mm-40 -86.34 110.44 19.68 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.95 -119.19 9.47 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.683 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.47 1.44 12.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.476 1.131 . . . . 0.0 109.358 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -79.77 142.04 35.75 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.06 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 38.7 t -86.31 154.29 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.42 178.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.3 m -142.46 -162.71 1.46 Allowed 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.011 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.703 ' N ' HD21 ' A' ' 26' ' ' ASN . . . 97.15 -50.37 1.48 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 117.412 -2.327 . . . . 0.0 113.518 174.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.59 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.3 tt0 -59.66 118.75 6.48 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.435 -177.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.84 -8.14 16.93 Favored Glycine 0 C--N 1.305 -1.166 0 N-CA-C 107.536 -2.226 . . . . 0.0 107.536 -176.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.703 HD21 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.97 -173.83 2.8 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.969 -179.43 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HZ3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.25 116.58 13.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.695 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' GLY . 13.5 t -79.24 153.89 29.6 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 117.421 -1.711 . . . . 0.0 110.672 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.532 ' CG1' ' HZ3' ' A' ' 27' ' ' LYS . 16.9 mm -148.36 124.59 2.51 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.479 0 CA-C-N 113.163 -1.835 . . . . 0.0 111.731 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' H ' ' HB3' ' A' ' 9' ' ' SER . 3.4 mt . . . . . 0 N--CA 1.514 2.747 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.615 176.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.804 0.811 . . . . 0.0 110.696 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.445 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 11.3 tt0 -160.02 170.11 22.0 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.92 177.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.445 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 22.1 m -131.41 64.69 1.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -79.98 125.84 39.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.855 -173.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 6.5 t -29.06 155.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 113.087 -1.869 . . . . 0.0 112.373 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.73 -154.3 16.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -142.11 124.73 15.85 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.472 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.09 -113.48 3.81 Favored Glycine 0 N--CA 1.479 1.527 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.887 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.88 141.19 7.44 Favored Pre-proline 0 C--N 1.296 -1.736 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.746 -178.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.9 Cg_endo -67.43 111.8 2.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.881 1.054 . . . . 0.0 109.412 174.181 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' PRO . 14.4 tttp . . . . . 0 N--CA 1.502 2.162 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.613 -178.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.743 0.306 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -110.31 -116.69 0.3 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.657 0.742 . . . . 0.0 110.029 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -165.26 175.76 8.97 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.686 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.13 134.5 36.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.921 0.867 . . . . 0.0 112.723 -174.576 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.435 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 3.2 m -48.81 158.07 0.34 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.886 176.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -140.69 7.07 2.08 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.253 174.088 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.62 126.7 0.9 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.288 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.469 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -50.51 157.54 0.72 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.489 175.765 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.15 -3.41 84.57 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.66 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.541 HE22 ' CG ' ' A' ' 47' ' ' LYS . 12.5 mt-30 -86.55 -166.19 1.49 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.502 178.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.606 HD22 ' H ' ' A' ' 44' ' ' GLY . 6.2 m-20 -139.83 -80.49 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -175.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mt -71.63 41.67 0.08 Allowed 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.651 -172.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.513 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.8 p -107.75 178.75 4.43 Favored 'General case' 0 C--O 1.194 -1.834 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.854 176.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -89.78 79.72 6.66 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 123.05 1.405 . . . . 0.0 108.286 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 33.9 t -61.99 -94.48 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.024 0 CA-C-N 111.832 -2.44 . . . . 0.0 111.191 -176.47 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.43 122.29 26.8 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.421 -1.311 . . . . 0.0 109.592 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.63 -123.82 23.14 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.327 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -116.23 2.75 13.35 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 122.393 1.092 . . . . 0.0 109.652 -179.598 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.73 144.92 30.79 Favored 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.761 -177.196 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 22.8 t -86.67 149.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.645 178.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -136.64 -165.1 1.67 Allowed 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 174.529 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.686 ' N ' ' ND2' ' A' ' 26' ' ' ASN . . . 112.67 -68.52 0.23 Allowed Glycine 0 N--CA 1.484 1.893 0 C-N-CA 117.662 -2.209 . . . . 0.0 113.488 174.048 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.602 ' N ' HD22 ' A' ' 26' ' ' ASN . 0.2 OUTLIER -64.55 124.79 22.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.776 -175.065 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.6 -5.55 44.93 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -175.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.686 ' ND2' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -133.82 -170.66 2.55 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.674 -179.376 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 40' ' ' VAL . 19.4 tttp -156.27 105.95 2.34 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.292 177.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 11.1 m -80.48 158.86 25.76 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 117.665 -1.614 . . . . 0.0 111.038 -179.151 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mm -139.5 106.87 2.83 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.288 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.469 ' H ' ' HB3' ' A' ' 9' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.506 2.374 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.932 -178.104 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.7 m120 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.505 0.669 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -147.56 167.66 23.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.097 174.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 m -131.74 73.15 1.52 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -91.24 125.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.898 -173.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.3 t -32.99 159.18 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.476 177.604 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.51 -150.97 19.1 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.882 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -153.95 114.1 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.606 ' H ' HD22 ' A' ' 12' ' ' ASN . . . -104.92 -109.76 3.44 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.16 148.27 11.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.55 -177.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.27 129.07 29.83 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.11 1.207 . . . . 0.0 109.876 175.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' CG ' HE22 ' A' ' 11' ' ' GLN . 5.2 tmtm? . . . . . 0 CA--C 1.564 1.505 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.861 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.794 0.33 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -145.19 -114.0 0.09 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.009 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.36 164.22 38.94 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.9 -178.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.86 131.92 35.26 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.555 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 150.35 4.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.578 176.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -145.63 15.36 1.42 Allowed 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -162.46 113.67 1.57 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.41 -177.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -46.87 155.41 0.26 Allowed 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.515 178.258 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 10.87 85.64 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.449 -1.357 . . . . 0.0 111.293 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.618 HE22 ' HZ2' ' A' ' 47' ' ' LYS . 13.0 mt-30 -79.39 -168.52 1.55 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.814 178.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 14' ' ' CYS . 28.7 t-20 -130.95 -91.18 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 114.835 -177.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.35 37.58 0.11 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.857 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.524 ' H ' ' C ' ' A' ' 12' ' ' ASN . 21.5 p -96.37 -178.85 4.43 Favored 'General case' 0 C--O 1.192 -1.922 0 C-N-CA 118.175 -1.41 . . . . 0.0 109.721 179.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -92.92 79.8 4.64 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 122.504 1.145 . . . . 0.0 108.577 -177.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.9 t -66.97 -85.42 0.02 OUTLIER 'General case' 0 C--N 1.253 -3.593 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.42 -176.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -80.77 120.3 24.47 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.71 -121.88 26.28 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.527 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -114.99 2.9 14.36 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.635 1.207 . . . . 0.0 109.126 179.689 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' N ' HD21 ' A' ' 20' ' ' ASN . 1.4 m-80 -78.88 142.44 36.8 Favored 'General case' 0 C--N 1.26 -3.315 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.518 -178.009 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 39.2 t -85.7 153.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 118.379 -1.328 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.7 m -139.52 -166.93 2.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.183 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.685 ' N ' HD21 ' A' ' 26' ' ' ASN . . . 98.04 -47.04 1.53 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 117.268 -2.396 . . . . 0.0 114.14 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 26' ' ' ASN . 20.5 tt0 -60.49 103.21 0.22 Allowed 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.768 -176.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.32 55.82 Favored Glycine 0 C--N 1.303 -1.27 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -175.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.685 HD21 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -119.38 -164.45 1.06 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.884 -1.158 . . . . 0.0 111.102 178.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HZ3' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -159.81 134.78 7.97 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.668 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 t -94.73 159.5 15.04 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.438 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.477 ' CD1' ' HZ3' ' A' ' 27' ' ' LYS . 31.1 mm -137.27 110.06 7.6 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.413 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.786 177.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.42 ' H ' ' HB3' ' A' ' 9' ' ' SER . 63.1 mt . . . . . 0 N--CA 1.498 1.965 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.348 0.594 . . . . 0.0 111.843 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 59.0 tt0 -82.7 162.71 21.71 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.087 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.2 m -123.9 67.74 1.04 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -85.18 131.18 34.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 117.844 -1.543 . . . . 0.0 111.78 -172.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.518 ' HG1' ' N ' ' A' ' 42' ' ' GLY . 2.2 t -36.13 165.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.272 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.518 ' N ' ' HG1' ' A' ' 41' ' ' THR . . . 125.3 -129.95 7.13 Favored Glycine 0 N--CA 1.484 1.894 1 N-CA-C 129.596 6.599 . . . . 0.0 129.596 -178.321 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -161.07 115.4 2.06 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.199 178.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.8 -106.69 2.96 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.86 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.1 140.62 8.77 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.87 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.5 Cg_endo -61.85 96.6 0.14 Allowed 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 121.132 1.221 . . . . 0.0 110.227 176.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HZ2' HE22 ' A' ' 11' ' ' GLN . 32.3 tptt . . . . . 0 N--CA 1.491 1.595 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.754 -179.139 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 78.9 m-85 -104.66 -128.4 0.25 Allowed 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.359 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.677 -174.097 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.04 129.49 34.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.842 179.104 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.8 m -44.62 155.44 0.1 Allowed 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.17 178.238 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.75 11.48 2.26 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.978 175.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.65 134.31 4.48 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.01 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.47 155.25 3.02 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.317 176.59 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 77.62 13.56 83.37 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.485 -179.378 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -75.63 -168.65 0.88 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.014 179.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' CYS . 77.2 m-20 -151.14 -72.05 0.16 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.248 -1.381 . . . . 0.0 113.741 -178.842 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 24.0 mt -75.73 20.7 0.17 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.19 -175.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.7 p -102.77 176.68 5.08 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.383 -179.342 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 15' ' ' LEU . 6.6 mt -80.62 73.31 7.57 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-O 122.934 1.35 . . . . 0.0 108.194 -177.018 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.0 m -72.38 -81.69 0.05 Allowed 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.169 -175.82 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.99 112.13 12.1 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.55 -179.759 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.7 -121.76 12.97 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.97 1.91 12.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.593 1.187 . . . . 0.0 108.918 178.872 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -85.81 151.2 24.01 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.766 -177.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.8 t -84.3 142.4 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.023 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -142.37 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.897 174.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.4 120.65 0.96 Allowed Glycine 0 C--N 1.282 -2.419 0 C-N-CA 116.88 -2.581 . . . . 0.0 111.683 -178.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.6 tt0 -31.42 150.9 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.561 -1.319 . . . . 0.0 110.092 177.233 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.14 -15.01 63.72 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 106.381 -2.688 . . . . 0.0 106.381 -172.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.652 ' OD1' ' N ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -115.36 -170.84 1.84 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.625 -1.288 . . . . 0.0 108.461 177.185 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.68 ' HZ2' ' CG1' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -161.32 117.1 2.13 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.609 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -95.97 122.5 38.86 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.837 -177.189 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CG1' ' HZ2' ' A' ' 27' ' ' LYS . 26.3 mm -97.12 117.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 113.097 -1.865 . . . . 0.0 112.698 -174.084 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.511 2.591 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.422 179.654 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.795 0.331 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -77.12 173.98 11.21 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 173.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.13 80.64 1.77 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.427 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -109.43 127.75 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.156 -175.231 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.652 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 t -16.71 141.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.696 172.391 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.17 -130.0 2.25 Favored Glycine 0 N--CA 1.484 1.856 1 N-CA-C 131.513 7.365 . . . . 0.0 131.513 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -161.05 100.31 1.23 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.281 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.78 -97.03 1.44 Allowed Glycine 0 N--CA 1.481 1.648 1 N-CA-C 129.105 6.402 . . . . 0.0 129.105 177.122 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.82 129.57 2.46 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.696 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.18 92.61 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.329 1.353 . . . . 0.0 110.441 172.893 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.239 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.681 -179.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.496 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 37.6 t . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.496 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 9.2 m-85 -114.38 -112.65 0.34 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.555 0.693 . . . . 0.0 110.253 -178.565 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -169.22 -174.4 1.98 Allowed 'General case' 0 C--N 1.255 -3.51 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.305 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.594 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.86 135.73 33.27 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.044 -177.301 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.76 155.38 0.58 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.648 175.284 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -133.46 4.82 3.7 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.952 176.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.405 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 7.1 pt-20 -168.51 132.55 1.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.757 179.585 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -42.0 166.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.668 176.565 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 68.17 20.48 73.12 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.806 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.485 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -85.58 -172.78 4.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.864 -179.463 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' CYS . 3.1 m120 -154.95 -67.29 0.13 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.415 -1.314 . . . . 0.0 113.952 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 5.2 mt -74.07 22.9 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.455 -176.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ASN . 16.8 p -115.36 179.49 3.95 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 15' ' ' LEU . 5.5 mt -81.04 72.15 8.06 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.444 -178.195 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.0 m -70.39 -83.22 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.517 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.009 -177.145 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 1.3 tm-20 -77.45 122.62 25.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.336 -1.346 . . . . 0.0 109.93 178.964 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.18 -125.0 38.39 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.793 -178.361 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -114.02 4.61 15.77 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.893 1.33 . . . . 0.0 108.278 178.64 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 142.68 34.86 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 111.965 -2.379 . . . . 0.0 111.877 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 5.0 t -84.22 135.43 24.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.12 -1.432 . . . . 0.0 109.624 176.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.56 -143.33 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.726 175.439 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -166.91 119.32 0.84 Allowed Glycine 0 C--N 1.275 -2.857 0 C-N-CA 117.533 -2.27 . . . . 0.0 110.671 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.485 HE22 ' CG ' ' A' ' 12' ' ' ASN . 3.5 tp-100 -35.09 151.06 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.416 177.085 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.57 -13.3 67.83 Favored Glycine 0 C--N 1.292 -1.89 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -172.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 41' ' ' THR . 27.2 t30 -111.4 -161.75 0.77 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.198 -1.001 . . . . 0.0 109.208 177.166 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HZ3' ' CG1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.92 110.63 1.47 Allowed 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.18 179.055 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -105.26 125.28 50.81 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.004 177.7 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.493 ' CG1' ' HZ3' ' A' ' 27' ' ' LYS . 37.0 mm -105.0 113.86 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.209 -178.553 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 N--CA 1.529 3.507 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.673 -177.177 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.521 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.495 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 9.7 tt0 -119.82 170.63 9.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.161 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.495 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -139.86 82.56 1.88 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.267 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -125.08 141.31 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.354 -176.674 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.528 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -16.76 152.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 112.408 -2.178 . . . . 0.0 113.519 171.749 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.54 -143.26 12.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.73 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.91 111.51 1.76 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.818 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.85 -88.22 0.82 Allowed Glycine 0 N--CA 1.491 2.333 1 N-CA-C 129.77 6.668 . . . . 0.0 129.77 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -147.18 124.12 5.71 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.989 178.152 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.45 98.96 1.25 Allowed 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.474 1.449 . . . . 0.0 111.123 175.394 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.4 tptp . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.463 179.31 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.0 t -117.22 166.0 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.759 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 32.8 m-85 -120.12 -110.46 0.34 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.268 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 173.15 178.71 0.09 Allowed 'General case' 0 C--N 1.258 -3.395 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -76.47 130.18 37.6 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.644 -1.223 . . . . 0.0 111.175 -176.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 96.2 m -40.6 168.06 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.15 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -143.66 11.85 1.67 Allowed 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 113.066 -1.879 . . . . 0.0 107.626 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -173.9 125.76 0.36 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.433 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -47.1 158.06 0.15 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.224 178.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 95.57 -28.26 12.88 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.588 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.89 176.92 0.49 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.938 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -156.49 20.18 0.34 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 116.947 -1.901 . . . . 0.0 114.863 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -134.14 16.0 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -102.04 -179.62 4.05 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.025 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.1 mt -77.85 72.69 4.4 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.003 1.383 . . . . 0.0 108.003 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.4 t -77.68 -82.85 0.08 Allowed 'General case' 0 C--N 1.25 -3.733 0 CA-C-N 112.051 -2.341 . . . . 0.0 110.356 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.81 110.86 9.46 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.859 -1.536 . . . . 0.0 108.505 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.3 -154.56 33.52 Favored Glycine 0 N--CA 1.479 1.528 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -82.8 5.56 21.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.52 1.153 . . . . 0.0 109.324 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.42 149.01 25.3 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.657 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.1 t -82.65 144.56 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.027 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -144.67 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.965 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -141.3 82.91 0.23 Allowed Glycine 0 C--N 1.282 -2.464 1 N-CA-C 128.17 6.028 . . . . 0.0 128.17 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.1 tm0? -19.22 126.0 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 124.595 0.82 . . . . 0.0 111.483 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.48 56.95 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 106.551 -2.619 . . . . 0.0 106.551 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.0 m-20 -110.12 -169.74 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.188 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -144.36 130.9 19.95 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.043 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.612 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 52.6 t -99.58 168.29 10.05 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.586 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.434 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 28.1 mm -145.95 119.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 C-N-CA 118.298 -1.361 . . . . 0.0 112.508 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 9' ' ' SER . 12.0 mt -91.52 126.57 36.65 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.49 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 71.23 90.14 0.1 OUTLIER Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.914 -1.612 . . . . 0.0 111.221 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.93 82.37 2.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 52.49 42.68 31.37 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.95 18.26 Favored Glycine 0 N--CA 1.483 1.813 1 N-CA-C 124.928 4.731 . . . . 0.0 124.928 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -97.98 95.72 7.67 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.358 -1.421 . . . . 0.0 109.718 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -62.79 1.94 0.35 Allowed 'General case' 1 C--N 1.231 -4.561 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.493 179.818 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.612 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER 179.6 111.77 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.909 -176.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.549 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 35.2 tt0 -127.6 161.21 29.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.02 71.13 1.04 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -174.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -101.79 113.12 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 118.161 -1.416 . . . . 0.0 113.27 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' VAL . 7.5 t -31.11 158.69 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.421 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.64 159.51 8.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -78.12 102.59 7.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.37 -104.65 2.93 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.64 137.86 6.77 Favored Pre-proline 0 C--N 1.303 -1.418 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.908 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.9 Cg_endo -68.87 91.68 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.735 0.957 . . . . 0.0 109.681 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 47.7 tttp -33.86 97.72 0.12 Allowed Pre-proline 0 N--CA 1.503 2.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.262 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -66.23 176.2 4.18 Favored 'Trans proline' 0 C--O 1.212 -0.778 0 C-N-CA 120.828 1.019 . . . . 0.0 110.97 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? . . . . . 0 C--N 1.308 -1.207 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.539 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t -115.24 171.41 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.294 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.446 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 33.1 m-85 -114.27 -116.74 0.32 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.719 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 1.3 p -165.59 176.62 7.96 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.909 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.66 125.57 35.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.191 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' ' NE2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -59.84 165.59 3.09 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-O 123.594 1.664 . . . . 0.0 111.897 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -142.31 13.32 1.99 Allowed 'General case' 1 C--N 1.239 -4.197 0 CA-C-N 110.595 -3.002 . . . . 0.0 105.338 174.198 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.436 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 16.1 mt-10 -160.31 139.47 10.73 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.584 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.525 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.65 -175.62 0.06 Allowed 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 123.236 1.493 . . . . 0.0 111.15 177.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 69.47 -36.87 0.34 Allowed Glycine 1 C--N 1.231 -5.294 0 CA-C-N 111.278 -2.692 . . . . 0.0 112.524 177.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.553 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -59.74 -171.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.555 -175.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.596 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -171.77 40.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.659 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 72.9 mt -143.02 1.32 1.26 Allowed 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.3 p -100.48 171.45 7.73 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.604 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -81.48 78.83 8.19 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 123.664 1.697 . . . . 0.0 107.998 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.568 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -79.76 -61.32 2.03 Favored 'General case' 1 C--N 1.235 -4.382 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.845 -178.724 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 11.4 mm-40 -73.99 72.17 1.61 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.66 -1.616 . . . . 0.0 108.284 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -113.4 4.07 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.3 p -99.91 -11.75 20.42 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-O 124.048 1.88 . . . . 0.0 109.197 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.04 119.39 19.14 Favored 'General case' 1 C--N 1.207 -5.628 0 CA-C-N 110.709 -2.95 . . . . 0.0 110.216 178.944 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 25.4 t -63.41 147.11 12.39 Favored 'Isoleucine or valine' 1 C--N 1.215 -5.279 0 CA-C-N 110.956 -2.838 . . . . 0.0 107.713 175.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -77.93 -132.16 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.77 89.75 0.1 OUTLIER Glycine 1 C--N 1.224 -5.677 0 C-N-CA 115.942 -3.028 . . . . 0.0 112.36 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' ASN . 36.2 tt0 -23.67 142.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 113.782 -1.209 . . . . 0.0 110.743 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -7.42 63.4 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -173.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.2 m-20 -111.11 -166.89 1.11 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.607 -1.297 . . . . 0.0 108.91 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -147.48 98.01 2.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 10' ' ' GLY . 51.1 t -75.68 154.84 36.26 Favored 'General case' 0 CA--C 1.435 -3.448 0 C-N-CA 116.55 -2.06 . . . . 0.0 109.918 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 37' ' ' ASN . 32.3 mm -139.08 120.97 16.67 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.246 0 CA-C-N 112.769 -2.014 . . . . 0.0 109.633 175.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' H ' ' HB3' ' A' ' 9' ' ' SER . 18.4 mt -75.51 144.81 41.78 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 36' ' ' LYS . . . -61.83 61.04 0.02 OUTLIER Glycine 0 C--N 1.288 -2.116 0 CA-C-N 110.233 -3.167 . . . . 0.0 110.562 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' GLY . 19.4 m -70.64 -124.96 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.573 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.55 69.47 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.981 0 O-C-N 125.377 1.673 . . . . 0.0 110.325 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 60.61 41.63 98.92 Favored Glycine 0 C--N 1.277 -2.739 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.49 -127.07 0.19 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.753 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 4.6 mttp -105.18 -118.04 0.23 Allowed 'General case' 0 C--N 1.268 -2.95 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -173.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER 119.7 36.76 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.994 -2.366 . . . . 0.0 105.76 -169.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -95.48 -173.36 2.88 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.56 -1.655 . . . . 0.0 108.629 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 85.6 m -133.59 67.12 1.53 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -91.17 136.02 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 117.011 -1.876 . . . . 0.0 114.829 -171.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.631 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 t -17.83 144.5 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 110.008 -3.269 . . . . 0.0 113.127 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.26 -137.03 6.6 Favored Glycine 0 N--CA 1.484 1.878 1 N-CA-C 130.2 6.84 . . . . 0.0 130.2 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.73 98.5 0.88 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.601 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.61 -104.86 2.85 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.745 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.41 138.44 10.09 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.9 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.24 104.33 1.53 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.325 1.35 . . . . 0.0 110.715 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.61 0.3 Allowed Pre-proline 0 N--CA 1.495 1.82 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.905 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.03 126.85 22.22 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.959 1.106 . . . . 0.0 112.067 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.286 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.396 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.1 167.26 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.966 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 22.0 m-85 -137.34 -111.15 0.18 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.655 0.741 . . . . 0.0 109.777 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 179.16 177.56 0.52 Allowed 'General case' 0 C--N 1.262 -3.229 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.64 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.07 131.68 37.4 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.387 -177.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 93.7 m -43.01 172.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.122 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -146.08 11.06 1.18 Allowed 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.727 172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -168.86 123.73 0.88 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.461 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.95 149.71 1.77 Allowed 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.152 173.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 93.08 -0.58 69.28 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.17 -1.49 . . . . 0.0 111.613 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -81.84 -173.6 4.55 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.695 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -167.69 30.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 116.689 -2.004 . . . . 0.0 115.348 -178.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.46 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 34.7 mt -146.07 14.56 1.32 Allowed 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -109.43 -179.98 3.98 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.725 -175.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.661 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 mt -76.27 70.22 2.87 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.142 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.535 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 4.1 m -75.89 -83.06 0.07 Allowed 'General case' 0 C--N 1.249 -3.761 0 CA-C-N 112.44 -2.164 . . . . 0.0 110.387 -176.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.73 107.01 6.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.108 -1.837 . . . . 0.0 108.75 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.12 -137.54 33.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.148 -1.501 . . . . 0.0 109.901 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -98.65 5.06 47.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.585 1.183 . . . . 0.0 109.223 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -85.74 145.38 27.28 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.147 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 17.7 t -79.3 143.15 12.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.94 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -75.27 -165.27 0.39 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -152.5 98.0 0.18 Allowed Glycine 0 C--N 1.288 -2.098 0 C-N-CA 116.02 -2.991 . . . . 0.0 112.261 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.0 tt0 -27.42 148.07 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 112.207 -1.997 . . . . 0.0 111.008 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.47 53.94 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 104.795 -3.322 . . . . 0.0 104.795 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 41' ' ' THR . 2.1 t-20 -105.16 -162.28 0.87 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 112.716 -1.742 . . . . 0.0 108.536 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' N ' HD22 ' A' ' 12' ' ' ASN . 0.7 OUTLIER -149.41 104.6 3.39 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 10' ' ' GLY . 36.1 t -77.5 149.88 34.94 Favored 'General case' 0 C--N 1.269 -2.918 0 C-N-CA 117.095 -1.842 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 37' ' ' ASN . 7.5 mm -137.14 118.72 18.5 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.194 0 CA-C-N 112.695 -2.048 . . . . 0.0 109.859 177.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.449 ' H ' ' HB3' ' A' ' 9' ' ' SER . 93.1 mt -75.77 141.39 42.58 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.769 -1.172 . . . . 0.0 113.757 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.628 ' CA ' ' N ' ' A' ' 36' ' ' LYS . . . -109.0 60.19 0.33 Allowed Glycine 0 N--CA 1.479 1.553 1 N-CA-C 128.25 6.06 . . . . 0.0 128.25 174.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 34' ' ' GLY . 11.4 m -53.76 -103.38 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -0.642 . . . . 0.0 109.439 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.42 72.05 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.707 0 O-C-N 125.687 1.867 . . . . 0.0 109.052 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.741 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 45.81 36.99 6.9 Favored Glycine 0 C--N 1.269 -3.16 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.696 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' CB ' ' CA ' ' A' ' 31' ' ' GLY . 6.9 mt-10 -86.18 -136.93 0.08 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.859 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.628 ' N ' ' CA ' ' A' ' 31' ' ' GLY . 35.6 mttm -96.12 -124.56 0.12 Allowed 'General case' 0 C--N 1.252 -3.659 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.602 ' N ' ' O ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER 116.41 36.22 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 112.254 -2.248 . . . . 0.0 107.598 -173.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.663 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 1.9 tt0 -102.42 -164.33 1.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.615 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.663 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -135.62 73.26 1.46 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -92.21 120.07 40.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.986 -173.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.615 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -6.17 141.89 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 112.668 -2.06 . . . . 0.0 114.437 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.96 -177.95 19.32 Favored Glycine 0 N--CA 1.488 2.166 1 N-CA-C 130.907 7.123 . . . . 0.0 130.907 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -108.78 90.78 3.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.799 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.63 -107.05 2.66 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.175 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.36 134.91 4.82 Favored Pre-proline 0 C--N 1.301 -1.53 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' LYS . 9.2 Cg_endo -75.87 97.23 1.09 Allowed 'Trans proline' 0 C--O 1.211 -0.855 0 C-N-CA 121.41 1.407 . . . . 0.0 110.648 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.0 tttm -35.91 95.37 0.09 OUTLIER Pre-proline 0 N--CA 1.512 2.632 0 O-C-N 123.543 0.527 . . . . 0.0 111.093 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.0 Cg_endo -71.41 162.33 42.71 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.135 1.223 . . . . 0.0 111.287 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.624 ' NE2' ' H ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.296 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.619 ' CG2' ' H ' ' A' ' 2' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.619 ' H ' ' CG2' ' A' ' 1' ' ' VAL . 98.6 t -105.78 2.4 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.373 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -139.4 -117.88 0.13 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 179.52 177.33 0.59 Allowed 'General case' 0 C--N 1.253 -3.588 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.443 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.569 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.14 131.57 34.22 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.325 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -48.08 155.43 0.46 Allowed 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.939 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -134.18 7.15 3.65 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.021 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.539 ' N ' HE22 ' A' ' 11' ' ' GLN . 0.2 OUTLIER -163.29 138.64 6.58 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.898 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -55.47 146.43 20.06 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.579 ' CA ' ' HZ3' ' A' ' 27' ' ' LYS . . . 97.84 -16.05 60.87 Favored Glycine 0 N--CA 1.497 2.715 1 N-CA-C 127.634 5.814 . . . . 0.0 127.634 -172.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.539 HE22 ' N ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -78.8 -171.47 2.58 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 118.896 -1.121 . . . . 0.0 109.069 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.564 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.4 m120 -148.23 -53.29 0.19 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 117.562 -1.655 . . . . 0.0 115.413 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.2 mt -73.22 14.29 0.33 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.094 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.6 p -102.58 173.88 6.14 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.42 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.19 72.58 5.76 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.885 1.326 . . . . 0.0 108.283 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 88.1 m -75.29 -71.82 0.34 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 112.254 -2.248 . . . . 0.0 109.224 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 90.88 2.99 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 117.987 -1.485 . . . . 0.0 109.448 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.48 -138.31 40.53 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.413 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -0.02 50.76 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.309 1.052 . . . . 0.0 109.996 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -88.98 144.16 26.36 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.668 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.0 t -85.46 143.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.743 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -75.93 -152.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.484 173.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -150.82 98.69 0.19 Allowed Glycine 0 C--N 1.27 -3.113 0 C-N-CA 116.738 -2.648 . . . . 0.0 111.122 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.4 tt0 -27.94 147.92 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 112.413 -1.893 . . . . 0.0 110.379 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -12.22 70.32 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 43' ' ' GLU . 28.0 t30 -111.64 -159.6 0.69 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.982 -1.109 . . . . 0.0 108.989 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.615 ' O ' ' O ' ' A' ' 40' ' ' VAL . 30.7 tttp -157.2 111.81 2.72 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 118.656 -1.217 . . . . 0.0 111.723 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 11' ' ' GLN . 5.3 m -78.62 157.77 28.61 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 117.871 -1.532 . . . . 0.0 110.409 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.7 mm -133.52 110.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.321 173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' H ' ' HB3' ' A' ' 9' ' ' SER . 46.8 mt -83.2 112.6 19.99 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.784 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.46 -65.62 3.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.454 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 34' ' ' GLY . 3.4 t -134.87 -140.86 0.18 Allowed 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' H ' ' HG ' ' A' ' 32' ' ' SER . 2.1 t70 -66.96 62.42 0.05 OUTLIER 'General case' 0 C--N 1.263 -3.18 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.398 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 84.52 27.35 36.0 Favored Glycine 0 C--N 1.281 -2.5 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' HB2' ' H ' ' A' ' 32' ' ' SER . 17.5 mm-40 -84.38 -103.16 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -73.9 51.23 0.38 Allowed 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.472 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m-20 -58.68 85.85 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.928 171.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.471 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 8.3 tt0 -78.0 175.33 10.17 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 117.687 -1.605 . . . . 0.0 106.884 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.77 74.51 1.48 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.071 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.615 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -120.12 138.91 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.355 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 3.5 t -50.4 160.89 0.35 Allowed 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.22 -23.34 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.992 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -162.99 -150.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.485 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.543 ' H ' ' CD ' ' A' ' 43' ' ' GLU . . . 176.8 85.74 0.06 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.189 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.84 139.3 29.93 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.032 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.0 Cg_endo -75.8 117.36 4.7 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.146 1.231 . . . . 0.0 110.203 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.1 tmtt? -40.33 100.94 0.23 Allowed Pre-proline 0 N--CA 1.498 1.937 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.197 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.0 149.23 92.22 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.9 1.067 . . . . 0.0 111.53 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 C--N 1.306 -1.309 0 CA-C-O 116.252 -1.833 . . . . 0.0 110.412 179.497 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.89 170.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.88 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 2.4 m-85 -130.83 -99.48 0.32 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.538 0.685 . . . . 0.0 110.204 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 178.07 -178.92 0.26 Allowed 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.027 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.58 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -94.91 134.99 36.96 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.103 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -55.89 158.77 3.54 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.476 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -146.65 14.87 1.23 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.003 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -166.37 137.16 3.44 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.715 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -54.64 152.33 7.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.838 176.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.39 -1.99 73.61 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.088 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.27 -165.98 0.76 Allowed 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.265 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.4 m-20 -164.04 -56.88 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 18.3 mt -74.87 12.99 0.72 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.592 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.573 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.2 p -105.13 178.98 4.4 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.841 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 15' ' ' LEU . 7.1 mt -78.99 76.83 5.47 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-O 123.082 1.42 . . . . 0.0 108.936 -176.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 84.9 m -75.44 -84.83 0.05 OUTLIER 'General case' 1 C--N 1.243 -4.034 0 CA-C-N 112.027 -2.352 . . . . 0.0 111.123 -177.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.58 104.46 6.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.174 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.36 -111.38 3.46 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.916 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.28 3.99 7.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.472 1.129 . . . . 0.0 109.463 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -87.24 145.19 26.48 Favored 'General case' 0 C--N 1.257 -3.424 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.9 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.8 t -82.92 143.24 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.328 -1.349 . . . . 0.0 109.956 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.84 -178.22 4.16 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.028 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.716 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -121.24 116.78 3.25 Favored Glycine 0 C--N 1.278 -2.645 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.072 -169.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -41.8 3.28 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.048 0 CA-C-N 111.345 -2.427 . . . . 0.0 114.11 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.716 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -102.62 16.01 55.23 Favored Glycine 0 C--N 1.262 -3.53 0 N-CA-C 105.935 -2.866 . . . . 0.0 105.935 172.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.584 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.7 t-20 -138.61 -154.53 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.619 -1.29 . . . . 0.0 108.748 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG3' ' H ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -163.0 109.3 1.17 Allowed 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.084 177.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -84.64 139.36 32.1 Favored 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.435 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.7 mm -125.77 119.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.713 -1.585 . . . . 0.0 112.123 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 9' ' ' SER . 21.6 mt -76.93 121.65 23.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.606 -1.238 . . . . 0.0 109.98 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . 72.65 89.28 0.14 Allowed Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.205 -1.474 . . . . 0.0 111.469 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -124.38 84.01 2.22 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t0 44.48 44.83 7.34 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.722 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.64 -1.31 18.06 Favored Glycine 0 C--N 1.295 -1.71 1 N-CA-C 124.351 4.5 . . . . 0.0 124.351 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 37' ' ' ASN . 6.1 mm-40 -121.31 103.35 8.9 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 113.169 -1.516 . . . . 0.0 109.265 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 31' ' ' GLY . 9.8 mttm -68.41 3.11 1.9 Allowed 'General case' 1 C--N 1.2 -5.935 0 CA-C-N 111.923 -2.399 . . . . 0.0 110.848 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.541 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER 175.85 89.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.138 -175.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 10.4 tt0 -89.05 -169.26 2.45 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.337 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.537 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -158.57 46.17 0.31 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.872 -174.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.5 m -114.39 158.44 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -12.65 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.084 0 CA-C-N 110.883 -2.871 . . . . 0.0 114.009 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.77 -99.11 0.12 Allowed Glycine 0 N--CA 1.496 2.652 1 N-CA-C 132.148 7.619 . . . . 0.0 132.148 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -161.17 28.37 0.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.003 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 13.64 73.29 0.01 OUTLIER Glycine 0 C--N 1.3 -1.462 1 N-CA-C 129.598 6.599 . . . . 0.0 129.598 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.92 130.31 64.07 Favored Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.188 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -76.23 106.13 2.21 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 121.392 1.394 . . . . 0.0 110.748 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -51.9 109.28 1.33 Allowed Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 118.746 -1.181 . . . . 0.0 109.607 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.37 153.67 75.55 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.803 1.002 . . . . 0.0 111.42 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.266 0 CA-C-O 116.348 -1.786 . . . . 0.0 110.482 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t -82.17 165.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.887 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 9.3 m-85 -104.18 -112.57 0.24 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.419 0.628 . . . . 0.0 110.335 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.94 169.18 19.71 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.661 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.4 127.24 35.8 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.103 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.7 m -46.86 155.37 0.26 Allowed 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.723 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -147.97 16.68 1.09 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.822 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -163.06 131.82 3.97 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.08 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.41 153.3 7.54 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.4 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.42 -23.79 20.16 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 118.359 -1.877 . . . . 0.0 111.295 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' GLY . 13.1 mm-40 -54.76 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.254 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.626 ' C ' ' H ' ' A' ' 14' ' ' CYS . 5.0 m-20 -176.67 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.166 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.443 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 6.0 mt -73.68 8.03 2.13 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.626 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.5 p -102.44 -179.97 4.13 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.622 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mt -79.41 71.61 5.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.739 1.257 . . . . 0.0 108.371 -177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 34.1 t -70.82 -77.58 0.09 Allowed 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.428 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 89.61 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 117.76 -1.576 . . . . 0.0 109.019 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.21 -142.47 44.64 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.631 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -0.05 30.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.124 0.964 . . . . 0.0 110.35 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -87.63 143.59 27.1 Favored 'General case' 0 C--N 1.26 -3.317 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.849 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 8.0 t -88.75 142.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.095 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -77.69 -160.56 0.19 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.015 175.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -143.83 96.43 0.19 Allowed Glycine 0 C--O 1.186 -2.895 0 C-N-CA 117.904 -2.093 . . . . 0.0 108.862 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -30.59 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -82.51 7.09 66.06 Favored Glycine 1 C--N 1.238 -4.903 0 N-CA-C 105.741 -2.944 . . . . 0.0 105.741 172.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.631 ' N ' ' O ' ' A' ' 23' ' ' GLY . 64.6 m-20 -121.97 -156.44 0.69 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.477 -1.362 . . . . 0.0 108.6 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -152.31 103.29 2.83 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.645 176.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 42.1 t -78.31 162.75 26.27 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 117.521 -1.672 . . . . 0.0 108.876 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.2 mm -149.88 121.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.386 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.3 mt -88.06 139.41 30.54 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.988 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . 57.19 75.77 0.24 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.084 -1.531 . . . . 0.0 111.805 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.616 ' OG ' ' N ' ' A' ' 33' ' ' ASP . 7.2 p -100.06 -141.73 0.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.616 ' N ' ' OG ' ' A' ' 32' ' ' SER . 4.3 t0 -68.03 59.34 0.07 Allowed 'General case' 0 C--N 1.258 -3.393 0 O-C-N 124.794 1.309 . . . . 0.0 109.125 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 89.72 41.79 5.58 Favored Glycine 0 C--N 1.285 -2.292 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 37' ' ' ASN . 22.3 mt-10 -145.07 104.67 3.99 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 123.178 1.466 . . . . 0.0 111.745 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 31' ' ' GLY . 12.7 pttm -64.37 0.05 1.14 Allowed 'General case' 1 C--N 1.211 -5.417 0 CA-C-N 111.998 -2.364 . . . . 0.0 111.897 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.597 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER 175.83 113.28 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.436 -176.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.9 tt0 -122.08 159.77 26.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -122.69 66.58 0.95 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -176.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -90.41 121.59 40.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.425 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -37.55 173.47 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.89 177.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' N ' ' HA ' ' A' ' 26' ' ' ASN . . . 126.44 -105.54 0.79 Allowed Glycine 0 N--CA 1.484 1.871 1 N-CA-C 128.411 6.124 . . . . 0.0 128.411 -176.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -165.01 88.9 0.47 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.49 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' ASN . . . -102.23 -123.02 5.17 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.682 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.42 134.52 10.2 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.938 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -70.1 98.83 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 N-CA-C 109.683 -0.93 . . . . 0.0 109.683 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' NZ ' HE22 ' A' ' 11' ' ' GLN . 26.3 tttp -43.99 105.35 0.43 Allowed Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.025 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.62 141.63 95.43 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.916 1.077 . . . . 0.0 111.711 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.357 -1.782 . . . . 0.0 110.494 179.269 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.03 161.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.082 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 58.3 m-85 -102.93 -116.53 0.2 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 p -160.13 165.78 31.03 Favored 'General case' 0 C--N 1.257 -3.429 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.928 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.21 129.54 34.56 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.992 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' OE1' ' A' ' 11' ' ' GLN . 13.7 m -46.58 169.8 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 CA-C-O 122.639 1.209 . . . . 0.0 110.436 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -150.08 14.36 0.8 Allowed 'General case' 0 C--N 1.258 -3.388 0 CA-C-N 112.415 -2.175 . . . . 0.0 106.783 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -164.96 123.13 1.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.196 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.37 153.92 1.95 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.626 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 10.2 85.51 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' OE1' ' CB ' ' A' ' 6' ' ' CYS . 3.4 mt-30 -82.62 -166.45 1.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 14' ' ' CYS . 6.2 t-20 -135.64 -93.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.199 -1.8 . . . . 0.0 115.323 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 2.5 mt -75.13 40.32 0.15 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.804 -173.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -94.59 -160.94 0.81 Allowed 'General case' 0 C--O 1.18 -2.593 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.016 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.1 mt -109.04 81.2 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 m -76.35 -81.71 0.08 Allowed 'General case' 0 C--N 1.249 -3.768 0 CA-C-N 112.944 -1.934 . . . . 0.0 111.209 -174.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 4.0 mm-40 -78.36 107.22 10.83 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.86 -1.536 . . . . 0.0 109.238 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.93 11.86 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 2.15 15.25 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.26 1.029 . . . . 0.0 110.056 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.61 149.32 25.94 Favored 'General case' 0 C--N 1.259 -3.353 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.931 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 35.5 t -88.2 148.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 118.491 -1.283 . . . . 0.0 111.049 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.2 m -136.62 -166.64 1.93 Allowed 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 93.21 -43.39 2.54 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 117.336 -2.364 . . . . 0.0 111.748 175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.572 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.8 tt0 -59.04 105.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.081 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.06 -10.16 28.47 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -118.89 -165.23 1.11 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.428 -0.886 . . . . 0.0 111.653 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -156.69 112.76 2.98 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.004 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.58 152.01 28.8 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 118.304 -1.359 . . . . 0.0 110.857 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.8 mm -139.53 104.7 2.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.455 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.67 165.36 5.15 Favored 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 118.676 -1.21 . . . . 0.0 110.146 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -153.46 -81.62 0.03 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 118.297 -1.906 . . . . 0.0 112.02 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.516 ' H ' ' N ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER 167.17 119.33 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.468 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.6 86.47 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.014 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.67 -49.41 4.04 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.575 ' C ' ' H ' ' A' ' 37' ' ' ASN . 1.9 mt-10 -85.8 -2.88 58.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.679 1.228 . . . . 0.0 109.557 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.516 ' N ' ' H ' ' A' ' 32' ' ' SER . 8.5 tttm -50.74 -14.3 0.19 Allowed 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.529 -2.123 . . . . 0.0 111.963 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 35' ' ' GLU . 30.0 m-80 -159.55 88.8 0.87 Allowed 'General case' 0 C--N 1.247 -3.869 0 CA-C-N 112.724 -2.035 . . . . 0.0 111.467 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -87.37 166.37 14.9 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.842 -1.543 . . . . 0.0 107.6 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.3 m -133.34 71.31 1.46 Allowed 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -91.37 137.71 21.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.507 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.8 t -34.83 168.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.815 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 122.48 -146.14 16.65 Favored Glycine 0 N--CA 1.482 1.706 1 N-CA-C 130.014 6.766 . . . . 0.0 130.014 -178.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -161.89 119.55 2.21 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.553 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.84 -91.3 1.11 Allowed Glycine 0 N--CA 1.486 2.032 1 N-CA-C 129.742 6.657 . . . . 0.0 129.742 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.8 122.14 4.25 Favored Pre-proline 0 C--N 1.302 -1.5 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.356 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.2 Cg_endo -66.71 95.26 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.07 1.18 . . . . 0.0 109.638 177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' PRO . 11.9 tttt -39.47 99.41 0.19 Allowed Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.211 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.89 158.33 29.65 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 120.855 1.037 . . . . 0.0 111.78 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' OE1' ' N ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.56 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.65 163.68 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.277 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.485 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 5.8 m-85 -141.84 -114.01 0.12 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.967 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 2.0 p -163.79 176.51 9.46 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.272 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.48 132.48 35.01 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.584 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.33 149.26 7.62 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.975 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -148.69 18.34 1.02 Allowed 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -161.54 109.37 1.46 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.287 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.405 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -47.83 147.1 2.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.471 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 100.92 -5.82 56.59 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.791 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -85.57 -164.96 1.1 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.285 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 14' ' ' CYS . 35.5 m-20 -164.28 -43.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.806 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 51.7 mt -76.91 17.26 0.44 Allowed 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.051 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.541 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.2 p -108.43 176.93 4.94 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.457 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 ' N ' HD22 ' A' ' 15' ' ' LEU . 5.2 mt -78.59 73.57 5.14 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 123.0 1.381 . . . . 0.0 108.16 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 32.1 t -67.79 -82.96 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.936 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 16' ' ' CYS . 4.0 mm-40 -84.25 120.98 26.86 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.9 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.27 -115.94 6.36 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.036 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.93 5.59 5.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.753 1.263 . . . . 0.0 108.819 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -88.29 144.46 26.41 Favored 'General case' 0 C--N 1.262 -3.204 0 CA-C-N 112.342 -2.208 . . . . 0.0 112.256 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 22.1 t -80.0 139.08 18.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.744 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.4 -140.64 0.08 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 118.416 -1.314 . . . . 0.0 109.371 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -157.65 111.89 0.5 Allowed Glycine 0 C--N 1.286 -2.233 0 C-N-CA 116.339 -2.839 . . . . 0.0 112.574 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.5 tt0 -36.21 152.06 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 113.482 -1.359 . . . . 0.0 108.448 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.88 -18.11 57.3 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.3 t-20 -106.33 -161.83 0.82 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.989 -1.605 . . . . 0.0 107.081 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -160.35 101.96 1.39 Allowed 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.901 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 22.2 m -78.64 155.71 29.4 Favored 'General case' 0 CA--C 1.46 -2.487 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.424 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -136.3 108.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.649 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 32' ' ' SER . 18.0 mt -60.29 113.04 2.17 Favored 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 118.155 -1.418 . . . . 0.0 108.394 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -16.46 -36.52 0.0 OUTLIER Glycine 0 N--CA 1.492 2.402 1 N-CA-C 126.879 5.512 . . . . 0.0 126.879 -176.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' LEU . 5.1 t 170.51 99.74 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.778 -1.211 . . . . 0.0 108.39 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 54.51 47.49 22.63 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.163 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.88 6.24 63.72 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.468 -1.348 . . . . 0.0 112.24 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.404 ' HB2' ' N ' ' A' ' 32' ' ' SER . 3.4 mt-10 -64.73 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.143 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 31' ' ' GLY . 20.5 mttm -90.97 -134.74 0.13 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.3 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.8 p30 167.71 89.76 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.598 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.481 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 14.3 tt0 -83.46 -176.1 6.14 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -136.68 75.16 1.52 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -109.25 127.54 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.156 -1.418 . . . . 0.0 114.363 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.559 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 t -27.37 148.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 112.579 -2.1 . . . . 0.0 113.566 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.48 -101.37 0.19 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.551 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -98.61 -139.54 0.31 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.346 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.551 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 179.95 88.66 0.07 OUTLIER Glycine 0 C--N 1.28 -2.539 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.9 139.56 25.12 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.527 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -77.14 136.62 16.39 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.199 1.266 . . . . 0.0 109.16 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 16.4 tttp -51.79 -51.18 72.83 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 117.791 -1.564 . . . . 0.0 111.021 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 2.8 Cg_endo -67.3 108.79 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.803 1.002 . . . . 0.0 111.114 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.333 179.375 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 52.0 t . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 21.9 t -89.72 174.47 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.404 -0.919 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 5.8 m-85 -137.99 -112.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.069 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.714 ' HG1' ' H ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -172.08 176.5 3.47 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.036 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.714 ' H ' ' HG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.27 131.0 34.37 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.168 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -53.44 158.46 1.73 Allowed 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.734 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -140.16 8.99 2.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.125 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -161.0 143.98 12.84 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.52 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.453 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.03 147.92 45.64 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.658 175.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 94.61 -7.44 71.14 Favored Glycine 0 N--CA 1.503 3.154 1 N-CA-C 126.736 5.454 . . . . 0.0 126.736 -172.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 75.9 mt-30 -83.67 -167.41 1.71 Allowed 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 114.283 -0.959 . . . . 0.0 111.09 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.2 m-80 -156.38 -51.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.985 -1.486 . . . . 0.0 114.553 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 59.5 mt -76.09 13.69 0.84 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.618 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.5 p -110.13 177.8 4.6 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.73 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 mt -77.77 75.92 4.31 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-O 122.811 1.291 . . . . 0.0 108.552 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.62 -80.43 0.08 Allowed 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.647 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.32 107.62 12.22 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.156 -1.418 . . . . 0.0 109.502 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.46 -144.02 48.74 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.176 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -90.26 5.06 48.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.38 1.086 . . . . 0.0 109.778 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -88.6 143.59 26.85 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.941 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.76 139.28 17.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.277 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -146.14 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.735 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.99 117.54 0.77 Allowed Glycine 0 C--N 1.278 -2.664 0 C-N-CA 117.451 -2.309 . . . . 0.0 110.67 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.5 tt0 -33.23 154.17 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.054 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.42 -6.31 82.36 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 41' ' ' THR . 8.7 t30 -122.25 -164.16 1.14 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.929 -1.136 . . . . 0.0 108.493 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 40' ' ' VAL . 36.2 tttp -162.22 112.35 1.53 Allowed 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.9 m -83.04 153.63 24.83 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.64 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.58 117.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.284 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' H ' ' HB3' ' A' ' 9' ' ' SER . 19.1 mt -105.01 124.03 48.82 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.921 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.762 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . -175.99 42.65 0.11 Allowed Glycine 1 N--CA 1.516 4.022 1 N-CA-C 133.678 8.231 . . . . 0.0 133.678 176.217 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.753 ' H ' ' C ' ' A' ' 35' ' ' GLU . 26.5 t -106.07 -120.8 0.23 Allowed 'General case' 0 C--O 1.188 -2.165 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.601 ' H ' ' HG ' ' A' ' 32' ' ' SER . 1.6 m-20 -66.11 55.05 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 91.58 1.55 71.16 Favored Glycine 0 C--N 1.288 -2.084 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.753 ' C ' ' H ' ' A' ' 32' ' ' SER 0.252 15.0 mt-10 -170.68 90.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -174.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' H ' ' N ' ' A' ' 31' ' ' GLY . 21.2 tttm -100.86 66.52 1.18 Allowed 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 167.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -56.41 143.14 35.84 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.517 -1.219 . . . . 0.0 113.92 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.431 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 12.7 tt0 -153.46 170.89 19.62 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.052 -1.885 . . . . 0.0 107.206 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -145.31 79.12 1.57 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.429 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.77 146.25 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 C-N-CA 117.776 -1.57 . . . . 0.0 114.879 -176.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -18.14 146.6 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 113.059 -1.882 . . . . 0.0 114.176 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.24 -120.94 1.02 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 7.4 mm-40 -78.67 -135.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.48 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.03 97.44 0.12 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 144.83 55.16 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.422 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.23 126.07 8.93 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.356 1.371 . . . . 0.0 109.469 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.94 130.99 22.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.992 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.1 130.23 35.39 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 110.293 -0.695 . . . . 0.0 110.293 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 116.41 -1.757 . . . . 0.0 110.651 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 2' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 3.5 t -79.51 -178.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.183 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 61.5 m-85 -106.06 -115.82 0.25 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.73 0.776 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -178.1 175.35 1.26 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.77 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 134.68 36.4 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.653 -176.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.43 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 92.7 m -47.8 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.662 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -138.05 3.14 2.4 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.725 -1.58 . . . . 0.0 107.992 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -171.16 136.55 1.07 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.424 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.499 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -51.27 157.88 0.89 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.468 178.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -20.97 46.7 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.663 -1.732 . . . . 0.0 112.629 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.15 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -161.65 21.9 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 115.668 -2.413 . . . . 0.0 115.285 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.2 mt -146.71 25.88 1.16 Allowed 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -104.81 179.8 4.17 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.227 -176.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.635 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 mt -84.06 75.55 10.14 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.661 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 2.3 t -73.58 -68.99 0.46 Allowed 'General case' 0 C--N 1.254 -3.572 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.472 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -84.32 89.32 7.34 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.52 -133.22 25.47 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.045 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 -1.66 58.21 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.144 0.973 . . . . 0.0 110.412 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -81.49 137.88 35.55 Favored 'General case' 0 C--N 1.26 -3.301 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.48 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 52.4 t -83.03 155.15 3.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.231 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.521 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 10.9 m -145.19 -173.21 4.04 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.687 ' N ' HD21 ' A' ' 26' ' ' ASN . . . 99.31 -45.55 1.54 Allowed Glycine 0 C--O 1.206 -1.6 0 C-N-CA 117.547 -2.264 . . . . 0.0 114.611 173.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.56 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -63.48 115.89 5.07 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.586 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.92 -10.56 39.41 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.687 HD21 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -125.96 -158.24 0.84 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.919 -1.141 . . . . 0.0 111.417 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -154.82 124.36 6.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.527 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -78.82 155.13 29.35 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 117.54 -1.664 . . . . 0.0 109.5 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 38' ' ' GLN . 15.2 mm -150.77 122.43 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.619 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.716 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.499 ' H ' ' HB3' ' A' ' 9' ' ' SER . 7.7 mt -94.88 129.79 41.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.186 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 76.58 92.44 0.22 Allowed Glycine 0 N--CA 1.502 3.079 0 C-N-CA 118.708 -1.711 . . . . 0.0 110.891 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -132.96 91.1 2.84 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' SER . 7.7 t0 35.57 49.91 0.55 Allowed 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.725 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.04 7.18 12.99 Favored Glycine 0 C--N 1.297 -1.626 1 N-CA-C 125.29 4.876 . . . . 0.0 125.29 -174.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' A' ' 37' ' ' ASN . 36.4 mt-10 -142.8 108.16 5.02 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.767 -1.216 . . . . 0.0 111.036 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -66.31 6.18 0.46 Allowed 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.598 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.672 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -166.57 130.27 2.0 Allowed 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.751 -176.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.606 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 40.2 tt0 -150.71 155.85 40.12 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.2 m -116.94 65.1 0.72 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -77.78 130.34 36.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 117.709 -1.597 . . . . 0.0 111.515 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.4 t -35.77 167.45 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.057 -1.883 . . . . 0.0 112.395 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 123.04 -133.93 9.28 Favored Glycine 0 N--CA 1.488 2.108 1 N-CA-C 130.387 6.915 . . . . 0.0 130.387 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -161.99 116.2 1.88 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.595 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.95 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.42 -1.372 . . . . 0.0 111.511 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.85 152.58 19.32 Favored Pre-proline 0 C--N 1.31 -1.136 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.404 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -72.3 116.29 4.65 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 121.212 1.275 . . . . 0.0 109.733 170.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -46.52 112.78 1.97 Allowed Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.702 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -67.87 133.0 27.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.457 0.772 . . . . 0.0 110.426 176.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.1 tt0 . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 116.387 -1.768 . . . . 0.0 111.461 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.27 165.39 2.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.146 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 2.3 m-85 -132.06 -111.84 0.24 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.813 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 2.7 p -162.34 177.31 9.69 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.809 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.55 134.02 34.32 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.678 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 m -52.54 155.48 2.16 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.052 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -140.54 9.73 2.24 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.688 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -163.33 139.85 7.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.838 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.87 156.92 6.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.496 176.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 85.18 0.66 88.67 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.086 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.417 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 27.2 mt-30 -84.4 -177.37 6.61 Favored 'General case' 0 N--CA 1.514 2.768 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.175 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.3 m-20 -151.81 -50.88 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 117.978 -1.489 . . . . 0.0 114.394 -177.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 87.1 mt -75.99 17.99 0.3 Allowed 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.299 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.558 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.7 p -110.35 178.92 4.23 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.94 73.0 6.72 Favored 'General case' 0 CA--C 1.465 -2.289 0 CA-C-O 122.843 1.306 . . . . 0.0 108.552 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 94.4 m -69.94 -93.41 0.01 OUTLIER 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.28 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.09 116.55 13.76 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.394 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.28 -139.63 42.28 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.796 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -99.93 6.31 45.21 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.526 1.155 . . . . 0.0 108.992 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.88 144.7 28.23 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.305 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 6.9 t -85.12 138.93 18.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 118.154 -1.418 . . . . 0.0 109.556 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -140.18 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.954 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.45 122.19 1.03 Allowed Glycine 0 C--N 1.275 -2.837 0 C-N-CA 117.303 -2.379 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.4 tt0 -34.41 157.17 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.579 -1.31 . . . . 0.0 110.028 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -18.35 21.52 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 24' ' ' GLN . 13.0 t30 -104.19 -164.39 1.05 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.915 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -161.67 102.77 1.19 Allowed 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.046 -1.461 . . . . 0.0 111.65 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -79.84 153.6 28.97 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.45 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.4 mm -134.71 115.58 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.893 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' H ' ' HB3' ' A' ' 9' ' ' SER . 10.6 mt -92.68 140.16 29.82 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.642 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . -149.11 -87.16 0.06 OUTLIER Glycine 0 N--CA 1.502 3.065 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.874 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.64 120.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.656 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t0 52.42 88.39 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.476 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.31 -47.18 3.45 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 37' ' ' ASN . 1.7 mt-10 -91.43 -3.13 56.96 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.526 1.155 . . . . 0.0 109.788 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -55.4 -11.66 0.88 Allowed 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 112.831 -1.986 . . . . 0.0 112.029 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.694 HD21 ' N ' ' A' ' 38' ' ' GLN . 1.2 t-20 175.02 129.9 0.03 OUTLIER 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.274 -175.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.694 ' N ' HD21 ' A' ' 37' ' ' ASN . 38.6 tt0 -144.1 171.0 14.89 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.416 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -132.58 73.21 1.52 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -113.11 130.3 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -172.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.9 t -22.71 155.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.573 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.35 -123.56 1.93 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.609 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -76.85 -131.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.393 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.609 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 157.2 80.09 0.03 OUTLIER Glycine 0 C--N 1.282 -2.431 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.933 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.36 131.52 42.08 Favored Pre-proline 0 CA--C 1.559 1.29 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.871 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.65 119.56 6.5 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.123 1.215 . . . . 0.0 110.928 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 114.25 8.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.539 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' GLN . 5.3 Cg_exo -56.67 -173.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 120.644 0.896 . . . . 0.0 111.558 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 48' ' ' PRO . 29.5 mt-30 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.762 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.415 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 20.1 t -83.7 170.53 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.452 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 26.8 m-85 -103.82 -113.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -159.0 169.17 24.91 Favored 'General case' 0 C--N 1.261 -3.28 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.992 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.47 130.2 34.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.69 -1.204 . . . . 0.0 111.103 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.7 m -47.4 171.61 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.331 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -144.33 8.1 1.37 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.704 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -170.49 139.24 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.4 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.459 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -52.97 159.31 1.19 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.79 176.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.61 50.01 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.037 -1.554 . . . . 0.0 112.461 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.47 -173.06 3.88 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.496 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 14' ' ' CYS . 69.6 m-80 -155.77 -45.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.72 -1.592 . . . . 0.0 113.937 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 45.5 mt -76.59 16.24 0.52 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.163 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -100.4 -170.1 1.82 Allowed 'General case' 0 C--O 1.181 -2.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.64 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 mt -91.52 71.38 5.94 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.8 t -64.2 -84.4 0.02 OUTLIER 'General case' 0 C--N 1.254 -3.554 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.929 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 tm-20 -69.88 88.0 0.55 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.067 -1.453 . . . . 0.0 109.227 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.49 -130.9 18.76 Favored Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.399 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.96 0.75 57.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.184 0.992 . . . . 0.0 110.38 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -90.41 147.18 23.59 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.065 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 23.6 t -85.99 147.16 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 117.979 -1.488 . . . . 0.0 110.813 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.4 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -76.29 -129.91 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.36 115.45 0.57 Allowed Glycine 0 C--N 1.276 -2.751 0 C-N-CA 117.871 -2.109 . . . . 0.0 110.892 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 12.4 tt0 -34.44 149.22 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.279 -0.96 . . . . 0.0 109.905 177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.39 -10.89 65.07 Favored Glycine 0 C--N 1.292 -1.906 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 20.4 t30 -108.09 -162.9 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 40' ' ' VAL . 50.4 tttp -154.24 104.26 2.59 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.74 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 52.6 t -77.4 159.57 29.36 Favored 'General case' 0 CA--C 1.462 -2.425 0 C-N-CA 117.01 -1.876 . . . . 0.0 109.284 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.415 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 8.9 mm -137.23 115.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.132 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' CD2' ' ND2' ' A' ' 37' ' ' ASN . 18.9 mt -101.24 109.18 21.0 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.575 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.889 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . -165.79 67.54 0.2 Allowed Glycine 1 N--CA 1.517 4.065 0 C-N-CA 115.569 -3.205 . . . . 0.0 117.617 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.809 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 29.6 t -114.49 -139.49 0.38 Allowed 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' N ' ' OG ' ' A' ' 32' ' ' SER . 3.3 m-20 -47.94 -21.52 0.45 Allowed 'General case' 0 C--N 1.273 -2.751 0 CA-C-O 123.512 1.625 . . . . 0.0 107.858 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.579 ' N ' ' C ' ' A' ' 32' ' ' SER . . . -165.27 -4.14 0.04 OUTLIER Glycine 1 C--N 1.245 -4.512 0 CA-C-N 110.763 -2.926 . . . . 0.0 108.867 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.809 ' CA ' ' H ' ' A' ' 32' ' ' SER 0.267 13.8 mt-10 -177.28 101.13 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.889 ' H ' ' N ' ' A' ' 31' ' ' GLY . 16.4 tttt -98.15 69.28 2.01 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -49.41 136.94 15.43 Favored 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.603 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 15.7 tt0 -155.02 164.35 39.01 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -130.11 75.72 1.67 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.572 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -119.32 130.42 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.569 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 42' ' ' GLY . 8.1 t -51.09 154.56 1.52 Allowed 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.388 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' N ' ' HG1' ' A' ' 41' ' ' THR . . . 170.06 -24.32 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.117 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.507 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 3.3 tt0 -162.89 -143.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.367 0.603 . . . . 0.0 110.265 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.507 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -179.2 85.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.757 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.484 ' H ' ' HG1' ' A' ' 45' ' ' THR . 0.1 OUTLIER -105.72 107.1 58.67 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.667 179.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 Cg_endo -68.68 92.9 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 48' ' ' PRO . 4.7 tmtm? -40.39 118.19 1.44 Allowed Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.668 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 5.8 Cg_exo -59.48 108.46 0.46 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.587 0.858 . . . . 0.0 110.833 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' NE2' ' H ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 116.244 -1.836 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.92 170.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.014 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 69.4 m-85 -139.68 -121.95 0.12 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.64 0.733 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 3.0 t 177.99 -177.77 0.22 Allowed 'General case' 0 C--N 1.259 -3.332 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.823 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.32 133.09 36.61 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.521 -177.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.461 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 86.7 m -46.14 169.1 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.089 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -155.27 17.3 0.41 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.921 172.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 2.0 tt0 -167.31 124.14 1.18 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.905 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.443 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -55.78 151.64 10.9 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.646 177.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.86 -16.53 59.19 Favored Glycine 0 C--N 1.282 -2.439 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.25 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 17.5 mt-30 -60.23 179.21 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' HB3' ' H ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -161.3 25.55 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 115.523 -2.471 . . . . 0.0 115.352 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 34.6 mt -147.61 26.74 1.02 Allowed 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.46 177.74 4.7 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.373 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.644 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 mt -80.38 70.86 7.13 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.054 -1.884 . . . . 0.0 107.408 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 41.4 m -73.28 -61.9 1.66 Allowed 'General case' 1 C--N 1.239 -4.211 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.541 -173.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.6 88.92 7.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.075 -1.45 . . . . 0.0 109.526 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.47 -105.37 1.77 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.112 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.42 -2.5 11.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.229 1.014 . . . . 0.0 110.485 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.77 139.99 30.17 Favored 'General case' 0 C--N 1.254 -3.583 0 CA-C-N 113.326 -1.761 . . . . 0.0 111.419 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 42.6 t -79.25 151.15 4.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 117.723 -1.591 . . . . 0.0 109.314 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 86.4 m -140.49 -173.75 3.77 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 102.74 -49.87 0.95 Allowed Glycine 0 C--O 1.2 -2.002 0 C-N-CA 117.496 -2.287 . . . . 0.0 114.263 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 26' ' ' ASN . 9.7 tm0? -63.78 115.14 4.52 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.493 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.42 52.59 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.98 -163.7 1.33 Allowed 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.156 -1.022 . . . . 0.0 111.623 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HZ3' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -158.21 133.08 8.44 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.092 175.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.9 m -90.2 149.97 22.18 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.005 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.433 ' CD1' ' HZ3' ' A' ' 27' ' ' LYS . 32.1 mm -140.35 111.86 4.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.795 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' H ' ' HB3' ' A' ' 9' ' ' SER . 8.9 mt -75.71 127.03 32.16 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.341 -1.343 . . . . 0.0 109.208 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 80.69 80.85 0.83 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 118.728 -1.701 . . . . 0.0 109.95 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -132.63 79.58 1.86 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.908 0.861 . . . . 0.0 109.42 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 0.8 OUTLIER 42.3 67.45 0.59 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.236 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.43 3.44 61.33 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.038 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 37' ' ' ASN . 2.4 mm-40 -131.96 95.55 3.72 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.283 1.039 . . . . 0.0 111.179 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 31' ' ' GLY . 15.0 pttt -66.47 8.86 0.2 Allowed 'General case' 0 C--N 1.245 -3.958 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.119 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -178.87 69.95 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.62 -175.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.43 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 9.6 tt0 -79.3 172.93 13.12 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.486 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 90.0 m -134.03 62.46 1.65 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -79.45 135.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 117.913 -1.515 . . . . 0.0 111.931 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.7 t -38.8 165.13 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.332 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.02 -151.73 17.83 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -143.07 124.48 14.72 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.524 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.3 -113.02 3.75 Favored Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.775 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.484 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -151.83 149.1 22.95 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.056 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.33 115.25 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.333 1.355 . . . . 0.0 110.546 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.24 113.66 5.88 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.632 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.64 134.12 60.97 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 120.653 0.902 . . . . 0.0 111.443 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.321 -1.799 . . . . 0.0 110.702 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.7 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.98 163.74 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.175 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.504 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -142.59 -113.75 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.914 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -159.31 173.42 16.31 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.506 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.56 132.18 34.14 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.564 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.1 155.12 2.0 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.218 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -148.13 14.92 1.03 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.007 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 19.9 mt-10 -161.52 127.04 3.63 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.619 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.453 ' CB ' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -53.5 158.24 1.84 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.088 177.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 79.67 11.21 84.96 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.582 -1.77 . . . . 0.0 110.435 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.46 HE21 ' CG ' ' A' ' 47' ' ' LYS . 1.8 tp60 -74.71 -164.63 0.29 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.269 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 14' ' ' CYS . 9.8 m-20 -162.86 -69.36 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 117.914 -1.515 . . . . 0.0 113.93 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 72.0 mt -76.3 19.72 0.24 Allowed 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.538 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.562 ' H ' ' C ' ' A' ' 12' ' ' ASN . 22.7 p -103.55 177.99 4.68 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.372 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -79.85 70.74 6.46 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 122.829 1.299 . . . . 0.0 107.765 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.625 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 39.5 t -69.21 -74.45 0.13 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.583 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.72 130.5 40.65 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.411 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 23.61 -91.26 0.01 OUTLIER Glycine 0 N--CA 1.503 3.155 1 N-CA-C 127.198 5.639 . . . . 0.0 127.198 -174.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.09 2.56 10.42 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.926 1.346 . . . . 0.0 107.864 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -89.73 143.01 27.15 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.882 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 6.7 t -84.35 143.5 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.241 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.486 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -71.85 -142.43 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.06 115.44 0.57 Allowed Glycine 0 C--N 1.279 -2.619 0 C-N-CA 117.314 -2.374 . . . . 0.0 110.844 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.46 ' C ' ' H ' ' A' ' 26' ' ' ASN . 11.3 tt0 -34.87 155.21 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.39 -0.905 . . . . 0.0 109.478 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.81 -16.33 55.02 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 106.452 -2.659 . . . . 0.0 106.452 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.517 HD22 ' C ' ' A' ' 39' ' ' CYS . 14.2 t30 -106.72 -156.55 0.58 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.081 -1.06 . . . . 0.0 108.776 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' H ' ' CG ' ' A' ' 26' ' ' ASN . 1.2 ttpp -159.63 103.54 1.56 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.57 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 42.7 t -78.28 156.98 29.38 Favored 'General case' 0 CA--C 1.462 -2.41 0 C-N-CA 116.808 -1.957 . . . . 0.0 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.3 mm -145.62 118.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.772 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.078 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' H ' ' CB ' ' A' ' 9' ' ' SER . 12.8 mt -92.13 129.31 38.11 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.673 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 82.88 84.31 0.85 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.433 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' GLU . 2.5 t -137.98 80.23 1.79 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.725 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 32' ' ' SER . 49.0 m-20 37.68 69.95 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.68 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.78 4.73 57.84 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.808 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 37' ' ' ASN . 30.6 mt-10 -136.36 94.59 3.04 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.83 0.824 . . . . 0.0 111.061 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 10.92 0.65 Allowed 'General case' 0 C--N 1.251 -3.681 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.625 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER 179.75 107.48 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.966 -176.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.529 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.0 tt0 -119.95 164.08 16.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -123.57 71.48 1.09 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -101.3 124.72 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -171.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 11.3 t -18.69 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 112.416 -2.174 . . . . 0.0 113.168 171.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.75 -155.73 20.74 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.54 98.32 5.18 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.93 -115.79 2.12 Favored Glycine 0 C--O 1.215 -1.042 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.653 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -164.84 150.96 9.03 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.565 -177.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -76.97 132.87 13.21 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.751 1.634 . . . . 0.0 110.057 170.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.502 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -64.46 -40.02 46.86 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.775 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 47' ' ' LYS . 2.0 Cg_endo -65.88 146.28 82.6 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.357 0.705 . . . . 0.0 111.064 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.275 179.489 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.476 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 15.5 t -113.91 178.7 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.476 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 16.9 m-85 -140.3 -114.73 0.14 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.688 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 p -158.13 175.25 14.03 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.211 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.18 132.05 36.94 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.273 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.07 151.09 2.81 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.082 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -138.13 8.03 2.69 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.994 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -166.79 132.88 2.29 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.409 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.94 154.38 0.74 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.568 177.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 87.87 11.23 68.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.41 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -82.99 -170.09 2.85 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.786 177.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.6 m120 -151.94 -73.51 0.15 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 118.406 -1.318 . . . . 0.0 113.365 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 51.8 mt -74.57 27.85 0.08 Allowed 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.176 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 20.9 p -105.55 177.29 4.89 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.598 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 ' N ' HD22 ' A' ' 15' ' ' LEU . 7.4 mt -79.91 73.23 6.69 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.992 1.377 . . . . 0.0 107.629 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 76.2 m -69.52 -78.82 0.07 Allowed 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 111.864 -2.426 . . . . 0.0 110.869 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.22 107.36 9.55 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.544 -1.263 . . . . 0.0 109.867 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -115.05 6.83 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.95 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.93 0.6 11.93 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.361 1.077 . . . . 0.0 110.033 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.67 146.51 25.67 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.856 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.75 140.29 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 C-N-CA 118.367 -1.333 . . . . 0.0 110.014 177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.17 -138.8 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.95 175.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -166.31 121.25 0.97 Allowed Glycine 0 C--N 1.272 -3.008 0 C-N-CA 117.839 -2.124 . . . . 0.0 110.008 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.9 tt0 -34.65 159.44 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.081 -1.06 . . . . 0.0 110.251 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.0 -16.4 58.67 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.6 t30 -105.91 -161.22 0.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.873 -1.163 . . . . 0.0 108.864 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -160.95 96.42 1.11 Allowed 'General case' 0 C--N 1.28 -2.453 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.24 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.78 133.9 37.05 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 117.642 -1.623 . . . . 0.0 109.635 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -122.98 120.46 60.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.646 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' H ' ' HB3' ' A' ' 9' ' ' SER . 22.6 mt -81.94 139.06 34.83 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.162 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.44 -74.64 0.27 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.698 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.0 m -154.23 -127.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 67.47 0.0 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.746 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.54 35.13 89.54 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HB2' ' H ' ' A' ' 32' ' ' SER . 58.8 mm-40 -78.68 -109.87 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.566 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -93.1 -141.13 0.21 Allowed 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.457 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.545 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.2 OUTLIER 172.65 123.32 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.162 0 CA-C-N 112.522 -2.126 . . . . 0.0 109.172 -169.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 5.5 tt0 -117.2 -179.93 3.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.446 ' C ' HD22 ' A' ' 26' ' ' ASN . 0.5 OUTLIER -145.55 78.85 1.56 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.508 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -114.74 131.51 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 C-N-CA 118.331 -1.347 . . . . 0.0 114.635 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.563 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -9.41 143.77 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.263 171.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.03 -145.71 15.3 Favored Glycine 0 N--CA 1.489 2.225 1 N-CA-C 131.067 7.187 . . . . 0.0 131.067 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -146.87 84.77 1.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.719 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -107.88 2.43 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.232 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -161.64 145.56 9.69 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.99 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.09 105.5 2.08 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.52 1.48 . . . . 0.0 110.496 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -43.78 106.18 0.49 Allowed Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.714 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 125.32 15.26 Favored 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.709 0.939 . . . . 0.0 111.377 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.585 179.452 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 t -84.28 172.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.679 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.451 ' CG ' ' O ' ' A' ' 13' ' ' LEU . 60.0 m-85 -130.23 -118.29 0.23 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.67 0.748 . . . . 0.0 110.478 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.584 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -179.17 178.06 0.75 Allowed 'General case' 0 C--N 1.259 -3.367 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.643 -178.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.584 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.94 132.95 35.27 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.986 0.898 . . . . 0.0 112.119 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -52.96 154.49 2.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.843 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -139.38 11.27 2.54 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.979 174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.426 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 13.6 tt0 -166.34 125.39 1.54 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.272 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.483 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -45.14 155.58 0.12 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.819 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.08 -18.71 56.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 22.4 mt-30 -79.71 -175.66 4.97 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.91 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 14' ' ' CYS . 65.8 m-80 -152.2 -48.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 117.68 -1.608 . . . . 0.0 114.126 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.451 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 29.0 mt -75.35 17.73 0.25 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.557 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.8 p -103.25 175.73 5.38 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.962 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.1 mt -78.88 73.19 5.43 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 122.959 1.362 . . . . 0.0 108.284 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.61 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 35.8 t -72.8 -82.24 0.05 Allowed 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 112.11 -2.314 . . . . 0.0 109.816 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.71 97.76 3.3 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 117.452 -1.699 . . . . 0.0 109.129 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 20' ' ' ASN . . . 64.65 -148.78 51.38 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.217 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -78.86 3.54 16.61 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.358 1.075 . . . . 0.0 109.553 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.45 ' H ' ' C ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -87.14 143.07 27.47 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.79 -178.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 t -84.49 144.91 8.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.51 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.09 -137.33 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.13 109.11 0.35 Allowed Glycine 0 C--N 1.282 -2.457 0 C-N-CA 117.414 -2.327 . . . . 0.0 111.128 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.9 tm0? -34.36 150.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.36 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.95 57.37 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 16.3 t30 -106.5 -161.34 0.79 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 40' ' ' VAL . 49.0 tttp -155.42 105.82 2.5 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.357 175.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.609 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 51.9 t -76.34 158.17 31.72 Favored 'General case' 0 CA--C 1.462 -2.408 0 C-N-CA 116.845 -1.942 . . . . 0.0 108.718 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.1 mm -138.13 115.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.082 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.679 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.483 ' H ' ' HB3' ' A' ' 9' ' ' SER . 13.7 mt -91.74 123.95 35.51 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.215 176.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.92 86.87 0.51 Allowed Glycine 0 N--CA 1.503 3.135 0 C-N-CA 118.639 -1.744 . . . . 0.0 110.665 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 32' ' ' SER . 1.0 OUTLIER -135.53 82.5 1.96 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.949 0.881 . . . . 0.0 109.214 177.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 47.6 58.47 4.93 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.88 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.75 5.75 58.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.113 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 37' ' ' ASN . 42.6 mt-10 -125.64 94.8 4.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 122.246 1.022 . . . . 0.0 110.146 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.86 6.74 0.81 Allowed 'General case' 0 C--N 1.248 -3.84 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.962 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER 179.01 112.1 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.902 -176.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.2 tt0 -128.78 166.43 19.02 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -126.04 72.24 1.29 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -115.45 130.68 69.63 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.167 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.117 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.3 t -42.58 159.72 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.844 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.4 -103.26 0.22 Allowed Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.854 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -79.15 -148.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.022 0.439 . . . . 0.0 109.949 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.57 80.57 0.06 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.54 126.72 28.27 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.934 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -73.39 115.67 4.42 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 121.409 1.406 . . . . 0.0 111.734 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -66.86 113.98 15.69 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.105 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 49' ' ' GLN . 3.9 Cg_exo -59.7 163.65 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.491 0.794 . . . . 0.0 111.348 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 48' ' ' PRO . 3.3 mt-30 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.583 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.8 t -101.18 172.69 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.747 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 12.1 m-85 -115.77 -116.46 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.388 0.614 . . . . 0.0 110.709 -177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -152.1 172.74 15.86 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.534 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 131.08 34.88 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.96 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -49.08 150.77 1.49 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.771 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -141.24 12.94 2.19 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -165.25 125.59 1.89 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.572 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.77 159.8 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.237 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.77 -5.91 72.65 Favored Glycine 0 N--CA 1.505 3.288 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.327 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -70.43 -176.48 1.24 Allowed 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.573 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 14' ' ' CYS . 5.2 m120 -148.29 -64.22 0.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.562 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 9.6 mt -73.06 22.53 0.07 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.899 -177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.641 ' H ' ' C ' ' A' ' 12' ' ' ASN . 17.2 p -104.96 176.76 5.05 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.28 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -82.65 70.82 9.7 Favored 'General case' 0 C--N 1.27 -2.884 0 CA-C-O 122.703 1.239 . . . . 0.0 107.859 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.9 t -67.51 -88.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.258 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -73.43 109.2 6.77 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.064 -1.854 . . . . 0.0 109.849 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.43 -132.19 24.96 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -103.51 4.91 36.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.741 1.258 . . . . 0.0 108.549 178.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -87.69 149.81 24.02 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.374 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 5.4 t -87.51 141.2 14.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.123 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -141.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.636 ' N ' ' ND2' ' A' ' 26' ' ' ASN . . . -164.23 101.98 0.19 Allowed Glycine 0 N--CA 1.504 3.175 0 C-N-CA 115.608 -3.187 . . . . 0.0 112.98 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLY . 13.6 tm0? -27.45 114.63 0.07 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.519 1.152 . . . . 0.0 110.558 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.497 ' H ' HD21 ' A' ' 12' ' ' ASN . . . 130.03 -16.82 5.48 Favored Glycine 0 C--N 1.28 -2.561 0 N-CA-C 105.263 -3.135 . . . . 0.0 105.263 -171.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.636 ' ND2' ' N ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.63 -171.41 1.98 Allowed 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 20.5 tttp -143.93 99.64 3.43 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.605 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 48.6 t -76.93 163.63 26.55 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.361 -1.736 . . . . 0.0 108.716 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.3 mm -147.36 118.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.102 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.7 144.16 26.98 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.297 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 32' ' ' SER . . . -48.56 -80.63 0.06 OUTLIER Glycine 0 N--CA 1.499 2.842 0 C-N-CA 117.908 -2.091 . . . . 0.0 110.631 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.652 ' H ' ' HA ' ' A' ' 35' ' ' GLU . 5.2 t 138.84 -93.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.605 1.193 . . . . 0.0 108.359 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -79.2 40.52 0.42 Allowed 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 112.831 -1.986 . . . . 0.0 107.967 177.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 32' ' ' SER . . . 152.35 33.42 0.03 OUTLIER Glycine 0 C--N 1.286 -2.225 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 -176.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.652 ' HA ' ' H ' ' A' ' 32' ' ' SER . 42.3 mt-10 -26.25 104.06 0.02 OUTLIER 'General case' 0 CA--C 1.462 -2.42 0 CA-C-O 123.698 1.713 . . . . 0.0 114.007 -177.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' N ' ' H ' ' A' ' 31' ' ' GLY . 8.5 mttp -87.79 -141.38 0.12 Allowed 'General case' 1 C--N 1.24 -4.181 0 CA-C-N 110.386 -3.097 . . . . 0.0 104.077 170.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.605 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER 174.22 114.69 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.973 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.938 -176.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 11.6 tt0 -124.76 163.36 22.27 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -124.05 65.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 t -89.44 131.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.914 -1.514 . . . . 0.0 111.816 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 42' ' ' GLY . 1.9 t -44.83 170.45 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.55 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 131.89 -111.64 1.08 Allowed Glycine 0 N--CA 1.494 2.502 1 N-CA-C 130.141 6.816 . . . . 0.0 130.141 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASN . 37.1 mt-10 -77.14 -144.53 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.092 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.2 96.3 0.1 Allowed Glycine 0 C--N 1.288 -2.123 0 C-N-CA 118.263 -1.922 . . . . 0.0 112.236 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.72 123.44 34.73 Favored Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.82 176.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.67 118.09 4.73 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.489 1.46 . . . . 0.0 110.561 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -47.14 105.97 0.54 Allowed Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.686 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.5 104.0 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.798 0.999 . . . . 0.0 111.323 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 116.456 -1.735 . . . . 0.0 110.171 179.548 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.26 169.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.249 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.417 ' HB3' HD22 ' A' ' 37' ' ' ASN . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 2.4 t30 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.675 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 9' ' ' SER . 11.3 mt -85.19 140.04 31.2 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 84.1 86.89 0.86 Allowed Glycine 0 N--CA 1.507 3.419 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.676 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -140.14 76.02 1.54 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.495 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER 42.25 68.24 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.911 -0.715 . . . . 0.0 111.126 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.8 0.28 62.38 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.441 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 37' ' ' ASN . 3.9 mm-40 -127.48 91.35 3.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.05 0.928 . . . . 0.0 110.383 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -72.07 13.06 0.34 Allowed 'General case' 1 C--N 1.243 -4.055 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.827 -179.951 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -176.13 107.99 0.08 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.095 -175.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.543 ' N ' HD21 ' A' ' 37' ' ' ASN . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' C ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.97 106.98 0.51 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.7 Cg_endo -61.82 102.03 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.455 0.77 . . . . 0.0 110.771 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.798 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.483 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 22.8 t -117.94 176.74 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 19.6 m-85 -147.61 -114.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.461 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p -162.55 172.92 14.69 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.436 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.26 126.81 33.07 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.581 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 178.33 0.09 Allowed 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 122.781 1.277 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -151.96 18.32 0.68 Allowed 'General case' 0 C--N 1.258 -3.412 0 CA-C-N 111.923 -2.399 . . . . 0.0 106.311 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -161.43 134.27 6.17 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 117.73 -1.588 . . . . 0.0 114.789 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.479 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -63.59 154.23 33.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.507 172.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.25 -20.9 40.61 Favored Glycine 0 C--N 1.287 -2.143 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.953 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -82.59 -174.03 4.97 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.908 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.6 -36.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.609 -176.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 61.0 mt -76.11 11.5 1.46 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.501 -1.28 . . . . 0.0 110.187 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.537 ' H ' ' C ' ' A' ' 12' ' ' ASN . 5.1 p -104.08 174.58 5.81 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.07 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -78.07 74.77 4.61 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 122.855 1.312 . . . . 0.0 108.208 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -71.02 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 111.803 -2.453 . . . . 0.0 110.076 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 3.9 mm-40 -76.04 121.46 22.79 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.709 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.33 -144.93 23.79 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.482 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -91.24 4.16 53.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.589 1.185 . . . . 0.0 109.139 178.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -83.31 146.55 28.45 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.742 -2.026 . . . . 0.0 111.403 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.9 t -82.32 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.529 -1.268 . . . . 0.0 110.342 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.6 -130.43 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -168.37 109.93 0.36 Allowed Glycine 0 C--N 1.276 -2.793 0 C-N-CA 118.315 -1.898 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 26' ' ' ASN . 10.8 tt0 -35.11 154.38 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.032 178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -17.25 27.36 Favored Glycine 0 C--N 1.29 -1.987 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.521 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 27.6 t30 -96.56 -157.96 0.62 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.549 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -159.07 98.67 1.47 Allowed 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.702 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 53.2 t -78.23 166.03 23.21 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.199 -1.8 . . . . 0.0 110.541 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.489 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 7.6 mm -137.89 108.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.003 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' H ' ' HB3' ' A' ' 9' ' ' SER . 96.1 mt -86.49 108.36 18.5 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.121 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.636 ' O ' ' N ' ' A' ' 34' ' ' GLY . . . 0.42 67.91 0.0 OUTLIER Glycine 0 C--O 1.188 -2.761 1 N-CA-C 129.041 6.376 . . . . 0.0 129.041 173.629 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -23.69 86.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.958 1.034 . . . . 0.0 109.446 175.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 31' ' ' GLY . 32.6 t0 61.79 54.67 2.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 31' ' ' GLY . . . 84.48 9.37 81.7 Favored Glycine 0 N--CA 1.484 1.861 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.562 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 31' ' ' GLY . 5.3 mm-40 -75.24 -95.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.555 -1.258 . . . . 0.0 113.19 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.621 ' N ' ' CA ' ' A' ' 31' ' ' GLY . 19.9 mttp -82.25 -131.73 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER 127.88 37.68 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.897 -2.41 . . . . 0.0 106.106 -169.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 tt0 -79.88 164.53 23.49 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.211 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.78 65.65 1.03 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -105.3 127.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 118.226 -1.39 . . . . 0.0 113.121 -172.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.469 ' HG1' ' N ' ' A' ' 42' ' ' GLY . 5.5 t -53.98 156.41 2.96 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.505 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' N ' ' HG1' ' A' ' 41' ' ' THR . . . 171.63 -62.89 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.763 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.61 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -121.93 -141.32 0.33 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.639 0.733 . . . . 0.0 110.728 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.61 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -172.66 70.53 0.1 Allowed Glycine 0 N--CA 1.493 2.456 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.81 109.29 60.86 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.737 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.12 121.79 7.54 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.201 1.267 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -50.0 -48.5 78.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.268 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 2.9 Cg_endo -62.66 146.8 95.32 Favored 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 120.575 0.85 . . . . 0.0 111.352 173.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.417 -1.754 . . . . 0.0 110.603 178.689 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.476 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 12.4 p . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.84 162.73 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.519 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.435 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 45.1 m-85 -131.54 -117.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 3.0 p -161.45 166.54 27.1 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.821 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.74 127.74 33.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.029 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' HA ' HE22 ' A' ' 11' ' ' GLN . 2.9 m -44.91 154.09 0.15 Allowed 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.986 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.774 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -149.78 18.8 0.9 Allowed 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.591 174.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -164.73 120.07 1.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.967 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -49.21 154.15 0.87 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.147 178.143 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.93 -1.89 85.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.367 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.774 HE22 ' H ' ' A' ' 7' ' ' THR . 6.1 mt-30 -73.95 -172.29 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.115 -1.434 . . . . 0.0 108.28 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.702 HD22 ' H ' ' A' ' 44' ' ' GLY . 5.1 m-20 -136.77 -82.04 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 117.516 -1.674 . . . . 0.0 115.282 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 19.9 mt -73.16 34.64 0.08 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.347 -172.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.585 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.1 p -103.07 174.42 5.88 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.26 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.81 77.69 10.03 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.839 1.304 . . . . 0.0 108.505 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.9 m -73.5 -87.45 0.03 OUTLIER 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.442 -176.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.93 107.51 7.05 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.668 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.4 -147.29 50.62 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.909 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -87.52 4.69 42.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.278 1.037 . . . . 0.0 110.1 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.46 140.25 32.45 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 113.268 -1.787 . . . . 0.0 111.642 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 36.7 t -82.91 155.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.334 -1.347 . . . . 0.0 109.91 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.535 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.5 m -141.41 -163.79 1.63 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.673 ' N ' ' ND2' ' A' ' 26' ' ' ASN . . . 105.61 -60.32 0.39 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 118.094 -2.003 . . . . 0.0 112.973 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 8.7 tt0 -66.8 110.32 3.24 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.131 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 -7.34 76.32 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.673 ' ND2' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.01 -171.19 2.56 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.919 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -155.4 114.01 3.5 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.028 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.1 m -82.96 149.8 26.79 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.064 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.5 mm -138.5 118.3 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.858 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' SER . 13.7 mt -91.04 140.55 29.72 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.799 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.31 88.48 0.02 OUTLIER Glycine 0 N--CA 1.501 3.025 0 C-N-CA 118.643 -1.741 . . . . 0.0 111.315 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -137.08 79.64 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.723 0.773 . . . . 0.0 109.151 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 55.1 58.58 4.61 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.328 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.74 -6.56 70.33 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.696 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 37' ' ' ASN . 14.0 mt-10 -106.31 89.86 3.18 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.691 1.234 . . . . 0.0 110.007 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.27 5.08 0.79 Allowed 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 112.503 -2.135 . . . . 0.0 111.598 -179.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.676 ' ND2' ' N ' ' A' ' 38' ' ' GLN . 1.3 t-20 178.36 134.62 0.08 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.167 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.676 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 8.2 tt0 -146.45 174.19 11.62 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.66 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.79 61.54 1.65 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -80.05 129.88 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.309 -172.064 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.9 t -25.91 156.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.875 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.97 -139.6 11.56 Favored Glycine 0 N--CA 1.492 2.423 1 N-CA-C 131.506 7.362 . . . . 0.0 131.506 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.56 109.51 3.28 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.702 ' H ' HD22 ' A' ' 12' ' ' ASN . . . -107.07 -110.25 3.45 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.858 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.02 139.41 7.31 Favored Pre-proline 0 C--N 1.299 -1.596 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.473 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.0 Cg_exo -58.63 125.76 19.29 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 N-CA-C 109.41 -1.035 . . . . 0.0 109.41 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.5 tmtt? -44.38 114.76 2.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.827 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.42 142.29 70.29 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.841 1.027 . . . . 0.0 111.945 -173.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 116.305 -1.807 . . . . 0.0 110.479 179.566 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.506 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 43.4 t -129.56 175.81 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.576 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.506 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 24.9 m-85 -108.66 -117.74 0.27 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.681 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 6.7 p -161.21 174.29 13.84 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.897 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.33 131.74 35.68 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -48.85 158.81 0.29 Allowed 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.902 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -145.8 13.74 1.34 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.991 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -166.96 121.23 1.04 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.815 -177.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.55 156.6 0.43 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.266 176.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.27 -23.26 28.11 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.057 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' GLY . 11.1 mm-40 -54.07 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.568 -179.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.21 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.519 -1.672 . . . . 0.0 114.28 177.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 19.9 mt -130.52 11.56 5.33 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' A' ' 16' ' ' CYS . 26.5 p -102.78 178.23 4.62 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.319 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mt -77.09 73.09 3.68 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 123.057 1.408 . . . . 0.0 107.656 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 31.7 t -77.14 -75.86 0.19 Allowed 'General case' 0 C--N 1.254 -3.558 0 CA-C-N 111.863 -2.426 . . . . 0.0 110.507 -175.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.415 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.94 -126.25 26.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -1.74 24.13 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.678 1.227 . . . . 0.0 108.703 178.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -83.26 151.7 25.5 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.865 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 43.3 t -81.21 149.21 5.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.301 -1.359 . . . . 0.0 111.273 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -73.74 -140.78 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 175.288 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.24 110.48 0.4 Allowed Glycine 0 C--N 1.281 -2.501 0 C-N-CA 117.488 -2.291 . . . . 0.0 111.135 176.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -32.69 145.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.489 -0.856 . . . . 0.0 110.515 177.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.17 -2.79 63.77 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 -174.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.5 ' ND2' ' C ' ' A' ' 39' ' ' CYS . 8.9 t30 -117.1 -157.91 0.68 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.952 -1.124 . . . . 0.0 109.188 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HZ3' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -160.68 102.85 1.35 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.665 176.55 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 10' ' ' GLY . 43.9 t -78.35 165.9 23.29 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 117.7 -1.6 . . . . 0.0 110.146 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 11.8 mm -149.12 120.25 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.409 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.7 mt -78.18 77.24 4.68 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.442 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' CA ' ' CB ' ' A' ' 36' ' ' LYS . . . -17.18 -43.25 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 1 N-CA-C 127.735 5.854 . . . . 0.0 127.735 -177.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.07 89.25 0.08 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.572 177.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.04 41.37 8.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.133 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.43 8.97 67.5 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.678 -1.248 . . . . 0.0 110.42 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -74.69 -92.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.931 0.872 . . . . 0.0 112.831 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -70.52 44.85 0.08 Allowed 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 113.791 -1.55 . . . . 0.0 114.863 -174.526 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.512 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -45.71 90.21 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.595 174.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 36' ' ' LYS . 7.3 tt0 -105.76 164.83 11.62 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.233 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -121.2 71.67 0.96 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -177.304 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -96.55 120.85 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 118.194 -1.402 . . . . 0.0 114.78 -171.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.1 t -19.75 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 112.456 -2.156 . . . . 0.0 113.781 171.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.24 -151.01 20.15 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.25 122.86 7.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.187 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 -95.56 0.19 Allowed Glycine 0 N--CA 1.478 1.493 1 N-CA-C 131.52 7.368 . . . . 0.0 131.52 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.0 104.48 20.59 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.529 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -70.41 103.36 1.26 Allowed 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.003 1.135 . . . . 0.0 110.484 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.17 126.28 15.01 Favored Pre-proline 0 CA--C 1.563 1.448 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.571 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.46 138.58 39.12 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 120.508 0.805 . . . . 0.0 110.324 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.614 -179.836 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.46 161.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.893 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -140.63 -112.93 0.14 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.886 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.54 171.85 17.48 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.003 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -94.46 133.67 37.81 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.283 -177.55 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -56.4 156.59 5.79 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.84 176.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.453 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -143.08 9.38 1.69 Allowed 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.71 173.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 7' ' ' THR . 12.3 mt-10 -164.95 145.96 7.58 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.502 -179.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.494 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -59.67 152.72 21.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.532 176.448 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 97.7 -17.65 58.55 Favored Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.137 -1.506 . . . . 0.0 112.376 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.437 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 10.3 mm-40 -61.41 -166.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.022 -179.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.592 HD22 ' H ' ' A' ' 26' ' ' ASN . 1.7 m-20 -158.48 -68.18 0.09 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.748 -178.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.63 18.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.277 -176.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.4 p -100.39 175.96 5.52 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.731 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mt -79.87 73.53 6.62 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.793 1.282 . . . . 0.0 108.417 -177.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 43.4 t -72.32 -83.41 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 112.39 -2.186 . . . . 0.0 110.226 -177.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -75.2 110.82 9.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.341 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.04 -139.91 43.1 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -95.68 3.7 53.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.54 1.162 . . . . 0.0 109.276 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-N 112.898 -1.956 . . . . 0.0 111.467 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.8 t -80.18 144.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -78.67 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.429 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -146.31 96.01 0.18 Allowed Glycine 0 C--N 1.282 -2.463 1 N-CA-C 129.618 6.607 . . . . 0.0 129.618 179.074 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.487 ' C ' ' O ' ' A' ' 23' ' ' GLY . 35.2 tp60 -33.88 121.48 0.44 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.658 178.024 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.06 -6.77 34.95 Favored Glycine 0 C--N 1.291 -1.968 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 -172.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.592 ' H ' HD22 ' A' ' 12' ' ' ASN . 13.5 t30 -118.22 -167.61 1.38 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.316 -0.942 . . . . 0.0 109.292 177.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -142.1 106.41 4.8 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.267 176.206 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLY . 7.9 t -76.11 158.55 31.65 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 116.413 -2.115 . . . . 0.0 108.262 177.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.483 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 14.6 mm -147.11 124.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.274 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.494 ' H ' ' HB3' ' A' ' 9' ' ' SER . 8.3 mt -95.67 130.45 42.55 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.402 175.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 64.69 92.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.85 -1.643 . . . . 0.0 111.899 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -124.16 78.2 1.62 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.31 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.4 t0 51.17 45.23 28.15 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.01 178.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 3.63 28.09 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.704 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 36' ' ' LYS . 41.3 mt-10 -125.26 99.06 5.9 Favored 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 121.953 0.883 . . . . 0.0 109.596 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -56.29 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.247 -3.865 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.803 -179.239 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -57.32 139.9 51.6 Favored 'General case' 1 C--N 1.229 -4.641 0 CA-C-N 112.979 -1.919 . . . . 0.0 110.528 177.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 24.0 tt0 -151.57 165.46 34.21 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.532 ' C ' HD22 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -125.38 66.75 1.14 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -100.71 117.75 46.4 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 118.281 -1.368 . . . . 0.0 110.685 -175.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.2 150.48 3.29 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.25 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.23 -37.56 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.268 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 22.4 tt0 -157.29 -129.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.821 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.75 97.41 0.13 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.616 -1.278 . . . . 0.0 111.314 176.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.23 107.96 60.7 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.492 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.25 101.54 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.785 0.99 . . . . 0.0 110.262 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.35 104.5 0.36 Allowed Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.276 -178.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -59.99 113.14 1.52 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.597 0.865 . . . . 0.0 111.051 -177.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 . . . . . 0 C--N 1.305 -1.353 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.799 -179.448 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.26 169.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.249 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.417 ' HB3' HD22 ' A' ' 37' ' ' ASN . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 2.4 t30 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.675 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 9' ' ' SER . 11.3 mt -85.19 140.04 31.2 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 84.1 86.89 0.86 Allowed Glycine 0 N--CA 1.507 3.419 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.676 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -140.14 76.02 1.54 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.495 177.521 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER 42.25 68.24 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.911 -0.715 . . . . 0.0 111.126 178.321 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.8 0.28 62.38 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.441 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 37' ' ' ASN . 3.9 mm-40 -127.48 91.35 3.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.05 0.928 . . . . 0.0 110.383 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -72.07 13.06 0.34 Allowed 'General case' 1 C--N 1.243 -4.055 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.827 -179.951 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -176.13 107.99 0.08 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.095 -175.333 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.543 ' N ' HD21 ' A' ' 37' ' ' ASN . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' C ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.97 106.98 0.51 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.7 Cg_endo -61.82 102.03 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.455 0.77 . . . . 0.0 110.771 -178.022 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.798 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.83 4.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' O ' ' CG2' ' A' ' 4' ' ' THR . 65.0 m-85 -132.76 -130.28 0.18 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.651 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 6.9 p -165.23 177.71 7.44 Favored 'General case' 0 C--N 1.256 -3.459 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.622 -176.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.76 129.93 34.76 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.422 178.13 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -43.69 158.16 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.594 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -138.31 10.7 2.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.541 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -165.43 130.04 2.42 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.42 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.45 153.02 0.39 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.608 -0.837 . . . . 0.0 108.754 172.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 80.35 19.38 69.2 Favored Glycine 0 C--N 1.278 -2.666 0 C-N-CA 119.994 -1.098 . . . . 0.0 112.45 -178.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 11.1 mm-40 -89.95 -166.32 1.56 Allowed 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.919 178.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.611 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.0 m120 -153.5 -72.46 0.13 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 37.5 mt -71.82 17.16 0.1 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.566 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.611 ' H ' ' C ' ' A' ' 12' ' ' ASN . 26.7 p -103.93 176.48 5.14 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.218 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 15' ' ' LEU . 5.1 mt -80.77 72.72 7.75 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 122.676 1.227 . . . . 0.0 108.156 -177.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 99.6 m -70.93 -79.51 0.06 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 112.555 -2.112 . . . . 0.0 110.315 -176.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 3.2 mp0 -74.36 91.97 2.26 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.061 -1.456 . . . . 0.0 108.788 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.78 -140.36 31.48 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.188 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -86.76 4.09 42.33 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.016 0.912 . . . . 0.0 110.65 -178.916 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -90.87 140.01 30.21 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.235 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 22' ' ' CYS . 12.6 t -80.48 146.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.73 177.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.532 ' SG ' ' OE1' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -100.0 -146.96 0.34 Allowed 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.327 176.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -157.18 123.05 1.24 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 116.721 -2.656 . . . . 0.0 111.885 -177.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.616 HE22 ' CA ' ' A' ' 46' ' ' PRO . 5.2 tp-100 -35.25 160.76 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.036 -1.582 . . . . 0.0 110.052 175.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.78 52.73 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 -174.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' A' ' 41' ' ' THR . 18.1 t30 -109.15 -163.43 0.87 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.249 -0.976 . . . . 0.0 109.23 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.39 96.75 1.19 Allowed 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.241 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -84.1 126.08 32.75 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 117.896 -1.522 . . . . 0.0 112.306 -178.413 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 37' ' ' ASN . 11.4 mm -99.32 116.56 42.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.275 -176.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.6 mt -74.54 135.55 42.15 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.429 ' HA2' ' N ' ' A' ' 36' ' ' LYS . . . -61.08 66.18 0.01 OUTLIER Glycine 0 N--CA 1.477 1.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.861 172.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.659 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.2 t -67.78 -123.12 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.3 70.36 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.088 0 O-C-N 125.295 1.622 . . . . 0.0 110.026 -179.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 56.67 41.97 90.48 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -178.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -96.39 -127.1 0.14 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.384 -177.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 5.8 mmtm -98.31 -118.69 0.14 Allowed 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.627 -176.026 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 29' ' ' ILE . 1.6 t-20 114.18 40.37 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 111.992 -2.367 . . . . 0.0 106.675 -170.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 5.1 tt0 -103.03 -165.28 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.029 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -147.98 89.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.268 -177.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -105.62 123.68 60.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 112.982 -1.917 . . . . 0.0 113.169 -176.7 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.3 t -6.35 144.05 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 112.534 -2.121 . . . . 0.0 113.824 171.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 136.07 172.15 12.54 Favored Glycine 0 N--CA 1.487 2.095 1 N-CA-C 130.979 7.151 . . . . 0.0 130.979 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.47 94.76 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.953 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.17 -113.33 3.52 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -164.07 134.18 3.18 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.725 -179.898 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.616 ' CA ' HE22 ' A' ' 24' ' ' GLN . 9.5 Cg_endo -76.81 98.62 1.23 Allowed 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.458 1.439 . . . . 0.0 110.481 173.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.4 tttp -43.15 105.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.203 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.53 -168.63 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.449 0.766 . . . . 0.0 110.993 -177.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.481 ' NE2' ' H ' ' A' ' 49' ' ' GLN . 2.0 mp0 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 116.432 -1.747 . . . . 0.0 110.606 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.7 t -82.48 6.43 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.856 -178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.83 -121.8 0.21 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.709 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 1.8 t -170.71 178.86 3.42 Favored 'General case' 0 C--N 1.254 -3.56 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.251 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.555 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -95.12 131.22 41.37 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.155 -178.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.406 ' HA ' HE22 ' A' ' 11' ' ' GLN . 1.9 m -47.65 153.88 0.53 Allowed 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.8 177.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -148.57 18.03 1.03 Allowed 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.87 174.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.11 122.84 1.89 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.709 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -52.55 146.73 9.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.575 0.703 . . . . 0.0 110.663 178.835 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 98.96 -0.34 57.55 Favored Glycine 0 C--N 1.277 -2.749 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.66 178.112 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.4 mt-30 -88.39 179.17 6.38 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.653 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -148.0 -42.16 0.16 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.423 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.2 mp -75.76 22.88 0.13 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.608 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.559 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.2 p -121.8 177.21 5.37 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.602 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.8 mt -79.5 74.73 6.14 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 122.672 1.225 . . . . 0.0 108.915 -176.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.8 m -69.89 -77.77 0.08 Allowed 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.03 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.77 114.99 17.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.785 -179.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.42 -120.76 24.13 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.255 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -111.71 4.59 18.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.486 1.136 . . . . 0.0 109.821 -179.327 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -88.72 143.9 26.62 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.911 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 12.8 t -83.03 136.73 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.342 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -140.2 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.541 174.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.86 123.77 1.18 Allowed Glycine 0 C--N 1.27 -3.103 0 C-N-CA 116.58 -2.724 . . . . 0.0 111.58 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -33.94 150.78 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 113.009 -1.596 . . . . 0.0 109.078 175.687 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 96.99 -12.7 65.55 Favored Glycine 0 C--N 1.29 -2.007 0 N-CA-C 106.359 -2.696 . . . . 0.0 106.359 -173.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.5 t-20 -114.15 -163.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.904 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -157.36 99.28 1.76 Allowed 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.395 176.148 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 10' ' ' GLY . 3.6 m -78.38 149.78 33.3 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.6 -1.64 . . . . 0.0 109.848 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.3 mm -128.38 115.68 38.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.598 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.419 ' H ' ' HB3' ' A' ' 9' ' ' SER . 29.0 mt -70.01 132.41 45.86 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.279 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 63.64 90.18 0.03 OUTLIER Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.238 -1.458 . . . . 0.0 111.61 177.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 32' ' ' SER . 12.0 p -136.53 85.5 2.15 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.062 0.934 . . . . 0.0 109.225 176.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 t70 58.21 42.2 22.34 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.329 177.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.94 -1.25 31.68 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.671 -1.252 . . . . 0.0 111.319 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.587 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.6 mt-10 -116.64 102.0 9.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.439 1.114 . . . . 0.0 110.38 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 31' ' ' GLY . 5.9 mttp -63.95 9.36 0.07 Allowed 'General case' 1 C--N 1.243 -4.036 0 CA-C-N 113.282 -1.781 . . . . 0.0 111.494 179.504 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.587 ' H ' ' C ' ' A' ' 35' ' ' GLU . 1.8 p30 172.18 87.39 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.098 -177.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.57 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 5.3 tt0 -78.77 -179.0 6.26 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -135.47 68.81 1.45 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.878 -1.129 . . . . 0.0 107.954 178.952 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -104.22 124.51 58.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.517 -175.692 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.546 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 10.2 t -55.03 154.59 5.28 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.53 -24.05 0.15 Allowed Glycine 0 N--CA 1.494 2.505 0 CA-C-N 113.744 -1.571 . . . . 0.0 109.762 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 5.4 tt0 -159.46 -140.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA3' ' H ' ' A' ' 25' ' ' GLY . . . 163.8 102.06 0.16 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.196 -1.478 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.6 139.98 32.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.633 178.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -76.86 102.13 1.58 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.773 1.649 . . . . 0.0 109.273 172.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -56.03 -62.79 4.1 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 118.3 -1.36 . . . . 0.0 111.732 -177.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 49' ' ' GLN . 3.3 Cg_exo -50.7 112.27 0.72 Allowed 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.824 1.016 . . . . 0.0 111.57 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 116.376 -1.773 . . . . 0.0 110.432 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 2' ' ' VAL . 2.7 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' N ' ' CG2' ' A' ' 1' ' ' VAL . 4.2 t -104.04 169.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.465 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -114.08 -110.25 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.559 0.695 . . . . 0.0 110.683 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 177.2 179.22 0.24 Allowed 'General case' 0 C--N 1.261 -3.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.784 -179.097 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.572 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -82.84 130.88 35.19 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.459 -176.992 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 m -47.56 160.72 0.11 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.729 175.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 t -141.78 9.43 1.96 Allowed 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.786 175.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -168.18 154.13 7.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.218 178.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 157.16 14.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.898 176.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 91.85 -22.56 30.61 Favored Glycine 0 N--CA 1.51 3.604 0 C-N-CA 119.336 -1.411 . . . . 0.0 114.147 177.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -78.52 160.95 27.39 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.719 -177.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 28' ' ' CYS . 6.8 m-80 -151.21 21.33 0.75 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 115.535 1.679 . . . . 0.0 115.535 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.639 ' CD1' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -123.65 8.29 8.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.159 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.9 p -102.53 179.97 4.14 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.226 -178.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 mt -79.75 74.88 6.44 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.95 1.357 . . . . 0.0 108.476 -177.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.0 t -72.14 -80.77 0.06 Allowed 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 112.098 -2.319 . . . . 0.0 110.116 -177.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.31 106.86 10.51 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.957 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.58 -151.79 46.05 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.06 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -81.17 5.36 17.12 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.1 0.952 . . . . 0.0 110.332 -179.468 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -89.63 142.2 27.9 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.679 -1.601 . . . . 0.0 112.588 -176.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 43.0 t -82.56 151.2 4.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.72 178.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -103.69 -143.26 0.36 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.71 176.26 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ASN . . . -159.44 118.81 0.85 Allowed Glycine 0 C--O 1.203 -1.792 0 C-N-CA 116.782 -2.627 . . . . 0.0 112.469 -176.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.556 ' C ' ' H ' ' A' ' 26' ' ' ASN . 52.3 tt0 -35.3 162.02 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.699 -1.25 . . . . 0.0 110.179 174.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' GLN . . . 87.91 -24.29 11.33 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 106.006 -2.837 . . . . 0.0 106.006 -172.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.7 t30 -96.42 -167.17 1.53 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.35 102.88 1.24 Allowed 'General case' 0 C--N 1.265 -3.103 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.61 177.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 97.3 m -78.29 158.98 28.71 Favored 'General case' 0 CA--C 1.442 -3.184 0 C-N-CA 117.372 -1.731 . . . . 0.0 108.86 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.6 mm -142.72 114.3 3.01 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.355 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.027 174.237 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.59 123.62 18.4 Favored 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 118.132 -1.427 . . . . 0.0 109.09 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -102.25 -86.83 1.96 Allowed Glycine 0 N--CA 1.503 3.137 0 C-N-CA 119.323 -1.418 . . . . 0.0 112.877 -175.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER 168.05 115.64 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.523 -175.412 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 53.37 85.38 0.05 Allowed 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.035 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -40.93 2.59 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.129 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' O ' ' O ' ' A' ' 36' ' ' LYS . 2.0 mt-10 -84.77 9.24 14.61 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.769 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.62 ' C ' ' H ' ' A' ' 31' ' ' GLY . 11.6 mttp -48.34 -117.94 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.267 -175.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.85 89.95 0.01 OUTLIER 'General case' 0 C--N 1.245 -3.942 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.326 -177.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -81.09 171.96 14.29 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -137.5 75.58 1.54 Allowed 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.644 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -110.97 131.02 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 117.997 -1.481 . . . . 0.0 114.88 -174.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.572 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -9.15 153.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 112.296 -2.229 . . . . 0.0 115.233 172.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.38 -136.21 8.53 Favored Glycine 0 N--CA 1.495 2.616 1 N-CA-C 129.937 6.735 . . . . 0.0 129.937 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.636 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -76.55 -131.13 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.46 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.636 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 140.13 107.54 0.71 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.471 176.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.82 135.06 36.01 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.037 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -68.07 100.72 0.65 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 120.512 0.808 . . . . 0.0 110.196 173.882 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.639 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 12.4 tptm -38.63 104.89 0.32 Allowed Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.003 -179.157 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.37 129.93 20.1 Favored 'Trans proline' 0 C--O 1.217 -0.574 0 C-N-CA 120.793 0.995 . . . . 0.0 110.939 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 116.307 -1.806 . . . . 0.0 110.299 179.849 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 33.4 t -115.06 171.27 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.673 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.479 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 2.8 m-85 -118.4 -96.72 0.47 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.441 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -178.34 178.56 0.86 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.9 178.346 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.554 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.44 132.11 34.02 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.559 -175.683 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 m -48.88 160.13 0.21 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.362 176.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -152.8 14.77 0.55 Allowed 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.533 173.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 6.5 tt0 -166.2 117.97 1.03 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.982 -178.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.81 160.99 0.05 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.709 177.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.99 -29.34 8.81 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 118.839 -1.648 . . . . 0.0 112.482 -179.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 33.2 mt-30 -67.6 -168.84 0.1 Allowed 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.615 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 11.5 m-20 -166.0 -28.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 117.716 -1.594 . . . . 0.0 113.998 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.53 15.04 5.89 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.706 -178.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.5 p -105.63 177.11 4.95 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.992 -178.055 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -77.74 75.76 4.28 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.76 1.266 . . . . 0.0 108.726 -176.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 14.3 m -82.24 -72.68 0.43 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.265 -2.243 . . . . 0.0 111.251 -177.215 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.03 87.88 1.87 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.505 179.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -142.16 37.38 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.176 -1.487 . . . . 0.0 109.682 -178.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 0.98 43.34 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.187 0.994 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -90.64 150.39 21.71 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.413 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.2 t -81.3 150.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.335 -178.303 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -72.91 -136.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.542 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -169.67 111.46 0.42 Allowed Glycine 0 C--N 1.283 -2.395 0 C-N-CA 117.429 -2.32 . . . . 0.0 110.785 174.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 23' ' ' GLY . 34.9 tt0 -34.76 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.778 177.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.12 -12.46 62.23 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 -174.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.492 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 34.9 t30 -108.0 -162.09 0.81 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 40' ' ' VAL . 23.0 tttt -147.74 103.32 3.5 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.132 173.536 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 38.0 t -75.93 156.92 33.77 Favored 'General case' 0 C--N 1.272 -2.77 0 C-N-CA 117.692 -1.603 . . . . 0.0 109.752 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.0 mm -139.05 116.05 10.85 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.099 179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.9 mt -95.7 107.03 19.2 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.577 179.284 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.98 -40.5 9.83 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 117.535 -2.269 . . . . 0.0 108.304 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.36 89.22 0.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.51 0.671 . . . . 0.0 109.984 176.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 3.6 m-20 43.76 72.52 0.18 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.034 178.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.41 -1.67 88.35 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.044 176.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' A' ' 37' ' ' ASN . 8.7 mm-40 -71.74 -104.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.04 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -78.95 45.14 0.59 Allowed 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.267 1.032 . . . . 0.0 110.253 -179.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -42.61 130.42 4.03 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 113.215 -1.812 . . . . 0.0 112.814 170.685 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.513 ' HG3' ' H ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -133.25 175.48 9.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.669 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 1.3 m -137.93 67.96 1.41 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.561 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -107.19 128.18 62.34 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.809 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.04 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.461 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -52.94 151.35 4.71 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.6 -27.19 0.12 Allowed Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.404 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 26' ' ' ASN . 69.2 mt-10 -154.18 -135.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.432 0.634 . . . . 0.0 109.546 -178.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 159.71 97.93 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.684 177.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.15 144.45 52.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.249 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -78.85 130.19 9.45 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.726 1.617 . . . . 0.0 110.678 173.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -60.92 127.57 87.78 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 118.401 -1.32 . . . . 0.0 108.673 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.13 155.57 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.536 0.824 . . . . 0.0 111.231 -178.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 116.205 -1.855 . . . . 0.0 110.514 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -89.48 165.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.331 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -106.36 -114.17 0.26 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.304 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -176.63 174.3 1.87 Allowed 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.532 178.856 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.538 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.43 133.77 36.54 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.888 -175.882 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.9 m -47.35 170.26 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.458 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.457 176.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.38 10.23 1.45 Allowed 'General case' 0 C--N 1.262 -3.207 0 CA-C-N 113.406 -1.725 . . . . 0.0 107.276 172.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -169.94 128.82 0.92 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.512 -179.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -46.81 163.21 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.442 177.645 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.64 -15.46 24.96 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.011 -2.042 . . . . 0.0 111.597 178.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -58.64 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.763 -1.175 . . . . 0.0 108.613 177.95 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -145.68 -81.48 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.345 -1.742 . . . . 0.0 114.348 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.32 36.72 0.12 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.831 -173.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -101.39 -176.69 3.22 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.337 179.758 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.615 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 11.3 mt -90.99 80.61 5.72 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.925 -176.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.59 -78.64 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 CA-C-N 112.862 -1.972 . . . . 0.0 110.709 -177.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 79.7 mm-40 -86.34 110.44 19.68 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.95 -119.19 9.47 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.683 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.47 1.44 12.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.476 1.131 . . . . 0.0 109.358 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -79.77 142.04 35.75 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.06 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 38.7 t -86.31 154.29 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.42 178.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.3 m -142.46 -162.71 1.46 Allowed 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.011 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.703 ' N ' HD21 ' A' ' 26' ' ' ASN . . . 97.15 -50.37 1.48 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 117.412 -2.327 . . . . 0.0 113.518 174.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.59 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.3 tt0 -59.66 118.75 6.48 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.435 -177.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.84 -8.14 16.93 Favored Glycine 0 C--N 1.305 -1.166 0 N-CA-C 107.536 -2.226 . . . . 0.0 107.536 -176.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.703 HD21 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.97 -173.83 2.8 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.969 -179.43 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HZ3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.25 116.58 13.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.695 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' GLY . 13.5 t -79.24 153.89 29.6 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 117.421 -1.711 . . . . 0.0 110.672 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.532 ' CG1' ' HZ3' ' A' ' 27' ' ' LYS . 16.9 mm -148.36 124.59 2.51 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.479 0 CA-C-N 113.163 -1.835 . . . . 0.0 111.731 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' H ' ' HB3' ' A' ' 9' ' ' SER . 3.4 mt -99.67 135.13 41.54 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.615 176.796 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 64.33 92.74 0.03 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 118.546 -1.788 . . . . 0.0 110.884 178.582 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -129.14 84.63 2.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.633 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' SER . 49.9 t0 39.55 50.63 2.17 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.218 176.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.11 19.75 9.26 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.282 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 32' ' ' SER . 15.0 mt-10 -147.6 103.68 3.55 Favored 'General case' 0 C--O 1.198 -1.637 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.817 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 35' ' ' GLU . 1.1 mptp? -56.85 -121.28 0.0 OUTLIER 'General case' 0 C--N 1.255 -3.506 0 CA-C-O 122.761 1.267 . . . . 0.0 109.189 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.04 149.94 22.14 Favored 'General case' 1 C--N 1.236 -4.367 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.696 176.584 . . . . . . . . 4 4 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' OE1' ' A' ' 35' ' ' GLU . 11.3 tt0 -160.02 170.11 22.0 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.92 177.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.445 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 22.1 m -131.41 64.69 1.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -79.98 125.84 39.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.855 -173.487 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 6.5 t -29.06 155.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 113.087 -1.869 . . . . 0.0 112.373 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.73 -154.3 16.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -142.11 124.73 15.85 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.472 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.09 -113.48 3.81 Favored Glycine 0 N--CA 1.479 1.527 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.887 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.88 141.19 7.44 Favored Pre-proline 0 C--N 1.296 -1.736 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.746 -178.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.9 Cg_endo -67.43 111.8 2.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.881 1.054 . . . . 0.0 109.412 174.181 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' PRO . 14.4 tttp -39.85 101.39 0.23 Allowed Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.613 -178.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.83 -169.2 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.986 1.124 . . . . 0.0 111.712 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.409 -1.758 . . . . 0.0 110.558 179.752 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.14 170.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.688 -178.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -110.31 -116.69 0.3 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.657 0.742 . . . . 0.0 110.029 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -165.26 175.76 8.97 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.686 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.13 134.5 36.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.921 0.867 . . . . 0.0 112.723 -174.576 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.435 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 3.2 m -48.81 158.07 0.34 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.886 176.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -140.69 7.07 2.08 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.253 174.088 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.62 126.7 0.9 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.288 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.469 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -50.51 157.54 0.72 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.489 175.765 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.15 -3.41 84.57 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.66 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.541 HE22 ' CG ' ' A' ' 47' ' ' LYS . 12.5 mt-30 -86.55 -166.19 1.49 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.502 178.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.606 HD22 ' H ' ' A' ' 44' ' ' GLY . 6.2 m-20 -139.83 -80.49 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -175.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mt -71.63 41.67 0.08 Allowed 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.651 -172.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.513 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.8 p -107.75 178.75 4.43 Favored 'General case' 0 C--O 1.194 -1.834 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.854 176.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -89.78 79.72 6.66 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 123.05 1.405 . . . . 0.0 108.286 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 33.9 t -61.99 -94.48 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.024 0 CA-C-N 111.832 -2.44 . . . . 0.0 111.191 -176.47 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.43 122.29 26.8 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.421 -1.311 . . . . 0.0 109.592 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.63 -123.82 23.14 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.327 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -116.23 2.75 13.35 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 122.393 1.092 . . . . 0.0 109.652 -179.598 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.73 144.92 30.79 Favored 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.761 -177.196 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 22.8 t -86.67 149.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.645 178.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -136.64 -165.1 1.67 Allowed 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 174.529 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.686 ' N ' ' ND2' ' A' ' 26' ' ' ASN . . . 112.67 -68.52 0.23 Allowed Glycine 0 N--CA 1.484 1.893 0 C-N-CA 117.662 -2.209 . . . . 0.0 113.488 174.048 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.602 ' N ' HD22 ' A' ' 26' ' ' ASN . 0.2 OUTLIER -64.55 124.79 22.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.776 -175.065 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.6 -5.55 44.93 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -175.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.686 ' ND2' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -133.82 -170.66 2.55 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.674 -179.376 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 40' ' ' VAL . 19.4 tttp -156.27 105.95 2.34 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.292 177.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 11.1 m -80.48 158.86 25.76 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 117.665 -1.614 . . . . 0.0 111.038 -179.151 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mm -139.5 106.87 2.83 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.288 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.469 ' H ' ' HB3' ' A' ' 9' ' ' SER . 0.8 OUTLIER -113.55 123.7 50.62 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.932 -178.104 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.892 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . 176.75 80.85 0.05 OUTLIER Glycine 0 CA--C 1.568 3.393 0 C-N-CA 117.419 -2.324 . . . . 0.0 115.536 176.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.788 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 67.0 m -102.26 -137.96 0.34 Allowed 'General case' 0 C--O 1.197 -1.668 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 171.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -19.25 0.36 Allowed 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 123.513 1.625 . . . . 0.0 107.571 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' C ' ' A' ' 32' ' ' SER . . . -167.75 -5.6 0.03 OUTLIER Glycine 1 C--N 1.251 -4.174 0 CA-C-N 110.821 -2.9 . . . . 0.0 109.011 174.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.788 ' CA ' ' H ' ' A' ' 32' ' ' SER . 19.8 mt-10 -167.53 95.19 0.45 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -174.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.892 ' H ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -99.19 63.25 1.3 Allowed 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 172.278 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -51.37 131.73 28.82 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.351 -179.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -147.56 167.66 23.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.097 174.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 m -131.74 73.15 1.52 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -91.24 125.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.898 -173.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.3 t -32.99 159.18 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.476 177.604 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.51 -150.97 19.1 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.882 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -153.95 114.1 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.606 ' H ' HD22 ' A' ' 12' ' ' ASN . . . -104.92 -109.76 3.44 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.16 148.27 11.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.55 -177.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.27 129.07 29.83 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.11 1.207 . . . . 0.0 109.876 175.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' CG ' HE22 ' A' ' 11' ' ' GLN . 5.2 tmtm? -45.85 -50.95 32.74 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.861 -179.594 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 4.4 Cg_exo -51.38 117.43 3.44 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.515 0.81 . . . . 0.0 111.352 174.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.499 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 t -92.59 161.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.264 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -145.19 -114.0 0.09 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.009 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.36 164.22 38.94 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.9 -178.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.86 131.92 35.26 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.555 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 150.35 4.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.578 176.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -145.63 15.36 1.42 Allowed 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -162.46 113.67 1.57 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.41 -177.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -46.87 155.41 0.26 Allowed 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.515 178.258 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 10.87 85.64 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.449 -1.357 . . . . 0.0 111.293 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.618 HE22 ' HZ2' ' A' ' 47' ' ' LYS . 13.0 mt-30 -79.39 -168.52 1.55 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.814 178.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 14' ' ' CYS . 28.7 t-20 -130.95 -91.18 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 114.835 -177.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.35 37.58 0.11 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.857 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.524 ' H ' ' C ' ' A' ' 12' ' ' ASN . 21.5 p -96.37 -178.85 4.43 Favored 'General case' 0 C--O 1.192 -1.922 0 C-N-CA 118.175 -1.41 . . . . 0.0 109.721 179.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -92.92 79.8 4.64 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 122.504 1.145 . . . . 0.0 108.577 -177.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.9 t -66.97 -85.42 0.02 OUTLIER 'General case' 0 C--N 1.253 -3.593 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.42 -176.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -80.77 120.3 24.47 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.71 -121.88 26.28 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.527 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -114.99 2.9 14.36 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.635 1.207 . . . . 0.0 109.126 179.689 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' N ' HD21 ' A' ' 20' ' ' ASN . 1.4 m-80 -78.88 142.44 36.8 Favored 'General case' 0 C--N 1.26 -3.315 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.518 -178.009 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 39.2 t -85.7 153.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 118.379 -1.328 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.7 m -139.52 -166.93 2.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.183 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.685 ' N ' HD21 ' A' ' 26' ' ' ASN . . . 98.04 -47.04 1.53 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 117.268 -2.396 . . . . 0.0 114.14 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 26' ' ' ASN . 20.5 tt0 -60.49 103.21 0.22 Allowed 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.768 -176.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.32 55.82 Favored Glycine 0 C--N 1.303 -1.27 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -175.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.685 HD21 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -119.38 -164.45 1.06 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.884 -1.158 . . . . 0.0 111.102 178.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HZ3' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -159.81 134.78 7.97 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.668 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 t -94.73 159.5 15.04 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.438 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.477 ' CD1' ' HZ3' ' A' ' 27' ' ' LYS . 31.1 mm -137.27 110.06 7.6 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.413 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.786 177.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' H ' ' HB3' ' A' ' 9' ' ' SER . 63.1 mt -75.16 112.55 11.54 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.64 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.68 -44.49 12.31 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 118.985 -1.579 . . . . 0.0 109.876 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.6 t -175.48 100.66 0.08 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.022 179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.4 m-20 54.82 51.35 13.87 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.68 176.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.17 11.41 67.2 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.132 -1.509 . . . . 0.0 111.561 177.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -78.34 -107.45 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.755 -179.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -80.0 62.67 4.27 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 122.702 1.239 . . . . 0.0 112.233 -175.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -54.77 93.42 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 113.369 -1.741 . . . . 0.0 111.843 174.623 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 59.0 tt0 -82.7 162.71 21.71 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.087 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.2 m -123.9 67.74 1.04 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -85.18 131.18 34.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 117.844 -1.543 . . . . 0.0 111.78 -172.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.518 ' HG1' ' N ' ' A' ' 42' ' ' GLY . 2.2 t -36.13 165.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.272 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.518 ' N ' ' HG1' ' A' ' 41' ' ' THR . . . 125.3 -129.95 7.13 Favored Glycine 0 N--CA 1.484 1.894 1 N-CA-C 129.596 6.599 . . . . 0.0 129.596 -178.321 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -161.07 115.4 2.06 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.199 178.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.8 -106.69 2.96 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.86 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.1 140.62 8.77 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.87 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.5 Cg_endo -61.85 96.6 0.14 Allowed 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 121.132 1.221 . . . . 0.0 110.227 176.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HZ2' HE22 ' A' ' 11' ' ' GLN . 32.3 tptt -39.32 104.81 0.33 Allowed Pre-proline 0 N--CA 1.491 1.595 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.754 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.77 142.03 81.19 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.442 0.762 . . . . 0.0 110.943 178.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 116.397 -1.763 . . . . 0.0 110.539 -179.796 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t -142.61 16.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.171 -178.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 78.9 m-85 -104.66 -128.4 0.25 Allowed 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.359 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.677 -174.097 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.04 129.49 34.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.842 179.104 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.8 m -44.62 155.44 0.1 Allowed 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.17 178.238 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.75 11.48 2.26 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.978 175.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.65 134.31 4.48 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.01 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.47 155.25 3.02 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.317 176.59 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 77.62 13.56 83.37 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.485 -179.378 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -75.63 -168.65 0.88 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.014 179.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' CYS . 77.2 m-20 -151.14 -72.05 0.16 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.248 -1.381 . . . . 0.0 113.741 -178.842 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 24.0 mt -75.73 20.7 0.17 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.19 -175.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.7 p -102.77 176.68 5.08 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.383 -179.342 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' N ' HD22 ' A' ' 15' ' ' LEU . 6.6 mt -80.62 73.31 7.57 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-O 122.934 1.35 . . . . 0.0 108.194 -177.018 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.0 m -72.38 -81.69 0.05 Allowed 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.169 -175.82 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.99 112.13 12.1 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.55 -179.759 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.7 -121.76 12.97 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.97 1.91 12.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.593 1.187 . . . . 0.0 108.918 178.872 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -85.81 151.2 24.01 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.766 -177.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.8 t -84.3 142.4 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.023 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -142.37 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.897 174.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.4 120.65 0.96 Allowed Glycine 0 C--N 1.282 -2.419 0 C-N-CA 116.88 -2.581 . . . . 0.0 111.683 -178.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.6 tt0 -31.42 150.9 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.561 -1.319 . . . . 0.0 110.092 177.233 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.14 -15.01 63.72 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 106.381 -2.688 . . . . 0.0 106.381 -172.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.652 ' OD1' ' N ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -115.36 -170.84 1.84 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.625 -1.288 . . . . 0.0 108.461 177.185 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.68 ' HZ2' ' CG1' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -161.32 117.1 2.13 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.609 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -95.97 122.5 38.86 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.837 -177.189 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CG1' ' HZ2' ' A' ' 27' ' ' LYS . 26.3 mm -97.12 117.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 113.097 -1.865 . . . . 0.0 112.698 -174.084 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mt -79.42 123.29 27.38 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.422 179.654 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . -120.5 -89.58 1.12 Allowed Glycine 0 N--CA 1.507 3.396 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.33 -179.393 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.28 106.67 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.979 -176.634 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 t0 45.45 85.01 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.812 174.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 36' ' ' LYS . . . 94.82 -51.89 1.97 Allowed Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.92 -0.73 36.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.468 1.127 . . . . 0.0 108.022 176.911 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 35' ' ' GLU . 23.8 tttt -53.53 -134.73 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 111.871 -2.422 . . . . 0.0 112.307 -176.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -64.65 85.99 0.05 OUTLIER 'General case' 0 C--N 1.249 -3.791 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.767 -178.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -77.12 173.98 11.21 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 173.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.13 80.64 1.77 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.427 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -109.43 127.75 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.156 -175.231 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.652 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 t -16.71 141.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.696 172.391 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.17 -130.0 2.25 Favored Glycine 0 N--CA 1.484 1.856 1 N-CA-C 131.513 7.365 . . . . 0.0 131.513 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -161.05 100.31 1.23 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.281 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.78 -97.03 1.44 Allowed Glycine 0 N--CA 1.481 1.648 1 N-CA-C 129.105 6.402 . . . . 0.0 129.105 177.122 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.82 129.57 2.46 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.696 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.18 92.61 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.329 1.353 . . . . 0.0 110.441 172.893 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 103.54 0.29 Allowed Pre-proline 0 N--CA 1.504 2.239 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.681 -179.525 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.68 -174.24 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.351 0.701 . . . . 0.0 111.027 -179.355 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 116.275 -1.821 . . . . 0.0 110.527 -179.962 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.496 ' CG1' ' H ' ' A' ' 3' ' ' TYR . 37.6 t -78.9 173.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.871 179.779 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 9.2 m-85 -114.38 -112.65 0.34 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.555 0.693 . . . . 0.0 110.253 -178.565 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -169.22 -174.4 1.98 Allowed 'General case' 0 C--N 1.255 -3.51 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.305 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.594 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.86 135.73 33.27 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.044 -177.301 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.76 155.38 0.58 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.648 175.284 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -133.46 4.82 3.7 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.952 176.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.405 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 7.1 pt-20 -168.51 132.55 1.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.757 179.585 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -42.0 166.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.668 176.565 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 68.17 20.48 73.12 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.806 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.485 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -85.58 -172.78 4.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.864 -179.463 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' CYS . 3.1 m120 -154.95 -67.29 0.13 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.415 -1.314 . . . . 0.0 113.952 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 5.2 mt -74.07 22.9 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.455 -176.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ASN . 16.8 p -115.36 179.49 3.95 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 15' ' ' LEU . 5.5 mt -81.04 72.15 8.06 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.444 -178.195 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.0 m -70.39 -83.22 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.517 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.009 -177.145 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 37' ' ' ASN . 1.3 tm-20 -77.45 122.62 25.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.336 -1.346 . . . . 0.0 109.93 178.964 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.18 -125.0 38.39 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.793 -178.361 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -114.02 4.61 15.77 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.893 1.33 . . . . 0.0 108.278 178.64 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 142.68 34.86 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 111.965 -2.379 . . . . 0.0 111.877 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 5.0 t -84.22 135.43 24.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.12 -1.432 . . . . 0.0 109.624 176.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.56 -143.33 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.726 175.439 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -166.91 119.32 0.84 Allowed Glycine 0 C--N 1.275 -2.857 0 C-N-CA 117.533 -2.27 . . . . 0.0 110.671 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.485 HE22 ' CG ' ' A' ' 12' ' ' ASN . 3.5 tp-100 -35.09 151.06 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.416 177.085 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.57 -13.3 67.83 Favored Glycine 0 C--N 1.292 -1.89 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -172.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 41' ' ' THR . 27.2 t30 -111.4 -161.75 0.77 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.198 -1.001 . . . . 0.0 109.208 177.166 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HZ3' ' CG1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.92 110.63 1.47 Allowed 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.18 179.055 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -105.26 125.28 50.81 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.004 177.7 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.493 ' CG1' ' HZ3' ' A' ' 27' ' ' LYS . 37.0 mm -105.0 113.86 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.209 -178.553 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.61 120.92 22.48 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.673 -177.177 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.96 -57.13 21.32 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.954 177.575 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -168.16 90.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.76 179.338 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER 65.59 52.31 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.63 178.406 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.57 0.41 73.13 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.2 -101.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.614 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -93.27 61.94 3.39 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.057 -177.414 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.521 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -80.32 146.3 31.67 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.262 175.707 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.495 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 9.7 tt0 -119.82 170.63 9.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.161 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.495 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -139.86 82.56 1.88 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.267 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -125.08 141.31 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.354 -176.674 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.528 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -16.76 152.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 112.408 -2.178 . . . . 0.0 113.519 171.749 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.54 -143.26 12.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.73 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.91 111.51 1.76 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.818 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.85 -88.22 0.82 Allowed Glycine 0 N--CA 1.491 2.333 1 N-CA-C 129.77 6.668 . . . . 0.0 129.77 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -147.18 124.12 5.71 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.989 178.152 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.45 98.96 1.25 Allowed 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.474 1.449 . . . . 0.0 111.123 175.394 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -54.11 113.61 5.32 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.463 179.31 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.61 148.92 85.44 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.667 0.911 . . . . 0.0 111.218 -177.445 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.51 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 116.369 -1.777 . . . . 0.0 110.283 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 3' ' ' TYR . 7.0 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.517 ' C ' HG22 ' A' ' 4' ' ' THR . 32.8 m-85 -120.12 -110.46 0.34 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.268 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 173.15 178.71 0.09 Allowed 'General case' 0 C--N 1.258 -3.395 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -76.47 130.18 37.6 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.644 -1.223 . . . . 0.0 111.175 -176.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 96.2 m -40.6 168.06 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.15 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 HG22 ' NZ ' ' A' ' 47' ' ' LYS . 14.9 t -143.66 11.85 1.67 Allowed 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 113.066 -1.879 . . . . 0.0 107.626 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -173.9 125.76 0.36 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.433 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -47.1 158.06 0.15 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.224 178.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 95.57 -28.26 12.88 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.588 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.89 176.92 0.49 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.938 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -156.49 20.18 0.34 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 116.947 -1.901 . . . . 0.0 114.863 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.764 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -134.14 16.0 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.064 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -102.04 -179.62 4.05 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.025 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.1 mt -77.85 72.69 4.4 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.003 1.383 . . . . 0.0 108.003 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.4 t -77.68 -82.85 0.08 Allowed 'General case' 0 C--N 1.25 -3.733 0 CA-C-N 112.051 -2.341 . . . . 0.0 110.356 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.81 110.86 9.46 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.859 -1.536 . . . . 0.0 108.505 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.3 -154.56 33.52 Favored Glycine 0 N--CA 1.479 1.528 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -82.8 5.56 21.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.52 1.153 . . . . 0.0 109.324 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.42 149.01 25.3 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.657 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 HG13 ' C ' ' A' ' 13' ' ' LEU . 28.1 t -82.65 144.56 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.027 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -71.15 -144.67 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.965 177.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -141.3 82.91 0.23 Allowed Glycine 0 C--N 1.282 -2.464 1 N-CA-C 128.17 6.028 . . . . 0.0 128.17 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -19.22 126.0 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 124.595 0.82 . . . . 0.0 111.483 -177.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.48 56.95 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 106.551 -2.619 . . . . 0.0 106.551 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.0 m-20 -110.12 -169.74 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.188 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.876 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -144.36 130.9 19.95 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.043 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.596 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 52.6 t -99.58 168.29 10.05 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.586 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.876 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 28.1 mm -145.95 119.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 C-N-CA 118.298 -1.361 . . . . 0.0 112.508 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 9' ' ' SER . 12.0 mt . . . . . 0 N--CA 1.494 1.754 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.49 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 120.864 0.364 . . . . 0.0 110.909 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.622 ' N ' HD22 ' A' ' 37' ' ' ASN . 35.2 tt0 -127.6 161.21 29.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.02 71.13 1.04 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -174.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -101.79 113.12 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 118.161 -1.416 . . . . 0.0 113.27 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' VAL . 7.5 t -31.11 158.69 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.421 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.64 159.51 8.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -78.12 102.59 7.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.37 -104.65 2.93 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.64 137.86 6.77 Favored Pre-proline 0 C--N 1.303 -1.418 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.908 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.708 ' HA ' HD11 ' A' ' 13' ' ' LEU . 2.9 Cg_endo -68.87 91.68 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.735 0.957 . . . . 0.0 109.681 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 47.7 tttp . . . . . 0 N--CA 1.503 2.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.262 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 3' ' ' TYR . 16.0 t . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.64 ' O ' HG23 ' A' ' 4' ' ' THR . 33.1 m-85 -114.27 -116.74 0.32 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.719 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.3 p -165.59 176.62 7.96 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.909 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.66 125.57 35.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.191 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' ' NE2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -59.84 165.59 3.09 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-O 123.594 1.664 . . . . 0.0 111.897 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -142.31 13.32 1.99 Allowed 'General case' 1 C--N 1.239 -4.197 0 CA-C-N 110.595 -3.002 . . . . 0.0 105.338 174.198 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' C ' HD12 ' A' ' 30' ' ' LEU . 16.1 mt-10 -160.31 139.47 10.73 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.584 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.63 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.65 -175.62 0.06 Allowed 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 123.236 1.493 . . . . 0.0 111.15 177.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 69.47 -36.87 0.34 Allowed Glycine 1 C--N 1.231 -5.294 0 CA-C-N 111.278 -2.692 . . . . 0.0 112.524 177.02 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.553 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -59.74 -171.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.555 -175.573 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -171.77 40.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.659 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 24' ' ' GLN . 72.9 mt -143.02 1.32 1.26 Allowed 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.477 ' C ' HD23 ' A' ' 15' ' ' LEU . 3.3 p -100.48 171.45 7.73 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.604 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.785 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -81.48 78.83 8.19 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 123.664 1.697 . . . . 0.0 107.998 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -79.76 -61.32 2.03 Favored 'General case' 1 C--N 1.235 -4.382 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.845 -178.724 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 11.4 mm-40 -73.99 72.17 1.61 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.66 -1.616 . . . . 0.0 108.284 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -113.4 4.07 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.3 p -99.91 -11.75 20.42 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-O 124.048 1.88 . . . . 0.0 109.197 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.04 119.39 19.14 Favored 'General case' 1 C--N 1.207 -5.628 0 CA-C-N 110.709 -2.95 . . . . 0.0 110.216 178.944 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 22' ' ' CYS . 25.4 t -63.41 147.11 12.39 Favored 'Isoleucine or valine' 1 C--N 1.215 -5.279 0 CA-C-N 110.956 -2.838 . . . . 0.0 107.713 175.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -77.93 -132.16 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.77 89.75 0.1 OUTLIER Glycine 1 C--N 1.224 -5.677 0 C-N-CA 115.942 -3.028 . . . . 0.0 112.36 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' ASN . 36.2 tt0 -23.67 142.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 113.782 -1.209 . . . . 0.0 110.743 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -7.42 63.4 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -173.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.2 m-20 -111.11 -166.89 1.11 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.607 -1.297 . . . . 0.0 108.91 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -147.48 98.01 2.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 10' ' ' GLY . 51.1 t -75.68 154.84 36.26 Favored 'General case' 0 CA--C 1.435 -3.448 0 C-N-CA 116.55 -2.06 . . . . 0.0 109.918 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.57 HD11 ' CE ' ' A' ' 27' ' ' LYS . 32.3 mm -139.08 120.97 16.67 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.246 0 CA-C-N 112.769 -2.014 . . . . 0.0 109.633 175.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 9' ' ' SER . 18.4 mt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 16' ' ' CYS . 45.7 t-20 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -95.48 -173.36 2.88 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.56 -1.655 . . . . 0.0 108.629 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.59 67.12 1.53 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -91.17 136.02 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 117.011 -1.876 . . . . 0.0 114.829 -171.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.631 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 t -17.83 144.5 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 110.008 -3.269 . . . . 0.0 113.127 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.26 -137.03 6.6 Favored Glycine 0 N--CA 1.484 1.878 1 N-CA-C 130.2 6.84 . . . . 0.0 130.2 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.73 98.5 0.88 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.601 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.61 -104.86 2.85 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.745 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.41 138.44 10.09 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.9 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.24 104.33 1.53 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.325 1.35 . . . . 0.0 110.715 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.905 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.961 0.41 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.651 ' CE2' HD22 ' A' ' 13' ' ' LEU . 22.0 m-85 -137.34 -111.15 0.18 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.655 0.741 . . . . 0.0 109.777 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 179.16 177.56 0.52 Allowed 'General case' 0 C--N 1.262 -3.229 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.64 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.07 131.68 37.4 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.387 -177.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.452 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 93.7 m -43.01 172.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.122 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.571 HG22 HE22 ' A' ' 11' ' ' GLN . 2.3 t -146.08 11.06 1.18 Allowed 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.727 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -168.86 123.73 0.88 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.461 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.95 149.71 1.77 Allowed 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.152 173.092 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 93.08 -0.58 69.28 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.17 -1.49 . . . . 0.0 111.613 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.571 HE22 HG22 ' A' ' 7' ' ' THR . 24.1 mt-30 -81.84 -173.6 4.55 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.695 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.566 HD21 ' C ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -167.69 30.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 116.689 -2.004 . . . . 0.0 115.348 -178.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.651 HD22 ' CE2' ' A' ' 3' ' ' TYR . 34.7 mt -146.07 14.56 1.32 Allowed 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -109.43 -179.98 3.98 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.725 -175.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.661 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 mt -76.27 70.22 2.87 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.142 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.616 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 4.1 m -75.89 -83.06 0.07 Allowed 'General case' 0 C--N 1.249 -3.761 0 CA-C-N 112.44 -2.164 . . . . 0.0 110.387 -176.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.73 107.01 6.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.108 -1.837 . . . . 0.0 108.75 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.12 -137.54 33.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.148 -1.501 . . . . 0.0 109.901 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.65 5.06 47.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.585 1.183 . . . . 0.0 109.223 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.74 145.38 27.28 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.147 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 22' ' ' CYS . 17.7 t -79.3 143.15 12.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.94 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.655 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.27 -165.27 0.39 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -152.5 98.0 0.18 Allowed Glycine 0 C--N 1.288 -2.098 0 C-N-CA 116.02 -2.991 . . . . 0.0 112.261 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.0 tt0 -27.42 148.07 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 112.207 -1.997 . . . . 0.0 111.008 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.47 53.94 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 104.795 -3.322 . . . . 0.0 104.795 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 41' ' ' THR . 2.1 t-20 -105.16 -162.28 0.87 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 112.716 -1.742 . . . . 0.0 108.536 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.445 ' N ' HD21 ' A' ' 12' ' ' ASN . 0.7 OUTLIER -149.41 104.6 3.39 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.923 ' O ' HD13 ' A' ' 29' ' ' ILE . 36.1 t -77.5 149.88 34.94 Favored 'General case' 0 C--N 1.269 -2.918 0 C-N-CA 117.095 -1.842 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.5 mm -137.14 118.72 18.5 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.194 0 CA-C-N 112.695 -2.048 . . . . 0.0 109.859 177.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.442 ' H ' ' HB3' ' A' ' 9' ' ' SER . 93.1 mt . . . . . 0 N--CA 1.505 2.3 0 C-N-CA 118.769 -1.172 . . . . 0.0 113.757 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 16' ' ' CYS . 51.2 t-20 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.652 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 1.9 tt0 -102.42 -164.33 1.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.615 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.652 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -135.62 73.26 1.46 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -92.21 120.07 40.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.986 -173.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.615 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -6.17 141.89 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 112.668 -2.06 . . . . 0.0 114.437 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.96 -177.95 19.32 Favored Glycine 0 N--CA 1.488 2.166 1 N-CA-C 130.907 7.123 . . . . 0.0 130.907 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -108.78 90.78 3.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.799 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.63 -107.05 2.66 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.175 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.36 134.91 4.82 Favored Pre-proline 0 C--N 1.301 -1.53 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' LYS . 9.2 Cg_endo -75.87 97.23 1.09 Allowed 'Trans proline' 0 C--O 1.211 -0.855 0 C-N-CA 121.41 1.407 . . . . 0.0 110.648 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.0 tttm . . . . . 0 N--CA 1.512 2.632 0 O-C-N 123.543 0.527 . . . . 0.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 2' ' ' VAL . 98.6 t . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.512 0.672 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.495 ' CE1' HD13 ' A' ' 13' ' ' LEU . 61.9 m-85 -139.4 -117.88 0.13 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.013 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 179.52 177.33 0.59 Allowed 'General case' 0 C--N 1.253 -3.588 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.443 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.569 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.14 131.57 34.22 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.325 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -48.08 155.43 0.46 Allowed 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.939 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -134.18 7.15 3.65 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.021 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.679 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -163.29 138.64 6.58 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.898 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -55.47 146.43 20.06 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.628 ' HA2' ' HG2' ' A' ' 27' ' ' LYS . . . 97.84 -16.05 60.87 Favored Glycine 0 N--CA 1.497 2.715 1 N-CA-C 127.634 5.814 . . . . 0.0 127.634 -172.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.637 HE22 ' N ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -78.8 -171.47 2.58 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 118.896 -1.121 . . . . 0.0 109.069 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.4 m120 -148.23 -53.29 0.19 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 117.562 -1.655 . . . . 0.0 115.413 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 3' ' ' TYR . 66.2 mt -73.22 14.29 0.33 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.094 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.6 p -102.58 173.88 6.14 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.42 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.9 mt -79.19 72.58 5.76 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.885 1.326 . . . . 0.0 108.283 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 88.1 m -75.29 -71.82 0.34 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 112.254 -2.248 . . . . 0.0 109.224 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 90.88 2.99 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 117.987 -1.485 . . . . 0.0 109.448 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.48 -138.31 40.53 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.413 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -0.02 50.76 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.309 1.052 . . . . 0.0 109.996 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -88.98 144.16 26.36 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.668 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.0 t -85.46 143.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.743 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.682 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -75.93 -152.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.484 173.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -150.82 98.69 0.19 Allowed Glycine 0 C--N 1.27 -3.113 0 C-N-CA 116.738 -2.648 . . . . 0.0 111.122 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.4 tt0 -27.94 147.92 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 112.413 -1.893 . . . . 0.0 110.379 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -12.22 70.32 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 43' ' ' GLU . 28.0 t30 -111.64 -159.6 0.69 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.982 -1.109 . . . . 0.0 108.989 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 30.7 tttp -157.2 111.81 2.72 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 118.656 -1.217 . . . . 0.0 111.723 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.752 ' O ' HD13 ' A' ' 29' ' ' ILE . 5.3 m -78.62 157.77 28.61 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 117.871 -1.532 . . . . 0.0 110.409 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 28' ' ' CYS . 10.7 mm -133.52 110.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.321 173.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 8' ' ' GLU . 46.8 mt . . . . . 0 N--CA 1.514 2.746 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.784 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.886 0.374 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 8.3 tt0 -78.0 175.33 10.17 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 117.687 -1.605 . . . . 0.0 106.884 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.77 74.51 1.48 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.071 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.615 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -120.12 138.91 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.355 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 3.5 t -50.4 160.89 0.35 Allowed 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.22 -23.34 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.992 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -162.99 -150.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.485 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' H ' ' CD ' ' A' ' 43' ' ' GLU . . . 176.8 85.74 0.06 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.189 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.84 139.3 29.93 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.032 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.0 Cg_endo -75.8 117.36 4.7 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.146 1.231 . . . . 0.0 110.203 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.1 tmtt? . . . . . 0 N--CA 1.498 1.937 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.472 ' C ' HG22 ' A' ' 4' ' ' THR . 2.4 m-85 -130.83 -99.48 0.32 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.538 0.685 . . . . 0.0 110.204 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 178.07 -178.92 0.26 Allowed 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.027 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.58 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -94.91 134.99 36.96 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.103 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -55.89 158.77 3.54 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.476 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -146.65 14.87 1.23 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.003 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -166.37 137.16 3.44 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.715 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.613 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -54.64 152.33 7.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.838 176.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.39 -1.99 73.61 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.088 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.27 -165.98 0.76 Allowed 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.265 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.788 HD21 ' HB3' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -164.04 -56.88 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 18.3 mt -74.87 12.99 0.72 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.592 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.2 p -105.13 178.98 4.4 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.841 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.1 mt -78.99 76.83 5.47 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-O 123.082 1.42 . . . . 0.0 108.936 -176.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.839 ' HA ' HD22 ' A' ' 37' ' ' ASN . 84.9 m -75.44 -84.83 0.05 OUTLIER 'General case' 1 C--N 1.243 -4.034 0 CA-C-N 112.027 -2.352 . . . . 0.0 111.123 -177.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.58 104.46 6.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.174 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.36 -111.38 3.46 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.916 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.28 3.99 7.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.472 1.129 . . . . 0.0 109.463 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -87.24 145.19 26.48 Favored 'General case' 0 C--N 1.257 -3.424 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.9 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.8 t -82.92 143.24 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.328 -1.349 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.788 ' HB3' HD21 ' A' ' 12' ' ' ASN . 0.1 OUTLIER -96.84 -178.22 4.16 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.028 175.121 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -121.24 116.78 3.25 Favored Glycine 0 C--N 1.278 -2.645 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.072 -169.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.735 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 2.4 pt20 -41.8 3.28 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.048 0 CA-C-N 111.345 -2.427 . . . . 0.0 114.11 174.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -102.62 16.01 55.23 Favored Glycine 0 C--N 1.262 -3.53 0 N-CA-C 105.935 -2.866 . . . . 0.0 105.935 172.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.584 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.7 t-20 -138.61 -154.53 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.619 -1.29 . . . . 0.0 108.748 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -163.0 109.3 1.17 Allowed 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.084 177.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -84.64 139.36 32.1 Favored 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.435 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.634 HD11 ' CE ' ' A' ' 27' ' ' LYS . 29.7 mm -125.77 119.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.713 -1.585 . . . . 0.0 112.123 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 9' ' ' SER . 21.6 mt . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 118.606 -1.238 . . . . 0.0 109.98 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.839 HD22 ' HA ' ' A' ' 16' ' ' CYS . 51.1 t-20 . . . . . 0 C--O 1.215 -0.746 0 CA-C-O 120.823 0.344 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 10.4 tt0 -89.05 -169.26 2.45 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.337 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.537 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -158.57 46.17 0.31 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.872 -174.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.5 m -114.39 158.44 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -12.65 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.084 0 CA-C-N 110.883 -2.871 . . . . 0.0 114.009 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 27' ' ' LYS . . . -179.77 -99.11 0.12 Allowed Glycine 0 N--CA 1.496 2.652 1 N-CA-C 132.148 7.619 . . . . 0.0 132.148 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -161.17 28.37 0.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.003 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.735 ' HA3' ' O ' ' A' ' 24' ' ' GLN . . . 13.64 73.29 0.01 OUTLIER Glycine 0 C--N 1.3 -1.462 1 N-CA-C 129.598 6.599 . . . . 0.0 129.598 177.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.92 130.31 64.07 Favored Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.188 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -76.23 106.13 2.21 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 121.392 1.394 . . . . 0.0 110.748 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 118.746 -1.181 . . . . 0.0 109.607 -179.68 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.732 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 9.3 m-85 -104.18 -112.57 0.24 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.419 0.628 . . . . 0.0 110.335 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.404 ' H ' ' HB3' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -146.94 169.18 19.71 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.661 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.4 127.24 35.8 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.103 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.7 m -46.86 155.37 0.26 Allowed 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.723 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -147.97 16.68 1.09 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.822 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -163.06 131.82 3.97 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.08 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -55.41 153.3 7.54 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.4 174.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.42 -23.79 20.16 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 118.359 -1.877 . . . . 0.0 111.295 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.568 HE22 ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -54.76 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.254 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.619 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -176.67 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.166 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.732 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 6.0 mt -73.68 8.03 2.13 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.619 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.5 p -102.44 -179.97 4.13 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.622 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 15' ' ' LEU . 6.3 mt -79.41 71.61 5.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.739 1.257 . . . . 0.0 108.371 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.739 ' HA ' HD22 ' A' ' 37' ' ' ASN . 34.1 t -70.82 -77.58 0.09 Allowed 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.428 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 89.61 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 117.76 -1.576 . . . . 0.0 109.019 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.21 -142.47 44.64 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.631 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -0.05 30.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.124 0.964 . . . . 0.0 110.35 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -87.63 143.59 27.1 Favored 'General case' 0 C--N 1.26 -3.317 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.849 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 22' ' ' CYS . 8.0 t -88.75 142.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.095 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.672 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -77.69 -160.56 0.19 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.015 175.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -143.83 96.43 0.19 Allowed Glycine 0 C--O 1.186 -2.895 0 C-N-CA 117.904 -2.093 . . . . 0.0 108.862 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -30.59 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -82.51 7.09 66.06 Favored Glycine 1 C--N 1.238 -4.903 0 N-CA-C 105.741 -2.944 . . . . 0.0 105.741 172.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.631 ' N ' ' O ' ' A' ' 23' ' ' GLY . 64.6 m-20 -121.97 -156.44 0.69 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.477 -1.362 . . . . 0.0 108.6 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.694 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -152.31 103.29 2.83 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.645 176.274 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 10' ' ' GLY . 42.1 t -78.31 162.75 26.27 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 117.521 -1.672 . . . . 0.0 108.876 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.694 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 22.2 mm -149.88 121.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.386 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 9' ' ' SER . 12.3 mt . . . . . 0 N--CA 1.506 2.33 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.988 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.739 HD22 ' HA ' ' A' ' 16' ' ' CYS . 25.0 t-20 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.141 0.496 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.9 tt0 -122.08 159.77 26.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -122.69 66.58 0.95 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -176.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -90.41 121.59 40.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.425 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -37.55 173.47 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.89 177.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' N ' ' HA ' ' A' ' 26' ' ' ASN . . . 126.44 -105.54 0.79 Allowed Glycine 0 N--CA 1.484 1.871 1 N-CA-C 128.411 6.124 . . . . 0.0 128.411 -176.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -165.01 88.9 0.47 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.49 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' ASN . . . -102.23 -123.02 5.17 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.682 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.42 134.52 10.2 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.938 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -70.1 98.83 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 N-CA-C 109.683 -0.93 . . . . 0.0 109.683 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' HE22 ' A' ' 11' ' ' GLN . 26.3 tttp . . . . . 0 N--CA 1.491 1.607 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.025 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.097 0.475 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.534 ' O ' HG23 ' A' ' 4' ' ' THR . 58.3 m-85 -102.93 -116.53 0.2 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.5 p -160.13 165.78 31.03 Favored 'General case' 0 C--N 1.257 -3.429 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.928 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.21 129.54 34.56 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.992 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' OE1' ' A' ' 11' ' ' GLN . 13.7 m -46.58 169.8 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 CA-C-O 122.639 1.209 . . . . 0.0 110.436 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -150.08 14.36 0.8 Allowed 'General case' 0 C--N 1.258 -3.388 0 CA-C-N 112.415 -2.175 . . . . 0.0 106.783 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -164.96 123.13 1.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.196 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.611 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -51.37 153.92 1.95 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.626 175.224 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 10.2 85.51 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' OE1' ' CB ' ' A' ' 6' ' ' CYS . 3.4 mt-30 -82.62 -166.45 1.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 14' ' ' CYS . 6.2 t-20 -135.64 -93.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.199 -1.8 . . . . 0.0 115.323 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 2.5 mt -75.13 40.32 0.15 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.804 -173.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -94.59 -160.94 0.81 Allowed 'General case' 0 C--O 1.18 -2.593 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.016 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.1 mt -109.04 81.2 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 m -76.35 -81.71 0.08 Allowed 'General case' 0 C--N 1.249 -3.768 0 CA-C-N 112.944 -1.934 . . . . 0.0 111.209 -174.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 4.0 mm-40 -78.36 107.22 10.83 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.86 -1.536 . . . . 0.0 109.238 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.93 11.86 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 2.15 15.25 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.26 1.029 . . . . 0.0 110.056 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.61 149.32 25.94 Favored 'General case' 0 C--N 1.259 -3.353 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.931 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 35.5 t -88.2 148.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 118.491 -1.283 . . . . 0.0 111.049 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.2 m -136.62 -166.64 1.93 Allowed 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 93.21 -43.39 2.54 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 117.336 -2.364 . . . . 0.0 111.748 175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -59.04 105.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.081 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.06 -10.16 28.47 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -118.89 -165.23 1.11 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.428 -0.886 . . . . 0.0 111.653 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.545 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -156.69 112.76 2.98 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.004 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.58 152.01 28.8 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 118.304 -1.359 . . . . 0.0 110.857 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.545 HD11 ' CE ' ' A' ' 27' ' ' LYS . 31.8 mm -139.53 104.7 2.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.455 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 9' ' ' SER . 10.2 mt . . . . . 0 N--CA 1.509 2.477 0 C-N-CA 118.676 -1.21 . . . . 0.0 110.146 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.423 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 30.0 m-80 . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -87.37 166.37 14.9 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.842 -1.543 . . . . 0.0 107.6 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.3 m -133.34 71.31 1.46 Allowed 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -91.37 137.71 21.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.507 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.8 t -34.83 168.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.815 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 122.48 -146.14 16.65 Favored Glycine 0 N--CA 1.482 1.706 1 N-CA-C 130.014 6.766 . . . . 0.0 130.014 -178.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -161.89 119.55 2.21 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.553 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.84 -91.3 1.11 Allowed Glycine 0 N--CA 1.486 2.032 1 N-CA-C 129.742 6.657 . . . . 0.0 129.742 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.8 122.14 4.25 Favored Pre-proline 0 C--N 1.302 -1.5 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.356 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.2 Cg_endo -66.71 95.26 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.07 1.18 . . . . 0.0 109.638 177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' PRO . 11.9 tttt . . . . . 0 N--CA 1.497 1.918 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.211 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 4' ' ' THR . 5.8 m-85 -141.84 -114.01 0.12 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.967 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.0 p -163.79 176.51 9.46 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.272 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.48 132.48 35.01 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.584 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.33 149.26 7.62 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.975 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 7' ' ' THR . 1.9 t -148.69 18.34 1.02 Allowed 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -161.54 109.37 1.46 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.287 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.612 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -47.83 147.1 2.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.471 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 100.92 -5.82 56.59 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.791 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.634 HE21 ' HA ' ' A' ' 47' ' ' LYS . 61.4 mt-30 -85.57 -164.96 1.1 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.285 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.5 m120 -164.28 -43.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.806 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 51.7 mt -76.91 17.26 0.44 Allowed 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.051 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.2 p -108.43 176.93 4.94 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.457 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.2 mt -78.59 73.57 5.14 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 123.0 1.381 . . . . 0.0 108.16 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 32.1 t -67.79 -82.96 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.936 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.25 120.98 26.86 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.9 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.27 -115.94 6.36 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.036 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.93 5.59 5.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.753 1.263 . . . . 0.0 108.819 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -88.29 144.46 26.41 Favored 'General case' 0 C--N 1.262 -3.204 0 CA-C-N 112.342 -2.208 . . . . 0.0 112.256 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 22' ' ' CYS . 22.1 t -80.0 139.08 18.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.744 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.59 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -85.4 -140.64 0.08 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 118.416 -1.314 . . . . 0.0 109.371 175.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -157.65 111.89 0.5 Allowed Glycine 0 C--N 1.286 -2.233 0 C-N-CA 116.339 -2.839 . . . . 0.0 112.574 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.5 tt0 -36.21 152.06 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 113.482 -1.359 . . . . 0.0 108.448 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.88 -18.11 57.3 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.3 t-20 -106.33 -161.83 0.82 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.989 -1.605 . . . . 0.0 107.081 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' CG ' ' H ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -160.35 101.96 1.39 Allowed 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.901 174.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.852 ' O ' HD13 ' A' ' 29' ' ' ILE . 22.2 m -78.64 155.71 29.4 Favored 'General case' 0 CA--C 1.46 -2.487 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.424 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.3 mm -136.3 108.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.649 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 9' ' ' SER . 18.0 mt . . . . . 0 N--CA 1.507 2.424 0 C-N-CA 118.155 -1.418 . . . . 0.0 108.394 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.601 ' HB3' HD23 ' A' ' 30' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 111.598 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.442 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 14.3 tt0 -83.46 -176.1 6.14 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -136.68 75.16 1.52 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -109.25 127.54 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.156 -1.418 . . . . 0.0 114.363 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.559 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 t -27.37 148.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 112.579 -2.1 . . . . 0.0 113.566 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.48 -101.37 0.19 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -98.61 -139.54 0.31 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.346 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 179.95 88.66 0.07 OUTLIER Glycine 0 C--N 1.28 -2.539 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.9 139.56 25.12 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.527 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -77.14 136.62 16.39 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.199 1.266 . . . . 0.0 109.16 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HA ' HE21 ' A' ' 11' ' ' GLN . 16.4 tttp . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 117.791 -1.564 . . . . 0.0 111.021 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 3' ' ' TYR . 21.9 t . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.623 ' N ' HG12 ' A' ' 2' ' ' VAL . 5.8 m-85 -137.99 -112.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.069 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -172.08 176.5 3.47 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.036 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.562 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.27 131.0 34.37 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.168 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -53.44 158.46 1.73 Allowed 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.734 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -140.16 8.99 2.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.125 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.501 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.7 mm-40 -161.0 143.98 12.84 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.52 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.03 147.92 45.64 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.658 175.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 27' ' ' LYS . . . 94.61 -7.44 71.14 Favored Glycine 0 N--CA 1.503 3.154 1 N-CA-C 126.736 5.454 . . . . 0.0 126.736 -172.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 75.9 mt-30 -83.67 -167.41 1.71 Allowed 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 114.283 -0.959 . . . . 0.0 111.09 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.746 HD21 ' C ' ' A' ' 26' ' ' ASN . 2.2 m-80 -156.38 -51.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.985 -1.486 . . . . 0.0 114.553 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 59.5 mt -76.09 13.69 0.84 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.618 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.5 p -110.13 177.8 4.6 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.73 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 15' ' ' LEU . 10.3 mt -77.77 75.92 4.31 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-O 122.811 1.291 . . . . 0.0 108.552 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.62 -80.43 0.08 Allowed 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.647 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.32 107.62 12.22 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.156 -1.418 . . . . 0.0 109.502 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.46 -144.02 48.74 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.176 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.26 5.06 48.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.38 1.086 . . . . 0.0 109.778 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -88.6 143.59 26.85 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.941 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 22' ' ' CYS . 11.4 t -83.76 139.28 17.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.277 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.625 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -78.47 -146.14 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.735 175.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.99 117.54 0.77 Allowed Glycine 0 C--N 1.278 -2.664 0 C-N-CA 117.451 -2.309 . . . . 0.0 110.67 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.5 tt0 -33.23 154.17 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.054 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.42 -6.31 82.36 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.746 ' C ' HD21 ' A' ' 12' ' ' ASN . 8.7 t30 -122.25 -164.16 1.14 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.929 -1.136 . . . . 0.0 108.493 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 40' ' ' VAL . 36.2 tttp -162.22 112.35 1.53 Allowed 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 11' ' ' GLN . 1.9 m -83.04 153.63 24.83 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.64 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.58 117.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.284 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 8' ' ' GLU . 19.1 mt . . . . . 0 N--CA 1.518 2.959 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.787 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 122.448 1.118 . . . . 0.0 113.92 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 12.7 tt0 -153.46 170.89 19.62 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.052 -1.885 . . . . 0.0 107.206 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.426 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -145.31 79.12 1.57 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.429 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.77 146.25 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 C-N-CA 117.776 -1.57 . . . . 0.0 114.879 -176.173 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -18.14 146.6 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 113.059 -1.882 . . . . 0.0 114.176 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.24 -120.94 1.02 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 7.4 mm-40 -78.67 -135.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.48 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 12' ' ' ASN . . . 162.03 97.44 0.12 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 144.83 55.16 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.422 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.23 126.07 8.93 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.356 1.371 . . . . 0.0 109.469 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 N--CA 1.489 1.505 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.992 -179.096 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.792 HG12 ' H ' ' A' ' 3' ' ' TYR . 3.5 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 120.941 0.4 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.792 ' H ' HG12 ' A' ' 2' ' ' VAL . 61.5 m-85 -106.06 -115.82 0.25 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.73 0.776 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -178.1 175.35 1.26 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.77 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 134.68 36.4 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.653 -176.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 92.7 m -47.8 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.662 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -138.05 3.14 2.4 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.725 -1.58 . . . . 0.0 107.992 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' C ' HD12 ' A' ' 30' ' ' LEU . 9.0 tt0 -171.16 136.55 1.07 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.424 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -51.27 157.88 0.89 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.468 178.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -20.97 46.7 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.663 -1.732 . . . . 0.0 112.629 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.15 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -161.65 21.9 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 115.668 -2.413 . . . . 0.0 115.285 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 3' ' ' TYR . 40.2 mt -146.71 25.88 1.16 Allowed 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -104.81 179.8 4.17 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.227 -176.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.635 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 mt -84.06 75.55 10.14 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.661 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 2.3 t -73.58 -68.99 0.46 Allowed 'General case' 0 C--N 1.254 -3.572 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.472 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.569 ' HA ' HD22 ' A' ' 37' ' ' ASN . 17.4 mm-40 -84.32 89.32 7.34 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.472 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.52 -133.22 25.47 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.045 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 -1.66 58.21 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.144 0.973 . . . . 0.0 110.412 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -81.49 137.88 35.55 Favored 'General case' 0 C--N 1.26 -3.301 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.48 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 22' ' ' CYS . 52.4 t -83.03 155.15 3.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.231 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' N ' HG12 ' A' ' 21' ' ' VAL . 10.9 m -145.19 -173.21 4.04 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 99.31 -45.55 1.54 Allowed Glycine 0 C--O 1.206 -1.6 0 C-N-CA 117.547 -2.264 . . . . 0.0 114.611 173.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.566 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -63.48 115.89 5.07 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.586 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.92 -10.56 39.41 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.59 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -125.96 -158.24 0.84 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.919 -1.141 . . . . 0.0 111.417 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -154.82 124.36 6.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.527 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -78.82 155.13 29.35 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 117.54 -1.664 . . . . 0.0 109.5 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.581 HD11 ' CE ' ' A' ' 27' ' ' LYS . 15.2 mm -150.77 122.43 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.619 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.716 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 9' ' ' SER . 7.7 mt . . . . . 0 N--CA 1.495 1.808 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.186 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.569 HD22 ' HA ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.214 -0.809 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.554 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 40.2 tt0 -150.71 155.85 40.12 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.2 m -116.94 65.1 0.72 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -77.78 130.34 36.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 117.709 -1.597 . . . . 0.0 111.515 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.4 t -35.77 167.45 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.057 -1.883 . . . . 0.0 112.395 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 123.04 -133.93 9.28 Favored Glycine 0 N--CA 1.488 2.108 1 N-CA-C 130.387 6.915 . . . . 0.0 130.387 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -161.99 116.2 1.88 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.595 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.95 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.42 -1.372 . . . . 0.0 111.511 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -158.85 152.58 19.32 Favored Pre-proline 0 C--N 1.31 -1.136 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.404 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -72.3 116.29 4.65 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 121.212 1.275 . . . . 0.0 109.733 170.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tttp . . . . . 0 C--N 1.303 -1.441 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.702 -178.739 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 4' ' ' THR . 2.3 m-85 -132.06 -111.84 0.24 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.813 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.7 p -162.34 177.31 9.69 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.809 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.55 134.02 34.32 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.678 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 m -52.54 155.48 2.16 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.052 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -140.54 9.73 2.24 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.688 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.668 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.0 mm-40 -163.33 139.85 7.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.838 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.435 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.87 156.92 6.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.496 176.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 85.18 0.66 88.67 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.086 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.417 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 27.2 mt-30 -84.4 -177.37 6.61 Favored 'General case' 0 N--CA 1.514 2.768 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.175 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -151.81 -50.88 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 117.978 -1.489 . . . . 0.0 114.394 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 87.1 mt -75.99 17.99 0.3 Allowed 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.299 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.528 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.7 p -110.35 178.92 4.23 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.45 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.6 mt -79.94 73.0 6.72 Favored 'General case' 0 CA--C 1.465 -2.289 0 CA-C-O 122.843 1.306 . . . . 0.0 108.552 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 94.4 m -69.94 -93.41 0.01 OUTLIER 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.28 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.09 116.55 13.76 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.394 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.28 -139.63 42.28 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.796 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 6.31 45.21 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.526 1.155 . . . . 0.0 108.992 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.88 144.7 28.23 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.305 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.9 t -85.12 138.93 18.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 118.154 -1.418 . . . . 0.0 109.556 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -77.33 -140.18 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.954 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.45 122.19 1.03 Allowed Glycine 0 C--N 1.275 -2.837 0 C-N-CA 117.303 -2.379 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.4 tt0 -34.41 157.17 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.579 -1.31 . . . . 0.0 110.028 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -18.35 21.52 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.52 ' HB3' HD22 ' A' ' 12' ' ' ASN . 13.0 t30 -104.19 -164.39 1.05 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.915 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.631 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -161.67 102.77 1.19 Allowed 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.046 -1.461 . . . . 0.0 111.65 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -79.84 153.6 28.97 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.45 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.631 HD11 ' CE ' ' A' ' 27' ' ' LYS . 33.4 mm -134.71 115.58 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.893 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.668 HD12 ' C ' ' A' ' 8' ' ' GLU . 10.6 mt . . . . . 0 N--CA 1.504 2.233 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.642 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.682 HD22 ' N ' ' A' ' 38' ' ' GLN . 1.2 t-20 . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.571 0.701 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.682 ' N ' HD22 ' A' ' 37' ' ' ASN . 38.6 tt0 -144.1 171.0 14.89 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 73.21 1.52 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -113.11 130.3 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -172.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.9 t -22.71 155.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.573 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.35 -123.56 1.93 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -76.85 -131.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.393 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.574 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 157.2 80.09 0.03 OUTLIER Glycine 0 C--N 1.282 -2.431 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.933 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.36 131.52 42.08 Favored Pre-proline 0 CA--C 1.559 1.29 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.871 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.65 119.56 6.5 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.123 1.215 . . . . 0.0 110.928 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.406 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.539 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 3' ' ' TYR . 20.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.937 0.399 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.598 ' N ' HG12 ' A' ' 2' ' ' VAL . 26.8 m-85 -103.82 -113.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.1 p -159.0 169.17 24.91 Favored 'General case' 0 C--N 1.261 -3.28 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.992 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.47 130.2 34.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.69 -1.204 . . . . 0.0 111.103 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.434 ' CB ' HD11 ' A' ' 30' ' ' LEU . 43.7 m -47.4 171.61 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.331 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -144.33 8.1 1.37 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.704 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.746 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.6 tt0 -170.49 139.24 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.4 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.476 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -52.97 159.31 1.19 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.79 176.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.61 50.01 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.037 -1.554 . . . . 0.0 112.461 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.47 -173.06 3.88 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.496 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 14' ' ' CYS . 69.6 m-80 -155.77 -45.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.72 -1.592 . . . . 0.0 113.937 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 3' ' ' TYR . 45.5 mt -76.59 16.24 0.52 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.163 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -100.4 -170.1 1.82 Allowed 'General case' 0 C--O 1.181 -2.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.64 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 mt -91.52 71.38 5.94 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.8 t -64.2 -84.4 0.02 OUTLIER 'General case' 0 C--N 1.254 -3.554 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.929 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.451 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 tm-20 -69.88 88.0 0.55 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.067 -1.453 . . . . 0.0 109.227 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.49 -130.9 18.76 Favored Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.399 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.96 0.75 57.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.184 0.992 . . . . 0.0 110.38 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -90.41 147.18 23.59 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.065 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 23.6 t -85.99 147.16 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 117.979 -1.488 . . . . 0.0 110.813 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.415 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -76.29 -129.91 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.36 115.45 0.57 Allowed Glycine 0 C--N 1.276 -2.751 0 C-N-CA 117.871 -2.109 . . . . 0.0 110.892 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 3.5 tt0 -34.44 149.22 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.279 -0.96 . . . . 0.0 109.905 177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.39 -10.89 65.07 Favored Glycine 0 C--N 1.292 -1.906 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 43' ' ' GLU . 20.4 t30 -108.09 -162.9 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 40' ' ' VAL . 50.4 tttp -154.24 104.26 2.59 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.74 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 52.6 t -77.4 159.57 29.36 Favored 'General case' 0 CA--C 1.462 -2.425 0 C-N-CA 117.01 -1.876 . . . . 0.0 109.284 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.9 mm -137.23 115.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.132 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.746 HD12 ' C ' ' A' ' 8' ' ' GLU . 18.9 mt . . . . . 0 N--CA 1.497 1.898 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.575 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.742 0 CA-C-O 121.75 0.785 . . . . 0.0 112.603 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 15.7 tt0 -155.02 164.35 39.01 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -130.11 75.72 1.67 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.572 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -119.32 130.42 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.569 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.419 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 8.1 t -51.09 154.56 1.52 Allowed 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.388 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.06 -24.32 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.117 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . 3.3 tt0 -162.89 -143.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.367 0.603 . . . . 0.0 110.265 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -179.2 85.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.757 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.72 107.1 58.67 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 Cg_endo -68.68 92.9 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.7 tmtm? . . . . . 0 N--CA 1.491 1.607 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.668 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.924 0.392 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.66 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 69.4 m-85 -139.68 -121.95 0.12 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.64 0.733 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 3.0 t 177.99 -177.77 0.22 Allowed 'General case' 0 C--N 1.259 -3.332 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.823 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.32 133.09 36.61 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.521 -177.49 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 86.7 m -46.14 169.1 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.089 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.534 HG22 HE22 ' A' ' 11' ' ' GLN . 5.5 t -155.27 17.3 0.41 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.921 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 2.0 tt0 -167.31 124.14 1.18 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.905 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.598 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -55.78 151.64 10.9 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.646 177.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.86 -16.53 59.19 Favored Glycine 0 C--N 1.282 -2.439 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.25 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.534 HE22 HG22 ' A' ' 7' ' ' THR . 17.5 mt-30 -60.23 179.21 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' HB3' ' H ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -161.3 25.55 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 115.523 -2.471 . . . . 0.0 115.352 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 34.6 mt -147.61 26.74 1.02 Allowed 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.46 177.74 4.7 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.373 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.644 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 mt -80.38 70.86 7.13 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.054 -1.884 . . . . 0.0 107.408 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.595 ' HA ' HD22 ' A' ' 37' ' ' ASN . 41.4 m -73.28 -61.9 1.66 Allowed 'General case' 1 C--N 1.239 -4.211 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.541 -173.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.6 88.92 7.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.075 -1.45 . . . . 0.0 109.526 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.47 -105.37 1.77 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.112 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.42 -2.5 11.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.229 1.014 . . . . 0.0 110.485 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.77 139.99 30.17 Favored 'General case' 0 C--N 1.254 -3.583 0 CA-C-N 113.326 -1.761 . . . . 0.0 111.419 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 42.6 t -79.25 151.15 4.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 117.723 -1.591 . . . . 0.0 109.314 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 86.4 m -140.49 -173.75 3.77 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 102.74 -49.87 0.95 Allowed Glycine 0 C--O 1.2 -2.002 0 C-N-CA 117.496 -2.287 . . . . 0.0 114.263 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 26' ' ' ASN . 9.7 tm0? -63.78 115.14 4.52 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.493 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.42 52.59 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.98 -163.7 1.33 Allowed 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.156 -1.022 . . . . 0.0 111.623 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.717 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -158.21 133.08 8.44 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.092 175.459 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.9 m -90.2 149.97 22.18 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.005 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.717 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 32.1 mm -140.35 111.86 4.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.795 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 9' ' ' SER . 8.9 mt . . . . . 0 N--CA 1.499 1.977 0 C-N-CA 118.341 -1.343 . . . . 0.0 109.208 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.595 HD22 ' HA ' ' A' ' 16' ' ' CYS . 27.0 t-20 . . . . . 0 C--O 1.215 -0.747 0 CA-C-O 121.383 0.611 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -79.3 172.93 13.12 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.486 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.0 m -134.03 62.46 1.65 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -79.45 135.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 117.913 -1.515 . . . . 0.0 111.931 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.7 t -38.8 165.13 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.332 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.02 -151.73 17.83 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -143.07 124.48 14.72 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.524 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.3 -113.02 3.75 Favored Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.775 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.507 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -151.83 149.1 22.95 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.056 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.33 115.25 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.333 1.355 . . . . 0.0 110.546 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.522 ' HG2' HE21 ' A' ' 11' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.408 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.632 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.504 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -142.59 -113.75 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.914 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.3 p -159.31 173.42 16.31 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.506 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.56 132.18 34.14 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.564 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.1 155.12 2.0 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.218 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -148.13 14.92 1.03 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.007 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.624 ' C ' HD12 ' A' ' 30' ' ' LEU . 19.9 mt-10 -161.52 127.04 3.63 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.619 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.586 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -53.5 158.24 1.84 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.088 177.019 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 79.67 11.21 84.96 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.582 -1.77 . . . . 0.0 110.435 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -74.71 -164.63 0.29 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.269 179.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 14' ' ' CYS . 9.8 m-20 -162.86 -69.36 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 117.914 -1.515 . . . . 0.0 113.93 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 72.0 mt -76.3 19.72 0.24 Allowed 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.538 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 22.7 p -103.55 177.99 4.68 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.372 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.3 mt -79.85 70.74 6.46 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 122.829 1.299 . . . . 0.0 107.765 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.745 ' HA ' HD22 ' A' ' 37' ' ' ASN . 39.5 t -69.21 -74.45 0.13 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.583 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.72 130.5 40.65 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.411 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 23.61 -91.26 0.01 OUTLIER Glycine 0 N--CA 1.503 3.155 1 N-CA-C 127.198 5.639 . . . . 0.0 127.198 -174.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.09 2.56 10.42 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.926 1.346 . . . . 0.0 107.864 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -89.73 143.01 27.15 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.882 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.7 t -84.35 143.5 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.241 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -71.85 -142.43 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.06 115.44 0.57 Allowed Glycine 0 C--N 1.279 -2.619 0 C-N-CA 117.314 -2.374 . . . . 0.0 110.844 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.3 tt0 -34.87 155.21 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.39 -0.905 . . . . 0.0 109.478 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.81 -16.33 55.02 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 106.452 -2.659 . . . . 0.0 106.452 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 41' ' ' THR . 5.4 t-20 -106.72 -156.55 0.58 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.081 -1.06 . . . . 0.0 108.776 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.69 ' CE ' HD11 ' A' ' 29' ' ' ILE . 1.2 ttpp -159.63 103.54 1.56 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 10' ' ' GLY . 42.7 t -78.28 156.98 29.38 Favored 'General case' 0 CA--C 1.462 -2.41 0 C-N-CA 116.808 -1.957 . . . . 0.0 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.69 HD11 ' CE ' ' A' ' 27' ' ' LYS . 24.3 mm -145.62 118.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.772 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.078 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 8' ' ' GLU . 12.8 mt . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.673 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.745 HD22 ' HA ' ' A' ' 16' ' ' CYS . 19.9 t-20 . . . . . 0 C--O 1.215 -0.716 0 CA-C-O 121.2 0.524 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.529 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 50.4 tt0 -119.95 164.08 16.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -123.57 71.48 1.09 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -101.3 124.72 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -171.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.497 ' HA ' ' ND2' ' A' ' 26' ' ' ASN . 11.3 t -18.69 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 112.416 -2.174 . . . . 0.0 113.168 171.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.75 -155.73 20.74 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.54 98.32 5.18 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -91.93 -115.79 2.12 Favored Glycine 0 C--O 1.215 -1.042 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.653 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -164.84 150.96 9.03 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.565 -177.596 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -76.97 132.87 13.21 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.751 1.634 . . . . 0.0 110.057 170.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.191 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.775 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 3' ' ' TYR . 15.5 t . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.732 ' H ' HG12 ' A' ' 2' ' ' VAL . 16.9 m-85 -140.3 -114.73 0.14 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.688 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 3' ' ' TYR . 11.1 p -158.13 175.25 14.03 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.211 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.18 132.05 36.94 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.273 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.07 151.09 2.81 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.082 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -138.13 8.03 2.69 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.994 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.557 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mt-10 -166.79 132.88 2.29 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.409 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.682 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.94 154.38 0.74 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.568 177.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 87.87 11.23 68.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.41 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -82.99 -170.09 2.85 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.786 177.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.6 m120 -151.94 -73.51 0.15 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 118.406 -1.318 . . . . 0.0 113.365 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.552 HD13 ' CE1' ' A' ' 3' ' ' TYR . 51.8 mt -74.57 27.85 0.08 Allowed 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.176 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 20.9 p -105.55 177.29 4.89 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.598 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.4 mt -79.91 73.23 6.69 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.992 1.377 . . . . 0.0 107.629 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.68 ' HA ' HD22 ' A' ' 37' ' ' ASN . 76.2 m -69.52 -78.82 0.07 Allowed 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 111.864 -2.426 . . . . 0.0 110.869 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.22 107.36 9.55 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.544 -1.263 . . . . 0.0 109.867 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -115.05 6.83 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.95 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.93 0.6 11.93 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.361 1.077 . . . . 0.0 110.033 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.67 146.51 25.67 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.856 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 22' ' ' CYS . 22.1 t -82.75 140.29 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 C-N-CA 118.367 -1.333 . . . . 0.0 110.014 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.541 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -83.17 -138.8 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.95 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -166.31 121.25 0.97 Allowed Glycine 0 C--N 1.272 -3.008 0 C-N-CA 117.839 -2.124 . . . . 0.0 110.008 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.9 tt0 -34.65 159.44 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.081 -1.06 . . . . 0.0 110.251 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.0 -16.4 58.67 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.6 t30 -105.91 -161.22 0.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.873 -1.163 . . . . 0.0 108.864 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -160.95 96.42 1.11 Allowed 'General case' 0 C--N 1.28 -2.453 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.24 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.78 133.9 37.05 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 117.642 -1.623 . . . . 0.0 109.635 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -122.98 120.46 60.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.646 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 9' ' ' SER . 22.6 mt . . . . . 0 N--CA 1.504 2.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.162 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.68 HD22 ' HA ' ' A' ' 16' ' ' CYS . 47.2 t-20 . . . . . 0 C--O 1.217 -0.648 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 29.3 tt0 -117.2 -179.93 3.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -145.55 78.85 1.56 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.508 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -114.74 131.51 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 C-N-CA 118.331 -1.347 . . . . 0.0 114.635 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.563 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -9.41 143.77 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.263 171.267 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.03 -145.71 15.3 Favored Glycine 0 N--CA 1.489 2.225 1 N-CA-C 131.067 7.187 . . . . 0.0 131.067 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -146.87 84.77 1.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.719 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -107.88 2.43 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.232 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -161.64 145.56 9.69 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.99 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.09 105.5 2.08 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.52 1.48 . . . . 0.0 110.496 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 N--CA 1.497 1.888 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.714 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 3' ' ' TYR . 12.4 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.575 ' H ' HG12 ' A' ' 2' ' ' VAL . 60.0 m-85 -130.23 -118.29 0.23 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.67 0.748 . . . . 0.0 110.478 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.584 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -179.17 178.06 0.75 Allowed 'General case' 0 C--N 1.259 -3.367 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.643 -178.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.584 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.94 132.95 35.27 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.986 0.898 . . . . 0.0 112.119 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -52.96 154.49 2.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.843 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.683 HG22 ' HE2' ' A' ' 47' ' ' LYS . 6.9 t -139.38 11.27 2.54 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.979 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.687 ' C ' HD12 ' A' ' 30' ' ' LEU . 13.6 tt0 -166.34 125.39 1.54 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.272 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.713 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -45.14 155.58 0.12 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.819 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.08 -18.71 56.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 22.4 mt-30 -79.71 -175.66 4.97 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.91 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 14' ' ' CYS . 65.8 m-80 -152.2 -48.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 117.68 -1.608 . . . . 0.0 114.126 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 46' ' ' PRO . 29.0 mt -75.35 17.73 0.25 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.8 p -103.25 175.73 5.38 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.962 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.1 mt -78.88 73.19 5.43 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 122.959 1.362 . . . . 0.0 108.284 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.653 ' HA ' HD22 ' A' ' 37' ' ' ASN . 35.8 t -72.8 -82.24 0.05 Allowed 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 112.11 -2.314 . . . . 0.0 109.816 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.71 97.76 3.3 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 117.452 -1.699 . . . . 0.0 109.129 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 20' ' ' ASN . . . 64.65 -148.78 51.38 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.217 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.86 3.54 16.61 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.358 1.075 . . . . 0.0 109.553 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -87.14 143.07 27.47 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.79 -178.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 22' ' ' CYS . 4.6 t -84.49 144.91 8.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.51 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -73.09 -137.33 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.13 109.11 0.35 Allowed Glycine 0 C--N 1.282 -2.457 0 C-N-CA 117.414 -2.327 . . . . 0.0 111.128 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -34.36 150.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.36 176.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.95 57.37 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.468 ' ND2' ' CA ' ' A' ' 41' ' ' THR . 6.0 t-20 -106.5 -161.34 0.79 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 40' ' ' VAL . 49.0 tttp -155.42 105.82 2.5 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.357 175.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 51.9 t -76.34 158.17 31.72 Favored 'General case' 0 CA--C 1.462 -2.408 0 C-N-CA 116.845 -1.942 . . . . 0.0 108.718 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.1 mm -138.13 115.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.082 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.679 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 9' ' ' SER . 13.7 mt . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.215 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.653 HD22 ' HA ' ' A' ' 16' ' ' CYS . 22.6 t-20 . . . . . 0 C--O 1.216 -0.679 0 CA-C-O 121.008 0.432 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.2 tt0 -128.78 166.43 19.02 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -126.04 72.24 1.29 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.563 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -115.45 130.68 69.63 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.167 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.117 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.468 ' CA ' ' ND2' ' A' ' 26' ' ' ASN . 5.3 t -42.58 159.72 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.844 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.4 -103.26 0.22 Allowed Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.854 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.522 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -79.15 -148.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.022 0.439 . . . . 0.0 109.949 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.57 80.57 0.06 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.54 126.72 28.27 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.934 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.454 ' HA ' HD12 ' A' ' 13' ' ' LEU . 6.4 Cg_endo -73.39 115.67 4.42 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 121.409 1.406 . . . . 0.0 111.734 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HE2' HG22 ' A' ' 7' ' ' THR . 19.5 tptp . . . . . 0 CA--C 1.565 1.529 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.105 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 3' ' ' TYR . 8.8 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.574 ' H ' HG12 ' A' ' 2' ' ' VAL . 12.1 m-85 -115.77 -116.46 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.388 0.614 . . . . 0.0 110.709 -177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' TYR . 6.0 p -152.1 172.74 15.86 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.534 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 131.08 34.88 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.96 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -49.08 150.77 1.49 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.771 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -141.24 12.94 2.19 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -165.25 125.59 1.89 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.572 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.77 159.8 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.237 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.77 -5.91 72.65 Favored Glycine 0 N--CA 1.505 3.288 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.327 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -70.43 -176.48 1.24 Allowed 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.573 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' CYS . 5.2 m120 -148.29 -64.22 0.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.562 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 9.6 mt -73.06 22.53 0.07 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.899 -177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ASN . 17.2 p -104.96 176.76 5.05 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.28 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.1 mt -82.65 70.82 9.7 Favored 'General case' 0 C--N 1.27 -2.884 0 CA-C-O 122.703 1.239 . . . . 0.0 107.859 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.9 t -67.51 -88.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.258 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -73.43 109.2 6.77 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.064 -1.854 . . . . 0.0 109.849 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.43 -132.19 24.96 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.51 4.91 36.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.741 1.258 . . . . 0.0 108.549 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -87.69 149.81 24.02 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.374 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.4 t -87.51 141.2 14.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.123 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.65 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -74.46 -141.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.381 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.866 ' CA ' HD21 ' A' ' 26' ' ' ASN . . . -164.23 101.98 0.19 Allowed Glycine 0 N--CA 1.504 3.175 0 C-N-CA 115.608 -3.187 . . . . 0.0 112.98 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLY . 13.6 tm0? -27.45 114.63 0.07 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.519 1.152 . . . . 0.0 110.558 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.03 -16.82 5.48 Favored Glycine 0 C--N 1.28 -2.561 0 N-CA-C 105.263 -3.135 . . . . 0.0 105.263 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.866 HD21 ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.63 -171.41 1.98 Allowed 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.8 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 20.5 tttp -143.93 99.64 3.43 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.579 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 48.6 t -76.93 163.63 26.55 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.361 -1.736 . . . . 0.0 108.716 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.8 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 19.3 mm -147.36 118.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.102 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.503 2.216 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.297 177.677 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.864 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.864 ' N ' HD22 ' A' ' 37' ' ' ASN . 11.6 tt0 -124.76 163.36 22.27 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -124.05 65.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 t -89.44 131.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.914 -1.514 . . . . 0.0 111.816 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 42' ' ' GLY . 1.9 t -44.83 170.45 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.55 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 131.89 -111.64 1.08 Allowed Glycine 0 N--CA 1.494 2.502 1 N-CA-C 130.141 6.816 . . . . 0.0 130.141 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASN . 37.1 mt-10 -77.14 -144.53 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.092 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.2 96.3 0.1 Allowed Glycine 0 C--N 1.288 -2.123 0 C-N-CA 118.263 -1.922 . . . . 0.0 112.236 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.72 123.44 34.73 Favored Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.82 176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.67 118.09 4.73 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.489 1.46 . . . . 0.0 110.561 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 tttp . . . . . 0 CA--C 1.562 1.425 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.686 179.148 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 HE22 ' A' ' 11' ' ' GLN . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.748 ' HA ' HD22 ' A' ' 37' ' ' ASN . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 41' ' ' THR . 1.6 t-20 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' SER . 11.3 mt . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.748 HD22 ' HA ' ' A' ' 16' ' ' CYS . 32.0 t-20 . . . . . 0 C--O 1.216 -0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 3' ' ' TYR . 22.8 t . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.701 ' H ' HG12 ' A' ' 2' ' ' VAL . 19.6 m-85 -147.61 -114.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.461 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 3' ' ' TYR . 5.0 p -162.55 172.92 14.69 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.436 -178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.26 126.81 33.07 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.581 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 178.33 0.09 Allowed 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 122.781 1.277 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -151.96 18.32 0.68 Allowed 'General case' 0 C--N 1.258 -3.412 0 CA-C-N 111.923 -2.399 . . . . 0.0 106.311 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.625 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.6 mt-10 -161.43 134.27 6.17 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 117.73 -1.588 . . . . 0.0 114.789 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.469 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -63.59 154.23 33.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.507 172.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.25 -20.9 40.61 Favored Glycine 0 C--N 1.287 -2.143 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.953 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.532 ' NE2' ' OE1' ' A' ' 8' ' ' GLU . 4.1 mt-30 -82.59 -174.03 4.97 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.908 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.588 ' N ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -153.6 -36.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.609 -176.667 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 61.0 mt -76.11 11.5 1.46 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.501 -1.28 . . . . 0.0 110.187 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.498 ' H ' ' C ' ' A' ' 12' ' ' ASN . 5.1 p -104.08 174.58 5.81 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.07 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.1 mt -78.07 74.77 4.61 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 122.855 1.312 . . . . 0.0 108.208 -177.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -71.02 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 111.803 -2.453 . . . . 0.0 110.076 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 3.9 mm-40 -76.04 121.46 22.79 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.709 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.33 -144.93 23.79 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.482 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.24 4.16 53.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.589 1.185 . . . . 0.0 109.139 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -83.31 146.55 28.45 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.742 -2.026 . . . . 0.0 111.403 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 22' ' ' CYS . 10.9 t -82.32 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.529 -1.268 . . . . 0.0 110.342 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -74.6 -130.43 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 174.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -168.37 109.93 0.36 Allowed Glycine 0 C--N 1.276 -2.793 0 C-N-CA 118.315 -1.898 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 10.8 tt0 -35.11 154.38 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.032 178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -17.25 27.36 Favored Glycine 0 C--N 1.29 -1.987 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 39' ' ' CYS . 27.6 t30 -96.56 -157.96 0.62 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.549 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -159.07 98.67 1.47 Allowed 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.702 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.898 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.2 t -78.23 166.03 23.21 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.199 -1.8 . . . . 0.0 110.541 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.6 mm -137.89 108.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.003 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 8' ' ' GLU . 96.1 mt . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.121 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' CG ' ' O ' ' A' ' 37' ' ' ASN . 41.1 t-20 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 53.8 tt0 -79.88 164.53 23.49 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.211 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.78 65.65 1.03 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -105.3 127.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 118.226 -1.39 . . . . 0.0 113.121 -172.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.428 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 5.5 t -53.98 156.41 2.96 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.505 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.63 -62.89 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.763 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.588 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -121.93 -141.32 0.33 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.639 0.733 . . . . 0.0 110.728 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.588 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -172.66 70.53 0.1 Allowed Glycine 0 N--CA 1.493 2.456 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.81 109.29 60.86 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.737 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.12 121.79 7.54 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.201 1.267 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.614 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.268 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.883 0.373 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.562 ' O ' HG23 ' A' ' 4' ' ' THR . 45.1 m-85 -131.54 -117.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 3' ' ' TYR . 3.0 p -161.45 166.54 27.1 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.821 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.74 127.74 33.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.029 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.9 m -44.91 154.09 0.15 Allowed 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.78 18.8 0.9 Allowed 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.591 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -164.73 120.07 1.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.967 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.482 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -49.21 154.15 0.87 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.147 178.143 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.93 -1.89 85.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.367 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -73.95 -172.29 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.115 -1.434 . . . . 0.0 108.28 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.545 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -136.77 -82.04 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 117.516 -1.674 . . . . 0.0 115.282 -176.604 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 19.9 mt -73.16 34.64 0.08 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.347 -172.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 27.1 p -103.07 174.42 5.88 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.26 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.0 mt -84.81 77.69 10.03 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.839 1.304 . . . . 0.0 108.505 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.9 m -73.5 -87.45 0.03 OUTLIER 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.442 -176.496 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.93 107.51 7.05 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.668 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.4 -147.29 50.62 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.909 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -87.52 4.69 42.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.278 1.037 . . . . 0.0 110.1 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.46 140.25 32.45 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 113.268 -1.787 . . . . 0.0 111.642 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 36.7 t -82.91 155.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.334 -1.347 . . . . 0.0 109.91 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.535 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.5 m -141.41 -163.79 1.63 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 105.61 -60.32 0.39 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 118.094 -2.003 . . . . 0.0 112.973 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.7 tt0 -66.8 110.32 3.24 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.131 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.597 ' C ' HD21 ' A' ' 26' ' ' ASN . . . 85.33 -7.34 76.32 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.675 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -132.01 -171.19 2.56 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.919 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -155.4 114.01 3.5 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.028 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.1 m -82.96 149.8 26.79 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.064 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' CE ' ' A' ' 27' ' ' LYS . 35.5 mm -138.5 118.3 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.858 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 9' ' ' SER . 13.7 mt . . . . . 0 N--CA 1.502 2.173 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.799 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.696 HD22 ' N ' ' A' ' 38' ' ' GLN . 1.3 t-20 . . . . . 0 C--O 1.215 -0.749 0 CA-C-O 121.247 0.546 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.696 ' N ' HD22 ' A' ' 37' ' ' ASN . 8.2 tt0 -146.45 174.19 11.62 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.66 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.79 61.54 1.65 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -80.05 129.88 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.309 -172.064 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.9 t -25.91 156.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.875 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.97 -139.6 11.56 Favored Glycine 0 N--CA 1.492 2.423 1 N-CA-C 131.506 7.362 . . . . 0.0 131.506 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.56 109.51 3.28 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.07 -110.25 3.45 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.858 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.02 139.41 7.31 Favored Pre-proline 0 C--N 1.299 -1.596 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.473 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.0 Cg_exo -58.63 125.76 19.29 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 N-CA-C 109.41 -1.035 . . . . 0.0 109.41 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.5 tmtt? . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.827 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' ' 3' ' ' TYR . 43.4 t . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.689 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.9 m-85 -108.66 -117.74 0.27 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.681 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 3' ' ' TYR . 6.7 p -161.21 174.29 13.84 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.897 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.33 131.74 35.68 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -48.85 158.81 0.29 Allowed 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.902 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -145.8 13.74 1.34 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.991 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -166.96 121.23 1.04 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.815 -177.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.475 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.55 156.6 0.43 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.266 176.484 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.27 -23.26 28.11 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.057 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' GLY . 11.1 mm-40 -54.07 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.568 -179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.21 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.519 -1.672 . . . . 0.0 114.28 177.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.628 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 19.9 mt -130.52 11.56 5.33 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 26.5 p -102.78 178.23 4.62 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.319 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.7 mt -77.09 73.09 3.68 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 123.057 1.408 . . . . 0.0 107.656 -178.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 31.7 t -77.14 -75.86 0.19 Allowed 'General case' 0 C--N 1.254 -3.558 0 CA-C-N 111.863 -2.426 . . . . 0.0 110.507 -175.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.415 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.94 -126.25 26.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -1.74 24.13 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.678 1.227 . . . . 0.0 108.703 178.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -83.26 151.7 25.5 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.865 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 43.3 t -81.21 149.21 5.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.301 -1.359 . . . . 0.0 111.273 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -73.74 -140.78 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 175.288 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.24 110.48 0.4 Allowed Glycine 0 C--N 1.281 -2.501 0 C-N-CA 117.488 -2.291 . . . . 0.0 111.135 176.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -32.69 145.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.489 -0.856 . . . . 0.0 110.515 177.898 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.17 -2.79 63.77 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 -174.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 41' ' ' THR . 3.1 t-20 -117.1 -157.91 0.68 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.952 -1.124 . . . . 0.0 109.188 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HE3' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -160.68 102.85 1.35 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.665 176.55 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 10' ' ' GLY . 43.9 t -78.35 165.9 23.29 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 117.7 -1.6 . . . . 0.0 110.146 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.525 HD11 ' HE3' ' A' ' 27' ' ' LYS . 11.8 mm -149.12 120.25 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.409 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 9' ' ' SER . 23.7 mt . . . . . 0 N--CA 1.497 1.876 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.442 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 . . . . . 0 C--O 1.216 -0.7 0 CA-C-O 121.407 0.622 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.534 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -105.76 164.83 11.62 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.233 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -121.2 71.67 0.96 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -177.304 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -96.55 120.85 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 118.194 -1.402 . . . . 0.0 114.78 -171.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.529 ' HA ' ' ND2' ' A' ' 26' ' ' ASN . 5.1 t -19.75 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 112.456 -2.156 . . . . 0.0 113.781 171.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.24 -151.01 20.15 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.25 122.86 7.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.187 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 -95.56 0.19 Allowed Glycine 0 N--CA 1.478 1.493 1 N-CA-C 131.52 7.368 . . . . 0.0 131.52 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.0 104.48 20.59 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.529 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -70.41 103.36 1.26 Allowed 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.003 1.135 . . . . 0.0 110.484 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.571 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.596 ' CE2' HD13 ' A' ' 13' ' ' LEU . 13.9 m-85 -140.63 -112.93 0.14 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.886 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.54 171.85 17.48 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.003 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -94.46 133.67 37.81 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.283 -177.55 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -56.4 156.59 5.79 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.84 176.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -143.08 9.38 1.69 Allowed 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.71 173.818 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.588 ' C ' HD12 ' A' ' 30' ' ' LEU . 12.3 mt-10 -164.95 145.96 7.58 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.502 -179.055 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.541 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -59.67 152.72 21.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.532 176.448 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 97.7 -17.65 58.55 Favored Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.137 -1.506 . . . . 0.0 112.376 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.587 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 10.3 mm-40 -61.41 -166.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.022 -179.27 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -158.48 -68.18 0.09 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.748 -178.876 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.596 HD13 ' CE2' ' A' ' 3' ' ' TYR . 96.1 mt -75.63 18.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.277 -176.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.4 p -100.39 175.96 5.52 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.731 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.449 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.6 mt -79.87 73.53 6.62 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.793 1.282 . . . . 0.0 108.417 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 43.4 t -72.32 -83.41 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 112.39 -2.186 . . . . 0.0 110.226 -177.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -75.2 110.82 9.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.341 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.04 -139.91 43.1 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -95.68 3.7 53.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.54 1.162 . . . . 0.0 109.276 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-N 112.898 -1.956 . . . . 0.0 111.467 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.8 t -80.18 144.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -78.67 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.429 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -146.31 96.01 0.18 Allowed Glycine 0 C--N 1.282 -2.463 1 N-CA-C 129.618 6.607 . . . . 0.0 129.618 179.074 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.2 tp60 -33.88 121.48 0.44 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.658 178.024 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.06 -6.77 34.95 Favored Glycine 0 C--N 1.291 -1.968 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 -172.004 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 39' ' ' CYS . 13.5 t30 -118.22 -167.61 1.38 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.316 -0.942 . . . . 0.0 109.292 177.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.637 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -142.1 106.41 4.8 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.267 176.206 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLY . 7.9 t -76.11 158.55 31.65 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 116.413 -2.115 . . . . 0.0 108.262 177.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.637 HD11 ' CE ' ' A' ' 27' ' ' LYS . 14.6 mm -147.11 124.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.274 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 8' ' ' GLU . 8.3 mt . . . . . 0 N--CA 1.499 1.997 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.402 175.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 C--O 1.214 -0.792 0 CA-C-O 121.185 0.517 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 24.0 tt0 -151.57 165.46 34.21 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.543 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -125.38 66.75 1.14 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -100.71 117.75 46.4 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 118.281 -1.368 . . . . 0.0 110.685 -175.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.2 150.48 3.29 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.25 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.23 -37.56 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.268 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 22.4 tt0 -157.29 -129.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.821 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' C ' HE22 ' A' ' 24' ' ' GLN . . . 157.75 97.41 0.13 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.616 -1.278 . . . . 0.0 111.314 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.23 107.96 60.7 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.492 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.25 101.54 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.785 0.99 . . . . 0.0 110.262 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HG2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.276 -178.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 HE22 ' A' ' 11' ' ' GLN . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.748 ' HA ' HD22 ' A' ' 37' ' ' ASN . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 41' ' ' THR . 1.6 t-20 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' SER . 11.3 mt . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.748 HD22 ' HA ' ' A' ' 16' ' ' CYS . 32.0 t-20 . . . . . 0 C--O 1.216 -0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.472 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.557 0.694 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 4' ' ' THR . 65.0 m-85 -132.76 -130.28 0.18 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.651 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 3' ' ' TYR . 6.9 p -165.23 177.71 7.44 Favored 'General case' 0 C--N 1.256 -3.459 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.622 -176.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.76 129.93 34.76 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.422 178.13 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -43.69 158.16 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.594 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -138.31 10.7 2.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.541 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -165.43 130.04 2.42 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.42 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.45 153.02 0.39 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.608 -0.837 . . . . 0.0 108.754 172.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 80.35 19.38 69.2 Favored Glycine 0 C--N 1.278 -2.666 0 C-N-CA 119.994 -1.098 . . . . 0.0 112.45 -178.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 11.1 mm-40 -89.95 -166.32 1.56 Allowed 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.919 178.106 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.0 m120 -153.5 -72.46 0.13 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 37.5 mt -71.82 17.16 0.1 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.566 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 26.7 p -103.93 176.48 5.14 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.218 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.1 mt -80.77 72.72 7.75 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 122.676 1.227 . . . . 0.0 108.156 -177.385 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 99.6 m -70.93 -79.51 0.06 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 112.555 -2.112 . . . . 0.0 110.315 -176.264 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.532 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 3.2 mp0 -74.36 91.97 2.26 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.061 -1.456 . . . . 0.0 108.788 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.694 ' H ' HD22 ' A' ' 37' ' ' ASN . . . 70.78 -140.36 31.48 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.188 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -86.76 4.09 42.33 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.016 0.912 . . . . 0.0 110.65 -178.916 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -90.87 140.01 30.21 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.235 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 22' ' ' CYS . 12.6 t -80.48 146.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.73 177.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -100.0 -146.96 0.34 Allowed 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.327 176.856 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -157.18 123.05 1.24 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 116.721 -2.656 . . . . 0.0 111.885 -177.158 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' GLY . 31.1 tp60 -35.25 160.76 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.036 -1.582 . . . . 0.0 110.052 175.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.78 52.73 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 -174.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.562 HD21 ' C ' ' A' ' 39' ' ' CYS . 18.1 t30 -109.15 -163.43 0.87 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.249 -0.976 . . . . 0.0 109.23 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.39 96.75 1.19 Allowed 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.241 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -84.1 126.08 32.75 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 117.896 -1.522 . . . . 0.0 112.306 -178.413 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 37' ' ' ASN . 11.4 mm -99.32 116.56 42.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.275 -176.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.296 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.694 HD22 ' H ' ' A' ' 18' ' ' GLY . 45.5 t30 . . . . . 0 CA--C 1.502 -0.881 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 5.1 tt0 -103.03 -165.28 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.029 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.562 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.0 OUTLIER -147.98 89.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.268 -177.963 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -105.62 123.68 60.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 112.982 -1.917 . . . . 0.0 113.169 -176.7 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.3 t -6.35 144.05 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 112.534 -2.121 . . . . 0.0 113.824 171.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 136.07 172.15 12.54 Favored Glycine 0 N--CA 1.487 2.095 1 N-CA-C 130.979 7.151 . . . . 0.0 130.979 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.47 94.76 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.953 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.17 -113.33 3.52 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -164.07 134.18 3.18 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.725 -179.898 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' LYS . 9.5 Cg_endo -76.81 98.62 1.23 Allowed 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.458 1.439 . . . . 0.0 110.481 173.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.4 tttp . . . . . 0 N--CA 1.493 1.684 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.203 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 2' ' ' VAL . 46.7 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.561 0.696 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.83 -121.8 0.21 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.709 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 1.8 t -170.71 178.86 3.42 Favored 'General case' 0 C--N 1.254 -3.56 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.251 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.555 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -95.12 131.22 41.37 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.155 -178.948 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -47.65 153.88 0.53 Allowed 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.8 177.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -148.57 18.03 1.03 Allowed 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.87 174.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -164.11 122.84 1.89 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.709 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.69 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -52.55 146.73 9.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.575 0.703 . . . . 0.0 110.663 178.835 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 98.96 -0.34 57.55 Favored Glycine 0 C--N 1.277 -2.749 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.66 178.112 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.4 mt-30 -88.39 179.17 6.38 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.653 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -148.0 -42.16 0.16 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.423 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 46' ' ' PRO . 8.2 mp -75.76 22.88 0.13 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.608 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.2 p -121.8 177.21 5.37 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.602 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.8 mt -79.5 74.73 6.14 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 122.672 1.225 . . . . 0.0 108.915 -176.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.8 m -69.89 -77.77 0.08 Allowed 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.03 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.77 114.99 17.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.785 -179.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.42 -120.76 24.13 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.255 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 4.59 18.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.486 1.136 . . . . 0.0 109.821 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -88.72 143.9 26.62 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.911 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 22' ' ' CYS . 12.8 t -83.03 136.73 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.342 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.632 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -82.35 -140.2 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.541 174.896 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.86 123.77 1.18 Allowed Glycine 0 C--N 1.27 -3.103 0 C-N-CA 116.58 -2.724 . . . . 0.0 111.58 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -33.94 150.78 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 113.009 -1.596 . . . . 0.0 109.078 175.687 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.504 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 96.99 -12.7 65.55 Favored Glycine 0 C--N 1.29 -2.007 0 N-CA-C 106.359 -2.696 . . . . 0.0 106.359 -173.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.5 t-20 -114.15 -163.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.904 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -157.36 99.28 1.76 Allowed 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.395 176.148 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.811 ' O ' HD13 ' A' ' 29' ' ' ILE . 3.6 m -78.38 149.78 33.3 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.6 -1.64 . . . . 0.0 109.848 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.3 mm -128.38 115.68 38.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.598 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 9' ' ' SER . 29.0 mt . . . . . 0 N--CA 1.498 1.955 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.516 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 5.3 tt0 -78.77 -179.0 6.26 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.516 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -135.47 68.81 1.45 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.878 -1.129 . . . . 0.0 107.954 178.952 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -104.22 124.51 58.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.517 -175.692 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.546 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 10.2 t -55.03 154.59 5.28 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.53 -24.05 0.15 Allowed Glycine 0 N--CA 1.494 2.505 0 CA-C-N 113.744 -1.571 . . . . 0.0 109.762 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 26' ' ' ASN . 5.4 tt0 -159.46 -140.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' ' H ' ' A' ' 25' ' ' GLY . . . 163.8 102.06 0.16 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.196 -1.478 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.6 139.98 32.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.633 178.396 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.641 ' HA ' HD13 ' A' ' 13' ' ' LEU . 11.7 Cg_endo -76.86 102.13 1.58 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.773 1.649 . . . . 0.0 109.273 172.36 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 tptt . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 118.3 -1.36 . . . . 0.0 111.732 -177.122 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 3' ' ' TYR . 4.2 t . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 120.672 0.273 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.504 ' H ' HG12 ' A' ' 2' ' ' VAL . 9.0 m-85 -114.08 -110.25 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.559 0.695 . . . . 0.0 110.683 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 177.2 179.22 0.24 Allowed 'General case' 0 C--N 1.261 -3.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.784 -179.097 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.572 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -82.84 130.88 35.19 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.459 -176.992 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 m -47.56 160.72 0.11 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.729 175.534 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 t -141.78 9.43 1.96 Allowed 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.786 175.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -168.18 154.13 7.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.218 178.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 157.16 14.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.898 176.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 91.85 -22.56 30.61 Favored Glycine 0 N--CA 1.51 3.604 0 C-N-CA 119.336 -1.411 . . . . 0.0 114.147 177.411 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -78.52 160.95 27.39 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.719 -177.014 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 28' ' ' CYS . 6.8 m-80 -151.21 21.33 0.75 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 115.535 1.679 . . . . 0.0 115.535 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.746 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -123.65 8.29 8.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.159 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 21.9 p -102.53 179.97 4.14 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.226 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.46 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.5 mt -79.75 74.88 6.44 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.95 1.357 . . . . 0.0 108.476 -177.463 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.0 t -72.14 -80.77 0.06 Allowed 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 112.098 -2.319 . . . . 0.0 110.116 -177.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.31 106.86 10.51 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.957 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.58 -151.79 46.05 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.06 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.17 5.36 17.12 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.1 0.952 . . . . 0.0 110.332 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -89.63 142.2 27.9 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.679 -1.601 . . . . 0.0 112.588 -176.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 13' ' ' LEU . 43.0 t -82.56 151.2 4.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.72 178.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -103.69 -143.26 0.36 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.71 176.26 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ASN . . . -159.44 118.81 0.85 Allowed Glycine 0 C--O 1.203 -1.792 0 C-N-CA 116.782 -2.627 . . . . 0.0 112.469 -176.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 26' ' ' ASN . 52.3 tt0 -35.3 162.02 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.699 -1.25 . . . . 0.0 110.179 174.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' GLN . . . 87.91 -24.29 11.33 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 106.006 -2.837 . . . . 0.0 106.006 -172.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.7 t30 -96.42 -167.17 1.53 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -161.35 102.88 1.24 Allowed 'General case' 0 C--N 1.265 -3.103 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.61 177.567 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 97.3 m -78.29 158.98 28.71 Favored 'General case' 0 CA--C 1.442 -3.184 0 C-N-CA 117.372 -1.731 . . . . 0.0 108.86 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.605 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.6 mm -142.72 114.3 3.01 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.355 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.027 174.237 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.507 2.409 0 C-N-CA 118.132 -1.427 . . . . 0.0 109.09 177.949 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -81.09 171.96 14.29 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -137.5 75.58 1.54 Allowed 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.644 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -110.97 131.02 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 117.997 -1.481 . . . . 0.0 114.88 -174.494 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.572 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -9.15 153.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 112.296 -2.229 . . . . 0.0 115.233 172.916 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.38 -136.21 8.53 Favored Glycine 0 N--CA 1.495 2.616 1 N-CA-C 129.937 6.735 . . . . 0.0 129.937 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -76.55 -131.13 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.46 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.603 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 140.13 107.54 0.71 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.471 176.293 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.82 135.06 36.01 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.037 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.602 ' HA ' HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -68.07 100.72 0.65 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 120.512 0.808 . . . . 0.0 110.196 173.882 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.671 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 12.4 tptm . . . . . 0 N--CA 1.492 1.627 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.003 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.657 HG12 ' N ' ' A' ' 3' ' ' TYR . 33.4 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.201 0.524 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.657 ' N ' HG12 ' A' ' 2' ' ' VAL . 2.8 m-85 -118.4 -96.72 0.47 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.441 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -178.34 178.56 0.86 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.9 178.346 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.554 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.44 132.11 34.02 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.559 -175.683 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 30' ' ' LEU . 2.7 m -48.88 160.13 0.21 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.362 176.099 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 7' ' ' THR . 5.1 t -152.8 14.77 0.55 Allowed 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.533 173.816 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.626 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.5 tt0 -166.2 117.97 1.03 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.982 -178.398 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -45.81 160.99 0.05 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.709 177.441 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.99 -29.34 8.81 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 118.839 -1.648 . . . . 0.0 112.482 -179.038 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 33.2 mt-30 -67.6 -168.84 0.1 Allowed 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.615 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.599 HD21 ' HB3' ' A' ' 22' ' ' CYS . 1.4 m120 -166.0 -28.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 117.716 -1.594 . . . . 0.0 113.998 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 46' ' ' PRO . 26.6 mt -86.53 15.04 5.89 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.706 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.5 p -105.63 177.11 4.95 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.992 -178.055 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.4 mt -77.74 75.76 4.28 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.76 1.266 . . . . 0.0 108.726 -176.763 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 14.3 m -82.24 -72.68 0.43 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.265 -2.243 . . . . 0.0 111.251 -177.215 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.03 87.88 1.87 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.505 179.329 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -142.16 37.38 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.176 -1.487 . . . . 0.0 109.682 -178.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 0.98 43.34 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.187 0.994 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -90.64 150.39 21.71 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.413 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.2 t -81.3 150.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.335 -178.303 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.599 ' HB3' HD21 ' A' ' 12' ' ' ASN . 0.0 OUTLIER -72.91 -136.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.542 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -169.67 111.46 0.42 Allowed Glycine 0 C--N 1.283 -2.395 0 C-N-CA 117.429 -2.32 . . . . 0.0 110.785 174.195 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 23' ' ' GLY . 34.9 tt0 -34.76 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.778 177.295 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 87.12 -12.46 62.23 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 -174.104 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.635 HD21 ' C ' ' A' ' 39' ' ' CYS . 34.9 t30 -108.0 -162.09 0.81 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 40' ' ' VAL . 23.0 tttt -147.74 103.32 3.5 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.132 173.536 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.813 ' O ' HD13 ' A' ' 29' ' ' ILE . 38.0 t -75.93 156.92 33.77 Favored 'General case' 0 C--N 1.272 -2.77 0 C-N-CA 117.692 -1.603 . . . . 0.0 109.752 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 28' ' ' CYS . 9.0 mm -139.05 116.05 10.85 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.099 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 8' ' ' GLU . 20.9 mt . . . . . 0 N--CA 1.506 2.361 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.577 179.284 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 16' ' ' CYS . 2.2 t-20 . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HG3' ' H ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -133.25 175.48 9.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.669 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.635 ' C ' HD21 ' A' ' 26' ' ' ASN . 1.3 m -137.93 67.96 1.41 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.561 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -107.19 128.18 62.34 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.809 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.04 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.461 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -52.94 151.35 4.71 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.6 -27.19 0.12 Allowed Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.404 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 26' ' ' ASN . 69.2 mt-10 -154.18 -135.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.432 0.634 . . . . 0.0 109.546 -178.395 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA3' ' H ' ' A' ' 25' ' ' GLY . . . 159.71 97.93 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.684 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.15 144.45 52.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.249 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.549 ' HA ' HD12 ' A' ' 13' ' ' LEU . 18.4 Cg_endo -78.85 130.19 9.45 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.726 1.617 . . . . 0.0 110.678 173.704 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp . . . . . 0 CA--C 1.564 1.503 0 C-N-CA 118.401 -1.32 . . . . 0.0 108.673 177.362 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 3' ' ' TYR . 3.3 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.996 0.427 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.567 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 72.3 m-85 -106.36 -114.17 0.26 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.304 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -176.63 174.3 1.87 Allowed 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.532 178.856 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.538 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.43 133.77 36.54 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.888 -175.882 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.9 m -47.35 170.26 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.458 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.457 176.243 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.38 10.23 1.45 Allowed 'General case' 0 C--N 1.262 -3.207 0 CA-C-N 113.406 -1.725 . . . . 0.0 107.276 172.009 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 30' ' ' LEU . 31.8 tt0 -169.94 128.82 0.92 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.512 -179.054 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.737 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -46.81 163.21 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.442 177.645 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.64 -15.46 24.96 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.011 -2.042 . . . . 0.0 111.597 178.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -58.64 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.763 -1.175 . . . . 0.0 108.613 177.95 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -145.68 -81.48 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.345 -1.742 . . . . 0.0 114.348 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 93.5 mt -75.32 36.72 0.12 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.831 -173.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -101.39 -176.69 3.22 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.337 179.758 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.615 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 11.3 mt -90.99 80.61 5.72 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.925 -176.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.59 -78.64 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 CA-C-N 112.862 -1.972 . . . . 0.0 110.709 -177.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 79.7 mm-40 -86.34 110.44 19.68 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.95 -119.19 9.47 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.683 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.47 1.44 12.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.476 1.131 . . . . 0.0 109.358 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -79.77 142.04 35.75 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.06 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 38.7 t -86.31 154.29 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.42 178.71 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.3 m -142.46 -162.71 1.46 Allowed 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.011 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 97.15 -50.37 1.48 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 117.412 -2.327 . . . . 0.0 113.518 174.107 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.572 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.3 tt0 -59.66 118.75 6.48 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.435 -177.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.84 -8.14 16.93 Favored Glycine 0 C--N 1.305 -1.166 0 N-CA-C 107.536 -2.226 . . . . 0.0 107.536 -176.345 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -122.97 -173.83 2.8 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.969 -179.43 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.587 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.25 116.58 13.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.695 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' GLY . 13.5 t -79.24 153.89 29.6 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 117.421 -1.711 . . . . 0.0 110.672 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.587 HD11 ' CE ' ' A' ' 27' ' ' LYS . 16.9 mm -148.36 124.59 2.51 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.479 0 CA-C-N 113.163 -1.835 . . . . 0.0 111.731 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 9' ' ' SER . 3.4 mt . . . . . 0 N--CA 1.514 2.747 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.615 176.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.804 0.811 . . . . 0.0 110.696 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 11.3 tt0 -160.02 170.11 22.0 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.92 177.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 22.1 m -131.41 64.69 1.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -79.98 125.84 39.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.855 -173.487 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 6.5 t -29.06 155.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 113.087 -1.869 . . . . 0.0 112.373 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.73 -154.3 16.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -142.11 124.73 15.85 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.472 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.09 -113.48 3.81 Favored Glycine 0 N--CA 1.479 1.527 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.887 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.88 141.19 7.44 Favored Pre-proline 0 C--N 1.296 -1.736 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.746 -178.726 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.9 Cg_endo -67.43 111.8 2.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.881 1.054 . . . . 0.0 109.412 174.181 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HD3' HG23 ' A' ' 4' ' ' THR . 14.4 tttp . . . . . 0 N--CA 1.502 2.162 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.613 -178.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.743 0.306 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -110.31 -116.69 0.3 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.657 0.742 . . . . 0.0 110.029 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -165.26 175.76 8.97 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.686 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.13 134.5 36.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.921 0.867 . . . . 0.0 112.723 -174.576 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.466 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 3.2 m -48.81 158.07 0.34 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.886 176.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -140.69 7.07 2.08 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.253 174.088 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.62 126.7 0.9 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.288 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -50.51 157.54 0.72 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.489 175.765 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.15 -3.41 84.57 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.66 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 26.3 mt-30 -86.55 -166.19 1.49 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.502 178.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.589 HD21 ' H ' ' A' ' 44' ' ' GLY . 6.2 m-20 -139.83 -80.49 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -175.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mt -71.63 41.67 0.08 Allowed 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.651 -172.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ASN . 31.8 p -107.75 178.75 4.43 Favored 'General case' 0 C--O 1.194 -1.834 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.854 176.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -89.78 79.72 6.66 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 123.05 1.405 . . . . 0.0 108.286 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 33.9 t -61.99 -94.48 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.024 0 CA-C-N 111.832 -2.44 . . . . 0.0 111.191 -176.47 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.43 122.29 26.8 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.421 -1.311 . . . . 0.0 109.592 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.63 -123.82 23.14 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.327 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -116.23 2.75 13.35 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 122.393 1.092 . . . . 0.0 109.652 -179.598 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -81.73 144.92 30.79 Favored 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.761 -177.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 22.8 t -86.67 149.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.645 178.558 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -136.64 -165.1 1.67 Allowed 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 174.529 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 112.67 -68.52 0.23 Allowed Glycine 0 N--CA 1.484 1.893 0 C-N-CA 117.662 -2.209 . . . . 0.0 113.488 174.048 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.581 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -64.55 124.79 22.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.776 -175.065 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.6 -5.55 44.93 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -175.655 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -133.82 -170.66 2.55 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.674 -179.376 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 40' ' ' VAL . 19.4 tttp -156.27 105.95 2.34 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.292 177.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.832 ' O ' HD13 ' A' ' 29' ' ' ILE . 11.1 m -80.48 158.86 25.76 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 117.665 -1.614 . . . . 0.0 111.038 -179.151 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.832 HD13 ' O ' ' A' ' 28' ' ' CYS . 10.1 mm -139.5 106.87 2.83 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.288 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.47 ' H ' ' HB3' ' A' ' 9' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.506 2.374 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.932 -178.104 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.7 m120 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.505 0.669 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -147.56 167.66 23.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.097 174.639 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 m -131.74 73.15 1.52 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -91.24 125.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.898 -173.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.3 t -32.99 159.18 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.476 177.604 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.51 -150.97 19.1 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.882 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -153.95 114.1 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.589 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -104.92 -109.76 3.44 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.16 148.27 11.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.55 -177.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.27 129.07 29.83 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.11 1.207 . . . . 0.0 109.876 175.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? . . . . . 0 CA--C 1.564 1.505 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.861 -179.594 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.794 0.33 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -145.19 -114.0 0.09 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.009 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.36 164.22 38.94 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.9 -178.68 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.86 131.92 35.26 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.555 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 150.35 4.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.578 176.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.829 HG22 ' HZ3' ' A' ' 47' ' ' LYS . 14.8 t -145.63 15.36 1.42 Allowed 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -162.46 113.67 1.57 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.41 -177.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.449 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -46.87 155.41 0.26 Allowed 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.515 178.258 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 10.87 85.64 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.449 -1.357 . . . . 0.0 111.293 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -79.39 -168.52 1.55 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.814 178.608 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' CYS . 28.7 t-20 -130.95 -91.18 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 114.835 -177.436 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.35 37.58 0.11 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.857 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 21.5 p -96.37 -178.85 4.43 Favored 'General case' 0 C--O 1.192 -1.922 0 C-N-CA 118.175 -1.41 . . . . 0.0 109.721 179.62 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -92.92 79.8 4.64 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 122.504 1.145 . . . . 0.0 108.577 -177.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.9 t -66.97 -85.42 0.02 OUTLIER 'General case' 0 C--N 1.253 -3.593 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.42 -176.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -80.77 120.3 24.47 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.71 -121.88 26.28 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.527 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.99 2.9 14.36 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.635 1.207 . . . . 0.0 109.126 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -78.88 142.44 36.8 Favored 'General case' 0 C--N 1.26 -3.315 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.518 -178.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 39.2 t -85.7 153.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 118.379 -1.328 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.7 m -139.52 -166.93 2.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.183 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 98.04 -47.04 1.53 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 117.268 -2.396 . . . . 0.0 114.14 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.629 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 20.5 tt0 -60.49 103.21 0.22 Allowed 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.768 -176.522 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.32 55.82 Favored Glycine 0 C--N 1.303 -1.27 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -175.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.668 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -119.38 -164.45 1.06 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.884 -1.158 . . . . 0.0 111.102 178.951 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.693 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -159.81 134.78 7.97 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.668 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 t -94.73 159.5 15.04 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.438 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.693 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 31.1 mm -137.27 110.06 7.6 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.413 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.786 177.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 9' ' ' SER . 63.1 mt . . . . . 0 N--CA 1.498 1.965 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.348 0.594 . . . . 0.0 111.843 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 59.0 tt0 -82.7 162.71 21.71 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.087 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.2 m -123.9 67.74 1.04 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.712 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -85.18 131.18 34.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 117.844 -1.543 . . . . 0.0 111.78 -172.677 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' VAL . 2.2 t -36.13 165.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.272 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.3 -129.95 7.13 Favored Glycine 0 N--CA 1.484 1.894 1 N-CA-C 129.596 6.599 . . . . 0.0 129.596 -178.321 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -161.07 115.4 2.06 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.199 178.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.8 -106.69 2.96 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.86 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.1 140.62 8.77 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.87 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.5 Cg_endo -61.85 96.6 0.14 Allowed 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 121.132 1.221 . . . . 0.0 110.227 176.891 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.829 ' HZ3' HG22 ' A' ' 7' ' ' THR . 32.3 tptt . . . . . 0 N--CA 1.491 1.595 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.754 -179.139 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 2' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.685 ' O ' HG23 ' A' ' 4' ' ' THR . 78.9 m-85 -104.66 -128.4 0.25 Allowed 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.359 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.677 -174.097 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.04 129.49 34.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.842 179.104 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.8 m -44.62 155.44 0.1 Allowed 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.17 178.238 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.75 11.48 2.26 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.978 175.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.65 134.31 4.48 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.01 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.531 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -53.47 155.25 3.02 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.317 176.59 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.812 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 77.62 13.56 83.37 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.485 -179.378 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.403 HE22 ' HG2' ' A' ' 47' ' ' LYS . 9.7 mm-40 -75.63 -168.65 0.88 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.014 179.047 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 14' ' ' CYS . 77.2 m-20 -151.14 -72.05 0.16 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.248 -1.381 . . . . 0.0 113.741 -178.842 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.502 HD13 ' CE1' ' A' ' 3' ' ' TYR . 24.0 mt -75.73 20.7 0.17 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.19 -175.812 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.7 p -102.77 176.68 5.08 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.383 -179.342 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.497 ' N ' HD23 ' A' ' 15' ' ' LEU . 6.6 mt -80.62 73.31 7.57 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-O 122.934 1.35 . . . . 0.0 108.194 -177.018 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.0 m -72.38 -81.69 0.05 Allowed 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.169 -175.82 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.99 112.13 12.1 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.55 -179.759 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.7 -121.76 12.97 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.284 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.97 1.91 12.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.593 1.187 . . . . 0.0 108.918 178.872 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -85.81 151.2 24.01 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.766 -177.611 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 22' ' ' CYS . 32.8 t -84.3 142.4 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.023 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.593 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -84.81 -142.37 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.897 174.451 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.4 120.65 0.96 Allowed Glycine 0 C--N 1.282 -2.419 0 C-N-CA 116.88 -2.581 . . . . 0.0 111.683 -178.758 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.6 tt0 -31.42 150.9 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.561 -1.319 . . . . 0.0 110.092 177.233 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.14 -15.01 63.72 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 106.381 -2.688 . . . . 0.0 106.381 -172.701 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.652 ' OD1' ' N ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -115.36 -170.84 1.84 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.625 -1.288 . . . . 0.0 108.461 177.185 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.82 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -161.32 117.1 2.13 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.609 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -95.97 122.5 38.86 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.837 -177.189 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.82 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.3 mm -97.12 117.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 113.097 -1.865 . . . . 0.0 112.698 -174.084 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 9' ' ' SER . 8.1 mt . . . . . 0 N--CA 1.511 2.591 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.422 179.654 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.795 0.331 . . . . 0.0 111.767 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -77.12 173.98 11.21 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 173.758 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.13 80.64 1.77 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.427 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -109.43 127.75 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.156 -175.231 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.652 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 t -16.71 141.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.696 172.391 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.17 -130.0 2.25 Favored Glycine 0 N--CA 1.484 1.856 1 N-CA-C 131.513 7.365 . . . . 0.0 131.513 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -161.05 100.31 1.23 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.281 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.812 ' HA3' ' O ' ' A' ' 10' ' ' GLY . . . -121.78 -97.03 1.44 Allowed Glycine 0 N--CA 1.481 1.648 1 N-CA-C 129.105 6.402 . . . . 0.0 129.105 177.122 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.82 129.57 2.46 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.696 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.18 92.61 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.329 1.353 . . . . 0.0 110.441 172.893 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HG2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.239 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.681 -179.525 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 3' ' ' TYR . 37.6 t . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.655 ' N ' HG12 ' A' ' 2' ' ' VAL . 9.2 m-85 -114.38 -112.65 0.34 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.555 0.693 . . . . 0.0 110.253 -178.565 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -169.22 -174.4 1.98 Allowed 'General case' 0 C--N 1.255 -3.51 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.305 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.594 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.86 135.73 33.27 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.044 -177.301 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.76 155.38 0.58 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.648 175.284 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -133.46 4.82 3.7 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.952 176.083 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.405 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 7.1 pt-20 -168.51 132.55 1.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.757 179.585 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -42.0 166.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.668 176.565 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 68.17 20.48 73.12 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.806 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.485 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -85.58 -172.78 4.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.864 -179.463 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 14' ' ' CYS . 3.1 m120 -154.95 -67.29 0.13 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.415 -1.314 . . . . 0.0 113.952 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 5.2 mt -74.07 22.9 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.455 -176.643 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.8 p -115.36 179.49 3.95 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.5 mt -81.04 72.15 8.06 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.444 -178.195 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.0 m -70.39 -83.22 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.517 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.009 -177.145 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 37' ' ' ASN . 1.3 tm-20 -77.45 122.62 25.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.336 -1.346 . . . . 0.0 109.93 178.964 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.18 -125.0 38.39 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.793 -178.361 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.02 4.61 15.77 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.893 1.33 . . . . 0.0 108.278 178.64 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 142.68 34.86 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 111.965 -2.379 . . . . 0.0 111.877 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.0 t -84.22 135.43 24.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.12 -1.432 . . . . 0.0 109.624 176.852 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.609 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -78.56 -143.33 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.726 175.439 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -166.91 119.32 0.84 Allowed Glycine 0 C--N 1.275 -2.857 0 C-N-CA 117.533 -2.27 . . . . 0.0 110.671 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' GLY . 30.9 tp60 -35.09 151.06 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.416 177.085 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.57 -13.3 67.83 Favored Glycine 0 C--N 1.292 -1.89 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -172.679 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 41' ' ' THR . 27.2 t30 -111.4 -161.75 0.77 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.198 -1.001 . . . . 0.0 109.208 177.166 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.92 110.63 1.47 Allowed 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.18 179.055 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -105.26 125.28 50.81 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.004 177.7 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.555 HD11 ' CE ' ' A' ' 27' ' ' LYS . 37.0 mm -105.0 113.86 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.209 -178.553 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 9' ' ' SER . 8.9 mt . . . . . 0 N--CA 1.529 3.507 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.673 -177.177 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.498 HD22 ' HA ' ' A' ' 17' ' ' GLU . 2.2 p30 . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 9.7 tt0 -119.82 170.63 9.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.161 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.488 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -139.86 82.56 1.88 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.267 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -125.08 141.31 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.354 -176.674 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.528 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -16.76 152.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 112.408 -2.178 . . . . 0.0 113.519 171.749 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.54 -143.26 12.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.73 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.91 111.51 1.76 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.818 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.85 -88.22 0.82 Allowed Glycine 0 N--CA 1.491 2.333 1 N-CA-C 129.77 6.668 . . . . 0.0 129.77 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -147.18 124.12 5.71 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.989 178.152 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.45 98.96 1.25 Allowed 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.474 1.449 . . . . 0.0 111.123 175.394 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.4 tptp . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.463 179.31 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 3' ' ' TYR . 7.0 t -117.22 166.0 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.759 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.517 ' C ' HG22 ' A' ' 4' ' ' THR . 32.8 m-85 -120.12 -110.46 0.34 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.268 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 173.15 178.71 0.09 Allowed 'General case' 0 C--N 1.258 -3.395 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -76.47 130.18 37.6 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.644 -1.223 . . . . 0.0 111.175 -176.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 96.2 m -40.6 168.06 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.15 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 HG22 ' NZ ' ' A' ' 47' ' ' LYS . 14.9 t -143.66 11.85 1.67 Allowed 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 113.066 -1.879 . . . . 0.0 107.626 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -173.9 125.76 0.36 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.433 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -47.1 158.06 0.15 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.224 178.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 95.57 -28.26 12.88 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.588 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.89 176.92 0.49 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.938 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -156.49 20.18 0.34 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 116.947 -1.901 . . . . 0.0 114.863 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.764 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -134.14 16.0 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.064 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -102.04 -179.62 4.05 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.025 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.1 mt -77.85 72.69 4.4 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.003 1.383 . . . . 0.0 108.003 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.4 t -77.68 -82.85 0.08 Allowed 'General case' 0 C--N 1.25 -3.733 0 CA-C-N 112.051 -2.341 . . . . 0.0 110.356 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.81 110.86 9.46 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.859 -1.536 . . . . 0.0 108.505 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.3 -154.56 33.52 Favored Glycine 0 N--CA 1.479 1.528 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -82.8 5.56 21.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.52 1.153 . . . . 0.0 109.324 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -86.42 149.01 25.3 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.657 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG13 ' C ' ' A' ' 13' ' ' LEU . 28.1 t -82.65 144.56 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.027 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -71.15 -144.67 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.965 177.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -141.3 82.91 0.23 Allowed Glycine 0 C--N 1.282 -2.464 1 N-CA-C 128.17 6.028 . . . . 0.0 128.17 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -19.22 126.0 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 124.595 0.82 . . . . 0.0 111.483 -177.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.48 56.95 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 106.551 -2.619 . . . . 0.0 106.551 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.0 m-20 -110.12 -169.74 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.188 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.876 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -144.36 130.9 19.95 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.043 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.596 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 52.6 t -99.58 168.29 10.05 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.586 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.876 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 28.1 mm -145.95 119.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 C-N-CA 118.298 -1.361 . . . . 0.0 112.508 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 9' ' ' SER . 12.0 mt -91.52 126.57 36.65 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.49 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' H ' ' CA ' ' A' ' 36' ' ' LYS . . . 71.23 90.14 0.1 OUTLIER Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.914 -1.612 . . . . 0.0 111.221 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.93 82.37 2.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 52.49 42.68 31.37 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.95 18.26 Favored Glycine 0 N--CA 1.483 1.813 1 N-CA-C 124.928 4.731 . . . . 0.0 124.928 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -97.98 95.72 7.67 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.358 -1.421 . . . . 0.0 109.718 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' CA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -62.79 1.94 0.35 Allowed 'General case' 1 C--N 1.231 -4.561 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.493 179.818 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER 179.6 111.77 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.909 -176.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.622 ' N ' HD22 ' A' ' 37' ' ' ASN . 35.2 tt0 -127.6 161.21 29.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.02 71.13 1.04 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -174.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -101.79 113.12 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 118.161 -1.416 . . . . 0.0 113.27 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' VAL . 7.5 t -31.11 158.69 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.421 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.64 159.51 8.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -78.12 102.59 7.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.37 -104.65 2.93 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.64 137.86 6.77 Favored Pre-proline 0 C--N 1.303 -1.418 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.908 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.708 ' HA ' HD11 ' A' ' 13' ' ' LEU . 2.9 Cg_endo -68.87 91.68 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.735 0.957 . . . . 0.0 109.681 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 47.7 tttp -33.86 97.72 0.12 Allowed Pre-proline 0 N--CA 1.503 2.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.262 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -66.23 176.2 4.18 Favored 'Trans proline' 0 C--O 1.212 -0.778 0 C-N-CA 120.828 1.019 . . . . 0.0 110.97 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? . . . . . 0 C--N 1.308 -1.207 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.539 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 3' ' ' TYR . 16.0 t -115.24 171.41 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.294 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.64 ' O ' HG23 ' A' ' 4' ' ' THR . 33.1 m-85 -114.27 -116.74 0.32 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.719 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.3 p -165.59 176.62 7.96 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.909 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.66 125.57 35.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.191 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' ' NE2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -59.84 165.59 3.09 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-O 123.594 1.664 . . . . 0.0 111.897 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -142.31 13.32 1.99 Allowed 'General case' 1 C--N 1.239 -4.197 0 CA-C-N 110.595 -3.002 . . . . 0.0 105.338 174.198 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' C ' HD12 ' A' ' 30' ' ' LEU . 16.1 mt-10 -160.31 139.47 10.73 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.584 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.63 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.65 -175.62 0.06 Allowed 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 123.236 1.493 . . . . 0.0 111.15 177.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 69.47 -36.87 0.34 Allowed Glycine 1 C--N 1.231 -5.294 0 CA-C-N 111.278 -2.692 . . . . 0.0 112.524 177.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.553 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -59.74 -171.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.555 -175.573 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -171.77 40.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.659 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 24' ' ' GLN . 72.9 mt -143.02 1.32 1.26 Allowed 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.477 ' C ' HD23 ' A' ' 15' ' ' LEU . 3.3 p -100.48 171.45 7.73 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.604 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.785 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -81.48 78.83 8.19 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 123.664 1.697 . . . . 0.0 107.998 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -79.76 -61.32 2.03 Favored 'General case' 1 C--N 1.235 -4.382 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.845 -178.724 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 11.4 mm-40 -73.99 72.17 1.61 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.66 -1.616 . . . . 0.0 108.284 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -113.4 4.07 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.3 p -99.91 -11.75 20.42 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-O 124.048 1.88 . . . . 0.0 109.197 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.04 119.39 19.14 Favored 'General case' 1 C--N 1.207 -5.628 0 CA-C-N 110.709 -2.95 . . . . 0.0 110.216 178.944 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 22' ' ' CYS . 25.4 t -63.41 147.11 12.39 Favored 'Isoleucine or valine' 1 C--N 1.215 -5.279 0 CA-C-N 110.956 -2.838 . . . . 0.0 107.713 175.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -77.93 -132.16 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.77 89.75 0.1 OUTLIER Glycine 1 C--N 1.224 -5.677 0 C-N-CA 115.942 -3.028 . . . . 0.0 112.36 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' ASN . 36.2 tt0 -23.67 142.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 113.782 -1.209 . . . . 0.0 110.743 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -7.42 63.4 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -173.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.2 m-20 -111.11 -166.89 1.11 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.607 -1.297 . . . . 0.0 108.91 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -147.48 98.01 2.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 10' ' ' GLY . 51.1 t -75.68 154.84 36.26 Favored 'General case' 0 CA--C 1.435 -3.448 0 C-N-CA 116.55 -2.06 . . . . 0.0 109.918 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.57 HD11 ' CE ' ' A' ' 27' ' ' LYS . 32.3 mm -139.08 120.97 16.67 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.246 0 CA-C-N 112.769 -2.014 . . . . 0.0 109.633 175.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 9' ' ' SER . 18.4 mt -75.51 144.81 41.78 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 36' ' ' LYS . . . -61.83 61.04 0.02 OUTLIER Glycine 0 C--N 1.288 -2.116 0 CA-C-N 110.233 -3.167 . . . . 0.0 110.562 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.629 ' O ' ' N ' ' A' ' 34' ' ' GLY . 19.4 m -70.64 -124.96 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.573 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.55 69.47 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.981 0 O-C-N 125.377 1.673 . . . . 0.0 110.325 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 60.61 41.63 98.92 Favored Glycine 0 C--N 1.277 -2.739 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.49 -127.07 0.19 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.753 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 4.6 mttp -105.18 -118.04 0.23 Allowed 'General case' 0 C--N 1.268 -2.95 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -173.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 16' ' ' CYS . 45.7 t-20 119.7 36.76 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.994 -2.366 . . . . 0.0 105.76 -169.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -95.48 -173.36 2.88 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.56 -1.655 . . . . 0.0 108.629 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.59 67.12 1.53 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -91.17 136.02 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 117.011 -1.876 . . . . 0.0 114.829 -171.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.631 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 t -17.83 144.5 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 110.008 -3.269 . . . . 0.0 113.127 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.26 -137.03 6.6 Favored Glycine 0 N--CA 1.484 1.878 1 N-CA-C 130.2 6.84 . . . . 0.0 130.2 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.73 98.5 0.88 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.601 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.61 -104.86 2.85 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.745 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.41 138.44 10.09 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.9 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.24 104.33 1.53 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.325 1.35 . . . . 0.0 110.715 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.61 0.3 Allowed Pre-proline 0 N--CA 1.495 1.82 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.905 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.03 126.85 22.22 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.959 1.106 . . . . 0.0 112.067 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--N 1.306 -1.286 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.396 179.059 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.8 t -80.1 167.26 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.966 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.651 ' CE2' HD22 ' A' ' 13' ' ' LEU . 22.0 m-85 -137.34 -111.15 0.18 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.655 0.741 . . . . 0.0 109.777 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 179.16 177.56 0.52 Allowed 'General case' 0 C--N 1.262 -3.229 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.64 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.07 131.68 37.4 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.387 -177.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.452 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 93.7 m -43.01 172.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.122 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.571 HG22 HE22 ' A' ' 11' ' ' GLN . 2.3 t -146.08 11.06 1.18 Allowed 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.727 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -168.86 123.73 0.88 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.461 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.95 149.71 1.77 Allowed 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.152 173.092 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 93.08 -0.58 69.28 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.17 -1.49 . . . . 0.0 111.613 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.571 HE22 HG22 ' A' ' 7' ' ' THR . 24.1 mt-30 -81.84 -173.6 4.55 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.695 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.566 HD21 ' C ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -167.69 30.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 116.689 -2.004 . . . . 0.0 115.348 -178.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.651 HD22 ' CE2' ' A' ' 3' ' ' TYR . 34.7 mt -146.07 14.56 1.32 Allowed 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -109.43 -179.98 3.98 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.725 -175.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.661 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 mt -76.27 70.22 2.87 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.142 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.616 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 4.1 m -75.89 -83.06 0.07 Allowed 'General case' 0 C--N 1.249 -3.761 0 CA-C-N 112.44 -2.164 . . . . 0.0 110.387 -176.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.73 107.01 6.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.108 -1.837 . . . . 0.0 108.75 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.12 -137.54 33.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.148 -1.501 . . . . 0.0 109.901 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.65 5.06 47.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.585 1.183 . . . . 0.0 109.223 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -85.74 145.38 27.28 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.147 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 22' ' ' CYS . 17.7 t -79.3 143.15 12.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.94 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.655 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.27 -165.27 0.39 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -152.5 98.0 0.18 Allowed Glycine 0 C--N 1.288 -2.098 0 C-N-CA 116.02 -2.991 . . . . 0.0 112.261 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.0 tt0 -27.42 148.07 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 112.207 -1.997 . . . . 0.0 111.008 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.47 53.94 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 104.795 -3.322 . . . . 0.0 104.795 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 41' ' ' THR . 2.1 t-20 -105.16 -162.28 0.87 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 112.716 -1.742 . . . . 0.0 108.536 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' N ' HD21 ' A' ' 12' ' ' ASN . 0.7 OUTLIER -149.41 104.6 3.39 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.923 ' O ' HD13 ' A' ' 29' ' ' ILE . 36.1 t -77.5 149.88 34.94 Favored 'General case' 0 C--N 1.269 -2.918 0 C-N-CA 117.095 -1.842 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.5 mm -137.14 118.72 18.5 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.194 0 CA-C-N 112.695 -2.048 . . . . 0.0 109.859 177.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.442 ' H ' ' HB3' ' A' ' 9' ' ' SER . 93.1 mt -75.77 141.39 42.58 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.769 -1.172 . . . . 0.0 113.757 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.88 ' HA2' ' CB ' ' A' ' 35' ' ' GLU . . . -109.0 60.19 0.33 Allowed Glycine 0 N--CA 1.479 1.553 1 N-CA-C 128.25 6.06 . . . . 0.0 128.25 174.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 34' ' ' GLY . 11.4 m -53.76 -103.38 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -0.642 . . . . 0.0 109.439 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.42 72.05 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.707 0 O-C-N 125.687 1.867 . . . . 0.0 109.052 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.741 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 45.81 36.99 6.9 Favored Glycine 0 C--N 1.269 -3.16 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.696 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.88 ' CB ' ' HA2' ' A' ' 31' ' ' GLY . 6.9 mt-10 -86.18 -136.93 0.08 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.859 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.628 ' N ' ' CA ' ' A' ' 31' ' ' GLY . 35.6 mttm -96.12 -124.56 0.12 Allowed 'General case' 0 C--N 1.252 -3.659 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 16' ' ' CYS . 51.2 t-20 116.41 36.22 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 112.254 -2.248 . . . . 0.0 107.598 -173.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.652 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 1.9 tt0 -102.42 -164.33 1.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.615 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.652 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -135.62 73.26 1.46 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -92.21 120.07 40.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.986 -173.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.615 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -6.17 141.89 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 112.668 -2.06 . . . . 0.0 114.437 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.96 -177.95 19.32 Favored Glycine 0 N--CA 1.488 2.166 1 N-CA-C 130.907 7.123 . . . . 0.0 130.907 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -108.78 90.78 3.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.799 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.63 -107.05 2.66 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.175 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.36 134.91 4.82 Favored Pre-proline 0 C--N 1.301 -1.53 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' LYS . 9.2 Cg_endo -75.87 97.23 1.09 Allowed 'Trans proline' 0 C--O 1.211 -0.855 0 C-N-CA 121.41 1.407 . . . . 0.0 110.648 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.0 tttm -35.91 95.37 0.09 OUTLIER Pre-proline 0 N--CA 1.512 2.632 0 O-C-N 123.543 0.527 . . . . 0.0 111.093 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.0 Cg_endo -71.41 162.33 42.71 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.135 1.223 . . . . 0.0 111.287 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.296 179.113 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.859 HG22 ' H ' ' A' ' 2' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.859 ' H ' HG22 ' A' ' 1' ' ' VAL . 98.6 t -105.78 2.4 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.373 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.495 ' CE1' HD13 ' A' ' 13' ' ' LEU . 61.9 m-85 -139.4 -117.88 0.13 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.013 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 179.52 177.33 0.59 Allowed 'General case' 0 C--N 1.253 -3.588 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.443 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.569 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.14 131.57 34.22 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.325 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -48.08 155.43 0.46 Allowed 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.939 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -134.18 7.15 3.65 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.021 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.679 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -163.29 138.64 6.58 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.898 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -55.47 146.43 20.06 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.628 ' HA2' ' HG2' ' A' ' 27' ' ' LYS . . . 97.84 -16.05 60.87 Favored Glycine 0 N--CA 1.497 2.715 1 N-CA-C 127.634 5.814 . . . . 0.0 127.634 -172.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.637 HE22 ' N ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -78.8 -171.47 2.58 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 118.896 -1.121 . . . . 0.0 109.069 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.4 m120 -148.23 -53.29 0.19 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 117.562 -1.655 . . . . 0.0 115.413 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 3' ' ' TYR . 66.2 mt -73.22 14.29 0.33 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.094 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.6 p -102.58 173.88 6.14 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.42 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.9 mt -79.19 72.58 5.76 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.885 1.326 . . . . 0.0 108.283 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 88.1 m -75.29 -71.82 0.34 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 112.254 -2.248 . . . . 0.0 109.224 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 90.88 2.99 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 117.987 -1.485 . . . . 0.0 109.448 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.48 -138.31 40.53 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.413 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -0.02 50.76 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.309 1.052 . . . . 0.0 109.996 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -88.98 144.16 26.36 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.668 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.0 t -85.46 143.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.743 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.682 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -75.93 -152.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.484 173.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -150.82 98.69 0.19 Allowed Glycine 0 C--N 1.27 -3.113 0 C-N-CA 116.738 -2.648 . . . . 0.0 111.122 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.4 tt0 -27.94 147.92 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 112.413 -1.893 . . . . 0.0 110.379 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -12.22 70.32 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 43' ' ' GLU . 28.0 t30 -111.64 -159.6 0.69 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.982 -1.109 . . . . 0.0 108.989 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 30.7 tttp -157.2 111.81 2.72 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 118.656 -1.217 . . . . 0.0 111.723 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.752 ' O ' HD13 ' A' ' 29' ' ' ILE . 5.3 m -78.62 157.77 28.61 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 117.871 -1.532 . . . . 0.0 110.409 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 28' ' ' CYS . 10.7 mm -133.52 110.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.321 173.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 8' ' ' GLU . 46.8 mt -83.2 112.6 19.99 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.784 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.46 -65.62 3.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.454 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 34' ' ' GLY . 3.4 t -134.87 -140.86 0.18 Allowed 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -66.96 62.42 0.05 OUTLIER 'General case' 0 C--N 1.263 -3.18 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.398 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 84.52 27.35 36.0 Favored Glycine 0 C--N 1.281 -2.5 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' A' ' 32' ' ' SER . 17.5 mm-40 -84.38 -103.16 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -73.9 51.23 0.38 Allowed 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.472 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m-20 -58.68 85.85 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.928 171.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 8.3 tt0 -78.0 175.33 10.17 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 117.687 -1.605 . . . . 0.0 106.884 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.77 74.51 1.48 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.071 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.615 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -120.12 138.91 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.355 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 3.5 t -50.4 160.89 0.35 Allowed 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.22 -23.34 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.992 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -162.99 -150.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.485 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' H ' ' CD ' ' A' ' 43' ' ' GLU . . . 176.8 85.74 0.06 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.189 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.84 139.3 29.93 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.032 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.0 Cg_endo -75.8 117.36 4.7 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.146 1.231 . . . . 0.0 110.203 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.1 tmtt? -40.33 100.94 0.23 Allowed Pre-proline 0 N--CA 1.498 1.937 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.197 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.0 149.23 92.22 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.9 1.067 . . . . 0.0 111.53 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 C--N 1.306 -1.309 0 CA-C-O 116.252 -1.833 . . . . 0.0 110.412 179.497 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.0 t -107.89 170.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.88 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.472 ' C ' HG22 ' A' ' 4' ' ' THR . 2.4 m-85 -130.83 -99.48 0.32 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.538 0.685 . . . . 0.0 110.204 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 178.07 -178.92 0.26 Allowed 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.027 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.58 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -94.91 134.99 36.96 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.103 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -55.89 158.77 3.54 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.476 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -146.65 14.87 1.23 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.003 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -166.37 137.16 3.44 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.715 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.613 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -54.64 152.33 7.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.838 176.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.39 -1.99 73.61 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.088 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.27 -165.98 0.76 Allowed 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.265 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.788 HD21 ' HB3' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -164.04 -56.88 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 18.3 mt -74.87 12.99 0.72 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.592 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.2 p -105.13 178.98 4.4 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.841 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.1 mt -78.99 76.83 5.47 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-O 123.082 1.42 . . . . 0.0 108.936 -176.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.839 ' HA ' HD22 ' A' ' 37' ' ' ASN . 84.9 m -75.44 -84.83 0.05 OUTLIER 'General case' 1 C--N 1.243 -4.034 0 CA-C-N 112.027 -2.352 . . . . 0.0 111.123 -177.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.58 104.46 6.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.174 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.36 -111.38 3.46 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.916 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.28 3.99 7.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.472 1.129 . . . . 0.0 109.463 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -87.24 145.19 26.48 Favored 'General case' 0 C--N 1.257 -3.424 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.9 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.8 t -82.92 143.24 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.328 -1.349 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.788 ' HB3' HD21 ' A' ' 12' ' ' ASN . 0.1 OUTLIER -96.84 -178.22 4.16 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.028 175.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -121.24 116.78 3.25 Favored Glycine 0 C--N 1.278 -2.645 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.072 -169.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.735 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 2.4 pt20 -41.8 3.28 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.048 0 CA-C-N 111.345 -2.427 . . . . 0.0 114.11 174.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -102.62 16.01 55.23 Favored Glycine 0 C--N 1.262 -3.53 0 N-CA-C 105.935 -2.866 . . . . 0.0 105.935 172.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.584 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.7 t-20 -138.61 -154.53 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.619 -1.29 . . . . 0.0 108.748 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -163.0 109.3 1.17 Allowed 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.084 177.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -84.64 139.36 32.1 Favored 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.435 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.634 HD11 ' CE ' ' A' ' 27' ' ' LYS . 29.7 mm -125.77 119.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.713 -1.585 . . . . 0.0 112.123 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 9' ' ' SER . 21.6 mt -76.93 121.65 23.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.606 -1.238 . . . . 0.0 109.98 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . 72.65 89.28 0.14 Allowed Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.205 -1.474 . . . . 0.0 111.469 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -124.38 84.01 2.22 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t0 44.48 44.83 7.34 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.722 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.64 -1.31 18.06 Favored Glycine 0 C--N 1.295 -1.71 1 N-CA-C 124.351 4.5 . . . . 0.0 124.351 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 37' ' ' ASN . 6.1 mm-40 -121.31 103.35 8.9 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 113.169 -1.516 . . . . 0.0 109.265 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' GLY . 9.8 mttm -68.41 3.11 1.9 Allowed 'General case' 1 C--N 1.2 -5.935 0 CA-C-N 111.923 -2.399 . . . . 0.0 110.848 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.839 HD22 ' HA ' ' A' ' 16' ' ' CYS . 51.1 t-20 175.85 89.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.138 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 10.4 tt0 -89.05 -169.26 2.45 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.337 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.537 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -158.57 46.17 0.31 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.872 -174.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.5 m -114.39 158.44 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -12.65 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.084 0 CA-C-N 110.883 -2.871 . . . . 0.0 114.009 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 27' ' ' LYS . . . -179.77 -99.11 0.12 Allowed Glycine 0 N--CA 1.496 2.652 1 N-CA-C 132.148 7.619 . . . . 0.0 132.148 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -161.17 28.37 0.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.003 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.735 ' HA3' ' O ' ' A' ' 24' ' ' GLN . . . 13.64 73.29 0.01 OUTLIER Glycine 0 C--N 1.3 -1.462 1 N-CA-C 129.598 6.599 . . . . 0.0 129.598 177.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.92 130.31 64.07 Favored Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.188 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -76.23 106.13 2.21 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 121.392 1.394 . . . . 0.0 110.748 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -51.9 109.28 1.33 Allowed Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 118.746 -1.181 . . . . 0.0 109.607 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.37 153.67 75.55 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.803 1.002 . . . . 0.0 111.42 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.266 0 CA-C-O 116.348 -1.786 . . . . 0.0 110.482 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 1' ' ' VAL . 37.3 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t -82.17 165.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.887 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.732 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 9.3 m-85 -104.18 -112.57 0.24 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.419 0.628 . . . . 0.0 110.335 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.404 ' H ' ' HB3' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -146.94 169.18 19.71 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.661 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.4 127.24 35.8 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.103 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.7 m -46.86 155.37 0.26 Allowed 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.723 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 t -147.97 16.68 1.09 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.822 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -163.06 131.82 3.97 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.08 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -55.41 153.3 7.54 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.4 174.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.42 -23.79 20.16 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 118.359 -1.877 . . . . 0.0 111.295 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.568 HE22 ' HA ' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -54.76 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.254 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.619 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -176.67 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.166 178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.732 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 6.0 mt -73.68 8.03 2.13 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.619 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.5 p -102.44 -179.97 4.13 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.622 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 15' ' ' LEU . 6.3 mt -79.41 71.61 5.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.739 1.257 . . . . 0.0 108.371 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.739 ' HA ' HD22 ' A' ' 37' ' ' ASN . 34.1 t -70.82 -77.58 0.09 Allowed 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.428 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 89.61 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 117.76 -1.576 . . . . 0.0 109.019 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.21 -142.47 44.64 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.631 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -0.05 30.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.124 0.964 . . . . 0.0 110.35 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -87.63 143.59 27.1 Favored 'General case' 0 C--N 1.26 -3.317 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.849 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 22' ' ' CYS . 8.0 t -88.75 142.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.095 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.672 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -77.69 -160.56 0.19 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.015 175.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -143.83 96.43 0.19 Allowed Glycine 0 C--O 1.186 -2.895 0 C-N-CA 117.904 -2.093 . . . . 0.0 108.862 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -30.59 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -82.51 7.09 66.06 Favored Glycine 1 C--N 1.238 -4.903 0 N-CA-C 105.741 -2.944 . . . . 0.0 105.741 172.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.631 ' N ' ' O ' ' A' ' 23' ' ' GLY . 64.6 m-20 -121.97 -156.44 0.69 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.477 -1.362 . . . . 0.0 108.6 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.694 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -152.31 103.29 2.83 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.645 176.274 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.522 ' O ' ' N ' ' A' ' 10' ' ' GLY . 42.1 t -78.31 162.75 26.27 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 117.521 -1.672 . . . . 0.0 108.876 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.694 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 22.2 mm -149.88 121.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.386 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 9' ' ' SER . 12.3 mt -88.06 139.41 30.54 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.988 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . 57.19 75.77 0.24 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.084 -1.531 . . . . 0.0 111.805 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.616 ' OG ' ' N ' ' A' ' 33' ' ' ASP . 7.2 p -100.06 -141.73 0.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.616 ' N ' ' OG ' ' A' ' 32' ' ' SER . 4.3 t0 -68.03 59.34 0.07 Allowed 'General case' 0 C--N 1.258 -3.393 0 O-C-N 124.794 1.309 . . . . 0.0 109.125 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 89.72 41.79 5.58 Favored Glycine 0 C--N 1.285 -2.292 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 31' ' ' GLY . 22.3 mt-10 -145.07 104.67 3.99 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 123.178 1.466 . . . . 0.0 111.745 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 31' ' ' GLY . 12.7 pttm -64.37 0.05 1.14 Allowed 'General case' 1 C--N 1.211 -5.417 0 CA-C-N 111.998 -2.364 . . . . 0.0 111.897 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.739 HD22 ' HA ' ' A' ' 16' ' ' CYS . 25.0 t-20 175.83 113.28 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.436 -176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.9 tt0 -122.08 159.77 26.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -122.69 66.58 0.95 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -176.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -90.41 121.59 40.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.425 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -37.55 173.47 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.89 177.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' N ' ' HA ' ' A' ' 26' ' ' ASN . . . 126.44 -105.54 0.79 Allowed Glycine 0 N--CA 1.484 1.871 1 N-CA-C 128.411 6.124 . . . . 0.0 128.411 -176.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -165.01 88.9 0.47 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.49 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' ASN . . . -102.23 -123.02 5.17 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.682 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.42 134.52 10.2 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.938 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -70.1 98.83 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 N-CA-C 109.683 -0.93 . . . . 0.0 109.683 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' HE22 ' A' ' 11' ' ' GLN . 26.3 tttp -43.99 105.35 0.43 Allowed Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.025 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.62 141.63 95.43 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.916 1.077 . . . . 0.0 111.711 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.357 -1.782 . . . . 0.0 110.494 179.269 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.03 161.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.082 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.534 ' O ' HG23 ' A' ' 4' ' ' THR . 58.3 m-85 -102.93 -116.53 0.2 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.5 p -160.13 165.78 31.03 Favored 'General case' 0 C--N 1.257 -3.429 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.928 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.21 129.54 34.56 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.992 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' OE1' ' A' ' 11' ' ' GLN . 13.7 m -46.58 169.8 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 CA-C-O 122.639 1.209 . . . . 0.0 110.436 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -150.08 14.36 0.8 Allowed 'General case' 0 C--N 1.258 -3.388 0 CA-C-N 112.415 -2.175 . . . . 0.0 106.783 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -164.96 123.13 1.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.196 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.611 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -51.37 153.92 1.95 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.626 175.224 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 10.2 85.51 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' OE1' ' CB ' ' A' ' 6' ' ' CYS . 3.4 mt-30 -82.62 -166.45 1.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 14' ' ' CYS . 6.2 t-20 -135.64 -93.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.199 -1.8 . . . . 0.0 115.323 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 2.5 mt -75.13 40.32 0.15 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.804 -173.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -94.59 -160.94 0.81 Allowed 'General case' 0 C--O 1.18 -2.593 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.016 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.1 mt -109.04 81.2 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 m -76.35 -81.71 0.08 Allowed 'General case' 0 C--N 1.249 -3.768 0 CA-C-N 112.944 -1.934 . . . . 0.0 111.209 -174.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 4.0 mm-40 -78.36 107.22 10.83 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.86 -1.536 . . . . 0.0 109.238 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.93 11.86 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 2.15 15.25 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.26 1.029 . . . . 0.0 110.056 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.61 149.32 25.94 Favored 'General case' 0 C--N 1.259 -3.353 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.931 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 35.5 t -88.2 148.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 118.491 -1.283 . . . . 0.0 111.049 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.2 m -136.62 -166.64 1.93 Allowed 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 93.21 -43.39 2.54 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 117.336 -2.364 . . . . 0.0 111.748 175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -59.04 105.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.081 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.06 -10.16 28.47 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -118.89 -165.23 1.11 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.428 -0.886 . . . . 0.0 111.653 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.545 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -156.69 112.76 2.98 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.004 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.58 152.01 28.8 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 118.304 -1.359 . . . . 0.0 110.857 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.545 HD11 ' CE ' ' A' ' 27' ' ' LYS . 31.8 mm -139.53 104.7 2.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.455 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 9' ' ' SER . 10.2 mt -61.67 165.36 5.15 Favored 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 118.676 -1.21 . . . . 0.0 110.146 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.538 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . -153.46 -81.62 0.03 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 118.297 -1.906 . . . . 0.0 112.02 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.547 ' H ' ' N ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER 167.17 119.33 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.468 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.6 86.47 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.014 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.67 -49.41 4.04 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 37' ' ' ASN . 1.9 mt-10 -85.8 -2.88 58.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.679 1.228 . . . . 0.0 109.557 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' N ' ' H ' ' A' ' 32' ' ' SER . 8.5 tttm -50.74 -14.3 0.19 Allowed 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.529 -2.123 . . . . 0.0 111.963 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 35' ' ' GLU . 30.0 m-80 -159.55 88.8 0.87 Allowed 'General case' 0 C--N 1.247 -3.869 0 CA-C-N 112.724 -2.035 . . . . 0.0 111.467 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -87.37 166.37 14.9 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.842 -1.543 . . . . 0.0 107.6 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.3 m -133.34 71.31 1.46 Allowed 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -91.37 137.71 21.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.507 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.8 t -34.83 168.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.815 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 122.48 -146.14 16.65 Favored Glycine 0 N--CA 1.482 1.706 1 N-CA-C 130.014 6.766 . . . . 0.0 130.014 -178.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -161.89 119.55 2.21 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.553 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.84 -91.3 1.11 Allowed Glycine 0 N--CA 1.486 2.032 1 N-CA-C 129.742 6.657 . . . . 0.0 129.742 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.8 122.14 4.25 Favored Pre-proline 0 C--N 1.302 -1.5 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.356 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.2 Cg_endo -66.71 95.26 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.07 1.18 . . . . 0.0 109.638 177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' PRO . 11.9 tttt -39.47 99.41 0.19 Allowed Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.211 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.89 158.33 29.65 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 120.855 1.037 . . . . 0.0 111.78 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.56 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 2' ' ' VAL . 1.2 t -90.65 163.68 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 4' ' ' THR . 5.8 m-85 -141.84 -114.01 0.12 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.967 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.0 p -163.79 176.51 9.46 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.272 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.48 132.48 35.01 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.584 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.33 149.26 7.62 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.975 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 7' ' ' THR . 1.9 t -148.69 18.34 1.02 Allowed 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -161.54 109.37 1.46 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.287 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.612 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -47.83 147.1 2.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.471 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 100.92 -5.82 56.59 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.791 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.634 HE21 ' HA ' ' A' ' 47' ' ' LYS . 61.4 mt-30 -85.57 -164.96 1.1 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.285 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.5 m120 -164.28 -43.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.806 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 51.7 mt -76.91 17.26 0.44 Allowed 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.051 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.2 p -108.43 176.93 4.94 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.457 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.2 mt -78.59 73.57 5.14 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 123.0 1.381 . . . . 0.0 108.16 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 32.1 t -67.79 -82.96 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.936 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.25 120.98 26.86 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.9 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.27 -115.94 6.36 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.036 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.93 5.59 5.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.753 1.263 . . . . 0.0 108.819 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -88.29 144.46 26.41 Favored 'General case' 0 C--N 1.262 -3.204 0 CA-C-N 112.342 -2.208 . . . . 0.0 112.256 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 22' ' ' CYS . 22.1 t -80.0 139.08 18.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.744 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.59 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -85.4 -140.64 0.08 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 118.416 -1.314 . . . . 0.0 109.371 175.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -157.65 111.89 0.5 Allowed Glycine 0 C--N 1.286 -2.233 0 C-N-CA 116.339 -2.839 . . . . 0.0 112.574 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.5 tt0 -36.21 152.06 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 113.482 -1.359 . . . . 0.0 108.448 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.88 -18.11 57.3 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.3 t-20 -106.33 -161.83 0.82 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.989 -1.605 . . . . 0.0 107.081 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' CG ' ' H ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -160.35 101.96 1.39 Allowed 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.901 174.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.852 ' O ' HD13 ' A' ' 29' ' ' ILE . 22.2 m -78.64 155.71 29.4 Favored 'General case' 0 CA--C 1.46 -2.487 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.424 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.3 mm -136.3 108.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.649 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 9' ' ' SER . 18.0 mt -60.29 113.04 2.17 Favored 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 118.155 -1.418 . . . . 0.0 108.394 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.584 ' HA3' ' H ' ' A' ' 36' ' ' LYS . . . -16.46 -36.52 0.0 OUTLIER Glycine 0 N--CA 1.492 2.402 1 N-CA-C 126.879 5.512 . . . . 0.0 126.879 -176.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' LEU . 5.1 t 170.51 99.74 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.778 -1.211 . . . . 0.0 108.39 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 54.51 47.49 22.63 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.163 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.88 6.24 63.72 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.468 -1.348 . . . . 0.0 112.24 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HB2' ' N ' ' A' ' 32' ' ' SER . 3.4 mt-10 -64.73 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.143 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.584 ' H ' ' HA3' ' A' ' 31' ' ' GLY . 20.5 mttm -90.97 -134.74 0.13 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.3 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.601 ' HB3' HD23 ' A' ' 30' ' ' LEU . 0.3 OUTLIER 167.71 89.76 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.598 -177.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.442 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 14.3 tt0 -83.46 -176.1 6.14 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -136.68 75.16 1.52 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -109.25 127.54 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.156 -1.418 . . . . 0.0 114.363 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.559 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 t -27.37 148.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 112.579 -2.1 . . . . 0.0 113.566 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.48 -101.37 0.19 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -98.61 -139.54 0.31 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.346 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 179.95 88.66 0.07 OUTLIER Glycine 0 C--N 1.28 -2.539 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.9 139.56 25.12 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.527 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -77.14 136.62 16.39 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.199 1.266 . . . . 0.0 109.16 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HA ' HE21 ' A' ' 11' ' ' GLN . 16.4 tttp -51.79 -51.18 72.83 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 117.791 -1.564 . . . . 0.0 111.021 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 2.8 Cg_endo -67.3 108.79 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.803 1.002 . . . . 0.0 111.114 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.4 mp0 . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.333 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 1' ' ' VAL . 52.0 t . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 3' ' ' TYR . 21.9 t -89.72 174.47 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.404 -0.919 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.623 ' N ' HG12 ' A' ' 2' ' ' VAL . 5.8 m-85 -137.99 -112.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.069 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -172.08 176.5 3.47 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.036 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.562 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.27 131.0 34.37 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.168 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -53.44 158.46 1.73 Allowed 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.734 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -140.16 8.99 2.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.125 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.501 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.7 mm-40 -161.0 143.98 12.84 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.52 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.03 147.92 45.64 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.658 175.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 27' ' ' LYS . . . 94.61 -7.44 71.14 Favored Glycine 0 N--CA 1.503 3.154 1 N-CA-C 126.736 5.454 . . . . 0.0 126.736 -172.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 75.9 mt-30 -83.67 -167.41 1.71 Allowed 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 114.283 -0.959 . . . . 0.0 111.09 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.746 HD21 ' C ' ' A' ' 26' ' ' ASN . 2.2 m-80 -156.38 -51.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.985 -1.486 . . . . 0.0 114.553 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 59.5 mt -76.09 13.69 0.84 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.618 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.5 p -110.13 177.8 4.6 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.73 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 15' ' ' LEU . 10.3 mt -77.77 75.92 4.31 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-O 122.811 1.291 . . . . 0.0 108.552 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.62 -80.43 0.08 Allowed 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.647 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.32 107.62 12.22 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.156 -1.418 . . . . 0.0 109.502 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.46 -144.02 48.74 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.176 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.26 5.06 48.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.38 1.086 . . . . 0.0 109.778 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -88.6 143.59 26.85 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.941 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 22' ' ' CYS . 11.4 t -83.76 139.28 17.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.277 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.625 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -78.47 -146.14 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.735 175.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.99 117.54 0.77 Allowed Glycine 0 C--N 1.278 -2.664 0 C-N-CA 117.451 -2.309 . . . . 0.0 110.67 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.5 tt0 -33.23 154.17 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.054 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.42 -6.31 82.36 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.746 ' C ' HD21 ' A' ' 12' ' ' ASN . 8.7 t30 -122.25 -164.16 1.14 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.929 -1.136 . . . . 0.0 108.493 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 40' ' ' VAL . 36.2 tttp -162.22 112.35 1.53 Allowed 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 11' ' ' GLN . 1.9 m -83.04 153.63 24.83 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.64 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.58 117.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.284 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 8' ' ' GLU . 19.1 mt -105.01 124.03 48.82 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.921 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.871 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . -175.99 42.65 0.11 Allowed Glycine 1 N--CA 1.516 4.022 1 N-CA-C 133.678 8.231 . . . . 0.0 133.678 176.217 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.809 ' H ' ' C ' ' A' ' 35' ' ' GLU . 26.5 t -106.07 -120.8 0.23 Allowed 'General case' 0 C--O 1.188 -2.165 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.11 55.05 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 91.58 1.55 71.16 Favored Glycine 0 C--N 1.288 -2.084 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.809 ' C ' ' H ' ' A' ' 32' ' ' SER 0.252 15.0 mt-10 -170.68 90.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -174.196 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.871 ' H ' ' N ' ' A' ' 31' ' ' GLY . 21.2 tttm -100.86 66.52 1.18 Allowed 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 167.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -56.41 143.14 35.84 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.517 -1.219 . . . . 0.0 113.92 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 12.7 tt0 -153.46 170.89 19.62 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.052 -1.885 . . . . 0.0 107.206 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.426 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -145.31 79.12 1.57 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.429 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.77 146.25 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 C-N-CA 117.776 -1.57 . . . . 0.0 114.879 -176.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -18.14 146.6 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 113.059 -1.882 . . . . 0.0 114.176 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.24 -120.94 1.02 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 7.4 mm-40 -78.67 -135.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.48 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 12' ' ' ASN . . . 162.03 97.44 0.12 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 144.83 55.16 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.422 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.23 126.07 8.93 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.356 1.371 . . . . 0.0 109.469 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.94 130.99 22.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.992 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.1 130.23 35.39 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 110.293 -0.695 . . . . 0.0 110.293 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 116.41 -1.757 . . . . 0.0 110.651 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 2' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.792 HG12 ' H ' ' A' ' 3' ' ' TYR . 3.5 t -79.51 -178.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.183 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.792 ' H ' HG12 ' A' ' 2' ' ' VAL . 61.5 m-85 -106.06 -115.82 0.25 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.73 0.776 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -178.1 175.35 1.26 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.77 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 134.68 36.4 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.653 -176.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 92.7 m -47.8 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.662 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -138.05 3.14 2.4 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.725 -1.58 . . . . 0.0 107.992 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' C ' HD12 ' A' ' 30' ' ' LEU . 9.0 tt0 -171.16 136.55 1.07 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.424 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -51.27 157.88 0.89 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.468 178.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -20.97 46.7 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.663 -1.732 . . . . 0.0 112.629 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.15 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -161.65 21.9 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 115.668 -2.413 . . . . 0.0 115.285 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 3' ' ' TYR . 40.2 mt -146.71 25.88 1.16 Allowed 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -104.81 179.8 4.17 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.227 -176.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.635 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 mt -84.06 75.55 10.14 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.661 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 2.3 t -73.58 -68.99 0.46 Allowed 'General case' 0 C--N 1.254 -3.572 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.472 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.569 ' HA ' HD22 ' A' ' 37' ' ' ASN . 17.4 mm-40 -84.32 89.32 7.34 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.472 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.52 -133.22 25.47 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.045 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 -1.66 58.21 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.144 0.973 . . . . 0.0 110.412 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -81.49 137.88 35.55 Favored 'General case' 0 C--N 1.26 -3.301 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.48 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 22' ' ' CYS . 52.4 t -83.03 155.15 3.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.231 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' N ' HG12 ' A' ' 21' ' ' VAL . 10.9 m -145.19 -173.21 4.04 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 99.31 -45.55 1.54 Allowed Glycine 0 C--O 1.206 -1.6 0 C-N-CA 117.547 -2.264 . . . . 0.0 114.611 173.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.566 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -63.48 115.89 5.07 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.586 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.92 -10.56 39.41 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.59 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -125.96 -158.24 0.84 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.919 -1.141 . . . . 0.0 111.417 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -154.82 124.36 6.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.527 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -78.82 155.13 29.35 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 117.54 -1.664 . . . . 0.0 109.5 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.581 HD11 ' CE ' ' A' ' 27' ' ' LYS . 15.2 mm -150.77 122.43 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.619 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.716 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 9' ' ' SER . 7.7 mt -94.88 129.79 41.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.186 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 76.58 92.44 0.22 Allowed Glycine 0 N--CA 1.502 3.079 0 C-N-CA 118.708 -1.711 . . . . 0.0 110.891 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -132.96 91.1 2.84 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' SER . 7.7 t0 35.57 49.91 0.55 Allowed 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.725 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.04 7.18 12.99 Favored Glycine 0 C--N 1.297 -1.626 1 N-CA-C 125.29 4.876 . . . . 0.0 125.29 -174.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 37' ' ' ASN . 36.4 mt-10 -142.8 108.16 5.02 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.767 -1.216 . . . . 0.0 111.036 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -66.31 6.18 0.46 Allowed 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.598 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.597 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -166.57 130.27 2.0 Allowed 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.751 -176.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.554 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 40.2 tt0 -150.71 155.85 40.12 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.2 m -116.94 65.1 0.72 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -77.78 130.34 36.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 117.709 -1.597 . . . . 0.0 111.515 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.4 t -35.77 167.45 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.057 -1.883 . . . . 0.0 112.395 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 123.04 -133.93 9.28 Favored Glycine 0 N--CA 1.488 2.108 1 N-CA-C 130.387 6.915 . . . . 0.0 130.387 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -161.99 116.2 1.88 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.595 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.95 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.42 -1.372 . . . . 0.0 111.511 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -158.85 152.58 19.32 Favored Pre-proline 0 C--N 1.31 -1.136 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.404 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -72.3 116.29 4.65 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 121.212 1.275 . . . . 0.0 109.733 170.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -46.52 112.78 1.97 Allowed Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.702 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -67.87 133.0 27.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.457 0.772 . . . . 0.0 110.426 176.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.1 tt0 . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 116.387 -1.768 . . . . 0.0 111.461 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.27 165.39 2.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.146 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 4' ' ' THR . 2.3 m-85 -132.06 -111.84 0.24 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.813 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.7 p -162.34 177.31 9.69 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.809 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.55 134.02 34.32 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.678 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 m -52.54 155.48 2.16 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.052 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -140.54 9.73 2.24 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.688 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.668 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.0 mm-40 -163.33 139.85 7.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.838 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.435 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.87 156.92 6.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.496 176.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 85.18 0.66 88.67 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.086 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.417 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 27.2 mt-30 -84.4 -177.37 6.61 Favored 'General case' 0 N--CA 1.514 2.768 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.175 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -151.81 -50.88 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 117.978 -1.489 . . . . 0.0 114.394 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 87.1 mt -75.99 17.99 0.3 Allowed 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.299 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.528 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.7 p -110.35 178.92 4.23 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.45 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.6 mt -79.94 73.0 6.72 Favored 'General case' 0 CA--C 1.465 -2.289 0 CA-C-O 122.843 1.306 . . . . 0.0 108.552 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 94.4 m -69.94 -93.41 0.01 OUTLIER 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.28 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.09 116.55 13.76 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.394 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.28 -139.63 42.28 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.796 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 6.31 45.21 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.526 1.155 . . . . 0.0 108.992 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.88 144.7 28.23 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.305 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.9 t -85.12 138.93 18.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 118.154 -1.418 . . . . 0.0 109.556 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -77.33 -140.18 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.954 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.45 122.19 1.03 Allowed Glycine 0 C--N 1.275 -2.837 0 C-N-CA 117.303 -2.379 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 26' ' ' ASN . 4.4 tt0 -34.41 157.17 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.579 -1.31 . . . . 0.0 110.028 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -18.35 21.52 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.52 ' HB3' HD22 ' A' ' 12' ' ' ASN . 13.0 t30 -104.19 -164.39 1.05 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.915 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -161.67 102.77 1.19 Allowed 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.046 -1.461 . . . . 0.0 111.65 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -79.84 153.6 28.97 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.45 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.631 HD11 ' CE ' ' A' ' 27' ' ' LYS . 33.4 mm -134.71 115.58 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.893 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.668 HD12 ' C ' ' A' ' 8' ' ' GLU . 10.6 mt -92.68 140.16 29.82 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.642 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . -149.11 -87.16 0.06 OUTLIER Glycine 0 N--CA 1.502 3.065 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.874 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.425 ' N ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 175.64 120.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.656 -176.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t0 52.42 88.39 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.476 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.31 -47.18 3.45 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 31' ' ' GLY . 1.7 mt-10 -91.43 -3.13 56.96 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.526 1.155 . . . . 0.0 109.788 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 12.1 pttt -55.4 -11.66 0.88 Allowed 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 112.831 -1.986 . . . . 0.0 112.029 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.682 HD22 ' N ' ' A' ' 38' ' ' GLN . 1.2 t-20 175.02 129.9 0.03 OUTLIER 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.274 -175.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.682 ' N ' HD22 ' A' ' 37' ' ' ASN . 38.6 tt0 -144.1 171.0 14.89 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 73.21 1.52 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -113.11 130.3 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -172.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.9 t -22.71 155.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.573 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.35 -123.56 1.93 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -76.85 -131.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.393 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.574 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 157.2 80.09 0.03 OUTLIER Glycine 0 C--N 1.282 -2.431 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.933 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.36 131.52 42.08 Favored Pre-proline 0 CA--C 1.559 1.29 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.871 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.65 119.56 6.5 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.123 1.215 . . . . 0.0 110.928 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 114.25 8.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.539 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' GLN . 5.3 Cg_exo -56.67 -173.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 120.644 0.896 . . . . 0.0 111.558 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 48' ' ' PRO . 29.5 mt-30 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.762 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 3' ' ' TYR . 20.1 t -83.7 170.53 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.452 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.598 ' N ' HG12 ' A' ' 2' ' ' VAL . 26.8 m-85 -103.82 -113.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.1 p -159.0 169.17 24.91 Favored 'General case' 0 C--N 1.261 -3.28 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.992 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.47 130.2 34.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.69 -1.204 . . . . 0.0 111.103 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.434 ' CB ' HD11 ' A' ' 30' ' ' LEU . 43.7 m -47.4 171.61 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.331 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -144.33 8.1 1.37 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.704 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.746 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.6 tt0 -170.49 139.24 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.4 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.476 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -52.97 159.31 1.19 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.79 176.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.61 50.01 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.037 -1.554 . . . . 0.0 112.461 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.47 -173.06 3.88 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.496 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 14' ' ' CYS . 69.6 m-80 -155.77 -45.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.72 -1.592 . . . . 0.0 113.937 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 3' ' ' TYR . 45.5 mt -76.59 16.24 0.52 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.163 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -100.4 -170.1 1.82 Allowed 'General case' 0 C--O 1.181 -2.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.64 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 mt -91.52 71.38 5.94 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.8 t -64.2 -84.4 0.02 OUTLIER 'General case' 0 C--N 1.254 -3.554 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.929 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 tm-20 -69.88 88.0 0.55 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.067 -1.453 . . . . 0.0 109.227 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.49 -130.9 18.76 Favored Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.399 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.96 0.75 57.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.184 0.992 . . . . 0.0 110.38 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -90.41 147.18 23.59 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.065 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 23.6 t -85.99 147.16 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 117.979 -1.488 . . . . 0.0 110.813 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.415 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -76.29 -129.91 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.36 115.45 0.57 Allowed Glycine 0 C--N 1.276 -2.751 0 C-N-CA 117.871 -2.109 . . . . 0.0 110.892 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 3.5 tt0 -34.44 149.22 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.279 -0.96 . . . . 0.0 109.905 177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.39 -10.89 65.07 Favored Glycine 0 C--N 1.292 -1.906 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 43' ' ' GLU . 20.4 t30 -108.09 -162.9 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 40' ' ' VAL . 50.4 tttp -154.24 104.26 2.59 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.74 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 52.6 t -77.4 159.57 29.36 Favored 'General case' 0 CA--C 1.462 -2.425 0 C-N-CA 117.01 -1.876 . . . . 0.0 109.284 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.9 mm -137.23 115.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.132 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.746 HD12 ' C ' ' A' ' 8' ' ' GLU . 18.9 mt -101.24 109.18 21.0 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.575 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.961 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . -165.79 67.54 0.2 Allowed Glycine 1 N--CA 1.517 4.065 0 C-N-CA 115.569 -3.205 . . . . 0.0 117.617 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.823 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 29.6 t -114.49 -139.49 0.38 Allowed 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' N ' ' OG ' ' A' ' 32' ' ' SER . 3.3 m-20 -47.94 -21.52 0.45 Allowed 'General case' 0 C--N 1.273 -2.751 0 CA-C-O 123.512 1.625 . . . . 0.0 107.858 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.579 ' N ' ' C ' ' A' ' 32' ' ' SER . . . -165.27 -4.14 0.04 OUTLIER Glycine 1 C--N 1.245 -4.512 0 CA-C-N 110.763 -2.926 . . . . 0.0 108.867 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.823 ' CA ' ' H ' ' A' ' 32' ' ' SER 0.267 13.8 mt-10 -177.28 101.13 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.374 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.961 ' H ' ' N ' ' A' ' 31' ' ' GLY . 16.4 tttt -98.15 69.28 2.01 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -49.41 136.94 15.43 Favored 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.603 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 15.7 tt0 -155.02 164.35 39.01 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -130.11 75.72 1.67 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.572 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -119.32 130.42 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.569 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.419 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 8.1 t -51.09 154.56 1.52 Allowed 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.388 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.06 -24.32 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.117 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . 3.3 tt0 -162.89 -143.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.367 0.603 . . . . 0.0 110.265 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -179.2 85.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.757 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.72 107.1 58.67 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 Cg_endo -68.68 92.9 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 48' ' ' PRO . 4.7 tmtm? -40.39 118.19 1.44 Allowed Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.668 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.513 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 5.8 Cg_exo -59.48 108.46 0.46 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.587 0.858 . . . . 0.0 110.833 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 116.244 -1.836 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.9 t -99.92 170.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.014 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.66 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 69.4 m-85 -139.68 -121.95 0.12 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.64 0.733 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 3.0 t 177.99 -177.77 0.22 Allowed 'General case' 0 C--N 1.259 -3.332 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.823 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.32 133.09 36.61 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.521 -177.49 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 86.7 m -46.14 169.1 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.089 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.534 HG22 HE22 ' A' ' 11' ' ' GLN . 5.5 t -155.27 17.3 0.41 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.921 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 2.0 tt0 -167.31 124.14 1.18 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.905 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.598 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -55.78 151.64 10.9 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.646 177.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.86 -16.53 59.19 Favored Glycine 0 C--N 1.282 -2.439 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.25 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.534 HE22 HG22 ' A' ' 7' ' ' THR . 17.5 mt-30 -60.23 179.21 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' HB3' ' H ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -161.3 25.55 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 115.523 -2.471 . . . . 0.0 115.352 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 34.6 mt -147.61 26.74 1.02 Allowed 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.46 177.74 4.7 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.373 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.644 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 mt -80.38 70.86 7.13 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.054 -1.884 . . . . 0.0 107.408 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.595 ' HA ' HD22 ' A' ' 37' ' ' ASN . 41.4 m -73.28 -61.9 1.66 Allowed 'General case' 1 C--N 1.239 -4.211 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.541 -173.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.6 88.92 7.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.075 -1.45 . . . . 0.0 109.526 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.47 -105.37 1.77 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.112 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.42 -2.5 11.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.229 1.014 . . . . 0.0 110.485 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.77 139.99 30.17 Favored 'General case' 0 C--N 1.254 -3.583 0 CA-C-N 113.326 -1.761 . . . . 0.0 111.419 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 42.6 t -79.25 151.15 4.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 117.723 -1.591 . . . . 0.0 109.314 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 86.4 m -140.49 -173.75 3.77 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 102.74 -49.87 0.95 Allowed Glycine 0 C--O 1.2 -2.002 0 C-N-CA 117.496 -2.287 . . . . 0.0 114.263 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 26' ' ' ASN . 9.7 tm0? -63.78 115.14 4.52 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.493 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.42 52.59 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.98 -163.7 1.33 Allowed 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.156 -1.022 . . . . 0.0 111.623 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.717 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -158.21 133.08 8.44 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.092 175.459 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.9 m -90.2 149.97 22.18 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.005 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.717 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 32.1 mm -140.35 111.86 4.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.795 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 9' ' ' SER . 8.9 mt -75.71 127.03 32.16 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.341 -1.343 . . . . 0.0 109.208 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 80.69 80.85 0.83 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 118.728 -1.701 . . . . 0.0 109.95 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -132.63 79.58 1.86 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.908 0.861 . . . . 0.0 109.42 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 0.8 OUTLIER 42.3 67.45 0.59 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.236 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.43 3.44 61.33 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.038 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 37' ' ' ASN . 2.4 mm-40 -131.96 95.55 3.72 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.283 1.039 . . . . 0.0 111.179 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 15.0 pttt -66.47 8.86 0.2 Allowed 'General case' 0 C--N 1.245 -3.958 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.119 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.595 HD22 ' HA ' ' A' ' 16' ' ' CYS . 27.0 t-20 -178.87 69.95 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.62 -175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -79.3 172.93 13.12 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.486 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.0 m -134.03 62.46 1.65 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -79.45 135.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 117.913 -1.515 . . . . 0.0 111.931 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.7 t -38.8 165.13 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.332 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.02 -151.73 17.83 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -143.07 124.48 14.72 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.524 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.3 -113.02 3.75 Favored Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.775 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.507 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -151.83 149.1 22.95 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.056 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.33 115.25 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.333 1.355 . . . . 0.0 110.546 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.522 ' HG2' HE21 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -55.24 113.66 5.88 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.632 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.64 134.12 60.97 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 120.653 0.902 . . . . 0.0 111.443 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.321 -1.799 . . . . 0.0 110.702 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.7 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.98 163.74 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.175 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.504 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -142.59 -113.75 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.914 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.3 p -159.31 173.42 16.31 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.506 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.56 132.18 34.14 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.564 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.1 155.12 2.0 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.218 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -148.13 14.92 1.03 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.007 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.624 ' C ' HD12 ' A' ' 30' ' ' LEU . 19.9 mt-10 -161.52 127.04 3.63 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.619 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.586 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -53.5 158.24 1.84 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.088 177.019 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 79.67 11.21 84.96 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.582 -1.77 . . . . 0.0 110.435 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -74.71 -164.63 0.29 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.269 179.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 14' ' ' CYS . 9.8 m-20 -162.86 -69.36 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 117.914 -1.515 . . . . 0.0 113.93 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 72.0 mt -76.3 19.72 0.24 Allowed 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.538 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 22.7 p -103.55 177.99 4.68 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.372 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.3 mt -79.85 70.74 6.46 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 122.829 1.299 . . . . 0.0 107.765 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.745 ' HA ' HD22 ' A' ' 37' ' ' ASN . 39.5 t -69.21 -74.45 0.13 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.583 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.72 130.5 40.65 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.411 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 23.61 -91.26 0.01 OUTLIER Glycine 0 N--CA 1.503 3.155 1 N-CA-C 127.198 5.639 . . . . 0.0 127.198 -174.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.09 2.56 10.42 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.926 1.346 . . . . 0.0 107.864 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -89.73 143.01 27.15 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.882 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.7 t -84.35 143.5 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.241 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -71.85 -142.43 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.06 115.44 0.57 Allowed Glycine 0 C--N 1.279 -2.619 0 C-N-CA 117.314 -2.374 . . . . 0.0 110.844 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.3 tt0 -34.87 155.21 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.39 -0.905 . . . . 0.0 109.478 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.81 -16.33 55.02 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 106.452 -2.659 . . . . 0.0 106.452 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 41' ' ' THR . 5.4 t-20 -106.72 -156.55 0.58 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.081 -1.06 . . . . 0.0 108.776 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.69 ' CE ' HD11 ' A' ' 29' ' ' ILE . 1.2 ttpp -159.63 103.54 1.56 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 10' ' ' GLY . 42.7 t -78.28 156.98 29.38 Favored 'General case' 0 CA--C 1.462 -2.41 0 C-N-CA 116.808 -1.957 . . . . 0.0 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.69 HD11 ' CE ' ' A' ' 27' ' ' LYS . 24.3 mm -145.62 118.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.772 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.078 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 8' ' ' GLU . 12.8 mt -92.13 129.31 38.11 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.673 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 82.88 84.31 0.85 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.433 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' GLU . 2.5 t -137.98 80.23 1.79 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.725 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 32' ' ' SER . 49.0 m-20 37.68 69.95 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.68 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.78 4.73 57.84 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.808 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 37' ' ' ASN . 30.6 mt-10 -136.36 94.59 3.04 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.83 0.824 . . . . 0.0 111.061 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 10.92 0.65 Allowed 'General case' 0 C--N 1.251 -3.681 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.745 HD22 ' HA ' ' A' ' 16' ' ' CYS . 19.9 t-20 179.75 107.48 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.966 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.529 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 50.4 tt0 -119.95 164.08 16.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -123.57 71.48 1.09 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -101.3 124.72 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -171.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.497 ' HA ' ' ND2' ' A' ' 26' ' ' ASN . 11.3 t -18.69 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 112.416 -2.174 . . . . 0.0 113.168 171.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.75 -155.73 20.74 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.54 98.32 5.18 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -91.93 -115.79 2.12 Favored Glycine 0 C--O 1.215 -1.042 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.653 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -164.84 150.96 9.03 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.565 -177.596 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -76.97 132.87 13.21 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.751 1.634 . . . . 0.0 110.057 170.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.502 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -64.46 -40.02 46.86 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.775 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 47' ' ' LYS . 2.0 Cg_endo -65.88 146.28 82.6 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.357 0.705 . . . . 0.0 111.064 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.275 179.489 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 3' ' ' TYR . 15.5 t -113.91 178.7 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.732 ' H ' HG12 ' A' ' 2' ' ' VAL . 16.9 m-85 -140.3 -114.73 0.14 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.688 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 3' ' ' TYR . 11.1 p -158.13 175.25 14.03 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.211 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.18 132.05 36.94 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.273 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.07 151.09 2.81 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.082 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -138.13 8.03 2.69 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.994 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.557 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mt-10 -166.79 132.88 2.29 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.409 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.682 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.94 154.38 0.74 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.568 177.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 87.87 11.23 68.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.41 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -82.99 -170.09 2.85 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.786 177.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.6 m120 -151.94 -73.51 0.15 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 118.406 -1.318 . . . . 0.0 113.365 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.552 HD13 ' CE1' ' A' ' 3' ' ' TYR . 51.8 mt -74.57 27.85 0.08 Allowed 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.176 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 20.9 p -105.55 177.29 4.89 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.598 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.4 mt -79.91 73.23 6.69 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.992 1.377 . . . . 0.0 107.629 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.68 ' HA ' HD22 ' A' ' 37' ' ' ASN . 76.2 m -69.52 -78.82 0.07 Allowed 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 111.864 -2.426 . . . . 0.0 110.869 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.22 107.36 9.55 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.544 -1.263 . . . . 0.0 109.867 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -115.05 6.83 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.95 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.93 0.6 11.93 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.361 1.077 . . . . 0.0 110.033 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.67 146.51 25.67 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.856 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 22' ' ' CYS . 22.1 t -82.75 140.29 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 C-N-CA 118.367 -1.333 . . . . 0.0 110.014 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.541 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -83.17 -138.8 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.95 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -166.31 121.25 0.97 Allowed Glycine 0 C--N 1.272 -3.008 0 C-N-CA 117.839 -2.124 . . . . 0.0 110.008 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.9 tt0 -34.65 159.44 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.081 -1.06 . . . . 0.0 110.251 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.0 -16.4 58.67 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.6 t30 -105.91 -161.22 0.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.873 -1.163 . . . . 0.0 108.864 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -160.95 96.42 1.11 Allowed 'General case' 0 C--N 1.28 -2.453 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.24 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.78 133.9 37.05 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 117.642 -1.623 . . . . 0.0 109.635 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -122.98 120.46 60.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.646 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 9' ' ' SER . 22.6 mt -81.94 139.06 34.83 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.162 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.44 -74.64 0.27 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.698 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.0 m -154.23 -127.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 67.47 0.0 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.746 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.54 35.13 89.54 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.581 ' HB2' ' H ' ' A' ' 32' ' ' SER . 58.8 mm-40 -78.68 -109.87 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.566 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 37' ' ' ASN . 3.6 pttt -93.1 -141.13 0.21 Allowed 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.457 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.68 HD22 ' HA ' ' A' ' 16' ' ' CYS . 47.2 t-20 172.65 123.32 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.162 0 CA-C-N 112.522 -2.126 . . . . 0.0 109.172 -169.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 29.3 tt0 -117.2 -179.93 3.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -145.55 78.85 1.56 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.508 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -114.74 131.51 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 C-N-CA 118.331 -1.347 . . . . 0.0 114.635 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.563 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -9.41 143.77 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.263 171.267 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.03 -145.71 15.3 Favored Glycine 0 N--CA 1.489 2.225 1 N-CA-C 131.067 7.187 . . . . 0.0 131.067 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -146.87 84.77 1.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.719 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -107.88 2.43 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.232 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -161.64 145.56 9.69 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.99 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.09 105.5 2.08 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.52 1.48 . . . . 0.0 110.496 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -43.78 106.18 0.49 Allowed Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.714 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 125.32 15.26 Favored 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.709 0.939 . . . . 0.0 111.377 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.585 179.452 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 3' ' ' TYR . 12.4 t -84.28 172.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.679 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.575 ' H ' HG12 ' A' ' 2' ' ' VAL . 60.0 m-85 -130.23 -118.29 0.23 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.67 0.748 . . . . 0.0 110.478 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.584 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -179.17 178.06 0.75 Allowed 'General case' 0 C--N 1.259 -3.367 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.643 -178.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.584 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.94 132.95 35.27 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.986 0.898 . . . . 0.0 112.119 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -52.96 154.49 2.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.843 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.683 HG22 ' HE2' ' A' ' 47' ' ' LYS . 6.9 t -139.38 11.27 2.54 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.979 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.687 ' C ' HD12 ' A' ' 30' ' ' LEU . 13.6 tt0 -166.34 125.39 1.54 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.272 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.713 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -45.14 155.58 0.12 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.819 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.08 -18.71 56.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 22.4 mt-30 -79.71 -175.66 4.97 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.91 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 14' ' ' CYS . 65.8 m-80 -152.2 -48.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 117.68 -1.608 . . . . 0.0 114.126 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 46' ' ' PRO . 29.0 mt -75.35 17.73 0.25 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.8 p -103.25 175.73 5.38 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.962 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.1 mt -78.88 73.19 5.43 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 122.959 1.362 . . . . 0.0 108.284 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.653 ' HA ' HD22 ' A' ' 37' ' ' ASN . 35.8 t -72.8 -82.24 0.05 Allowed 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 112.11 -2.314 . . . . 0.0 109.816 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.71 97.76 3.3 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 117.452 -1.699 . . . . 0.0 109.129 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 20' ' ' ASN . . . 64.65 -148.78 51.38 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.217 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.86 3.54 16.61 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.358 1.075 . . . . 0.0 109.553 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -87.14 143.07 27.47 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.79 -178.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 22' ' ' CYS . 4.6 t -84.49 144.91 8.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.51 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -73.09 -137.33 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.13 109.11 0.35 Allowed Glycine 0 C--N 1.282 -2.457 0 C-N-CA 117.414 -2.327 . . . . 0.0 111.128 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -34.36 150.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.36 176.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.95 57.37 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -173.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.468 ' ND2' ' CA ' ' A' ' 41' ' ' THR . 6.0 t-20 -106.5 -161.34 0.79 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 40' ' ' VAL . 49.0 tttp -155.42 105.82 2.5 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.357 175.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 51.9 t -76.34 158.17 31.72 Favored 'General case' 0 CA--C 1.462 -2.408 0 C-N-CA 116.845 -1.942 . . . . 0.0 108.718 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.1 mm -138.13 115.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.082 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.679 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 9' ' ' SER . 13.7 mt -91.74 123.95 35.51 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.215 176.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 78.92 86.87 0.51 Allowed Glycine 0 N--CA 1.503 3.135 0 C-N-CA 118.639 -1.744 . . . . 0.0 110.665 -177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 32' ' ' SER . 1.0 OUTLIER -135.53 82.5 1.96 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.949 0.881 . . . . 0.0 109.214 177.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 47.6 58.47 4.93 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.88 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.75 5.75 58.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.113 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 37' ' ' ASN . 42.6 mt-10 -125.64 94.8 4.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 122.246 1.022 . . . . 0.0 110.146 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -68.86 6.74 0.81 Allowed 'General case' 0 C--N 1.248 -3.84 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.962 -178.004 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.653 HD22 ' HA ' ' A' ' 16' ' ' CYS . 22.6 t-20 179.01 112.1 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.902 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 9.2 tt0 -128.78 166.43 19.02 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -126.04 72.24 1.29 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -115.45 130.68 69.63 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.167 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.117 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.468 ' CA ' ' ND2' ' A' ' 26' ' ' ASN . 5.3 t -42.58 159.72 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.844 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.4 -103.26 0.22 Allowed Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.854 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.522 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -79.15 -148.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.022 0.439 . . . . 0.0 109.949 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.57 80.57 0.06 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.54 126.72 28.27 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.934 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.454 ' HA ' HD12 ' A' ' 13' ' ' LEU . 6.4 Cg_endo -73.39 115.67 4.42 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 121.409 1.406 . . . . 0.0 111.734 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HE2' HG22 ' A' ' 7' ' ' THR . 19.5 tptp -66.86 113.98 15.69 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.105 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 49' ' ' GLN . 3.9 Cg_exo -59.7 163.65 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.491 0.794 . . . . 0.0 111.348 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 48' ' ' PRO . 3.3 mt-30 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.583 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 3' ' ' TYR . 8.8 t -101.18 172.69 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.747 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.574 ' H ' HG12 ' A' ' 2' ' ' VAL . 12.1 m-85 -115.77 -116.46 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.388 0.614 . . . . 0.0 110.709 -177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' TYR . 6.0 p -152.1 172.74 15.86 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.534 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 131.08 34.88 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.96 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -49.08 150.77 1.49 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.771 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -141.24 12.94 2.19 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -165.25 125.59 1.89 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.572 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.77 159.8 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.237 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.77 -5.91 72.65 Favored Glycine 0 N--CA 1.505 3.288 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.327 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -70.43 -176.48 1.24 Allowed 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.573 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' CYS . 5.2 m120 -148.29 -64.22 0.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.562 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 9.6 mt -73.06 22.53 0.07 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.899 -177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ASN . 17.2 p -104.96 176.76 5.05 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.28 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.1 mt -82.65 70.82 9.7 Favored 'General case' 0 C--N 1.27 -2.884 0 CA-C-O 122.703 1.239 . . . . 0.0 107.859 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.9 t -67.51 -88.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.258 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -73.43 109.2 6.77 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.064 -1.854 . . . . 0.0 109.849 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.43 -132.19 24.96 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.51 4.91 36.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.741 1.258 . . . . 0.0 108.549 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -87.69 149.81 24.02 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.374 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.4 t -87.51 141.2 14.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.123 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.65 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -74.46 -141.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.381 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.866 ' CA ' HD21 ' A' ' 26' ' ' ASN . . . -164.23 101.98 0.19 Allowed Glycine 0 N--CA 1.504 3.175 0 C-N-CA 115.608 -3.187 . . . . 0.0 112.98 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLY . 13.6 tm0? -27.45 114.63 0.07 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.519 1.152 . . . . 0.0 110.558 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.03 -16.82 5.48 Favored Glycine 0 C--N 1.28 -2.561 0 N-CA-C 105.263 -3.135 . . . . 0.0 105.263 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.866 HD21 ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.63 -171.41 1.98 Allowed 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.8 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 20.5 tttp -143.93 99.64 3.43 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.579 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 48.6 t -76.93 163.63 26.55 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.361 -1.736 . . . . 0.0 108.716 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.8 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 19.3 mm -147.36 118.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.102 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.7 144.16 26.98 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.297 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.621 ' H ' ' N ' ' A' ' 36' ' ' LYS . . . -48.56 -80.63 0.06 OUTLIER Glycine 0 N--CA 1.499 2.842 0 C-N-CA 117.908 -2.091 . . . . 0.0 110.631 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.691 ' H ' ' HA ' ' A' ' 35' ' ' GLU . 5.2 t 138.84 -93.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.605 1.193 . . . . 0.0 108.359 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -79.2 40.52 0.42 Allowed 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 112.831 -1.986 . . . . 0.0 107.967 177.45 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 32' ' ' SER . . . 152.35 33.42 0.03 OUTLIER Glycine 0 C--N 1.286 -2.225 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 -176.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.691 ' HA ' ' H ' ' A' ' 32' ' ' SER . 42.3 mt-10 -26.25 104.06 0.02 OUTLIER 'General case' 0 CA--C 1.462 -2.42 0 CA-C-O 123.698 1.713 . . . . 0.0 114.007 -177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.621 ' N ' ' H ' ' A' ' 31' ' ' GLY . 8.5 mttp -87.79 -141.38 0.12 Allowed 'General case' 1 C--N 1.24 -4.181 0 CA-C-N 110.386 -3.097 . . . . 0.0 104.077 170.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.864 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER 174.22 114.69 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.973 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.938 -176.181 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.864 ' N ' HD22 ' A' ' 37' ' ' ASN . 11.6 tt0 -124.76 163.36 22.27 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -124.05 65.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 t -89.44 131.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.914 -1.514 . . . . 0.0 111.816 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 42' ' ' GLY . 1.9 t -44.83 170.45 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.55 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 131.89 -111.64 1.08 Allowed Glycine 0 N--CA 1.494 2.502 1 N-CA-C 130.141 6.816 . . . . 0.0 130.141 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASN . 37.1 mt-10 -77.14 -144.53 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.092 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.2 96.3 0.1 Allowed Glycine 0 C--N 1.288 -2.123 0 C-N-CA 118.263 -1.922 . . . . 0.0 112.236 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.72 123.44 34.73 Favored Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.82 176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.67 118.09 4.73 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.489 1.46 . . . . 0.0 110.561 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -47.14 105.97 0.54 Allowed Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.686 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.5 104.0 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.798 0.999 . . . . 0.0 111.323 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 116.456 -1.735 . . . . 0.0 110.171 179.548 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.26 169.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.249 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 HE22 ' A' ' 11' ' ' GLN . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.748 ' HA ' HD22 ' A' ' 37' ' ' ASN . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 41' ' ' THR . 1.6 t-20 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' SER . 11.3 mt -85.19 140.04 31.2 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 84.1 86.89 0.86 Allowed Glycine 0 N--CA 1.507 3.419 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.676 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -140.14 76.02 1.54 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.495 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER 42.25 68.24 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.911 -0.715 . . . . 0.0 111.126 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.8 0.28 62.38 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.441 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 37' ' ' ASN . 3.9 mm-40 -127.48 91.35 3.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.05 0.928 . . . . 0.0 110.383 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.501 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -72.07 13.06 0.34 Allowed 'General case' 1 C--N 1.243 -4.055 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.827 -179.951 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.748 HD22 ' HA ' ' A' ' 16' ' ' CYS . 32.0 t-20 -176.13 107.99 0.08 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.095 -175.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.97 106.98 0.51 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.7 Cg_endo -61.82 102.03 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.455 0.77 . . . . 0.0 110.771 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.798 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 3' ' ' TYR . 22.8 t -117.94 176.74 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.701 ' H ' HG12 ' A' ' 2' ' ' VAL . 19.6 m-85 -147.61 -114.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.461 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 3' ' ' TYR . 5.0 p -162.55 172.92 14.69 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.436 -178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.26 126.81 33.07 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.581 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 178.33 0.09 Allowed 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 122.781 1.277 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -151.96 18.32 0.68 Allowed 'General case' 0 C--N 1.258 -3.412 0 CA-C-N 111.923 -2.399 . . . . 0.0 106.311 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.625 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.6 mt-10 -161.43 134.27 6.17 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 117.73 -1.588 . . . . 0.0 114.789 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.469 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -63.59 154.23 33.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.507 172.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.25 -20.9 40.61 Favored Glycine 0 C--N 1.287 -2.143 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.953 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.532 ' NE2' ' OE1' ' A' ' 8' ' ' GLU . 4.1 mt-30 -82.59 -174.03 4.97 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.908 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.588 ' N ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -153.6 -36.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.609 -176.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 61.0 mt -76.11 11.5 1.46 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.501 -1.28 . . . . 0.0 110.187 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.498 ' H ' ' C ' ' A' ' 12' ' ' ASN . 5.1 p -104.08 174.58 5.81 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.07 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.1 mt -78.07 74.77 4.61 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 122.855 1.312 . . . . 0.0 108.208 -177.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 3.5 t -71.02 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 111.803 -2.453 . . . . 0.0 110.076 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 3.9 mm-40 -76.04 121.46 22.79 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.709 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.33 -144.93 23.79 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.482 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.24 4.16 53.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.589 1.185 . . . . 0.0 109.139 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -83.31 146.55 28.45 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.742 -2.026 . . . . 0.0 111.403 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 22' ' ' CYS . 10.9 t -82.32 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.529 -1.268 . . . . 0.0 110.342 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -74.6 -130.43 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 174.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -168.37 109.93 0.36 Allowed Glycine 0 C--N 1.276 -2.793 0 C-N-CA 118.315 -1.898 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 10.8 tt0 -35.11 154.38 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.032 178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -17.25 27.36 Favored Glycine 0 C--N 1.29 -1.987 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 39' ' ' CYS . 27.6 t30 -96.56 -157.96 0.62 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.549 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -159.07 98.67 1.47 Allowed 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.702 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.898 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.2 t -78.23 166.03 23.21 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.199 -1.8 . . . . 0.0 110.541 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.6 mm -137.89 108.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.003 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 8' ' ' GLU . 96.1 mt -86.49 108.36 18.5 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.121 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 1.116 ' HA2' ' N ' ' A' ' 36' ' ' LYS . . . 0.42 67.91 0.0 OUTLIER Glycine 0 C--O 1.188 -2.761 1 N-CA-C 129.041 6.376 . . . . 0.0 129.041 173.629 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -23.69 86.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.958 1.034 . . . . 0.0 109.446 175.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 31' ' ' GLY . 32.6 t0 61.79 54.67 2.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 31' ' ' GLY . . . 84.48 9.37 81.7 Favored Glycine 0 N--CA 1.484 1.861 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.562 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 31' ' ' GLY . 5.3 mm-40 -75.24 -95.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.555 -1.258 . . . . 0.0 113.19 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 1.116 ' N ' ' HA2' ' A' ' 31' ' ' GLY . 19.9 mttp -82.25 -131.73 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 41.1 t-20 127.88 37.68 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.897 -2.41 . . . . 0.0 106.106 -169.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 53.8 tt0 -79.88 164.53 23.49 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.211 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.78 65.65 1.03 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -105.3 127.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 118.226 -1.39 . . . . 0.0 113.121 -172.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.428 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 5.5 t -53.98 156.41 2.96 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.505 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.63 -62.89 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.763 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.588 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -121.93 -141.32 0.33 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.639 0.733 . . . . 0.0 110.728 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.588 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -172.66 70.53 0.1 Allowed Glycine 0 N--CA 1.493 2.456 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.81 109.29 60.86 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.737 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.12 121.79 7.54 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.201 1.267 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -50.0 -48.5 78.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.268 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 2.9 Cg_endo -62.66 146.8 95.32 Favored 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 120.575 0.85 . . . . 0.0 111.352 173.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.417 -1.754 . . . . 0.0 110.603 178.689 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 1' ' ' VAL . 12.4 p . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.84 162.73 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.519 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.562 ' O ' HG23 ' A' ' 4' ' ' THR . 45.1 m-85 -131.54 -117.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 3' ' ' TYR . 3.0 p -161.45 166.54 27.1 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.821 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.74 127.74 33.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.029 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.9 m -44.91 154.09 0.15 Allowed 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.78 18.8 0.9 Allowed 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.591 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -164.73 120.07 1.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.967 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.482 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -49.21 154.15 0.87 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.147 178.143 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.93 -1.89 85.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.367 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.408 HE21 ' HD2' ' A' ' 48' ' ' PRO . 31.7 mt-30 -73.95 -172.29 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.115 -1.434 . . . . 0.0 108.28 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.545 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -136.77 -82.04 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 117.516 -1.674 . . . . 0.0 115.282 -176.604 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 19.9 mt -73.16 34.64 0.08 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.347 -172.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 27.1 p -103.07 174.42 5.88 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.26 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.0 mt -84.81 77.69 10.03 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.839 1.304 . . . . 0.0 108.505 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.9 m -73.5 -87.45 0.03 OUTLIER 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.442 -176.496 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.93 107.51 7.05 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.668 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.4 -147.29 50.62 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.909 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -87.52 4.69 42.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.278 1.037 . . . . 0.0 110.1 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.46 140.25 32.45 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 113.268 -1.787 . . . . 0.0 111.642 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 36.7 t -82.91 155.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.334 -1.347 . . . . 0.0 109.91 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.535 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.5 m -141.41 -163.79 1.63 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 105.61 -60.32 0.39 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 118.094 -2.003 . . . . 0.0 112.973 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.7 tt0 -66.8 110.32 3.24 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.131 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.597 ' C ' HD21 ' A' ' 26' ' ' ASN . . . 85.33 -7.34 76.32 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.675 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -132.01 -171.19 2.56 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.919 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -155.4 114.01 3.5 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.028 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.1 m -82.96 149.8 26.79 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.064 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' CE ' ' A' ' 27' ' ' LYS . 35.5 mm -138.5 118.3 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.858 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 9' ' ' SER . 13.7 mt -91.04 140.55 29.72 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.799 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 60.31 88.48 0.02 OUTLIER Glycine 0 N--CA 1.501 3.025 0 C-N-CA 118.643 -1.741 . . . . 0.0 111.315 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -137.08 79.64 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.723 0.773 . . . . 0.0 109.151 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 55.1 58.58 4.61 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.328 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.74 -6.56 70.33 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.696 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 37' ' ' ASN . 14.0 mt-10 -106.31 89.86 3.18 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.691 1.234 . . . . 0.0 110.007 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -67.27 5.08 0.79 Allowed 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 112.503 -2.135 . . . . 0.0 111.598 -179.199 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.696 HD22 ' N ' ' A' ' 38' ' ' GLN . 1.3 t-20 178.36 134.62 0.08 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.167 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.696 ' N ' HD22 ' A' ' 37' ' ' ASN . 8.2 tt0 -146.45 174.19 11.62 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.66 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.79 61.54 1.65 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -80.05 129.88 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.309 -172.064 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.9 t -25.91 156.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.875 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.97 -139.6 11.56 Favored Glycine 0 N--CA 1.492 2.423 1 N-CA-C 131.506 7.362 . . . . 0.0 131.506 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.56 109.51 3.28 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -107.07 -110.25 3.45 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.858 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.02 139.41 7.31 Favored Pre-proline 0 C--N 1.299 -1.596 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.473 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.0 Cg_exo -58.63 125.76 19.29 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 N-CA-C 109.41 -1.035 . . . . 0.0 109.41 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.5 tmtt? -44.38 114.76 2.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.827 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.408 ' HD2' HE21 ' A' ' 11' ' ' GLN . 6.1 Cg_exo -54.42 142.29 70.29 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.841 1.027 . . . . 0.0 111.945 -173.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 116.305 -1.807 . . . . 0.0 110.479 179.566 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' ' 3' ' ' TYR . 43.4 t -129.56 175.81 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.576 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.689 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.9 m-85 -108.66 -117.74 0.27 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.681 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 3' ' ' TYR . 6.7 p -161.21 174.29 13.84 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.897 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.33 131.74 35.68 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -48.85 158.81 0.29 Allowed 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.902 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -145.8 13.74 1.34 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.991 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -166.96 121.23 1.04 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.815 -177.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.475 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.55 156.6 0.43 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.266 176.484 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.27 -23.26 28.11 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.057 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' GLY . 11.1 mm-40 -54.07 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.568 -179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.21 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.519 -1.672 . . . . 0.0 114.28 177.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.628 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 19.9 mt -130.52 11.56 5.33 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 26.5 p -102.78 178.23 4.62 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.319 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.7 mt -77.09 73.09 3.68 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 123.057 1.408 . . . . 0.0 107.656 -178.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 31.7 t -77.14 -75.86 0.19 Allowed 'General case' 0 C--N 1.254 -3.558 0 CA-C-N 111.863 -2.426 . . . . 0.0 110.507 -175.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.415 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.94 -126.25 26.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -1.74 24.13 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.678 1.227 . . . . 0.0 108.703 178.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -83.26 151.7 25.5 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.865 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 43.3 t -81.21 149.21 5.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.301 -1.359 . . . . 0.0 111.273 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -73.74 -140.78 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 175.288 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.24 110.48 0.4 Allowed Glycine 0 C--N 1.281 -2.501 0 C-N-CA 117.488 -2.291 . . . . 0.0 111.135 176.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -32.69 145.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.489 -0.856 . . . . 0.0 110.515 177.898 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.17 -2.79 63.77 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 -174.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 41' ' ' THR . 3.1 t-20 -117.1 -157.91 0.68 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.952 -1.124 . . . . 0.0 109.188 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HE3' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -160.68 102.85 1.35 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.665 176.55 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 10' ' ' GLY . 43.9 t -78.35 165.9 23.29 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 117.7 -1.6 . . . . 0.0 110.146 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.525 HD11 ' HE3' ' A' ' 27' ' ' LYS . 11.8 mm -149.12 120.25 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.409 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 9' ' ' SER . 23.7 mt -78.18 77.24 4.68 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.442 177.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.919 ' HA3' ' CB ' ' A' ' 36' ' ' LYS . . . -17.18 -43.25 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 1 N-CA-C 127.735 5.854 . . . . 0.0 127.735 -177.602 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.07 89.25 0.08 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.572 177.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.04 41.37 8.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.133 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.43 8.97 67.5 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.678 -1.248 . . . . 0.0 110.42 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -74.69 -92.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.931 0.872 . . . . 0.0 112.831 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.919 ' CB ' ' HA3' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -70.52 44.85 0.08 Allowed 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 113.791 -1.55 . . . . 0.0 114.863 -174.526 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -45.71 90.21 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.595 174.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 36' ' ' LYS . 7.3 tt0 -105.76 164.83 11.62 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.233 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -121.2 71.67 0.96 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -177.304 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -96.55 120.85 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 118.194 -1.402 . . . . 0.0 114.78 -171.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.529 ' HA ' ' ND2' ' A' ' 26' ' ' ASN . 5.1 t -19.75 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 112.456 -2.156 . . . . 0.0 113.781 171.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.24 -151.01 20.15 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.25 122.86 7.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.187 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 -95.56 0.19 Allowed Glycine 0 N--CA 1.478 1.493 1 N-CA-C 131.52 7.368 . . . . 0.0 131.52 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.0 104.48 20.59 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.529 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -70.41 103.36 1.26 Allowed 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.003 1.135 . . . . 0.0 110.484 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.17 126.28 15.01 Favored Pre-proline 0 CA--C 1.563 1.448 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.571 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.46 138.58 39.12 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 120.508 0.805 . . . . 0.0 110.324 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.614 -179.836 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.46 161.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.893 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.596 ' CE2' HD13 ' A' ' 13' ' ' LEU . 13.9 m-85 -140.63 -112.93 0.14 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.886 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.54 171.85 17.48 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.003 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -94.46 133.67 37.81 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.283 -177.55 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -56.4 156.59 5.79 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.84 176.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -143.08 9.38 1.69 Allowed 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.71 173.818 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.588 ' C ' HD12 ' A' ' 30' ' ' LEU . 12.3 mt-10 -164.95 145.96 7.58 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.502 -179.055 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.541 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -59.67 152.72 21.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.532 176.448 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 97.7 -17.65 58.55 Favored Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.137 -1.506 . . . . 0.0 112.376 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.587 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 10.3 mm-40 -61.41 -166.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.022 -179.27 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 11' ' ' GLN . 0.3 OUTLIER -158.48 -68.18 0.09 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.748 -178.876 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.596 HD13 ' CE2' ' A' ' 3' ' ' TYR . 96.1 mt -75.63 18.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.277 -176.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.4 p -100.39 175.96 5.52 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.731 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.449 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.6 mt -79.87 73.53 6.62 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.793 1.282 . . . . 0.0 108.417 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 43.4 t -72.32 -83.41 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 112.39 -2.186 . . . . 0.0 110.226 -177.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -75.2 110.82 9.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.341 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.04 -139.91 43.1 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -95.68 3.7 53.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.54 1.162 . . . . 0.0 109.276 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-N 112.898 -1.956 . . . . 0.0 111.467 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.8 t -80.18 144.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -78.67 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.429 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -146.31 96.01 0.18 Allowed Glycine 0 C--N 1.282 -2.463 1 N-CA-C 129.618 6.607 . . . . 0.0 129.618 179.074 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.2 tp60 -33.88 121.48 0.44 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.658 178.024 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.06 -6.77 34.95 Favored Glycine 0 C--N 1.291 -1.968 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 -172.004 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 39' ' ' CYS . 13.5 t30 -118.22 -167.61 1.38 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.316 -0.942 . . . . 0.0 109.292 177.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.637 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -142.1 106.41 4.8 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.267 176.206 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLY . 7.9 t -76.11 158.55 31.65 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 116.413 -2.115 . . . . 0.0 108.262 177.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.637 HD11 ' CE ' ' A' ' 27' ' ' LYS . 14.6 mm -147.11 124.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.274 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 8' ' ' GLU . 8.3 mt -95.67 130.45 42.55 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.402 175.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.598 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 64.69 92.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.85 -1.643 . . . . 0.0 111.899 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -124.16 78.2 1.62 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.31 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.4 t0 51.17 45.23 28.15 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.01 178.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 3.63 28.09 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.704 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 36' ' ' LYS . 41.3 mt-10 -125.26 99.06 5.9 Favored 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 121.953 0.883 . . . . 0.0 109.596 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.598 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -56.29 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.247 -3.865 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.803 -179.239 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -57.32 139.9 51.6 Favored 'General case' 1 C--N 1.229 -4.641 0 CA-C-N 112.979 -1.919 . . . . 0.0 110.528 177.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 24.0 tt0 -151.57 165.46 34.21 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.543 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -125.38 66.75 1.14 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -100.71 117.75 46.4 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 118.281 -1.368 . . . . 0.0 110.685 -175.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.2 150.48 3.29 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.25 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.23 -37.56 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.268 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 22.4 tt0 -157.29 -129.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.821 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' C ' HE22 ' A' ' 24' ' ' GLN . . . 157.75 97.41 0.13 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.616 -1.278 . . . . 0.0 111.314 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.23 107.96 60.7 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.492 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.25 101.54 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.785 0.99 . . . . 0.0 110.262 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HG2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -42.35 104.5 0.36 Allowed Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.276 -178.778 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -59.99 113.14 1.52 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.597 0.865 . . . . 0.0 111.051 -177.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 . . . . . 0 C--N 1.305 -1.353 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.799 -179.448 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.26 169.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.249 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 HE22 ' A' ' 11' ' ' GLN . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.748 ' HA ' HD22 ' A' ' 37' ' ' ASN . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 41' ' ' THR . 1.6 t-20 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' SER . 11.3 mt -85.19 140.04 31.2 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 84.1 86.89 0.86 Allowed Glycine 0 N--CA 1.507 3.419 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.676 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -140.14 76.02 1.54 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.495 177.521 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER 42.25 68.24 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.911 -0.715 . . . . 0.0 111.126 178.321 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.8 0.28 62.38 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.441 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 37' ' ' ASN . 3.9 mm-40 -127.48 91.35 3.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.05 0.928 . . . . 0.0 110.383 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.501 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -72.07 13.06 0.34 Allowed 'General case' 1 C--N 1.243 -4.055 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.827 -179.951 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.748 HD22 ' HA ' ' A' ' 16' ' ' CYS . 32.0 t-20 -176.13 107.99 0.08 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.095 -175.333 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.97 106.98 0.51 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.7 Cg_endo -61.82 102.03 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.455 0.77 . . . . 0.0 110.771 -178.022 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.798 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 3' ' ' TYR . 2.0 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.83 4.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 4' ' ' THR . 65.0 m-85 -132.76 -130.28 0.18 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.651 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 3' ' ' TYR . 6.9 p -165.23 177.71 7.44 Favored 'General case' 0 C--N 1.256 -3.459 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.622 -176.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.76 129.93 34.76 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.422 178.13 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -43.69 158.16 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.594 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -138.31 10.7 2.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.541 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -165.43 130.04 2.42 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.42 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.45 153.02 0.39 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.608 -0.837 . . . . 0.0 108.754 172.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 80.35 19.38 69.2 Favored Glycine 0 C--N 1.278 -2.666 0 C-N-CA 119.994 -1.098 . . . . 0.0 112.45 -178.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 11.1 mm-40 -89.95 -166.32 1.56 Allowed 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.919 178.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.0 m120 -153.5 -72.46 0.13 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 37.5 mt -71.82 17.16 0.1 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.566 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 26.7 p -103.93 176.48 5.14 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.218 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.1 mt -80.77 72.72 7.75 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 122.676 1.227 . . . . 0.0 108.156 -177.385 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 99.6 m -70.93 -79.51 0.06 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 112.555 -2.112 . . . . 0.0 110.315 -176.264 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 3.2 mp0 -74.36 91.97 2.26 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.061 -1.456 . . . . 0.0 108.788 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.694 ' H ' HD22 ' A' ' 37' ' ' ASN . . . 70.78 -140.36 31.48 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.188 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -86.76 4.09 42.33 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.016 0.912 . . . . 0.0 110.65 -178.916 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -90.87 140.01 30.21 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.235 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 22' ' ' CYS . 12.6 t -80.48 146.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.73 177.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -100.0 -146.96 0.34 Allowed 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.327 176.856 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -157.18 123.05 1.24 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 116.721 -2.656 . . . . 0.0 111.885 -177.158 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 23' ' ' GLY . 31.1 tp60 -35.25 160.76 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.036 -1.582 . . . . 0.0 110.052 175.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.78 52.73 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 -174.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.562 HD21 ' C ' ' A' ' 39' ' ' CYS . 18.1 t30 -109.15 -163.43 0.87 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.249 -0.976 . . . . 0.0 109.23 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.39 96.75 1.19 Allowed 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.241 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -84.1 126.08 32.75 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 117.896 -1.522 . . . . 0.0 112.306 -178.413 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 37' ' ' ASN . 11.4 mm -99.32 116.56 42.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.275 -176.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' SER . 62.6 mt -74.54 135.55 42.15 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.296 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 37' ' ' ASN . . . -61.08 66.18 0.01 OUTLIER Glycine 0 N--CA 1.477 1.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.861 172.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.659 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.2 t -67.78 -123.12 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.129 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.3 70.36 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.088 0 O-C-N 125.295 1.622 . . . . 0.0 110.026 -179.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 56.67 41.97 90.48 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -178.209 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -96.39 -127.1 0.14 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.384 -177.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 5.8 mmtm -98.31 -118.69 0.14 Allowed 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.627 -176.026 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.694 HD22 ' H ' ' A' ' 18' ' ' GLY . 45.5 t30 114.18 40.37 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 111.992 -2.367 . . . . 0.0 106.675 -170.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 5.1 tt0 -103.03 -165.28 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.029 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.562 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.0 OUTLIER -147.98 89.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.268 -177.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -105.62 123.68 60.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 112.982 -1.917 . . . . 0.0 113.169 -176.7 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.3 t -6.35 144.05 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 112.534 -2.121 . . . . 0.0 113.824 171.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 136.07 172.15 12.54 Favored Glycine 0 N--CA 1.487 2.095 1 N-CA-C 130.979 7.151 . . . . 0.0 130.979 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.47 94.76 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.953 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.17 -113.33 3.52 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -164.07 134.18 3.18 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.725 -179.898 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' LYS . 9.5 Cg_endo -76.81 98.62 1.23 Allowed 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.458 1.439 . . . . 0.0 110.481 173.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.4 tttp -43.15 105.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.203 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.53 -168.63 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.449 0.766 . . . . 0.0 110.993 -177.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 116.432 -1.747 . . . . 0.0 110.606 179.359 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 2' ' ' VAL . 46.7 t -82.48 6.43 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.856 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.83 -121.8 0.21 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.709 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 1.8 t -170.71 178.86 3.42 Favored 'General case' 0 C--N 1.254 -3.56 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.251 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.555 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -95.12 131.22 41.37 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.155 -178.948 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -47.65 153.88 0.53 Allowed 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.8 177.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -148.57 18.03 1.03 Allowed 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.87 174.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -164.11 122.84 1.89 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.709 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.69 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -52.55 146.73 9.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.575 0.703 . . . . 0.0 110.663 178.835 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 98.96 -0.34 57.55 Favored Glycine 0 C--N 1.277 -2.749 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.66 178.112 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.4 mt-30 -88.39 179.17 6.38 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.653 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -148.0 -42.16 0.16 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.423 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 46' ' ' PRO . 8.2 mp -75.76 22.88 0.13 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.608 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.2 p -121.8 177.21 5.37 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.602 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.8 mt -79.5 74.73 6.14 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 122.672 1.225 . . . . 0.0 108.915 -176.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.8 m -69.89 -77.77 0.08 Allowed 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.03 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.77 114.99 17.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.785 -179.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.42 -120.76 24.13 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.255 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 4.59 18.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.486 1.136 . . . . 0.0 109.821 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -88.72 143.9 26.62 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.911 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 22' ' ' CYS . 12.8 t -83.03 136.73 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.342 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.632 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -82.35 -140.2 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.541 174.896 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.86 123.77 1.18 Allowed Glycine 0 C--N 1.27 -3.103 0 C-N-CA 116.58 -2.724 . . . . 0.0 111.58 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -33.94 150.78 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 113.009 -1.596 . . . . 0.0 109.078 175.687 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 96.99 -12.7 65.55 Favored Glycine 0 C--N 1.29 -2.007 0 N-CA-C 106.359 -2.696 . . . . 0.0 106.359 -173.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.5 t-20 -114.15 -163.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.904 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -157.36 99.28 1.76 Allowed 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.395 176.148 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.811 ' O ' HD13 ' A' ' 29' ' ' ILE . 3.6 m -78.38 149.78 33.3 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.6 -1.64 . . . . 0.0 109.848 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.3 mm -128.38 115.68 38.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.598 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 36' ' ' LYS . 29.0 mt -70.01 132.41 45.86 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.279 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 63.64 90.18 0.03 OUTLIER Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.238 -1.458 . . . . 0.0 111.61 177.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.5 ' O ' ' OG ' ' A' ' 32' ' ' SER . 12.0 p -136.53 85.5 2.15 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.062 0.934 . . . . 0.0 109.225 176.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 t70 58.21 42.2 22.34 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.329 177.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.94 -1.25 31.68 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.671 -1.252 . . . . 0.0 111.319 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.6 mt-10 -116.64 102.0 9.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.439 1.114 . . . . 0.0 110.38 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.713 ' O ' HD23 ' A' ' 30' ' ' LEU . 5.9 mttp -63.95 9.36 0.07 Allowed 'General case' 1 C--N 1.243 -4.036 0 CA-C-N 113.282 -1.781 . . . . 0.0 111.494 179.504 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 35' ' ' GLU . 1.8 p30 172.18 87.39 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.098 -177.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.516 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 5.3 tt0 -78.77 -179.0 6.26 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.516 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -135.47 68.81 1.45 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.878 -1.129 . . . . 0.0 107.954 178.952 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -104.22 124.51 58.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.517 -175.692 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.546 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 10.2 t -55.03 154.59 5.28 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.53 -24.05 0.15 Allowed Glycine 0 N--CA 1.494 2.505 0 CA-C-N 113.744 -1.571 . . . . 0.0 109.762 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 26' ' ' ASN . 5.4 tt0 -159.46 -140.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' ' H ' ' A' ' 25' ' ' GLY . . . 163.8 102.06 0.16 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.196 -1.478 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.6 139.98 32.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.633 178.396 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.641 ' HA ' HD13 ' A' ' 13' ' ' LEU . 11.7 Cg_endo -76.86 102.13 1.58 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.773 1.649 . . . . 0.0 109.273 172.36 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -56.03 -62.79 4.1 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 118.3 -1.36 . . . . 0.0 111.732 -177.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 49' ' ' GLN . 3.3 Cg_exo -50.7 112.27 0.72 Allowed 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.824 1.016 . . . . 0.0 111.57 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 116.376 -1.773 . . . . 0.0 110.432 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 2' ' ' VAL . 2.7 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 3' ' ' TYR . 4.2 t -104.04 169.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.465 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.504 ' H ' HG12 ' A' ' 2' ' ' VAL . 9.0 m-85 -114.08 -110.25 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.559 0.695 . . . . 0.0 110.683 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 177.2 179.22 0.24 Allowed 'General case' 0 C--N 1.261 -3.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.784 -179.097 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.572 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -82.84 130.88 35.19 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.459 -176.992 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 m -47.56 160.72 0.11 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.729 175.534 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 t -141.78 9.43 1.96 Allowed 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.786 175.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -168.18 154.13 7.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.218 178.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 157.16 14.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.898 176.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 91.85 -22.56 30.61 Favored Glycine 0 N--CA 1.51 3.604 0 C-N-CA 119.336 -1.411 . . . . 0.0 114.147 177.411 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -78.52 160.95 27.39 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.719 -177.014 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 28' ' ' CYS . 6.8 m-80 -151.21 21.33 0.75 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 115.535 1.679 . . . . 0.0 115.535 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.746 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -123.65 8.29 8.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.159 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 21.9 p -102.53 179.97 4.14 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.226 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.5 mt -79.75 74.88 6.44 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.95 1.357 . . . . 0.0 108.476 -177.463 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.0 t -72.14 -80.77 0.06 Allowed 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 112.098 -2.319 . . . . 0.0 110.116 -177.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.31 106.86 10.51 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.957 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.58 -151.79 46.05 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.06 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.17 5.36 17.12 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.1 0.952 . . . . 0.0 110.332 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -89.63 142.2 27.9 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.679 -1.601 . . . . 0.0 112.588 -176.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 13' ' ' LEU . 43.0 t -82.56 151.2 4.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.72 178.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -103.69 -143.26 0.36 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.71 176.26 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ASN . . . -159.44 118.81 0.85 Allowed Glycine 0 C--O 1.203 -1.792 0 C-N-CA 116.782 -2.627 . . . . 0.0 112.469 -176.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 26' ' ' ASN . 52.3 tt0 -35.3 162.02 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.699 -1.25 . . . . 0.0 110.179 174.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' GLN . . . 87.91 -24.29 11.33 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 106.006 -2.837 . . . . 0.0 106.006 -172.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.7 t30 -96.42 -167.17 1.53 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -161.35 102.88 1.24 Allowed 'General case' 0 C--N 1.265 -3.103 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.61 177.567 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 97.3 m -78.29 158.98 28.71 Favored 'General case' 0 CA--C 1.442 -3.184 0 C-N-CA 117.372 -1.731 . . . . 0.0 108.86 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.605 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.6 mm -142.72 114.3 3.01 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.355 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.027 174.237 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.59 123.62 18.4 Favored 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 118.132 -1.427 . . . . 0.0 109.09 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -102.25 -86.83 1.96 Allowed Glycine 0 N--CA 1.503 3.137 0 C-N-CA 119.323 -1.418 . . . . 0.0 112.877 -175.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER 168.05 115.64 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.523 -175.412 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 53.37 85.38 0.05 Allowed 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.035 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -40.93 2.59 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.129 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' O ' ' O ' ' A' ' 36' ' ' LYS . 2.0 mt-10 -84.77 9.24 14.61 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.769 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.633 ' C ' ' H ' ' A' ' 31' ' ' GLY . 11.6 mttp -48.34 -117.94 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.267 -175.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.85 89.95 0.01 OUTLIER 'General case' 0 C--N 1.245 -3.942 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.326 -177.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -81.09 171.96 14.29 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -137.5 75.58 1.54 Allowed 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.644 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -110.97 131.02 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 117.997 -1.481 . . . . 0.0 114.88 -174.494 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.572 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -9.15 153.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 112.296 -2.229 . . . . 0.0 115.233 172.916 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.38 -136.21 8.53 Favored Glycine 0 N--CA 1.495 2.616 1 N-CA-C 129.937 6.735 . . . . 0.0 129.937 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -76.55 -131.13 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.46 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.603 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 140.13 107.54 0.71 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.471 176.293 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.82 135.06 36.01 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.037 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.602 ' HA ' HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -68.07 100.72 0.65 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 120.512 0.808 . . . . 0.0 110.196 173.882 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.671 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 12.4 tptm -38.63 104.89 0.32 Allowed Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.003 -179.157 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.37 129.93 20.1 Favored 'Trans proline' 0 C--O 1.217 -0.574 0 C-N-CA 120.793 0.995 . . . . 0.0 110.939 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 116.307 -1.806 . . . . 0.0 110.299 179.849 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.657 HG12 ' N ' ' A' ' 3' ' ' TYR . 33.4 t -115.06 171.27 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.673 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.657 ' N ' HG12 ' A' ' 2' ' ' VAL . 2.8 m-85 -118.4 -96.72 0.47 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.441 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -178.34 178.56 0.86 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.9 178.346 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.554 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.44 132.11 34.02 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.559 -175.683 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 30' ' ' LEU . 2.7 m -48.88 160.13 0.21 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.362 176.099 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 7' ' ' THR . 5.1 t -152.8 14.77 0.55 Allowed 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.533 173.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.626 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.5 tt0 -166.2 117.97 1.03 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.982 -178.398 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -45.81 160.99 0.05 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.709 177.441 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.99 -29.34 8.81 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 118.839 -1.648 . . . . 0.0 112.482 -179.038 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 33.2 mt-30 -67.6 -168.84 0.1 Allowed 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.615 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.599 HD21 ' HB3' ' A' ' 22' ' ' CYS . 1.4 m120 -166.0 -28.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 117.716 -1.594 . . . . 0.0 113.998 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 46' ' ' PRO . 26.6 mt -86.53 15.04 5.89 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.706 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.5 p -105.63 177.11 4.95 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.992 -178.055 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.4 mt -77.74 75.76 4.28 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.76 1.266 . . . . 0.0 108.726 -176.763 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 14.3 m -82.24 -72.68 0.43 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.265 -2.243 . . . . 0.0 111.251 -177.215 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.03 87.88 1.87 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.505 179.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -142.16 37.38 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.176 -1.487 . . . . 0.0 109.682 -178.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 0.98 43.34 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.187 0.994 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -90.64 150.39 21.71 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.413 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.2 t -81.3 150.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.335 -178.303 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.599 ' HB3' HD21 ' A' ' 12' ' ' ASN . 0.0 OUTLIER -72.91 -136.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.542 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -169.67 111.46 0.42 Allowed Glycine 0 C--N 1.283 -2.395 0 C-N-CA 117.429 -2.32 . . . . 0.0 110.785 174.195 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 23' ' ' GLY . 34.9 tt0 -34.76 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.778 177.295 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 87.12 -12.46 62.23 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 -174.104 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.635 HD21 ' C ' ' A' ' 39' ' ' CYS . 34.9 t30 -108.0 -162.09 0.81 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 40' ' ' VAL . 23.0 tttt -147.74 103.32 3.5 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.132 173.536 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.813 ' O ' HD13 ' A' ' 29' ' ' ILE . 38.0 t -75.93 156.92 33.77 Favored 'General case' 0 C--N 1.272 -2.77 0 C-N-CA 117.692 -1.603 . . . . 0.0 109.752 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 28' ' ' CYS . 9.0 mm -139.05 116.05 10.85 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.099 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 8' ' ' GLU . 20.9 mt -95.7 107.03 19.2 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.577 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.98 -40.5 9.83 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 117.535 -2.269 . . . . 0.0 108.304 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.36 89.22 0.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.51 0.671 . . . . 0.0 109.984 176.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 3.6 m-20 43.76 72.52 0.18 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.034 178.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' H ' HD22 ' A' ' 30' ' ' LEU . . . 85.41 -1.67 88.35 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.044 176.601 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 37' ' ' ASN . 8.7 mm-40 -71.74 -104.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.04 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -78.95 45.14 0.59 Allowed 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.267 1.032 . . . . 0.0 110.253 -179.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -42.61 130.42 4.03 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 113.215 -1.812 . . . . 0.0 112.814 170.685 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HG3' ' H ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -133.25 175.48 9.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.669 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' C ' HD21 ' A' ' 26' ' ' ASN . 1.3 m -137.93 67.96 1.41 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.561 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -107.19 128.18 62.34 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.809 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.04 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.461 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -52.94 151.35 4.71 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.6 -27.19 0.12 Allowed Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.404 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 26' ' ' ASN . 69.2 mt-10 -154.18 -135.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.432 0.634 . . . . 0.0 109.546 -178.395 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' HA3' ' H ' ' A' ' 25' ' ' GLY . . . 159.71 97.93 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.684 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.15 144.45 52.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.249 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.549 ' HA ' HD12 ' A' ' 13' ' ' LEU . 18.4 Cg_endo -78.85 130.19 9.45 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.726 1.617 . . . . 0.0 110.678 173.704 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -60.92 127.57 87.78 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 118.401 -1.32 . . . . 0.0 108.673 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.13 155.57 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.536 0.824 . . . . 0.0 111.231 -178.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 116.205 -1.855 . . . . 0.0 110.514 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 3' ' ' TYR . 3.3 t -89.48 165.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.331 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.567 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 72.3 m-85 -106.36 -114.17 0.26 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.304 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -176.63 174.3 1.87 Allowed 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.532 178.856 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.538 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.43 133.77 36.54 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.888 -175.882 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.9 m -47.35 170.26 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.458 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.457 176.243 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.38 10.23 1.45 Allowed 'General case' 0 C--N 1.262 -3.207 0 CA-C-N 113.406 -1.725 . . . . 0.0 107.276 172.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 30' ' ' LEU . 31.8 tt0 -169.94 128.82 0.92 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.512 -179.054 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.737 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -46.81 163.21 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.442 177.645 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.64 -15.46 24.96 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.011 -2.042 . . . . 0.0 111.597 178.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -58.64 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.763 -1.175 . . . . 0.0 108.613 177.95 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -145.68 -81.48 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.345 -1.742 . . . . 0.0 114.348 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 93.5 mt -75.32 36.72 0.12 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.831 -173.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -101.39 -176.69 3.22 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.337 179.758 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.615 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 11.3 mt -90.99 80.61 5.72 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.925 -176.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.59 -78.64 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 CA-C-N 112.862 -1.972 . . . . 0.0 110.709 -177.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 79.7 mm-40 -86.34 110.44 19.68 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.95 -119.19 9.47 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.683 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.47 1.44 12.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.476 1.131 . . . . 0.0 109.358 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -79.77 142.04 35.75 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.06 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 38.7 t -86.31 154.29 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.42 178.71 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.3 m -142.46 -162.71 1.46 Allowed 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.011 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 97.15 -50.37 1.48 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 117.412 -2.327 . . . . 0.0 113.518 174.107 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.572 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.3 tt0 -59.66 118.75 6.48 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.435 -177.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.84 -8.14 16.93 Favored Glycine 0 C--N 1.305 -1.166 0 N-CA-C 107.536 -2.226 . . . . 0.0 107.536 -176.345 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -122.97 -173.83 2.8 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.969 -179.43 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.587 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.25 116.58 13.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.695 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' GLY . 13.5 t -79.24 153.89 29.6 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 117.421 -1.711 . . . . 0.0 110.672 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.587 HD11 ' CE ' ' A' ' 27' ' ' LYS . 16.9 mm -148.36 124.59 2.51 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.479 0 CA-C-N 113.163 -1.835 . . . . 0.0 111.731 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 9' ' ' SER . 3.4 mt -99.67 135.13 41.54 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.615 176.796 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 64.33 92.74 0.03 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 118.546 -1.788 . . . . 0.0 110.884 178.582 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -129.14 84.63 2.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.633 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' SER . 49.9 t0 39.55 50.63 2.17 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.218 176.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.11 19.75 9.26 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.282 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 32' ' ' SER . 15.0 mt-10 -147.6 103.68 3.55 Favored 'General case' 0 C--O 1.198 -1.637 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.817 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 35' ' ' GLU . 1.1 mptp? -56.85 -121.28 0.0 OUTLIER 'General case' 0 C--N 1.255 -3.506 0 CA-C-O 122.761 1.267 . . . . 0.0 109.189 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.04 149.94 22.14 Favored 'General case' 1 C--N 1.236 -4.367 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.696 176.584 . . . . . . . . 4 4 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' OE1' ' A' ' 35' ' ' GLU . 11.3 tt0 -160.02 170.11 22.0 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.92 177.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 22.1 m -131.41 64.69 1.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -79.98 125.84 39.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.855 -173.487 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 6.5 t -29.06 155.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 113.087 -1.869 . . . . 0.0 112.373 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.73 -154.3 16.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -142.11 124.73 15.85 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.472 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.09 -113.48 3.81 Favored Glycine 0 N--CA 1.479 1.527 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.887 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.88 141.19 7.44 Favored Pre-proline 0 C--N 1.296 -1.736 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.746 -178.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.9 Cg_endo -67.43 111.8 2.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.881 1.054 . . . . 0.0 109.412 174.181 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HD3' HG23 ' A' ' 4' ' ' THR . 14.4 tttp -39.85 101.39 0.23 Allowed Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.613 -178.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.83 -169.2 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.986 1.124 . . . . 0.0 111.712 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.409 -1.758 . . . . 0.0 110.558 179.752 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -92.14 170.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.688 -178.953 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -110.31 -116.69 0.3 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.657 0.742 . . . . 0.0 110.029 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -165.26 175.76 8.97 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.686 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.13 134.5 36.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.921 0.867 . . . . 0.0 112.723 -174.576 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.466 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 3.2 m -48.81 158.07 0.34 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.886 176.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -140.69 7.07 2.08 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.253 174.088 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.62 126.7 0.9 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.288 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -50.51 157.54 0.72 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.489 175.765 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.15 -3.41 84.57 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.66 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 26.3 mt-30 -86.55 -166.19 1.49 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.502 178.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.589 HD21 ' H ' ' A' ' 44' ' ' GLY . 6.2 m-20 -139.83 -80.49 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -175.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mt -71.63 41.67 0.08 Allowed 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.651 -172.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ASN . 31.8 p -107.75 178.75 4.43 Favored 'General case' 0 C--O 1.194 -1.834 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.854 176.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -89.78 79.72 6.66 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 123.05 1.405 . . . . 0.0 108.286 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 33.9 t -61.99 -94.48 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.024 0 CA-C-N 111.832 -2.44 . . . . 0.0 111.191 -176.47 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.43 122.29 26.8 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.421 -1.311 . . . . 0.0 109.592 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.63 -123.82 23.14 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.327 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -116.23 2.75 13.35 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 122.393 1.092 . . . . 0.0 109.652 -179.598 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -81.73 144.92 30.79 Favored 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.761 -177.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 22.8 t -86.67 149.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.645 178.558 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -136.64 -165.1 1.67 Allowed 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 174.529 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 112.67 -68.52 0.23 Allowed Glycine 0 N--CA 1.484 1.893 0 C-N-CA 117.662 -2.209 . . . . 0.0 113.488 174.048 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.581 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -64.55 124.79 22.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.776 -175.065 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.6 -5.55 44.93 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -175.655 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -133.82 -170.66 2.55 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.674 -179.376 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 40' ' ' VAL . 19.4 tttp -156.27 105.95 2.34 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.292 177.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.832 ' O ' HD13 ' A' ' 29' ' ' ILE . 11.1 m -80.48 158.86 25.76 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 117.665 -1.614 . . . . 0.0 111.038 -179.151 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.832 HD13 ' O ' ' A' ' 28' ' ' CYS . 10.1 mm -139.5 106.87 2.83 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.288 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.47 ' H ' ' HB3' ' A' ' 9' ' ' SER . 0.8 OUTLIER -113.55 123.7 50.62 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.932 -178.104 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 1.002 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . 176.75 80.85 0.05 OUTLIER Glycine 0 CA--C 1.568 3.393 0 C-N-CA 117.419 -2.324 . . . . 0.0 115.536 176.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.815 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 67.0 m -102.26 -137.96 0.34 Allowed 'General case' 0 C--O 1.197 -1.668 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 171.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -19.25 0.36 Allowed 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 123.513 1.625 . . . . 0.0 107.571 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' C ' ' A' ' 32' ' ' SER . . . -167.75 -5.6 0.03 OUTLIER Glycine 1 C--N 1.251 -4.174 0 CA-C-N 110.821 -2.9 . . . . 0.0 109.011 174.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.815 ' CA ' ' H ' ' A' ' 32' ' ' SER . 19.8 mt-10 -167.53 95.19 0.45 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -174.294 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 1.002 ' H ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -99.19 63.25 1.3 Allowed 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 172.278 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -51.37 131.73 28.82 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.351 -179.089 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -147.56 167.66 23.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.097 174.639 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 m -131.74 73.15 1.52 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -91.24 125.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.898 -173.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.3 t -32.99 159.18 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.476 177.604 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.51 -150.97 19.1 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.882 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -153.95 114.1 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.589 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -104.92 -109.76 3.44 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.16 148.27 11.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.55 -177.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.27 129.07 29.83 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.11 1.207 . . . . 0.0 109.876 175.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 5.2 tmtm? -45.85 -50.95 32.74 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.861 -179.594 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 4.4 Cg_exo -51.38 117.43 3.44 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.515 0.81 . . . . 0.0 111.352 174.253 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.499 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 t -92.59 161.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.264 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -145.19 -114.0 0.09 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.009 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.36 164.22 38.94 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.9 -178.68 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.86 131.92 35.26 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.555 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 150.35 4.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.578 176.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.829 HG22 ' HZ3' ' A' ' 47' ' ' LYS . 14.8 t -145.63 15.36 1.42 Allowed 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -162.46 113.67 1.57 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.41 -177.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.449 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -46.87 155.41 0.26 Allowed 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.515 178.258 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 10.87 85.64 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.449 -1.357 . . . . 0.0 111.293 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -79.39 -168.52 1.55 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.814 178.608 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' CYS . 28.7 t-20 -130.95 -91.18 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 114.835 -177.436 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.35 37.58 0.11 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.857 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 21.5 p -96.37 -178.85 4.43 Favored 'General case' 0 C--O 1.192 -1.922 0 C-N-CA 118.175 -1.41 . . . . 0.0 109.721 179.62 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -92.92 79.8 4.64 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 122.504 1.145 . . . . 0.0 108.577 -177.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.9 t -66.97 -85.42 0.02 OUTLIER 'General case' 0 C--N 1.253 -3.593 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.42 -176.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -80.77 120.3 24.47 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.71 -121.88 26.28 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.527 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.99 2.9 14.36 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.635 1.207 . . . . 0.0 109.126 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -78.88 142.44 36.8 Favored 'General case' 0 C--N 1.26 -3.315 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.518 -178.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 39.2 t -85.7 153.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 118.379 -1.328 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.7 m -139.52 -166.93 2.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.183 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 98.04 -47.04 1.53 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 117.268 -2.396 . . . . 0.0 114.14 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.629 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 20.5 tt0 -60.49 103.21 0.22 Allowed 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.768 -176.522 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.32 55.82 Favored Glycine 0 C--N 1.303 -1.27 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -175.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.668 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -119.38 -164.45 1.06 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.884 -1.158 . . . . 0.0 111.102 178.951 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.693 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -159.81 134.78 7.97 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.668 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 t -94.73 159.5 15.04 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.438 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.693 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 31.1 mm -137.27 110.06 7.6 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.413 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.786 177.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 9' ' ' SER . 63.1 mt -75.16 112.55 11.54 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.64 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.68 -44.49 12.31 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 118.985 -1.579 . . . . 0.0 109.876 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.6 t -175.48 100.66 0.08 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.022 179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.4 m-20 54.82 51.35 13.87 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.68 176.754 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.437 ' HA2' HD22 ' A' ' 30' ' ' LEU . . . 88.17 11.41 67.2 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.132 -1.509 . . . . 0.0 111.561 177.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -78.34 -107.45 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.755 -179.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -80.0 62.67 4.27 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 122.702 1.239 . . . . 0.0 112.233 -175.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -54.77 93.42 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 113.369 -1.741 . . . . 0.0 111.843 174.623 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 59.0 tt0 -82.7 162.71 21.71 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.087 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.2 m -123.9 67.74 1.04 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.712 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -85.18 131.18 34.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 117.844 -1.543 . . . . 0.0 111.78 -172.677 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' VAL . 2.2 t -36.13 165.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.272 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.3 -129.95 7.13 Favored Glycine 0 N--CA 1.484 1.894 1 N-CA-C 129.596 6.599 . . . . 0.0 129.596 -178.321 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -161.07 115.4 2.06 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.199 178.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.8 -106.69 2.96 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.86 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.1 140.62 8.77 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.87 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.5 Cg_endo -61.85 96.6 0.14 Allowed 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 121.132 1.221 . . . . 0.0 110.227 176.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.829 ' HZ3' HG22 ' A' ' 7' ' ' THR . 32.3 tptt -39.32 104.81 0.33 Allowed Pre-proline 0 N--CA 1.491 1.595 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.754 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.77 142.03 81.19 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.442 0.762 . . . . 0.0 110.943 178.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 116.397 -1.763 . . . . 0.0 110.539 -179.796 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 2' ' ' VAL . 22.0 t -142.61 16.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.171 -178.57 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.685 ' O ' HG23 ' A' ' 4' ' ' THR . 78.9 m-85 -104.66 -128.4 0.25 Allowed 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.359 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.677 -174.097 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.04 129.49 34.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.842 179.104 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.8 m -44.62 155.44 0.1 Allowed 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.17 178.238 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.75 11.48 2.26 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.978 175.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.65 134.31 4.48 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.01 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.531 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -53.47 155.25 3.02 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.317 176.59 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.812 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 77.62 13.56 83.37 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.485 -179.378 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.403 HE22 ' HG2' ' A' ' 47' ' ' LYS . 9.7 mm-40 -75.63 -168.65 0.88 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.014 179.047 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 14' ' ' CYS . 77.2 m-20 -151.14 -72.05 0.16 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.248 -1.381 . . . . 0.0 113.741 -178.842 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.502 HD13 ' CE1' ' A' ' 3' ' ' TYR . 24.0 mt -75.73 20.7 0.17 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.19 -175.812 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.7 p -102.77 176.68 5.08 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.383 -179.342 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.497 ' N ' HD23 ' A' ' 15' ' ' LEU . 6.6 mt -80.62 73.31 7.57 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-O 122.934 1.35 . . . . 0.0 108.194 -177.018 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.0 m -72.38 -81.69 0.05 Allowed 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.169 -175.82 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.99 112.13 12.1 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.55 -179.759 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.7 -121.76 12.97 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.284 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.97 1.91 12.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.593 1.187 . . . . 0.0 108.918 178.872 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -85.81 151.2 24.01 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.766 -177.611 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 22' ' ' CYS . 32.8 t -84.3 142.4 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.023 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.593 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -84.81 -142.37 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.897 174.451 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.4 120.65 0.96 Allowed Glycine 0 C--N 1.282 -2.419 0 C-N-CA 116.88 -2.581 . . . . 0.0 111.683 -178.758 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.6 tt0 -31.42 150.9 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.561 -1.319 . . . . 0.0 110.092 177.233 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.14 -15.01 63.72 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 106.381 -2.688 . . . . 0.0 106.381 -172.701 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.652 ' OD1' ' N ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -115.36 -170.84 1.84 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.625 -1.288 . . . . 0.0 108.461 177.185 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.82 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -161.32 117.1 2.13 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.609 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -95.97 122.5 38.86 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.837 -177.189 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.82 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.3 mm -97.12 117.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 113.097 -1.865 . . . . 0.0 112.698 -174.084 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 9' ' ' SER . 8.1 mt -79.42 123.29 27.38 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.422 179.654 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.656 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . -120.5 -89.58 1.12 Allowed Glycine 0 N--CA 1.507 3.396 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.33 -179.393 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.403 ' H ' ' N ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -179.28 106.67 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.979 -176.634 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 t0 45.45 85.01 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.812 174.985 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' LYS . . . 94.82 -51.89 1.97 Allowed Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.92 -0.73 36.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.468 1.127 . . . . 0.0 108.022 176.911 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.656 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 23.8 tttt -53.53 -134.73 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 111.871 -2.422 . . . . 0.0 112.307 -176.799 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.65 85.99 0.05 OUTLIER 'General case' 0 C--N 1.249 -3.791 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.767 -178.694 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -77.12 173.98 11.21 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 173.758 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.13 80.64 1.77 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.427 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -109.43 127.75 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.156 -175.231 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.652 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 t -16.71 141.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.696 172.391 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.17 -130.0 2.25 Favored Glycine 0 N--CA 1.484 1.856 1 N-CA-C 131.513 7.365 . . . . 0.0 131.513 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -161.05 100.31 1.23 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.281 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.812 ' HA3' ' O ' ' A' ' 10' ' ' GLY . . . -121.78 -97.03 1.44 Allowed Glycine 0 N--CA 1.481 1.648 1 N-CA-C 129.105 6.402 . . . . 0.0 129.105 177.122 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.82 129.57 2.46 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.696 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.18 92.61 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.329 1.353 . . . . 0.0 110.441 172.893 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HG2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -39.45 103.54 0.29 Allowed Pre-proline 0 N--CA 1.504 2.239 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.681 -179.525 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.68 -174.24 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.351 0.701 . . . . 0.0 111.027 -179.355 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 116.275 -1.821 . . . . 0.0 110.527 -179.962 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 3' ' ' TYR . 37.6 t -78.9 173.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.871 179.779 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.655 ' N ' HG12 ' A' ' 2' ' ' VAL . 9.2 m-85 -114.38 -112.65 0.34 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.555 0.693 . . . . 0.0 110.253 -178.565 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -169.22 -174.4 1.98 Allowed 'General case' 0 C--N 1.255 -3.51 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.305 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.594 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.86 135.73 33.27 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.044 -177.301 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.76 155.38 0.58 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.648 175.284 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -133.46 4.82 3.7 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.952 176.083 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.405 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 7.1 pt-20 -168.51 132.55 1.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.757 179.585 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -42.0 166.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.668 176.565 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 68.17 20.48 73.12 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.806 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.485 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -85.58 -172.78 4.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.864 -179.463 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 14' ' ' CYS . 3.1 m120 -154.95 -67.29 0.13 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.415 -1.314 . . . . 0.0 113.952 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 5.2 mt -74.07 22.9 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.455 -176.643 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.8 p -115.36 179.49 3.95 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.5 mt -81.04 72.15 8.06 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.444 -178.195 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.0 m -70.39 -83.22 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.517 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.009 -177.145 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HA ' HD22 ' A' ' 37' ' ' ASN . 1.3 tm-20 -77.45 122.62 25.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.336 -1.346 . . . . 0.0 109.93 178.964 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.18 -125.0 38.39 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.793 -178.361 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.02 4.61 15.77 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.893 1.33 . . . . 0.0 108.278 178.64 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 142.68 34.86 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 111.965 -2.379 . . . . 0.0 111.877 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.0 t -84.22 135.43 24.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.12 -1.432 . . . . 0.0 109.624 176.852 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.609 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -78.56 -143.33 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.726 175.439 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -166.91 119.32 0.84 Allowed Glycine 0 C--N 1.275 -2.857 0 C-N-CA 117.533 -2.27 . . . . 0.0 110.671 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' GLY . 30.9 tp60 -35.09 151.06 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.416 177.085 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.57 -13.3 67.83 Favored Glycine 0 C--N 1.292 -1.89 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -172.679 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 41' ' ' THR . 27.2 t30 -111.4 -161.75 0.77 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.198 -1.001 . . . . 0.0 109.208 177.166 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.92 110.63 1.47 Allowed 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.18 179.055 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -105.26 125.28 50.81 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.004 177.7 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.555 HD11 ' CE ' ' A' ' 27' ' ' LYS . 37.0 mm -105.0 113.86 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.209 -178.553 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 9' ' ' SER . 8.9 mt -76.61 120.92 22.48 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.673 -177.177 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.96 -57.13 21.32 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.954 177.575 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -168.16 90.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.76 179.338 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER 65.59 52.31 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.63 178.406 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.57 0.41 73.13 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.2 -101.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.614 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -93.27 61.94 3.39 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.057 -177.414 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.498 HD22 ' HA ' ' A' ' 17' ' ' GLU . 2.2 p30 -80.32 146.3 31.67 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.262 175.707 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 9.7 tt0 -119.82 170.63 9.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.161 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.488 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -139.86 82.56 1.88 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.267 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -125.08 141.31 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.354 -176.674 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.528 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -16.76 152.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 112.408 -2.178 . . . . 0.0 113.519 171.749 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.54 -143.26 12.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.73 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.91 111.51 1.76 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.818 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.85 -88.22 0.82 Allowed Glycine 0 N--CA 1.491 2.333 1 N-CA-C 129.77 6.668 . . . . 0.0 129.77 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -147.18 124.12 5.71 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.989 178.152 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.45 98.96 1.25 Allowed 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.474 1.449 . . . . 0.0 111.123 175.394 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -54.11 113.61 5.32 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.463 179.31 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.61 148.92 85.44 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.667 0.911 . . . . 0.0 111.218 -177.445 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.592 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 116.369 -1.777 . . . . 0.0 110.283 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 3' ' ' TYR . 7.0 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.307 0.575 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.517 ' C ' HG22 ' A' ' 4' ' ' THR . 32.8 m-85 -120.12 -110.46 0.34 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.268 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 173.15 178.71 0.09 Allowed 'General case' 0 C--N 1.258 -3.395 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -76.47 130.18 37.6 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.644 -1.223 . . . . 0.0 111.175 -176.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 96.2 m -40.6 168.06 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.15 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 HG22 ' NZ ' ' A' ' 47' ' ' LYS . 14.9 t -143.66 11.85 1.67 Allowed 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 113.066 -1.879 . . . . 0.0 107.626 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -173.9 125.76 0.36 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.433 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -47.1 158.06 0.15 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.224 178.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 95.57 -28.26 12.88 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.588 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.89 176.92 0.49 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.938 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -156.49 20.18 0.34 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 116.947 -1.901 . . . . 0.0 114.863 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.764 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -134.14 16.0 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -102.04 -179.62 4.05 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.025 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.1 mt -77.85 72.69 4.4 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.003 1.383 . . . . 0.0 108.003 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.4 t -77.68 -82.85 0.08 Allowed 'General case' 0 C--N 1.25 -3.733 0 CA-C-N 112.051 -2.341 . . . . 0.0 110.356 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.81 110.86 9.46 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.859 -1.536 . . . . 0.0 108.505 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.3 -154.56 33.52 Favored Glycine 0 N--CA 1.479 1.528 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -82.8 5.56 21.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.52 1.153 . . . . 0.0 109.324 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.42 149.01 25.3 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.657 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 HG13 ' C ' ' A' ' 13' ' ' LEU . 28.1 t -82.65 144.56 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.027 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -71.15 -144.67 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.965 177.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -141.3 82.91 0.23 Allowed Glycine 0 C--N 1.282 -2.464 1 N-CA-C 128.17 6.028 . . . . 0.0 128.17 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.1 tm0? -19.22 126.0 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 124.595 0.82 . . . . 0.0 111.483 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.48 56.95 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 106.551 -2.619 . . . . 0.0 106.551 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.0 m-20 -110.12 -169.74 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.188 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.876 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -144.36 130.9 19.95 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.043 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.596 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 52.6 t -99.58 168.29 10.05 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.586 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.876 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 28.1 mm -145.95 119.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 C-N-CA 118.298 -1.361 . . . . 0.0 112.508 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 9' ' ' SER . 12.0 mt . . . . . 0 N--CA 1.494 1.754 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.49 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.58 0 CA-C-O 120.864 0.364 . . . . 0.0 110.909 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.622 ' N ' HD22 ' A' ' 37' ' ' ASN . 35.2 tt0 -127.6 161.21 29.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.02 71.13 1.04 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -174.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -101.79 113.12 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 118.161 -1.416 . . . . 0.0 113.27 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' VAL . 7.5 t -31.11 158.69 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.421 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.64 159.51 8.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -78.12 102.59 7.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.37 -104.65 2.93 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.64 137.86 6.77 Favored Pre-proline 0 C--N 1.303 -1.418 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.908 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.708 ' HA ' HD11 ' A' ' 13' ' ' LEU . 2.9 Cg_endo -68.87 91.68 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.735 0.957 . . . . 0.0 109.681 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 47.7 tttp . . . . . 0 N--CA 1.503 2.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.262 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 3' ' ' TYR . 16.0 t . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.64 ' O ' HG23 ' A' ' 4' ' ' THR . 33.1 m-85 -114.27 -116.74 0.32 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.719 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.3 p -165.59 176.62 7.96 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.909 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.66 125.57 35.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.191 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' ' NE2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -59.84 165.59 3.09 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-O 123.594 1.664 . . . . 0.0 111.897 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -142.31 13.32 1.99 Allowed 'General case' 1 C--N 1.239 -4.197 0 CA-C-N 110.595 -3.002 . . . . 0.0 105.338 174.198 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' C ' HD12 ' A' ' 30' ' ' LEU . 16.1 mt-10 -160.31 139.47 10.73 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.584 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.63 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.65 -175.62 0.06 Allowed 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 123.236 1.493 . . . . 0.0 111.15 177.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 69.47 -36.87 0.34 Allowed Glycine 1 C--N 1.231 -5.294 0 CA-C-N 111.278 -2.692 . . . . 0.0 112.524 177.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.553 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -59.74 -171.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.555 -175.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.596 ' N ' ' ND2' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -171.77 40.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.659 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 24' ' ' GLN . 72.9 mt -143.02 1.32 1.26 Allowed 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.477 ' C ' HD23 ' A' ' 15' ' ' LEU . 3.3 p -100.48 171.45 7.73 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.604 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.785 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -81.48 78.83 8.19 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 123.664 1.697 . . . . 0.0 107.998 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.934 ' C ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -79.76 -61.32 2.03 Favored 'General case' 1 C--N 1.235 -4.382 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.845 -178.724 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 11.4 mm-40 -73.99 72.17 1.61 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.66 -1.616 . . . . 0.0 108.284 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -113.4 4.07 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.3 p -99.91 -11.75 20.42 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-O 124.048 1.88 . . . . 0.0 109.197 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.04 119.39 19.14 Favored 'General case' 1 C--N 1.207 -5.628 0 CA-C-N 110.709 -2.95 . . . . 0.0 110.216 178.944 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 22' ' ' CYS . 25.4 t -63.41 147.11 12.39 Favored 'Isoleucine or valine' 1 C--N 1.215 -5.279 0 CA-C-N 110.956 -2.838 . . . . 0.0 107.713 175.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -77.93 -132.16 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.77 89.75 0.1 OUTLIER Glycine 1 C--N 1.224 -5.677 0 C-N-CA 115.942 -3.028 . . . . 0.0 112.36 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' ASN . 36.2 tt0 -23.67 142.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 113.782 -1.209 . . . . 0.0 110.743 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -7.42 63.4 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -173.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.2 m-20 -111.11 -166.89 1.11 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.607 -1.297 . . . . 0.0 108.91 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -147.48 98.01 2.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 10' ' ' GLY . 51.1 t -75.68 154.84 36.26 Favored 'General case' 0 CA--C 1.435 -3.448 0 C-N-CA 116.55 -2.06 . . . . 0.0 109.918 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.57 HD11 ' CE ' ' A' ' 27' ' ' LYS . 32.3 mm -139.08 120.97 16.67 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.246 0 CA-C-N 112.769 -2.014 . . . . 0.0 109.633 175.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 9' ' ' SER . 18.4 mt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.934 HD21 ' C ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -95.48 -173.36 2.88 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.56 -1.655 . . . . 0.0 108.629 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.59 67.12 1.53 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -91.17 136.02 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 117.011 -1.876 . . . . 0.0 114.829 -171.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.631 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 t -17.83 144.5 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 110.008 -3.269 . . . . 0.0 113.127 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.26 -137.03 6.6 Favored Glycine 0 N--CA 1.484 1.878 1 N-CA-C 130.2 6.84 . . . . 0.0 130.2 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.73 98.5 0.88 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.601 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.61 -104.86 2.85 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.745 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.41 138.44 10.09 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.9 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.24 104.33 1.53 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.325 1.35 . . . . 0.0 110.715 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.905 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.961 0.41 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.651 ' CE2' HD22 ' A' ' 13' ' ' LEU . 22.0 m-85 -137.34 -111.15 0.18 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.655 0.741 . . . . 0.0 109.777 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 179.16 177.56 0.52 Allowed 'General case' 0 C--N 1.262 -3.229 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.64 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.07 131.68 37.4 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.387 -177.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.452 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 93.7 m -43.01 172.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.122 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.571 HG22 HE22 ' A' ' 11' ' ' GLN . 2.3 t -146.08 11.06 1.18 Allowed 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.727 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -168.86 123.73 0.88 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.461 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.95 149.71 1.77 Allowed 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.152 173.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 93.08 -0.58 69.28 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.17 -1.49 . . . . 0.0 111.613 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.571 HE22 HG22 ' A' ' 7' ' ' THR . 24.1 mt-30 -81.84 -173.6 4.55 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.695 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.566 HD21 ' C ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -167.69 30.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 116.689 -2.004 . . . . 0.0 115.348 -178.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.651 HD22 ' CE2' ' A' ' 3' ' ' TYR . 34.7 mt -146.07 14.56 1.32 Allowed 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -109.43 -179.98 3.98 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.725 -175.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.661 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 mt -76.27 70.22 2.87 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.142 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.621 ' C ' HD21 ' A' ' 37' ' ' ASN . 4.1 m -75.89 -83.06 0.07 Allowed 'General case' 0 C--N 1.249 -3.761 0 CA-C-N 112.44 -2.164 . . . . 0.0 110.387 -176.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.73 107.01 6.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.108 -1.837 . . . . 0.0 108.75 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.12 -137.54 33.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.148 -1.501 . . . . 0.0 109.901 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.65 5.06 47.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.585 1.183 . . . . 0.0 109.223 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -85.74 145.38 27.28 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.147 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 22' ' ' CYS . 17.7 t -79.3 143.15 12.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.94 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.655 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.27 -165.27 0.39 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -152.5 98.0 0.18 Allowed Glycine 0 C--N 1.288 -2.098 0 C-N-CA 116.02 -2.991 . . . . 0.0 112.261 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.0 tt0 -27.42 148.07 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 112.207 -1.997 . . . . 0.0 111.008 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.47 53.94 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 104.795 -3.322 . . . . 0.0 104.795 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 41' ' ' THR . 2.1 t-20 -105.16 -162.28 0.87 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 112.716 -1.742 . . . . 0.0 108.536 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.445 ' N ' HD21 ' A' ' 12' ' ' ASN . 0.7 OUTLIER -149.41 104.6 3.39 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.923 ' O ' HD13 ' A' ' 29' ' ' ILE . 36.1 t -77.5 149.88 34.94 Favored 'General case' 0 C--N 1.269 -2.918 0 C-N-CA 117.095 -1.842 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.5 mm -137.14 118.72 18.5 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.194 0 CA-C-N 112.695 -2.048 . . . . 0.0 109.859 177.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.442 ' H ' ' HB3' ' A' ' 9' ' ' SER . 93.1 mt . . . . . 0 N--CA 1.505 2.3 0 C-N-CA 118.769 -1.172 . . . . 0.0 113.757 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.621 HD21 ' C ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.652 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 1.9 tt0 -102.42 -164.33 1.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.615 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.652 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -135.62 73.26 1.46 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -92.21 120.07 40.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.986 -173.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.615 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -6.17 141.89 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 112.668 -2.06 . . . . 0.0 114.437 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.96 -177.95 19.32 Favored Glycine 0 N--CA 1.488 2.166 1 N-CA-C 130.907 7.123 . . . . 0.0 130.907 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -108.78 90.78 3.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.799 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.63 -107.05 2.66 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.175 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.36 134.91 4.82 Favored Pre-proline 0 C--N 1.301 -1.53 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' LYS . 9.2 Cg_endo -75.87 97.23 1.09 Allowed 'Trans proline' 0 C--O 1.211 -0.855 0 C-N-CA 121.41 1.407 . . . . 0.0 110.648 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.0 tttm . . . . . 0 N--CA 1.512 2.632 0 O-C-N 123.543 0.527 . . . . 0.0 111.093 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 2' ' ' VAL . 98.6 t . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.512 0.672 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.495 ' CE1' HD13 ' A' ' 13' ' ' LEU . 61.9 m-85 -139.4 -117.88 0.13 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.013 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 179.52 177.33 0.59 Allowed 'General case' 0 C--N 1.253 -3.588 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.443 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.569 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.14 131.57 34.22 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.325 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -48.08 155.43 0.46 Allowed 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.939 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -134.18 7.15 3.65 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.021 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.679 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -163.29 138.64 6.58 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.898 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -55.47 146.43 20.06 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.628 ' HA2' ' HG2' ' A' ' 27' ' ' LYS . . . 97.84 -16.05 60.87 Favored Glycine 0 N--CA 1.497 2.715 1 N-CA-C 127.634 5.814 . . . . 0.0 127.634 -172.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.637 HE22 ' N ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -78.8 -171.47 2.58 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 118.896 -1.121 . . . . 0.0 109.069 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.4 m120 -148.23 -53.29 0.19 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 117.562 -1.655 . . . . 0.0 115.413 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 3' ' ' TYR . 66.2 mt -73.22 14.29 0.33 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.094 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.6 p -102.58 173.88 6.14 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.42 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.9 mt -79.19 72.58 5.76 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.885 1.326 . . . . 0.0 108.283 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 88.1 m -75.29 -71.82 0.34 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 112.254 -2.248 . . . . 0.0 109.224 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 90.88 2.99 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 117.987 -1.485 . . . . 0.0 109.448 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.48 -138.31 40.53 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.413 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -0.02 50.76 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.309 1.052 . . . . 0.0 109.996 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -88.98 144.16 26.36 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.668 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.0 t -85.46 143.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.743 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.682 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -75.93 -152.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.484 173.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -150.82 98.69 0.19 Allowed Glycine 0 C--N 1.27 -3.113 0 C-N-CA 116.738 -2.648 . . . . 0.0 111.122 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.4 tt0 -27.94 147.92 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 112.413 -1.893 . . . . 0.0 110.379 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -12.22 70.32 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 43' ' ' GLU . 28.0 t30 -111.64 -159.6 0.69 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.982 -1.109 . . . . 0.0 108.989 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 30.7 tttp -157.2 111.81 2.72 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 118.656 -1.217 . . . . 0.0 111.723 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.752 ' O ' HD13 ' A' ' 29' ' ' ILE . 5.3 m -78.62 157.77 28.61 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 117.871 -1.532 . . . . 0.0 110.409 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 28' ' ' CYS . 10.7 mm -133.52 110.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.321 173.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 8' ' ' GLU . 46.8 mt . . . . . 0 N--CA 1.514 2.746 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.784 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m-20 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.886 0.374 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 8.3 tt0 -78.0 175.33 10.17 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 117.687 -1.605 . . . . 0.0 106.884 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.77 74.51 1.48 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.071 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.615 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -120.12 138.91 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.355 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 3.5 t -50.4 160.89 0.35 Allowed 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.22 -23.34 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.992 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -162.99 -150.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.485 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' H ' ' CD ' ' A' ' 43' ' ' GLU . . . 176.8 85.74 0.06 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.189 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.84 139.3 29.93 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.032 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.0 Cg_endo -75.8 117.36 4.7 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.146 1.231 . . . . 0.0 110.203 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.1 tmtt? . . . . . 0 N--CA 1.498 1.937 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.197 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.472 ' C ' HG22 ' A' ' 4' ' ' THR . 2.4 m-85 -130.83 -99.48 0.32 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.538 0.685 . . . . 0.0 110.204 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 178.07 -178.92 0.26 Allowed 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.027 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.58 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -94.91 134.99 36.96 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.103 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -55.89 158.77 3.54 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.476 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -146.65 14.87 1.23 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.003 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -166.37 137.16 3.44 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.715 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.613 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -54.64 152.33 7.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.838 176.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.39 -1.99 73.61 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.088 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.27 -165.98 0.76 Allowed 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.265 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.962 HD22 ' HA2' ' A' ' 44' ' ' GLY . 1.4 m-20 -164.04 -56.88 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 18.3 mt -74.87 12.99 0.72 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.592 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.2 p -105.13 178.98 4.4 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.841 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.1 mt -78.99 76.83 5.47 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-O 123.082 1.42 . . . . 0.0 108.936 -176.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 84.9 m -75.44 -84.83 0.05 OUTLIER 'General case' 1 C--N 1.243 -4.034 0 CA-C-N 112.027 -2.352 . . . . 0.0 111.123 -177.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.58 104.46 6.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.174 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.36 -111.38 3.46 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.916 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.28 3.99 7.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.472 1.129 . . . . 0.0 109.463 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -87.24 145.19 26.48 Favored 'General case' 0 C--N 1.257 -3.424 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.9 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.8 t -82.92 143.24 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.328 -1.349 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -96.84 -178.22 4.16 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.028 175.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -121.24 116.78 3.25 Favored Glycine 0 C--N 1.278 -2.645 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.072 -169.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.735 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 2.4 pt20 -41.8 3.28 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.048 0 CA-C-N 111.345 -2.427 . . . . 0.0 114.11 174.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -102.62 16.01 55.23 Favored Glycine 0 C--N 1.262 -3.53 0 N-CA-C 105.935 -2.866 . . . . 0.0 105.935 172.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.849 ' C ' HD21 ' A' ' 12' ' ' ASN . 1.7 t-20 -138.61 -154.53 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.619 -1.29 . . . . 0.0 108.748 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -163.0 109.3 1.17 Allowed 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.084 177.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -84.64 139.36 32.1 Favored 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.435 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.634 HD11 ' CE ' ' A' ' 27' ' ' LYS . 29.7 mm -125.77 119.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.713 -1.585 . . . . 0.0 112.123 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 9' ' ' SER . 21.6 mt . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 118.606 -1.238 . . . . 0.0 109.98 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.762 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.746 0 CA-C-O 120.823 0.344 . . . . 0.0 110.138 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 10.4 tt0 -89.05 -169.26 2.45 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.337 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.537 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -158.57 46.17 0.31 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.872 -174.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.5 m -114.39 158.44 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -12.65 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.084 0 CA-C-N 110.883 -2.871 . . . . 0.0 114.009 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 27' ' ' LYS . . . -179.77 -99.11 0.12 Allowed Glycine 0 N--CA 1.496 2.652 1 N-CA-C 132.148 7.619 . . . . 0.0 132.148 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -161.17 28.37 0.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.003 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.962 ' HA2' HD22 ' A' ' 12' ' ' ASN . . . 13.64 73.29 0.01 OUTLIER Glycine 0 C--N 1.3 -1.462 1 N-CA-C 129.598 6.599 . . . . 0.0 129.598 177.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.92 130.31 64.07 Favored Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.188 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -76.23 106.13 2.21 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 121.392 1.394 . . . . 0.0 110.748 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 118.746 -1.181 . . . . 0.0 109.607 -179.68 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.732 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 9.3 m-85 -104.18 -112.57 0.24 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.419 0.628 . . . . 0.0 110.335 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.404 ' H ' ' HB3' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -146.94 169.18 19.71 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.661 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.4 127.24 35.8 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.103 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.7 m -46.86 155.37 0.26 Allowed 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.723 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.51 HG22 ' HZ3' ' A' ' 47' ' ' LYS . 1.7 t -147.97 16.68 1.09 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.822 175.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -163.06 131.82 3.97 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.08 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -55.41 153.3 7.54 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.4 174.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.42 -23.79 20.16 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 118.359 -1.877 . . . . 0.0 111.295 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' GLY . 13.1 mm-40 -54.76 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.254 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.866 HD21 ' C ' ' A' ' 26' ' ' ASN . 5.0 m-20 -176.67 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.166 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.732 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 6.0 mt -73.68 8.03 2.13 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.619 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.5 p -102.44 -179.97 4.13 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.622 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 15' ' ' LEU . 6.3 mt -79.41 71.61 5.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.739 1.257 . . . . 0.0 108.371 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 34.1 t -70.82 -77.58 0.09 Allowed 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.428 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 89.61 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 117.76 -1.576 . . . . 0.0 109.019 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.21 -142.47 44.64 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.631 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -0.05 30.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.124 0.964 . . . . 0.0 110.35 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -87.63 143.59 27.1 Favored 'General case' 0 C--N 1.26 -3.317 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.849 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 22' ' ' CYS . 8.0 t -88.75 142.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.095 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.672 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -77.69 -160.56 0.19 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.015 175.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -143.83 96.43 0.19 Allowed Glycine 0 C--O 1.186 -2.895 0 C-N-CA 117.904 -2.093 . . . . 0.0 108.862 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.686 ' HA ' HD22 ' A' ' 12' ' ' ASN . 0.0 OUTLIER -30.59 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -82.51 7.09 66.06 Favored Glycine 1 C--N 1.238 -4.903 0 N-CA-C 105.741 -2.944 . . . . 0.0 105.741 172.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.866 ' C ' HD21 ' A' ' 12' ' ' ASN . 64.6 m-20 -121.97 -156.44 0.69 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.477 -1.362 . . . . 0.0 108.6 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.694 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -152.31 103.29 2.83 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.645 176.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 42.1 t -78.31 162.75 26.27 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 117.521 -1.672 . . . . 0.0 108.876 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.694 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 22.2 mm -149.88 121.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.386 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 9' ' ' SER . 12.3 mt . . . . . 0 N--CA 1.506 2.33 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.988 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.819 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.141 0.496 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.819 ' N ' HD22 ' A' ' 37' ' ' ASN . 9.9 tt0 -122.08 159.77 26.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -122.69 66.58 0.95 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -176.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -90.41 121.59 40.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.425 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -37.55 173.47 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.89 177.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' N ' ' HA ' ' A' ' 26' ' ' ASN . . . 126.44 -105.54 0.79 Allowed Glycine 0 N--CA 1.484 1.871 1 N-CA-C 128.411 6.124 . . . . 0.0 128.411 -176.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -165.01 88.9 0.47 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.49 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' ASN . . . -102.23 -123.02 5.17 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.682 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.42 134.52 10.2 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.938 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -70.1 98.83 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 N-CA-C 109.683 -0.93 . . . . 0.0 109.683 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HZ3' HG22 ' A' ' 7' ' ' THR . 26.3 tttp . . . . . 0 N--CA 1.491 1.607 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.025 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.097 0.475 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.534 ' O ' HG23 ' A' ' 4' ' ' THR . 58.3 m-85 -102.93 -116.53 0.2 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.5 p -160.13 165.78 31.03 Favored 'General case' 0 C--N 1.257 -3.429 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.928 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.21 129.54 34.56 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.992 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' OE1' ' A' ' 11' ' ' GLN . 13.7 m -46.58 169.8 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 CA-C-O 122.639 1.209 . . . . 0.0 110.436 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -150.08 14.36 0.8 Allowed 'General case' 0 C--N 1.258 -3.388 0 CA-C-N 112.415 -2.175 . . . . 0.0 106.783 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -164.96 123.13 1.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.196 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.611 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -51.37 153.92 1.95 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.626 175.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 10.2 85.51 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' OE1' ' CB ' ' A' ' 6' ' ' CYS . 3.4 mt-30 -82.62 -166.45 1.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 14' ' ' CYS . 6.2 t-20 -135.64 -93.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.199 -1.8 . . . . 0.0 115.323 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 2.5 mt -75.13 40.32 0.15 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.804 -173.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -94.59 -160.94 0.81 Allowed 'General case' 0 C--O 1.18 -2.593 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.016 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.1 mt -109.04 81.2 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 m -76.35 -81.71 0.08 Allowed 'General case' 0 C--N 1.249 -3.768 0 CA-C-N 112.944 -1.934 . . . . 0.0 111.209 -174.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 4.0 mm-40 -78.36 107.22 10.83 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.86 -1.536 . . . . 0.0 109.238 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.93 11.86 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 2.15 15.25 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.26 1.029 . . . . 0.0 110.056 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.61 149.32 25.94 Favored 'General case' 0 C--N 1.259 -3.353 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.931 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 35.5 t -88.2 148.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 118.491 -1.283 . . . . 0.0 111.049 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.2 m -136.62 -166.64 1.93 Allowed 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 93.21 -43.39 2.54 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 117.336 -2.364 . . . . 0.0 111.748 175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.8 tt0 -59.04 105.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.081 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.06 -10.16 28.47 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -118.89 -165.23 1.11 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.428 -0.886 . . . . 0.0 111.653 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.545 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -156.69 112.76 2.98 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.004 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.58 152.01 28.8 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 118.304 -1.359 . . . . 0.0 110.857 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.545 HD11 ' CE ' ' A' ' 27' ' ' LYS . 31.8 mm -139.53 104.7 2.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.455 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 9' ' ' SER . 10.2 mt . . . . . 0 N--CA 1.509 2.477 0 C-N-CA 118.676 -1.21 . . . . 0.0 110.146 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.423 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 30.0 m-80 . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -87.37 166.37 14.9 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.842 -1.543 . . . . 0.0 107.6 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.3 m -133.34 71.31 1.46 Allowed 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -91.37 137.71 21.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.507 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.8 t -34.83 168.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.815 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 122.48 -146.14 16.65 Favored Glycine 0 N--CA 1.482 1.706 1 N-CA-C 130.014 6.766 . . . . 0.0 130.014 -178.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -161.89 119.55 2.21 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.553 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.84 -91.3 1.11 Allowed Glycine 0 N--CA 1.486 2.032 1 N-CA-C 129.742 6.657 . . . . 0.0 129.742 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.8 122.14 4.25 Favored Pre-proline 0 C--N 1.302 -1.5 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.356 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.2 Cg_endo -66.71 95.26 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.07 1.18 . . . . 0.0 109.638 177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' PRO . 11.9 tttt . . . . . 0 N--CA 1.497 1.918 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.211 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 4' ' ' THR . 5.8 m-85 -141.84 -114.01 0.12 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.967 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.0 p -163.79 176.51 9.46 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.272 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.48 132.48 35.01 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.584 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.33 149.26 7.62 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.975 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 7' ' ' THR . 1.9 t -148.69 18.34 1.02 Allowed 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -161.54 109.37 1.46 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.287 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.612 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -47.83 147.1 2.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.471 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 100.92 -5.82 56.59 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.791 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.634 HE21 ' HA ' ' A' ' 47' ' ' LYS . 61.4 mt-30 -85.57 -164.96 1.1 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.285 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.753 HD21 ' C ' ' A' ' 26' ' ' ASN . 35.5 m-20 -164.28 -43.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.806 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 51.7 mt -76.91 17.26 0.44 Allowed 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.051 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.2 p -108.43 176.93 4.94 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.457 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.2 mt -78.59 73.57 5.14 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 123.0 1.381 . . . . 0.0 108.16 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 32.1 t -67.79 -82.96 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.936 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.25 120.98 26.86 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.9 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.27 -115.94 6.36 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.036 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.93 5.59 5.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.753 1.263 . . . . 0.0 108.819 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -88.29 144.46 26.41 Favored 'General case' 0 C--N 1.262 -3.204 0 CA-C-N 112.342 -2.208 . . . . 0.0 112.256 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 22' ' ' CYS . 22.1 t -80.0 139.08 18.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.744 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.59 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -85.4 -140.64 0.08 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 118.416 -1.314 . . . . 0.0 109.371 175.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -157.65 111.89 0.5 Allowed Glycine 0 C--N 1.286 -2.233 0 C-N-CA 116.339 -2.839 . . . . 0.0 112.574 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.5 tt0 -36.21 152.06 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 113.482 -1.359 . . . . 0.0 108.448 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.88 -18.11 57.3 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.753 ' C ' HD21 ' A' ' 12' ' ' ASN . 5.3 t-20 -106.33 -161.83 0.82 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.989 -1.605 . . . . 0.0 107.081 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HA ' HD21 ' A' ' 12' ' ' ASN . 0.5 OUTLIER -160.35 101.96 1.39 Allowed 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.901 174.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.852 ' O ' HD13 ' A' ' 29' ' ' ILE . 22.2 m -78.64 155.71 29.4 Favored 'General case' 0 CA--C 1.46 -2.487 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.424 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.3 mm -136.3 108.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.649 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 9' ' ' SER . 18.0 mt . . . . . 0 N--CA 1.507 2.424 0 C-N-CA 118.155 -1.418 . . . . 0.0 108.394 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.601 ' HB3' HD23 ' A' ' 30' ' ' LEU . 2.8 p30 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.442 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 14.3 tt0 -83.46 -176.1 6.14 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -136.68 75.16 1.52 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -109.25 127.54 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.156 -1.418 . . . . 0.0 114.363 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.559 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 t -27.37 148.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 112.579 -2.1 . . . . 0.0 113.566 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.48 -101.37 0.19 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -98.61 -139.54 0.31 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.346 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 179.95 88.66 0.07 OUTLIER Glycine 0 C--N 1.28 -2.539 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.9 139.56 25.12 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.527 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -77.14 136.62 16.39 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.199 1.266 . . . . 0.0 109.16 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HA ' HE21 ' A' ' 11' ' ' GLN . 16.4 tttp . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 117.791 -1.564 . . . . 0.0 111.021 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 3' ' ' TYR . 21.9 t . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.623 ' N ' HG12 ' A' ' 2' ' ' VAL . 5.8 m-85 -137.99 -112.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.069 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -172.08 176.5 3.47 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.036 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.562 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.27 131.0 34.37 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.168 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -53.44 158.46 1.73 Allowed 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.734 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -140.16 8.99 2.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.125 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.501 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.7 mm-40 -161.0 143.98 12.84 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.52 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.03 147.92 45.64 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.658 175.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 27' ' ' LYS . . . 94.61 -7.44 71.14 Favored Glycine 0 N--CA 1.503 3.154 1 N-CA-C 126.736 5.454 . . . . 0.0 126.736 -172.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 75.9 mt-30 -83.67 -167.41 1.71 Allowed 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 114.283 -0.959 . . . . 0.0 111.09 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.746 HD21 ' C ' ' A' ' 26' ' ' ASN . 2.2 m-80 -156.38 -51.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.985 -1.486 . . . . 0.0 114.553 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 59.5 mt -76.09 13.69 0.84 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.618 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.5 p -110.13 177.8 4.6 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.73 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 15' ' ' LEU . 10.3 mt -77.77 75.92 4.31 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-O 122.811 1.291 . . . . 0.0 108.552 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.62 -80.43 0.08 Allowed 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.647 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.32 107.62 12.22 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.156 -1.418 . . . . 0.0 109.502 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.46 -144.02 48.74 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.176 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.26 5.06 48.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.38 1.086 . . . . 0.0 109.778 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -88.6 143.59 26.85 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.941 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 22' ' ' CYS . 11.4 t -83.76 139.28 17.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.277 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.625 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -78.47 -146.14 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.735 175.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.99 117.54 0.77 Allowed Glycine 0 C--N 1.278 -2.664 0 C-N-CA 117.451 -2.309 . . . . 0.0 110.67 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.5 tt0 -33.23 154.17 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.054 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.42 -6.31 82.36 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.746 ' C ' HD21 ' A' ' 12' ' ' ASN . 8.7 t30 -122.25 -164.16 1.14 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.929 -1.136 . . . . 0.0 108.493 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 40' ' ' VAL . 36.2 tttp -162.22 112.35 1.53 Allowed 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 11' ' ' GLN . 1.9 m -83.04 153.63 24.83 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.64 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.58 117.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.284 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 8' ' ' GLU . 19.1 mt . . . . . 0 N--CA 1.518 2.959 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 122.448 1.118 . . . . 0.0 113.92 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 12.7 tt0 -153.46 170.89 19.62 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.052 -1.885 . . . . 0.0 107.206 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.426 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -145.31 79.12 1.57 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.429 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.77 146.25 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 C-N-CA 117.776 -1.57 . . . . 0.0 114.879 -176.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -18.14 146.6 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 113.059 -1.882 . . . . 0.0 114.176 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.24 -120.94 1.02 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 7.4 mm-40 -78.67 -135.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.48 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 12' ' ' ASN . . . 162.03 97.44 0.12 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 144.83 55.16 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.422 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.23 126.07 8.93 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.356 1.371 . . . . 0.0 109.469 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 N--CA 1.489 1.505 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.992 -179.096 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.792 HG12 ' H ' ' A' ' 3' ' ' TYR . 3.5 t . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 120.941 0.4 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.792 ' H ' HG12 ' A' ' 2' ' ' VAL . 61.5 m-85 -106.06 -115.82 0.25 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.73 0.776 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -178.1 175.35 1.26 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.77 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 134.68 36.4 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.653 -176.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 92.7 m -47.8 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.662 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -138.05 3.14 2.4 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.725 -1.58 . . . . 0.0 107.992 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' C ' HD12 ' A' ' 30' ' ' LEU . 9.0 tt0 -171.16 136.55 1.07 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.424 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -51.27 157.88 0.89 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.468 178.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -20.97 46.7 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.663 -1.732 . . . . 0.0 112.629 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.15 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -161.65 21.9 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 115.668 -2.413 . . . . 0.0 115.285 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 3' ' ' TYR . 40.2 mt -146.71 25.88 1.16 Allowed 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -104.81 179.8 4.17 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.227 -176.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.635 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 mt -84.06 75.55 10.14 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.661 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 2.3 t -73.58 -68.99 0.46 Allowed 'General case' 0 C--N 1.254 -3.572 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.472 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -84.32 89.32 7.34 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.52 -133.22 25.47 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.045 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 -1.66 58.21 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.144 0.973 . . . . 0.0 110.412 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -81.49 137.88 35.55 Favored 'General case' 0 C--N 1.26 -3.301 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.48 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 22' ' ' CYS . 52.4 t -83.03 155.15 3.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.231 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' N ' HG12 ' A' ' 21' ' ' VAL . 10.9 m -145.19 -173.21 4.04 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 1.015 ' N ' HD22 ' A' ' 26' ' ' ASN . . . 99.31 -45.55 1.54 Allowed Glycine 0 C--O 1.206 -1.6 0 C-N-CA 117.547 -2.264 . . . . 0.0 114.611 173.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -63.48 115.89 5.07 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.586 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.92 -10.56 39.41 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 1.015 HD22 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -125.96 -158.24 0.84 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.919 -1.141 . . . . 0.0 111.417 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -154.82 124.36 6.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.527 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -78.82 155.13 29.35 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 117.54 -1.664 . . . . 0.0 109.5 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.581 HD11 ' CE ' ' A' ' 27' ' ' LYS . 15.2 mm -150.77 122.43 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.619 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.716 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 9' ' ' SER . 7.7 mt . . . . . 0 N--CA 1.495 1.808 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.186 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.672 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.809 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.606 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 40.2 tt0 -150.71 155.85 40.12 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.2 m -116.94 65.1 0.72 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -77.78 130.34 36.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 117.709 -1.597 . . . . 0.0 111.515 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.4 t -35.77 167.45 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.057 -1.883 . . . . 0.0 112.395 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 123.04 -133.93 9.28 Favored Glycine 0 N--CA 1.488 2.108 1 N-CA-C 130.387 6.915 . . . . 0.0 130.387 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -161.99 116.2 1.88 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.595 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.95 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.42 -1.372 . . . . 0.0 111.511 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -158.85 152.58 19.32 Favored Pre-proline 0 C--N 1.31 -1.136 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.404 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -72.3 116.29 4.65 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 121.212 1.275 . . . . 0.0 109.733 170.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tttp . . . . . 0 C--N 1.303 -1.441 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.702 -178.739 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 4' ' ' THR . 2.3 m-85 -132.06 -111.84 0.24 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.813 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.7 p -162.34 177.31 9.69 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.809 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.55 134.02 34.32 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.678 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 m -52.54 155.48 2.16 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.052 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -140.54 9.73 2.24 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.688 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.668 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.0 mm-40 -163.33 139.85 7.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.838 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.435 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.87 156.92 6.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.496 176.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 85.18 0.66 88.67 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.086 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.417 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 27.2 mt-30 -84.4 -177.37 6.61 Favored 'General case' 0 N--CA 1.514 2.768 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.175 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.819 HD21 ' C ' ' A' ' 26' ' ' ASN . 2.3 m-20 -151.81 -50.88 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 117.978 -1.489 . . . . 0.0 114.394 -177.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 87.1 mt -75.99 17.99 0.3 Allowed 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.299 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.528 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.7 p -110.35 178.92 4.23 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.45 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.6 mt -79.94 73.0 6.72 Favored 'General case' 0 CA--C 1.465 -2.289 0 CA-C-O 122.843 1.306 . . . . 0.0 108.552 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 94.4 m -69.94 -93.41 0.01 OUTLIER 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.28 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.09 116.55 13.76 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.394 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.28 -139.63 42.28 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.796 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 6.31 45.21 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.526 1.155 . . . . 0.0 108.992 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.88 144.7 28.23 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.305 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.9 t -85.12 138.93 18.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 118.154 -1.418 . . . . 0.0 109.556 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -77.33 -140.18 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.954 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.45 122.19 1.03 Allowed Glycine 0 C--N 1.275 -2.837 0 C-N-CA 117.303 -2.379 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.603 ' HA ' HD22 ' A' ' 12' ' ' ASN . 4.4 tt0 -34.41 157.17 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.579 -1.31 . . . . 0.0 110.028 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -18.35 21.52 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.819 ' C ' HD21 ' A' ' 12' ' ' ASN . 13.0 t30 -104.19 -164.39 1.05 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.915 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.631 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -161.67 102.77 1.19 Allowed 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.046 -1.461 . . . . 0.0 111.65 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -79.84 153.6 28.97 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.45 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.631 HD11 ' CE ' ' A' ' 27' ' ' LYS . 33.4 mm -134.71 115.58 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.893 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.668 HD12 ' C ' ' A' ' 8' ' ' GLU . 10.6 mt . . . . . 0 N--CA 1.504 2.233 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.642 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.682 HD22 ' N ' ' A' ' 38' ' ' GLN . 1.2 t-20 . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.571 0.701 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.682 ' N ' HD22 ' A' ' 37' ' ' ASN . 38.6 tt0 -144.1 171.0 14.89 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 73.21 1.52 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -113.11 130.3 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -172.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.9 t -22.71 155.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.573 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.35 -123.56 1.93 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -76.85 -131.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.393 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.574 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 157.2 80.09 0.03 OUTLIER Glycine 0 C--N 1.282 -2.431 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.933 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.36 131.52 42.08 Favored Pre-proline 0 CA--C 1.559 1.29 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.871 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.65 119.56 6.5 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.123 1.215 . . . . 0.0 110.928 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.562 1.406 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.539 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 3' ' ' TYR . 20.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.937 0.399 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.598 ' N ' HG12 ' A' ' 2' ' ' VAL . 26.8 m-85 -103.82 -113.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.1 p -159.0 169.17 24.91 Favored 'General case' 0 C--N 1.261 -3.28 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.992 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.47 130.2 34.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.69 -1.204 . . . . 0.0 111.103 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.434 ' CB ' HD11 ' A' ' 30' ' ' LEU . 43.7 m -47.4 171.61 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.331 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -144.33 8.1 1.37 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.704 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.746 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.6 tt0 -170.49 139.24 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.4 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.476 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -52.97 159.31 1.19 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.79 176.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.61 50.01 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.037 -1.554 . . . . 0.0 112.461 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.47 -173.06 3.88 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.496 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 14' ' ' CYS . 69.6 m-80 -155.77 -45.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.72 -1.592 . . . . 0.0 113.937 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 3' ' ' TYR . 45.5 mt -76.59 16.24 0.52 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.163 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -100.4 -170.1 1.82 Allowed 'General case' 0 C--O 1.181 -2.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.64 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 mt -91.52 71.38 5.94 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.8 t -64.2 -84.4 0.02 OUTLIER 'General case' 0 C--N 1.254 -3.554 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.929 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.451 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 tm-20 -69.88 88.0 0.55 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.067 -1.453 . . . . 0.0 109.227 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.49 -130.9 18.76 Favored Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.399 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.96 0.75 57.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.184 0.992 . . . . 0.0 110.38 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -90.41 147.18 23.59 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.065 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 23.6 t -85.99 147.16 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 117.979 -1.488 . . . . 0.0 110.813 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.415 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -76.29 -129.91 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.36 115.45 0.57 Allowed Glycine 0 C--N 1.276 -2.751 0 C-N-CA 117.871 -2.109 . . . . 0.0 110.892 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 12.4 tt0 -34.44 149.22 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.279 -0.96 . . . . 0.0 109.905 177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.39 -10.89 65.07 Favored Glycine 0 C--N 1.292 -1.906 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 43' ' ' GLU . 20.4 t30 -108.09 -162.9 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 40' ' ' VAL . 50.4 tttp -154.24 104.26 2.59 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.74 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 52.6 t -77.4 159.57 29.36 Favored 'General case' 0 CA--C 1.462 -2.425 0 C-N-CA 117.01 -1.876 . . . . 0.0 109.284 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.9 mm -137.23 115.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.132 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.746 HD12 ' C ' ' A' ' 8' ' ' GLU . 18.9 mt . . . . . 0 N--CA 1.497 1.898 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.575 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.742 0 CA-C-O 121.75 0.785 . . . . 0.0 112.603 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 15.7 tt0 -155.02 164.35 39.01 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -130.11 75.72 1.67 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.572 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -119.32 130.42 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.569 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.419 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 8.1 t -51.09 154.56 1.52 Allowed 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.388 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.06 -24.32 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.117 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . 3.3 tt0 -162.89 -143.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.367 0.603 . . . . 0.0 110.265 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -179.2 85.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.757 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.72 107.1 58.67 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 Cg_endo -68.68 92.9 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.7 tmtm? . . . . . 0 N--CA 1.491 1.607 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.668 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.924 0.392 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.66 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 69.4 m-85 -139.68 -121.95 0.12 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.64 0.733 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 3.0 t 177.99 -177.77 0.22 Allowed 'General case' 0 C--N 1.259 -3.332 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.823 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.32 133.09 36.61 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.521 -177.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 86.7 m -46.14 169.1 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.089 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.534 HG22 HE22 ' A' ' 11' ' ' GLN . 5.5 t -155.27 17.3 0.41 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.921 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 2.0 tt0 -167.31 124.14 1.18 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.905 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.598 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -55.78 151.64 10.9 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.646 177.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.86 -16.53 59.19 Favored Glycine 0 C--N 1.282 -2.439 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.25 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.534 HE22 HG22 ' A' ' 7' ' ' THR . 17.5 mt-30 -60.23 179.21 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.507 ' HB3' ' H ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -161.3 25.55 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 115.523 -2.471 . . . . 0.0 115.352 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 34.6 mt -147.61 26.74 1.02 Allowed 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.46 177.74 4.7 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.373 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.644 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 mt -80.38 70.86 7.13 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.054 -1.884 . . . . 0.0 107.408 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 41.4 m -73.28 -61.9 1.66 Allowed 'General case' 1 C--N 1.239 -4.211 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.541 -173.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.6 88.92 7.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.075 -1.45 . . . . 0.0 109.526 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.47 -105.37 1.77 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.112 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.42 -2.5 11.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.229 1.014 . . . . 0.0 110.485 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.77 139.99 30.17 Favored 'General case' 0 C--N 1.254 -3.583 0 CA-C-N 113.326 -1.761 . . . . 0.0 111.419 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 42.6 t -79.25 151.15 4.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 117.723 -1.591 . . . . 0.0 109.314 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 86.4 m -140.49 -173.75 3.77 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 102.74 -49.87 0.95 Allowed Glycine 0 C--O 1.2 -2.002 0 C-N-CA 117.496 -2.287 . . . . 0.0 114.263 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 26' ' ' ASN . 9.7 tm0? -63.78 115.14 4.52 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.493 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.42 52.59 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.98 -163.7 1.33 Allowed 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.156 -1.022 . . . . 0.0 111.623 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.717 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -158.21 133.08 8.44 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.092 175.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.9 m -90.2 149.97 22.18 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.005 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.717 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 32.1 mm -140.35 111.86 4.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.795 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 9' ' ' SER . 8.9 mt . . . . . 0 N--CA 1.499 1.977 0 C-N-CA 118.341 -1.343 . . . . 0.0 109.208 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.761 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.747 0 CA-C-O 121.383 0.611 . . . . 0.0 109.62 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -79.3 172.93 13.12 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.486 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.0 m -134.03 62.46 1.65 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -79.45 135.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 117.913 -1.515 . . . . 0.0 111.931 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.7 t -38.8 165.13 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.332 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.02 -151.73 17.83 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -143.07 124.48 14.72 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.524 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.3 -113.02 3.75 Favored Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.775 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.507 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -151.83 149.1 22.95 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.056 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.33 115.25 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.333 1.355 . . . . 0.0 110.546 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.522 ' HG2' HE21 ' A' ' 11' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.408 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.632 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.504 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -142.59 -113.75 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.914 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.3 p -159.31 173.42 16.31 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.506 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.56 132.18 34.14 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.564 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.1 155.12 2.0 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.218 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -148.13 14.92 1.03 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.007 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.624 ' C ' HD12 ' A' ' 30' ' ' LEU . 19.9 mt-10 -161.52 127.04 3.63 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.619 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.586 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -53.5 158.24 1.84 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.088 177.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 79.67 11.21 84.96 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.582 -1.77 . . . . 0.0 110.435 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.793 HE21 ' CB ' ' A' ' 47' ' ' LYS . 1.8 tp60 -74.71 -164.63 0.29 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.269 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 14' ' ' CYS . 9.8 m-20 -162.86 -69.36 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 117.914 -1.515 . . . . 0.0 113.93 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 72.0 mt -76.3 19.72 0.24 Allowed 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.538 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 22.7 p -103.55 177.99 4.68 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.372 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.3 mt -79.85 70.74 6.46 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 122.829 1.299 . . . . 0.0 107.765 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.623 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 39.5 t -69.21 -74.45 0.13 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.583 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.72 130.5 40.65 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.411 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 23.61 -91.26 0.01 OUTLIER Glycine 0 N--CA 1.503 3.155 1 N-CA-C 127.198 5.639 . . . . 0.0 127.198 -174.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.09 2.56 10.42 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.926 1.346 . . . . 0.0 107.864 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -89.73 143.01 27.15 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.882 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.7 t -84.35 143.5 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.241 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -71.85 -142.43 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.06 115.44 0.57 Allowed Glycine 0 C--N 1.279 -2.619 0 C-N-CA 117.314 -2.374 . . . . 0.0 110.844 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.3 tt0 -34.87 155.21 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.39 -0.905 . . . . 0.0 109.478 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.81 -16.33 55.02 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 106.452 -2.659 . . . . 0.0 106.452 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.817 HD21 ' C ' ' A' ' 39' ' ' CYS . 14.2 t30 -106.72 -156.55 0.58 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.081 -1.06 . . . . 0.0 108.776 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.69 ' CE ' HD11 ' A' ' 29' ' ' ILE . 1.2 ttpp -159.63 103.54 1.56 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.538 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 42.7 t -78.28 156.98 29.38 Favored 'General case' 0 CA--C 1.462 -2.41 0 C-N-CA 116.808 -1.957 . . . . 0.0 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.69 HD11 ' CE ' ' A' ' 27' ' ' LYS . 24.3 mm -145.62 118.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.772 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.078 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 8' ' ' GLU . 12.8 mt . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.673 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.728 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.716 0 CA-C-O 121.2 0.524 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.682 ' N ' HD22 ' A' ' 37' ' ' ASN . 9.0 tt0 -119.95 164.08 16.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.817 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.5 OUTLIER -123.57 71.48 1.09 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -101.3 124.72 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -171.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 11.3 t -18.69 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 112.416 -2.174 . . . . 0.0 113.168 171.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.75 -155.73 20.74 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.54 98.32 5.18 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -91.93 -115.79 2.12 Favored Glycine 0 C--O 1.215 -1.042 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.653 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -164.84 150.96 9.03 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.565 -177.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -76.97 132.87 13.21 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.751 1.634 . . . . 0.0 110.057 170.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.793 ' CB ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.556 1.191 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.775 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 3' ' ' TYR . 15.5 t . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.732 ' H ' HG12 ' A' ' 2' ' ' VAL . 16.9 m-85 -140.3 -114.73 0.14 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.688 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 3' ' ' TYR . 11.1 p -158.13 175.25 14.03 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.211 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.18 132.05 36.94 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.273 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.07 151.09 2.81 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.082 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -138.13 8.03 2.69 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.994 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.557 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mt-10 -166.79 132.88 2.29 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.409 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.682 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.94 154.38 0.74 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.568 177.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 87.87 11.23 68.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.41 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -82.99 -170.09 2.85 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.786 177.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.6 m120 -151.94 -73.51 0.15 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 118.406 -1.318 . . . . 0.0 113.365 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.552 HD13 ' CE1' ' A' ' 3' ' ' TYR . 51.8 mt -74.57 27.85 0.08 Allowed 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.176 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 20.9 p -105.55 177.29 4.89 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.598 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.4 mt -79.91 73.23 6.69 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.992 1.377 . . . . 0.0 107.629 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 76.2 m -69.52 -78.82 0.07 Allowed 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 111.864 -2.426 . . . . 0.0 110.869 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.22 107.36 9.55 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.544 -1.263 . . . . 0.0 109.867 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -115.05 6.83 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.95 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.93 0.6 11.93 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.361 1.077 . . . . 0.0 110.033 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.67 146.51 25.67 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.856 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 22' ' ' CYS . 22.1 t -82.75 140.29 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 C-N-CA 118.367 -1.333 . . . . 0.0 110.014 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.541 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -83.17 -138.8 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.95 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -166.31 121.25 0.97 Allowed Glycine 0 C--N 1.272 -3.008 0 C-N-CA 117.839 -2.124 . . . . 0.0 110.008 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.9 tt0 -34.65 159.44 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.081 -1.06 . . . . 0.0 110.251 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.0 -16.4 58.67 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.6 t30 -105.91 -161.22 0.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.873 -1.163 . . . . 0.0 108.864 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -160.95 96.42 1.11 Allowed 'General case' 0 C--N 1.28 -2.453 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.24 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.78 133.9 37.05 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 117.642 -1.623 . . . . 0.0 109.635 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -122.98 120.46 60.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.646 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 9' ' ' SER . 22.6 mt . . . . . 0 N--CA 1.504 2.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.162 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.949 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.648 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.949 ' N ' HD22 ' A' ' 37' ' ' ASN . 5.5 tt0 -117.2 -179.93 3.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -145.55 78.85 1.56 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.508 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -114.74 131.51 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 C-N-CA 118.331 -1.347 . . . . 0.0 114.635 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.563 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -9.41 143.77 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.263 171.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.03 -145.71 15.3 Favored Glycine 0 N--CA 1.489 2.225 1 N-CA-C 131.067 7.187 . . . . 0.0 131.067 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -146.87 84.77 1.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.719 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -107.88 2.43 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.232 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -161.64 145.56 9.69 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.99 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.09 105.5 2.08 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.52 1.48 . . . . 0.0 110.496 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 N--CA 1.497 1.888 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.714 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 3' ' ' TYR . 12.4 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.575 ' H ' HG12 ' A' ' 2' ' ' VAL . 60.0 m-85 -130.23 -118.29 0.23 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.67 0.748 . . . . 0.0 110.478 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.584 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -179.17 178.06 0.75 Allowed 'General case' 0 C--N 1.259 -3.367 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.643 -178.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.584 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.94 132.95 35.27 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.986 0.898 . . . . 0.0 112.119 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -52.96 154.49 2.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.843 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.683 HG22 ' HE2' ' A' ' 47' ' ' LYS . 6.9 t -139.38 11.27 2.54 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.979 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.687 ' C ' HD12 ' A' ' 30' ' ' LEU . 13.6 tt0 -166.34 125.39 1.54 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.272 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.713 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -45.14 155.58 0.12 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.819 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.08 -18.71 56.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 22.4 mt-30 -79.71 -175.66 4.97 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.91 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 14' ' ' CYS . 65.8 m-80 -152.2 -48.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 117.68 -1.608 . . . . 0.0 114.126 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 46' ' ' PRO . 29.0 mt -75.35 17.73 0.25 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.8 p -103.25 175.73 5.38 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.962 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.1 mt -78.88 73.19 5.43 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 122.959 1.362 . . . . 0.0 108.284 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.61 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 35.8 t -72.8 -82.24 0.05 Allowed 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 112.11 -2.314 . . . . 0.0 109.816 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.71 97.76 3.3 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 117.452 -1.699 . . . . 0.0 109.129 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 20' ' ' ASN . . . 64.65 -148.78 51.38 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.217 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.86 3.54 16.61 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.358 1.075 . . . . 0.0 109.553 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -87.14 143.07 27.47 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.79 -178.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 22' ' ' CYS . 4.6 t -84.49 144.91 8.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.51 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -73.09 -137.33 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.13 109.11 0.35 Allowed Glycine 0 C--N 1.282 -2.457 0 C-N-CA 117.414 -2.327 . . . . 0.0 111.128 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.9 tm0? -34.36 150.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.36 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.417 ' N ' HE21 ' A' ' 24' ' ' GLN . . . 89.45 -15.95 57.37 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -173.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 16.3 t30 -106.5 -161.34 0.79 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 40' ' ' VAL . 49.0 tttp -155.42 105.82 2.5 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.357 175.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.609 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 51.9 t -76.34 158.17 31.72 Favored 'General case' 0 CA--C 1.462 -2.408 0 C-N-CA 116.845 -1.942 . . . . 0.0 108.718 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.1 mm -138.13 115.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.082 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.679 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 9' ' ' SER . 13.7 mt . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.215 176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.78 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.679 0 CA-C-O 121.008 0.432 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.78 ' N ' HD22 ' A' ' 37' ' ' ASN . 9.2 tt0 -128.78 166.43 19.02 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -126.04 72.24 1.29 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -115.45 130.68 69.63 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.167 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.117 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 5.3 t -42.58 159.72 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.844 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.4 -103.26 0.22 Allowed Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.854 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.522 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -79.15 -148.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.022 0.439 . . . . 0.0 109.949 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.57 80.57 0.06 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.54 126.72 28.27 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.934 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.454 ' HA ' HD12 ' A' ' 13' ' ' LEU . 6.4 Cg_endo -73.39 115.67 4.42 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 121.409 1.406 . . . . 0.0 111.734 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HE2' HG22 ' A' ' 7' ' ' THR . 19.5 tptp . . . . . 0 CA--C 1.565 1.529 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.105 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 3' ' ' TYR . 8.8 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.574 ' H ' HG12 ' A' ' 2' ' ' VAL . 12.1 m-85 -115.77 -116.46 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.388 0.614 . . . . 0.0 110.709 -177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' TYR . 6.0 p -152.1 172.74 15.86 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.534 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 131.08 34.88 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.96 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -49.08 150.77 1.49 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.771 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -141.24 12.94 2.19 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -165.25 125.59 1.89 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.572 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.77 159.8 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.237 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.77 -5.91 72.65 Favored Glycine 0 N--CA 1.505 3.288 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.327 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -70.43 -176.48 1.24 Allowed 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.573 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' CYS . 5.2 m120 -148.29 -64.22 0.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.562 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 9.6 mt -73.06 22.53 0.07 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.899 -177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ASN . 17.2 p -104.96 176.76 5.05 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.28 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.1 mt -82.65 70.82 9.7 Favored 'General case' 0 C--N 1.27 -2.884 0 CA-C-O 122.703 1.239 . . . . 0.0 107.859 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.9 t -67.51 -88.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.258 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -73.43 109.2 6.77 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.064 -1.854 . . . . 0.0 109.849 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.43 -132.19 24.96 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.51 4.91 36.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.741 1.258 . . . . 0.0 108.549 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -87.69 149.81 24.02 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.374 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.4 t -87.51 141.2 14.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.123 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.65 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -74.46 -141.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.381 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.866 ' CA ' HD21 ' A' ' 26' ' ' ASN . . . -164.23 101.98 0.19 Allowed Glycine 0 N--CA 1.504 3.175 0 C-N-CA 115.608 -3.187 . . . . 0.0 112.98 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLY . 13.6 tm0? -27.45 114.63 0.07 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.519 1.152 . . . . 0.0 110.558 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.03 -16.82 5.48 Favored Glycine 0 C--N 1.28 -2.561 0 N-CA-C 105.263 -3.135 . . . . 0.0 105.263 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.866 HD21 ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.63 -171.41 1.98 Allowed 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.8 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 20.5 tttp -143.93 99.64 3.43 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.579 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 48.6 t -76.93 163.63 26.55 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.361 -1.736 . . . . 0.0 108.716 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.8 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 19.3 mm -147.36 118.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.102 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.503 2.216 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.297 177.677 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.864 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.699 0 CA-C-O 121.162 0.506 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.864 ' N ' HD22 ' A' ' 37' ' ' ASN . 11.6 tt0 -124.76 163.36 22.27 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -124.05 65.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 t -89.44 131.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.914 -1.514 . . . . 0.0 111.816 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 42' ' ' GLY . 1.9 t -44.83 170.45 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.55 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 131.89 -111.64 1.08 Allowed Glycine 0 N--CA 1.494 2.502 1 N-CA-C 130.141 6.816 . . . . 0.0 130.141 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASN . 37.1 mt-10 -77.14 -144.53 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.092 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.2 96.3 0.1 Allowed Glycine 0 C--N 1.288 -2.123 0 C-N-CA 118.263 -1.922 . . . . 0.0 112.236 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.72 123.44 34.73 Favored Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.82 176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.67 118.09 4.73 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.489 1.46 . . . . 0.0 110.561 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 tttp . . . . . 0 CA--C 1.562 1.425 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.686 179.148 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 HE22 ' A' ' 11' ' ' GLN . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.698 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 2.4 t30 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.698 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' SER . 11.3 mt . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.763 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.653 ' N ' HD22 ' A' ' 37' ' ' ASN . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.535 ' C ' HD21 ' A' ' 26' ' ' ASN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' C ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 3' ' ' TYR . 22.8 t . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.701 ' H ' HG12 ' A' ' 2' ' ' VAL . 19.6 m-85 -147.61 -114.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.461 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 3' ' ' TYR . 5.0 p -162.55 172.92 14.69 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.436 -178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.26 126.81 33.07 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.581 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 178.33 0.09 Allowed 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 122.781 1.277 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -151.96 18.32 0.68 Allowed 'General case' 0 C--N 1.258 -3.412 0 CA-C-N 111.923 -2.399 . . . . 0.0 106.311 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.625 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.6 mt-10 -161.43 134.27 6.17 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 117.73 -1.588 . . . . 0.0 114.789 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.469 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -63.59 154.23 33.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.507 172.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.25 -20.9 40.61 Favored Glycine 0 C--N 1.287 -2.143 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.953 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.793 HE21 ' HB2' ' A' ' 47' ' ' LYS . 4.2 mt-30 -82.59 -174.03 4.97 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.908 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.6 -36.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.609 -176.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 61.0 mt -76.11 11.5 1.46 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.501 -1.28 . . . . 0.0 110.187 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.498 ' H ' ' C ' ' A' ' 12' ' ' ASN . 5.1 p -104.08 174.58 5.81 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.07 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.1 mt -78.07 74.77 4.61 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 122.855 1.312 . . . . 0.0 108.208 -177.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.829 ' C ' HD21 ' A' ' 37' ' ' ASN . 3.5 t -71.02 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 111.803 -2.453 . . . . 0.0 110.076 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 3.9 mm-40 -76.04 121.46 22.79 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.709 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.33 -144.93 23.79 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.482 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.24 4.16 53.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.589 1.185 . . . . 0.0 109.139 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -83.31 146.55 28.45 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.742 -2.026 . . . . 0.0 111.403 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 22' ' ' CYS . 10.9 t -82.32 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.529 -1.268 . . . . 0.0 110.342 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -74.6 -130.43 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 174.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -168.37 109.93 0.36 Allowed Glycine 0 C--N 1.276 -2.793 0 C-N-CA 118.315 -1.898 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 10.8 tt0 -35.11 154.38 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.032 178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -17.25 27.36 Favored Glycine 0 C--N 1.29 -1.987 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 39' ' ' CYS . 27.6 t30 -96.56 -157.96 0.62 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.549 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -159.07 98.67 1.47 Allowed 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.702 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.898 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.2 t -78.23 166.03 23.21 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.199 -1.8 . . . . 0.0 110.541 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.6 mm -137.89 108.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.003 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 8' ' ' GLU . 96.1 mt . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.121 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.829 HD21 ' C ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 tt0 -79.88 164.53 23.49 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.211 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.78 65.65 1.03 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -105.3 127.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 118.226 -1.39 . . . . 0.0 113.121 -172.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.428 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 5.5 t -53.98 156.41 2.96 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.505 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.63 -62.89 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.763 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.588 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -121.93 -141.32 0.33 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.639 0.733 . . . . 0.0 110.728 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.588 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -172.66 70.53 0.1 Allowed Glycine 0 N--CA 1.493 2.456 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.81 109.29 60.86 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.737 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.12 121.79 7.54 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.201 1.267 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.793 ' HB2' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.614 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.268 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 120.883 0.373 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.562 ' O ' HG23 ' A' ' 4' ' ' THR . 45.1 m-85 -131.54 -117.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 3' ' ' TYR . 3.0 p -161.45 166.54 27.1 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.821 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.74 127.74 33.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.029 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.9 m -44.91 154.09 0.15 Allowed 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.861 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -149.78 18.8 0.9 Allowed 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.591 174.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -164.73 120.07 1.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.967 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.482 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -49.21 154.15 0.87 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.147 178.143 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.93 -1.89 85.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.367 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.861 HE22 ' H ' ' A' ' 7' ' ' THR . 6.1 mt-30 -73.95 -172.29 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.115 -1.434 . . . . 0.0 108.28 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.729 HD21 ' H ' ' A' ' 44' ' ' GLY . 5.1 m-20 -136.77 -82.04 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 117.516 -1.674 . . . . 0.0 115.282 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 19.9 mt -73.16 34.64 0.08 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.347 -172.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 27.1 p -103.07 174.42 5.88 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.26 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.0 mt -84.81 77.69 10.03 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.839 1.304 . . . . 0.0 108.505 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.9 m -73.5 -87.45 0.03 OUTLIER 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.442 -176.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.93 107.51 7.05 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.668 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.4 -147.29 50.62 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.909 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -87.52 4.69 42.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.278 1.037 . . . . 0.0 110.1 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.46 140.25 32.45 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 113.268 -1.787 . . . . 0.0 111.642 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 36.7 t -82.91 155.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.334 -1.347 . . . . 0.0 109.91 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.535 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.5 m -141.41 -163.79 1.63 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.894 ' H ' HD22 ' A' ' 26' ' ' ASN . . . 105.61 -60.32 0.39 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 118.094 -2.003 . . . . 0.0 112.973 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 8.7 tt0 -66.8 110.32 3.24 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.131 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 -7.34 76.32 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.894 HD22 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.01 -171.19 2.56 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.919 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -155.4 114.01 3.5 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.028 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.1 m -82.96 149.8 26.79 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.064 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' CE ' ' A' ' 27' ' ' LYS . 35.5 mm -138.5 118.3 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.858 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 9' ' ' SER . 13.7 mt . . . . . 0 N--CA 1.502 2.173 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.799 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.696 HD22 ' N ' ' A' ' 38' ' ' GLN . 1.3 t-20 . . . . . 0 C--O 1.215 -0.749 0 CA-C-O 121.247 0.546 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.696 ' N ' HD22 ' A' ' 37' ' ' ASN . 8.2 tt0 -146.45 174.19 11.62 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.66 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.79 61.54 1.65 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -80.05 129.88 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.309 -172.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.9 t -25.91 156.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.875 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.97 -139.6 11.56 Favored Glycine 0 N--CA 1.492 2.423 1 N-CA-C 131.506 7.362 . . . . 0.0 131.506 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.56 109.51 3.28 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.729 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -107.07 -110.25 3.45 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.858 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.02 139.41 7.31 Favored Pre-proline 0 C--N 1.299 -1.596 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.473 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.0 Cg_exo -58.63 125.76 19.29 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 N-CA-C 109.41 -1.035 . . . . 0.0 109.41 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.5 tmtt? . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.827 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' ' 3' ' ' TYR . 43.4 t . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.689 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.9 m-85 -108.66 -117.74 0.27 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.681 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 3' ' ' TYR . 6.7 p -161.21 174.29 13.84 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.897 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.33 131.74 35.68 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -48.85 158.81 0.29 Allowed 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.902 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -145.8 13.74 1.34 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.991 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -166.96 121.23 1.04 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.815 -177.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.475 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.55 156.6 0.43 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.266 176.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.27 -23.26 28.11 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.057 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' GLY . 11.1 mm-40 -54.07 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.568 -179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.21 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.519 -1.672 . . . . 0.0 114.28 177.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.628 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 19.9 mt -130.52 11.56 5.33 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 26.5 p -102.78 178.23 4.62 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.319 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.7 mt -77.09 73.09 3.68 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 123.057 1.408 . . . . 0.0 107.656 -178.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 31.7 t -77.14 -75.86 0.19 Allowed 'General case' 0 C--N 1.254 -3.558 0 CA-C-N 111.863 -2.426 . . . . 0.0 110.507 -175.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.415 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.94 -126.25 26.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -1.74 24.13 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.678 1.227 . . . . 0.0 108.703 178.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -83.26 151.7 25.5 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.865 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 43.3 t -81.21 149.21 5.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.301 -1.359 . . . . 0.0 111.273 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -73.74 -140.78 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 175.288 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.24 110.48 0.4 Allowed Glycine 0 C--N 1.281 -2.501 0 C-N-CA 117.488 -2.291 . . . . 0.0 111.135 176.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.687 HE21 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -32.69 145.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.489 -0.856 . . . . 0.0 110.515 177.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.687 ' N ' HE21 ' A' ' 24' ' ' GLN . . . 96.17 -2.79 63.77 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 -174.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.713 HD21 ' C ' ' A' ' 39' ' ' CYS . 8.9 t30 -117.1 -157.91 0.68 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.952 -1.124 . . . . 0.0 109.188 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HE3' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -160.68 102.85 1.35 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.665 176.55 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 10' ' ' GLY . 43.9 t -78.35 165.9 23.29 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 117.7 -1.6 . . . . 0.0 110.146 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.525 HD11 ' HE3' ' A' ' 27' ' ' LYS . 11.8 mm -149.12 120.25 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.409 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 9' ' ' SER . 23.7 mt . . . . . 0 N--CA 1.497 1.876 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.442 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.512 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.7 0 CA-C-O 121.407 0.622 . . . . 0.0 110.595 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.534 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -105.76 164.83 11.62 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.233 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.713 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.8 OUTLIER -121.2 71.67 0.96 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -177.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -96.55 120.85 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 118.194 -1.402 . . . . 0.0 114.78 -171.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.1 t -19.75 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 112.456 -2.156 . . . . 0.0 113.781 171.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.24 -151.01 20.15 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.25 122.86 7.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.187 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 -95.56 0.19 Allowed Glycine 0 N--CA 1.478 1.493 1 N-CA-C 131.52 7.368 . . . . 0.0 131.52 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.0 104.48 20.59 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.529 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -70.41 103.36 1.26 Allowed 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.003 1.135 . . . . 0.0 110.484 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.571 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.596 ' CE2' HD13 ' A' ' 13' ' ' LEU . 13.9 m-85 -140.63 -112.93 0.14 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.886 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.54 171.85 17.48 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.003 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -94.46 133.67 37.81 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.283 -177.55 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -56.4 156.59 5.79 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.84 176.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -143.08 9.38 1.69 Allowed 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.71 173.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.588 ' C ' HD12 ' A' ' 30' ' ' LEU . 12.3 mt-10 -164.95 145.96 7.58 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.502 -179.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.541 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -59.67 152.72 21.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.532 176.448 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 97.7 -17.65 58.55 Favored Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.137 -1.506 . . . . 0.0 112.376 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.437 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 10.3 mm-40 -61.41 -166.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.022 -179.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.776 HD22 ' HA ' ' A' ' 24' ' ' GLN . 1.7 m-20 -158.48 -68.18 0.09 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.748 -178.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.596 HD13 ' CE2' ' A' ' 3' ' ' TYR . 96.1 mt -75.63 18.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.277 -176.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.4 p -100.39 175.96 5.52 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.731 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.449 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.6 mt -79.87 73.53 6.62 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.793 1.282 . . . . 0.0 108.417 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 43.4 t -72.32 -83.41 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 112.39 -2.186 . . . . 0.0 110.226 -177.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -75.2 110.82 9.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.341 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.04 -139.91 43.1 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -95.68 3.7 53.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.54 1.162 . . . . 0.0 109.276 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-N 112.898 -1.956 . . . . 0.0 111.467 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.8 t -80.18 144.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -78.67 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.429 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -146.31 96.01 0.18 Allowed Glycine 0 C--N 1.282 -2.463 1 N-CA-C 129.618 6.607 . . . . 0.0 129.618 179.074 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.776 ' HA ' HD22 ' A' ' 12' ' ' ASN . 35.2 tp60 -33.88 121.48 0.44 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.658 178.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.06 -6.77 34.95 Favored Glycine 0 C--N 1.291 -1.968 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 -172.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.599 ' C ' HD21 ' A' ' 12' ' ' ASN . 13.5 t30 -118.22 -167.61 1.38 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.316 -0.942 . . . . 0.0 109.292 177.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.637 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -142.1 106.41 4.8 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.267 176.206 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLY . 7.9 t -76.11 158.55 31.65 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 116.413 -2.115 . . . . 0.0 108.262 177.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.637 HD11 ' CE ' ' A' ' 27' ' ' LYS . 14.6 mm -147.11 124.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.274 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 8' ' ' GLU . 8.3 mt . . . . . 0 N--CA 1.499 1.997 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.402 175.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 C--O 1.214 -0.792 0 CA-C-O 121.185 0.517 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 24.0 tt0 -151.57 165.46 34.21 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.543 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -125.38 66.75 1.14 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -100.71 117.75 46.4 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 118.281 -1.368 . . . . 0.0 110.685 -175.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.2 150.48 3.29 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.25 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.23 -37.56 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.268 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 22.4 tt0 -157.29 -129.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.821 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' C ' HE22 ' A' ' 24' ' ' GLN . . . 157.75 97.41 0.13 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.616 -1.278 . . . . 0.0 111.314 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.23 107.96 60.7 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.492 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.25 101.54 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.785 0.99 . . . . 0.0 110.262 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HG2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.276 -178.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 HE22 ' A' ' 11' ' ' GLN . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.698 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 2.4 t30 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.698 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' SER . 11.3 mt . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.763 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.216 -0.672 0 CA-C-O 121.2 0.524 . . . . 0.0 110.095 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.653 ' N ' HD22 ' A' ' 37' ' ' ASN . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.535 ' C ' HD21 ' A' ' 26' ' ' ASN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' C ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.557 0.694 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 4' ' ' THR . 65.0 m-85 -132.76 -130.28 0.18 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.651 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 3' ' ' TYR . 6.9 p -165.23 177.71 7.44 Favored 'General case' 0 C--N 1.256 -3.459 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.622 -176.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.76 129.93 34.76 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.422 178.13 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -43.69 158.16 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.594 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -138.31 10.7 2.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.541 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -165.43 130.04 2.42 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.42 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.45 153.02 0.39 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.608 -0.837 . . . . 0.0 108.754 172.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 80.35 19.38 69.2 Favored Glycine 0 C--N 1.278 -2.666 0 C-N-CA 119.994 -1.098 . . . . 0.0 112.45 -178.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 11.1 mm-40 -89.95 -166.32 1.56 Allowed 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.919 178.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.0 m120 -153.5 -72.46 0.13 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 37.5 mt -71.82 17.16 0.1 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.566 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 26.7 p -103.93 176.48 5.14 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.218 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.1 mt -80.77 72.72 7.75 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 122.676 1.227 . . . . 0.0 108.156 -177.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.723 ' C ' HD21 ' A' ' 37' ' ' ASN . 99.6 m -70.93 -79.51 0.06 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 112.555 -2.112 . . . . 0.0 110.315 -176.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.532 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 3.2 mp0 -74.36 91.97 2.26 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.061 -1.456 . . . . 0.0 108.788 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.78 -140.36 31.48 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.188 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -86.76 4.09 42.33 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.016 0.912 . . . . 0.0 110.65 -178.916 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -90.87 140.01 30.21 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.235 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 22' ' ' CYS . 12.6 t -80.48 146.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.73 177.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -100.0 -146.96 0.34 Allowed 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.327 176.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -157.18 123.05 1.24 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 116.721 -2.656 . . . . 0.0 111.885 -177.158 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.577 HE22 ' CA ' ' A' ' 46' ' ' PRO . 5.2 tp-100 -35.25 160.76 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.036 -1.582 . . . . 0.0 110.052 175.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.78 52.73 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 -174.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.562 HD21 ' C ' ' A' ' 39' ' ' CYS . 18.1 t30 -109.15 -163.43 0.87 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.249 -0.976 . . . . 0.0 109.23 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.39 96.75 1.19 Allowed 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.241 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -84.1 126.08 32.75 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 117.896 -1.522 . . . . 0.0 112.306 -178.413 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 37' ' ' ASN . 11.4 mm -99.32 116.56 42.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.275 -176.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.296 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.723 HD21 ' C ' ' A' ' 16' ' ' CYS . 1.6 t-20 . . . . . 0 CA--C 1.502 -0.881 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 5.1 tt0 -103.03 -165.28 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.029 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.562 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.0 OUTLIER -147.98 89.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.268 -177.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -105.62 123.68 60.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 112.982 -1.917 . . . . 0.0 113.169 -176.7 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.3 t -6.35 144.05 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 112.534 -2.121 . . . . 0.0 113.824 171.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 136.07 172.15 12.54 Favored Glycine 0 N--CA 1.487 2.095 1 N-CA-C 130.979 7.151 . . . . 0.0 130.979 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.47 94.76 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.953 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.17 -113.33 3.52 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -164.07 134.18 3.18 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.725 -179.898 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.577 ' CA ' HE22 ' A' ' 24' ' ' GLN . 9.5 Cg_endo -76.81 98.62 1.23 Allowed 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.458 1.439 . . . . 0.0 110.481 173.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.4 tttp . . . . . 0 N--CA 1.493 1.684 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.203 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 2' ' ' VAL . 46.7 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.561 0.696 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.83 -121.8 0.21 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.709 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 1.8 t -170.71 178.86 3.42 Favored 'General case' 0 C--N 1.254 -3.56 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.251 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.555 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -95.12 131.22 41.37 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.155 -178.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -47.65 153.88 0.53 Allowed 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.8 177.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -148.57 18.03 1.03 Allowed 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.87 174.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -164.11 122.84 1.89 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.709 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.69 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -52.55 146.73 9.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.575 0.703 . . . . 0.0 110.663 178.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 98.96 -0.34 57.55 Favored Glycine 0 C--N 1.277 -2.749 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.66 178.112 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.4 mt-30 -88.39 179.17 6.38 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.653 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -148.0 -42.16 0.16 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.423 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 46' ' ' PRO . 8.2 mp -75.76 22.88 0.13 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.608 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.2 p -121.8 177.21 5.37 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.602 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.8 mt -79.5 74.73 6.14 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 122.672 1.225 . . . . 0.0 108.915 -176.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.8 m -69.89 -77.77 0.08 Allowed 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.03 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.77 114.99 17.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.785 -179.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.42 -120.76 24.13 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.255 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 4.59 18.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.486 1.136 . . . . 0.0 109.821 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -88.72 143.9 26.62 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.911 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 22' ' ' CYS . 12.8 t -83.03 136.73 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.342 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.632 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -82.35 -140.2 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.541 174.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.86 123.77 1.18 Allowed Glycine 0 C--N 1.27 -3.103 0 C-N-CA 116.58 -2.724 . . . . 0.0 111.58 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -33.94 150.78 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 113.009 -1.596 . . . . 0.0 109.078 175.687 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.504 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 96.99 -12.7 65.55 Favored Glycine 0 C--N 1.29 -2.007 0 N-CA-C 106.359 -2.696 . . . . 0.0 106.359 -173.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.5 t-20 -114.15 -163.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.904 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -157.36 99.28 1.76 Allowed 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.395 176.148 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.811 ' O ' HD13 ' A' ' 29' ' ' ILE . 3.6 m -78.38 149.78 33.3 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.6 -1.64 . . . . 0.0 109.848 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.3 mm -128.38 115.68 38.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.598 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 9' ' ' SER . 29.0 mt . . . . . 0 N--CA 1.498 1.955 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.516 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 5.3 tt0 -78.77 -179.0 6.26 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.516 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -135.47 68.81 1.45 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.878 -1.129 . . . . 0.0 107.954 178.952 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -104.22 124.51 58.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.517 -175.692 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.546 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 10.2 t -55.03 154.59 5.28 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.53 -24.05 0.15 Allowed Glycine 0 N--CA 1.494 2.505 0 CA-C-N 113.744 -1.571 . . . . 0.0 109.762 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 26' ' ' ASN . 5.4 tt0 -159.46 -140.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' ' H ' ' A' ' 25' ' ' GLY . . . 163.8 102.06 0.16 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.196 -1.478 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.6 139.98 32.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.633 178.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.641 ' HA ' HD13 ' A' ' 13' ' ' LEU . 11.7 Cg_endo -76.86 102.13 1.58 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.773 1.649 . . . . 0.0 109.273 172.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 tptt . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 118.3 -1.36 . . . . 0.0 111.732 -177.122 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 3' ' ' TYR . 4.2 t . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 120.672 0.273 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.504 ' H ' HG12 ' A' ' 2' ' ' VAL . 9.0 m-85 -114.08 -110.25 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.559 0.695 . . . . 0.0 110.683 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 177.2 179.22 0.24 Allowed 'General case' 0 C--N 1.261 -3.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.784 -179.097 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.572 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -82.84 130.88 35.19 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.459 -176.992 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 m -47.56 160.72 0.11 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.729 175.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 t -141.78 9.43 1.96 Allowed 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.786 175.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -168.18 154.13 7.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.218 178.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 157.16 14.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.898 176.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 91.85 -22.56 30.61 Favored Glycine 0 N--CA 1.51 3.604 0 C-N-CA 119.336 -1.411 . . . . 0.0 114.147 177.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -78.52 160.95 27.39 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.719 -177.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 28' ' ' CYS . 6.8 m-80 -151.21 21.33 0.75 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 115.535 1.679 . . . . 0.0 115.535 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.746 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -123.65 8.29 8.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.159 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 21.9 p -102.53 179.97 4.14 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.226 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.46 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.5 mt -79.75 74.88 6.44 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.95 1.357 . . . . 0.0 108.476 -177.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.0 t -72.14 -80.77 0.06 Allowed 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 112.098 -2.319 . . . . 0.0 110.116 -177.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.31 106.86 10.51 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.957 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.58 -151.79 46.05 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.06 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.17 5.36 17.12 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.1 0.952 . . . . 0.0 110.332 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -89.63 142.2 27.9 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.679 -1.601 . . . . 0.0 112.588 -176.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 13' ' ' LEU . 43.0 t -82.56 151.2 4.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.72 178.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -103.69 -143.26 0.36 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.71 176.26 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ASN . . . -159.44 118.81 0.85 Allowed Glycine 0 C--O 1.203 -1.792 0 C-N-CA 116.782 -2.627 . . . . 0.0 112.469 -176.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 26' ' ' ASN . 52.3 tt0 -35.3 162.02 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.699 -1.25 . . . . 0.0 110.179 174.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' GLN . . . 87.91 -24.29 11.33 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 106.006 -2.837 . . . . 0.0 106.006 -172.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.7 t30 -96.42 -167.17 1.53 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -161.35 102.88 1.24 Allowed 'General case' 0 C--N 1.265 -3.103 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.61 177.567 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 97.3 m -78.29 158.98 28.71 Favored 'General case' 0 CA--C 1.442 -3.184 0 C-N-CA 117.372 -1.731 . . . . 0.0 108.86 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.605 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.6 mm -142.72 114.3 3.01 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.355 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.027 174.237 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.507 2.409 0 C-N-CA 118.132 -1.427 . . . . 0.0 109.09 177.949 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -81.09 171.96 14.29 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -137.5 75.58 1.54 Allowed 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.644 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -110.97 131.02 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 117.997 -1.481 . . . . 0.0 114.88 -174.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.572 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -9.15 153.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 112.296 -2.229 . . . . 0.0 115.233 172.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.38 -136.21 8.53 Favored Glycine 0 N--CA 1.495 2.616 1 N-CA-C 129.937 6.735 . . . . 0.0 129.937 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -76.55 -131.13 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.46 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.603 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 140.13 107.54 0.71 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.471 176.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.82 135.06 36.01 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.037 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.602 ' HA ' HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -68.07 100.72 0.65 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 120.512 0.808 . . . . 0.0 110.196 173.882 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.671 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 12.4 tptm . . . . . 0 N--CA 1.492 1.627 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.003 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.657 HG12 ' N ' ' A' ' 3' ' ' TYR . 33.4 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.201 0.524 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.657 ' N ' HG12 ' A' ' 2' ' ' VAL . 2.8 m-85 -118.4 -96.72 0.47 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.441 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -178.34 178.56 0.86 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.9 178.346 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.554 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.44 132.11 34.02 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.559 -175.683 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 30' ' ' LEU . 2.7 m -48.88 160.13 0.21 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.362 176.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 7' ' ' THR . 5.1 t -152.8 14.77 0.55 Allowed 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.533 173.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.626 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.5 tt0 -166.2 117.97 1.03 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.982 -178.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -45.81 160.99 0.05 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.709 177.441 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.99 -29.34 8.81 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 118.839 -1.648 . . . . 0.0 112.482 -179.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 33.2 mt-30 -67.6 -168.84 0.1 Allowed 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.615 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.709 HD21 ' C ' ' A' ' 26' ' ' ASN . 11.5 m-20 -166.0 -28.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 117.716 -1.594 . . . . 0.0 113.998 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 46' ' ' PRO . 26.6 mt -86.53 15.04 5.89 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.706 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.5 p -105.63 177.11 4.95 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.992 -178.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.4 mt -77.74 75.76 4.28 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.76 1.266 . . . . 0.0 108.726 -176.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 14.3 m -82.24 -72.68 0.43 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.265 -2.243 . . . . 0.0 111.251 -177.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.03 87.88 1.87 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.505 179.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -142.16 37.38 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.176 -1.487 . . . . 0.0 109.682 -178.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 0.98 43.34 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.187 0.994 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -90.64 150.39 21.71 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.413 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.2 t -81.3 150.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.335 -178.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -72.91 -136.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.542 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -169.67 111.46 0.42 Allowed Glycine 0 C--N 1.283 -2.395 0 C-N-CA 117.429 -2.32 . . . . 0.0 110.785 174.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 23' ' ' GLY . 34.9 tt0 -34.76 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.778 177.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 87.12 -12.46 62.23 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 -174.104 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.709 ' C ' HD21 ' A' ' 12' ' ' ASN . 34.9 t30 -108.0 -162.09 0.81 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HA ' HD21 ' A' ' 12' ' ' ASN . 23.0 tttt -147.74 103.32 3.5 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.132 173.536 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.813 ' O ' HD13 ' A' ' 29' ' ' ILE . 38.0 t -75.93 156.92 33.77 Favored 'General case' 0 C--N 1.272 -2.77 0 C-N-CA 117.692 -1.603 . . . . 0.0 109.752 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 28' ' ' CYS . 9.0 mm -139.05 116.05 10.85 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.099 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 8' ' ' GLU . 20.9 mt . . . . . 0 N--CA 1.506 2.361 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.577 179.284 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.407 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HG3' ' H ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -133.25 175.48 9.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.669 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.635 ' C ' HD21 ' A' ' 26' ' ' ASN . 1.3 m -137.93 67.96 1.41 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.561 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -107.19 128.18 62.34 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.809 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.04 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.461 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -52.94 151.35 4.71 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.6 -27.19 0.12 Allowed Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.404 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 26' ' ' ASN . 69.2 mt-10 -154.18 -135.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.432 0.634 . . . . 0.0 109.546 -178.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' HD22 ' A' ' 12' ' ' ASN . . . 159.71 97.93 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.684 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.15 144.45 52.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.249 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.549 ' HA ' HD12 ' A' ' 13' ' ' LEU . 18.4 Cg_endo -78.85 130.19 9.45 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.726 1.617 . . . . 0.0 110.678 173.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp . . . . . 0 CA--C 1.564 1.503 0 C-N-CA 118.401 -1.32 . . . . 0.0 108.673 177.362 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 3' ' ' TYR . 3.3 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.996 0.427 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.567 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 72.3 m-85 -106.36 -114.17 0.26 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.304 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -176.63 174.3 1.87 Allowed 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.532 178.856 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.538 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.43 133.77 36.54 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.888 -175.882 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.9 m -47.35 170.26 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.458 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.457 176.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.38 10.23 1.45 Allowed 'General case' 0 C--N 1.262 -3.207 0 CA-C-N 113.406 -1.725 . . . . 0.0 107.276 172.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 30' ' ' LEU . 31.8 tt0 -169.94 128.82 0.92 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.512 -179.054 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.737 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -46.81 163.21 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.442 177.645 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.64 -15.46 24.96 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.011 -2.042 . . . . 0.0 111.597 178.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -58.64 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.763 -1.175 . . . . 0.0 108.613 177.95 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -145.68 -81.48 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.345 -1.742 . . . . 0.0 114.348 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 93.5 mt -75.32 36.72 0.12 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.831 -173.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -101.39 -176.69 3.22 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.337 179.758 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.615 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 11.3 mt -90.99 80.61 5.72 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.925 -176.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.59 -78.64 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 CA-C-N 112.862 -1.972 . . . . 0.0 110.709 -177.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 79.7 mm-40 -86.34 110.44 19.68 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.95 -119.19 9.47 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.683 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.47 1.44 12.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.476 1.131 . . . . 0.0 109.358 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -79.77 142.04 35.75 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.06 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 38.7 t -86.31 154.29 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.42 178.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.3 m -142.46 -162.71 1.46 Allowed 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.011 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.97 ' N ' HD22 ' A' ' 26' ' ' ASN . . . 97.15 -50.37 1.48 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 117.412 -2.327 . . . . 0.0 113.518 174.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.538 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.3 tt0 -59.66 118.75 6.48 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.435 -177.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.84 -8.14 16.93 Favored Glycine 0 C--N 1.305 -1.166 0 N-CA-C 107.536 -2.226 . . . . 0.0 107.536 -176.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.97 HD22 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.97 -173.83 2.8 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.969 -179.43 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.587 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.25 116.58 13.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.695 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' GLY . 13.5 t -79.24 153.89 29.6 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 117.421 -1.711 . . . . 0.0 110.672 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.587 HD11 ' CE ' ' A' ' 27' ' ' LYS . 16.9 mm -148.36 124.59 2.51 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.479 0 CA-C-N 113.163 -1.835 . . . . 0.0 111.731 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 9' ' ' SER . 3.4 mt . . . . . 0 N--CA 1.514 2.747 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.615 176.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.804 0.811 . . . . 0.0 110.696 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 11.3 tt0 -160.02 170.11 22.0 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.92 177.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 22.1 m -131.41 64.69 1.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -79.98 125.84 39.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.855 -173.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 6.5 t -29.06 155.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 113.087 -1.869 . . . . 0.0 112.373 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.73 -154.3 16.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -142.11 124.73 15.85 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.472 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.09 -113.48 3.81 Favored Glycine 0 N--CA 1.479 1.527 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.887 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.88 141.19 7.44 Favored Pre-proline 0 C--N 1.296 -1.736 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.746 -178.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.9 Cg_endo -67.43 111.8 2.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.881 1.054 . . . . 0.0 109.412 174.181 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HD3' HG23 ' A' ' 4' ' ' THR . 14.4 tttp . . . . . 0 N--CA 1.502 2.162 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.613 -178.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.743 0.306 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -110.31 -116.69 0.3 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.657 0.742 . . . . 0.0 110.029 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -165.26 175.76 8.97 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.686 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.13 134.5 36.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.921 0.867 . . . . 0.0 112.723 -174.576 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.466 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 3.2 m -48.81 158.07 0.34 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.886 176.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -140.69 7.07 2.08 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.253 174.088 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.62 126.7 0.9 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.288 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -50.51 157.54 0.72 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.489 175.765 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.15 -3.41 84.57 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.66 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' A' ' 47' ' ' LYS . 12.5 mt-30 -86.55 -166.19 1.49 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.502 178.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.589 HD21 ' H ' ' A' ' 44' ' ' GLY . 6.2 m-20 -139.83 -80.49 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -175.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mt -71.63 41.67 0.08 Allowed 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.651 -172.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ASN . 31.8 p -107.75 178.75 4.43 Favored 'General case' 0 C--O 1.194 -1.834 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.854 176.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -89.78 79.72 6.66 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 123.05 1.405 . . . . 0.0 108.286 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 33.9 t -61.99 -94.48 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.024 0 CA-C-N 111.832 -2.44 . . . . 0.0 111.191 -176.47 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.43 122.29 26.8 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.421 -1.311 . . . . 0.0 109.592 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.63 -123.82 23.14 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.327 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -116.23 2.75 13.35 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 122.393 1.092 . . . . 0.0 109.652 -179.598 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.73 144.92 30.79 Favored 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.761 -177.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 22.8 t -86.67 149.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.645 178.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -136.64 -165.1 1.67 Allowed 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 174.529 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 1.103 ' N ' HD22 ' A' ' 26' ' ' ASN . . . 112.67 -68.52 0.23 Allowed Glycine 0 N--CA 1.484 1.893 0 C-N-CA 117.662 -2.209 . . . . 0.0 113.488 174.048 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -64.55 124.79 22.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.776 -175.065 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.6 -5.55 44.93 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -175.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 1.103 HD22 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -133.82 -170.66 2.55 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.674 -179.376 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 40' ' ' VAL . 19.4 tttp -156.27 105.95 2.34 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.292 177.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.832 ' O ' HD13 ' A' ' 29' ' ' ILE . 11.1 m -80.48 158.86 25.76 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 117.665 -1.614 . . . . 0.0 111.038 -179.151 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.832 HD13 ' O ' ' A' ' 28' ' ' CYS . 10.1 mm -139.5 106.87 2.83 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.288 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.47 ' H ' ' HB3' ' A' ' 9' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.506 2.374 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.932 -178.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.7 m120 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.505 0.669 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -147.56 167.66 23.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.097 174.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 m -131.74 73.15 1.52 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -91.24 125.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.898 -173.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.3 t -32.99 159.18 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.476 177.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.51 -150.97 19.1 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.882 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -153.95 114.1 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.589 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -104.92 -109.76 3.44 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.16 148.27 11.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.55 -177.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.27 129.07 29.83 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.11 1.207 . . . . 0.0 109.876 175.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.457 ' HB2' HE21 ' A' ' 11' ' ' GLN . 5.2 tmtm? . . . . . 0 CA--C 1.564 1.505 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.861 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.794 0.33 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -145.19 -114.0 0.09 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.009 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.36 164.22 38.94 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.9 -178.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.86 131.92 35.26 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.555 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 150.35 4.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.578 176.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.829 HG22 ' HZ3' ' A' ' 47' ' ' LYS . 14.8 t -145.63 15.36 1.42 Allowed 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -162.46 113.67 1.57 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.41 -177.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.449 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -46.87 155.41 0.26 Allowed 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.515 178.258 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 10.87 85.64 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.449 -1.357 . . . . 0.0 111.293 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -79.39 -168.52 1.55 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.814 178.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' CYS . 28.7 t-20 -130.95 -91.18 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 114.835 -177.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.35 37.58 0.11 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.857 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 21.5 p -96.37 -178.85 4.43 Favored 'General case' 0 C--O 1.192 -1.922 0 C-N-CA 118.175 -1.41 . . . . 0.0 109.721 179.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -92.92 79.8 4.64 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 122.504 1.145 . . . . 0.0 108.577 -177.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.9 t -66.97 -85.42 0.02 OUTLIER 'General case' 0 C--N 1.253 -3.593 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.42 -176.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -80.77 120.3 24.47 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.71 -121.88 26.28 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.527 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.99 2.9 14.36 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.635 1.207 . . . . 0.0 109.126 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.529 ' N ' HD22 ' A' ' 20' ' ' ASN . 1.4 m-80 -78.88 142.44 36.8 Favored 'General case' 0 C--N 1.26 -3.315 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.518 -178.009 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 39.2 t -85.7 153.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 118.379 -1.328 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.7 m -139.52 -166.93 2.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.183 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.794 ' H ' HD22 ' A' ' 26' ' ' ASN . . . 98.04 -47.04 1.53 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 117.268 -2.396 . . . . 0.0 114.14 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' C ' ' H ' ' A' ' 26' ' ' ASN . 20.5 tt0 -60.49 103.21 0.22 Allowed 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.768 -176.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.32 55.82 Favored Glycine 0 C--N 1.303 -1.27 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -175.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.794 HD22 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -119.38 -164.45 1.06 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.884 -1.158 . . . . 0.0 111.102 178.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.693 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -159.81 134.78 7.97 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.668 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 t -94.73 159.5 15.04 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.438 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.693 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 31.1 mm -137.27 110.06 7.6 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.413 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.786 177.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 9' ' ' SER . 63.1 mt . . . . . 0 N--CA 1.498 1.965 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.64 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.348 0.594 . . . . 0.0 111.843 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 59.0 tt0 -82.7 162.71 21.71 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.087 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.2 m -123.9 67.74 1.04 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -85.18 131.18 34.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 117.844 -1.543 . . . . 0.0 111.78 -172.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' VAL . 2.2 t -36.13 165.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.272 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.3 -129.95 7.13 Favored Glycine 0 N--CA 1.484 1.894 1 N-CA-C 129.596 6.599 . . . . 0.0 129.596 -178.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -161.07 115.4 2.06 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.199 178.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.8 -106.69 2.96 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.86 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.1 140.62 8.77 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.87 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.5 Cg_endo -61.85 96.6 0.14 Allowed 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 121.132 1.221 . . . . 0.0 110.227 176.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.829 ' HZ3' HG22 ' A' ' 7' ' ' THR . 32.3 tptt . . . . . 0 N--CA 1.491 1.595 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.754 -179.139 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 2' ' ' VAL . 22.0 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.685 ' O ' HG23 ' A' ' 4' ' ' THR . 78.9 m-85 -104.66 -128.4 0.25 Allowed 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.359 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.677 -174.097 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.04 129.49 34.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.842 179.104 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.8 m -44.62 155.44 0.1 Allowed 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.17 178.238 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.75 11.48 2.26 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.978 175.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.65 134.31 4.48 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.01 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.531 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -53.47 155.25 3.02 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.317 176.59 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.812 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 77.62 13.56 83.37 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.485 -179.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.403 HE22 ' HG2' ' A' ' 47' ' ' LYS . 9.7 mm-40 -75.63 -168.65 0.88 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.014 179.047 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 14' ' ' CYS . 77.2 m-20 -151.14 -72.05 0.16 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.248 -1.381 . . . . 0.0 113.741 -178.842 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.502 HD13 ' CE1' ' A' ' 3' ' ' TYR . 24.0 mt -75.73 20.7 0.17 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.19 -175.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.7 p -102.77 176.68 5.08 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.383 -179.342 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.497 ' N ' HD23 ' A' ' 15' ' ' LEU . 6.6 mt -80.62 73.31 7.57 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-O 122.934 1.35 . . . . 0.0 108.194 -177.018 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.0 m -72.38 -81.69 0.05 Allowed 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.169 -175.82 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.99 112.13 12.1 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.55 -179.759 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.7 -121.76 12.97 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.97 1.91 12.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.593 1.187 . . . . 0.0 108.918 178.872 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -85.81 151.2 24.01 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.766 -177.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 22' ' ' CYS . 32.8 t -84.3 142.4 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.023 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.593 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -84.81 -142.37 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.897 174.451 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.4 120.65 0.96 Allowed Glycine 0 C--N 1.282 -2.419 0 C-N-CA 116.88 -2.581 . . . . 0.0 111.683 -178.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.6 tt0 -31.42 150.9 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.561 -1.319 . . . . 0.0 110.092 177.233 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.14 -15.01 63.72 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 106.381 -2.688 . . . . 0.0 106.381 -172.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.652 ' OD1' ' N ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -115.36 -170.84 1.84 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.625 -1.288 . . . . 0.0 108.461 177.185 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.82 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -161.32 117.1 2.13 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.609 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -95.97 122.5 38.86 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.837 -177.189 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.82 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.3 mm -97.12 117.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 113.097 -1.865 . . . . 0.0 112.698 -174.084 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 9' ' ' SER . 8.1 mt . . . . . 0 N--CA 1.511 2.591 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.422 179.654 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.795 0.331 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -77.12 173.98 11.21 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 173.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.13 80.64 1.77 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.427 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -109.43 127.75 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.156 -175.231 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.652 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 t -16.71 141.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.696 172.391 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.17 -130.0 2.25 Favored Glycine 0 N--CA 1.484 1.856 1 N-CA-C 131.513 7.365 . . . . 0.0 131.513 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -161.05 100.31 1.23 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.281 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.812 ' HA3' ' O ' ' A' ' 10' ' ' GLY . . . -121.78 -97.03 1.44 Allowed Glycine 0 N--CA 1.481 1.648 1 N-CA-C 129.105 6.402 . . . . 0.0 129.105 177.122 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.82 129.57 2.46 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.696 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.18 92.61 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.329 1.353 . . . . 0.0 110.441 172.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HG2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.239 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.681 -179.525 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 3' ' ' TYR . 37.6 t . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.655 ' N ' HG12 ' A' ' 2' ' ' VAL . 9.2 m-85 -114.38 -112.65 0.34 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.555 0.693 . . . . 0.0 110.253 -178.565 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -169.22 -174.4 1.98 Allowed 'General case' 0 C--N 1.255 -3.51 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.305 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.594 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.86 135.73 33.27 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.044 -177.301 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.76 155.38 0.58 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.648 175.284 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -133.46 4.82 3.7 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.952 176.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.405 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 7.1 pt-20 -168.51 132.55 1.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.757 179.585 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -42.0 166.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.668 176.565 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 68.17 20.48 73.12 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.806 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.485 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -85.58 -172.78 4.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.864 -179.463 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 14' ' ' CYS . 3.1 m120 -154.95 -67.29 0.13 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.415 -1.314 . . . . 0.0 113.952 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 5.2 mt -74.07 22.9 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.455 -176.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.8 p -115.36 179.49 3.95 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.5 mt -81.04 72.15 8.06 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.444 -178.195 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.0 m -70.39 -83.22 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.517 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.009 -177.145 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.696 ' HA ' HD21 ' A' ' 37' ' ' ASN . 1.3 tm-20 -77.45 122.62 25.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.336 -1.346 . . . . 0.0 109.93 178.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.18 -125.0 38.39 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.793 -178.361 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.02 4.61 15.77 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.893 1.33 . . . . 0.0 108.278 178.64 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 142.68 34.86 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 111.965 -2.379 . . . . 0.0 111.877 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.0 t -84.22 135.43 24.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.12 -1.432 . . . . 0.0 109.624 176.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.609 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -78.56 -143.33 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.726 175.439 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -166.91 119.32 0.84 Allowed Glycine 0 C--N 1.275 -2.857 0 C-N-CA 117.533 -2.27 . . . . 0.0 110.671 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' GLY . 3.5 tp-100 -35.09 151.06 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.416 177.085 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.57 -13.3 67.83 Favored Glycine 0 C--N 1.292 -1.89 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -172.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 41' ' ' THR . 27.2 t30 -111.4 -161.75 0.77 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.198 -1.001 . . . . 0.0 109.208 177.166 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.92 110.63 1.47 Allowed 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.18 179.055 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -105.26 125.28 50.81 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.004 177.7 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.555 HD11 ' CE ' ' A' ' 27' ' ' LYS . 37.0 mm -105.0 113.86 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.209 -178.553 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 9' ' ' SER . 8.9 mt . . . . . 0 N--CA 1.529 3.507 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.673 -177.177 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.696 HD21 ' HA ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 121.123 0.487 . . . . 0.0 111.262 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 9.7 tt0 -119.82 170.63 9.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.161 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.488 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -139.86 82.56 1.88 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.267 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -125.08 141.31 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.354 -176.674 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.528 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -16.76 152.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 112.408 -2.178 . . . . 0.0 113.519 171.749 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.54 -143.26 12.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.73 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.91 111.51 1.76 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.818 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.85 -88.22 0.82 Allowed Glycine 0 N--CA 1.491 2.333 1 N-CA-C 129.77 6.668 . . . . 0.0 129.77 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -147.18 124.12 5.71 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.989 178.152 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.45 98.96 1.25 Allowed 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.474 1.449 . . . . 0.0 111.123 175.394 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.4 tptp . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.463 179.31 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 3' ' ' TYR . 7.0 t -117.22 166.0 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.759 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.517 ' C ' HG22 ' A' ' 4' ' ' THR . 32.8 m-85 -120.12 -110.46 0.34 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.268 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 173.15 178.71 0.09 Allowed 'General case' 0 C--N 1.258 -3.395 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.275 178.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -76.47 130.18 37.6 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 118.644 -1.223 . . . . 0.0 111.175 -176.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 96.2 m -40.6 168.06 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.15 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 HG22 ' NZ ' ' A' ' 47' ' ' LYS . 14.9 t -143.66 11.85 1.67 Allowed 'General case' 0 C--N 1.267 -3.017 0 CA-C-N 113.066 -1.879 . . . . 0.0 107.626 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -173.9 125.76 0.36 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.433 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -47.1 158.06 0.15 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.224 178.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 95.57 -28.26 12.88 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.588 177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.89 176.92 0.49 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 118.711 -1.196 . . . . 0.0 109.938 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -156.49 20.18 0.34 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 116.947 -1.901 . . . . 0.0 114.863 -178.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.764 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -134.14 16.0 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -102.04 -179.62 4.05 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.025 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.1 mt -77.85 72.69 4.4 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-O 123.003 1.383 . . . . 0.0 108.003 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.4 t -77.68 -82.85 0.08 Allowed 'General case' 0 C--N 1.25 -3.733 0 CA-C-N 112.051 -2.341 . . . . 0.0 110.356 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.81 110.86 9.46 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 117.859 -1.536 . . . . 0.0 108.505 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.3 -154.56 33.52 Favored Glycine 0 N--CA 1.479 1.528 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -82.8 5.56 21.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.52 1.153 . . . . 0.0 109.324 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.42 149.01 25.3 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.657 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG13 ' C ' ' A' ' 13' ' ' LEU . 28.1 t -82.65 144.56 9.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 118.095 -1.442 . . . . 0.0 111.027 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -71.15 -144.67 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.965 177.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -141.3 82.91 0.23 Allowed Glycine 0 C--N 1.282 -2.464 1 N-CA-C 128.17 6.028 . . . . 0.0 128.17 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.1 tm0? -19.22 126.0 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 124.595 0.82 . . . . 0.0 111.483 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -11.48 56.95 Favored Glycine 0 C--N 1.296 -1.677 0 N-CA-C 106.551 -2.619 . . . . 0.0 106.551 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 49.0 m-20 -110.12 -169.74 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.586 -0.807 . . . . 0.0 109.188 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.876 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -144.36 130.9 19.95 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.043 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.596 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 52.6 t -99.58 168.29 10.05 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.586 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.876 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 28.1 mm -145.95 119.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 C-N-CA 118.298 -1.361 . . . . 0.0 112.508 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 9' ' ' SER . 12.0 mt -91.52 126.57 36.65 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.49 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.44 ' H ' ' CA ' ' A' ' 36' ' ' LYS . . . 71.23 90.14 0.1 OUTLIER Glycine 0 N--CA 1.5 2.913 0 C-N-CA 118.914 -1.612 . . . . 0.0 111.221 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.93 82.37 2.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 52.49 42.68 31.37 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.82 -16.95 18.26 Favored Glycine 0 N--CA 1.483 1.813 1 N-CA-C 124.928 4.731 . . . . 0.0 124.928 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -97.98 95.72 7.67 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.358 -1.421 . . . . 0.0 109.718 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' CA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -62.79 1.94 0.35 Allowed 'General case' 1 C--N 1.231 -4.561 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.493 179.818 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER 179.6 111.77 0.04 OUTLIER 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.909 -176.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.622 ' N ' HD22 ' A' ' 37' ' ' ASN . 35.2 tt0 -127.6 161.21 29.36 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.02 71.13 1.04 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -174.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -101.79 113.12 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 118.161 -1.416 . . . . 0.0 113.27 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 40' ' ' VAL . 7.5 t -31.11 158.69 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.421 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.64 159.51 8.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -78.12 102.59 7.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.277 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.37 -104.65 2.93 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.64 137.86 6.77 Favored Pre-proline 0 C--N 1.303 -1.418 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.908 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.708 ' HA ' HD11 ' A' ' 13' ' ' LEU . 2.9 Cg_endo -68.87 91.68 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 120.735 0.957 . . . . 0.0 109.681 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 47.7 tttp -33.86 97.72 0.12 Allowed Pre-proline 0 N--CA 1.503 2.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.262 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -66.23 176.2 4.18 Favored 'Trans proline' 0 C--O 1.212 -0.778 0 C-N-CA 120.828 1.019 . . . . 0.0 110.97 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? . . . . . 0 C--N 1.308 -1.207 0 CA-C-O 116.349 -1.786 . . . . 0.0 110.539 -179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 89.0 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 3' ' ' TYR . 16.0 t -115.24 171.41 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.294 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.64 ' O ' HG23 ' A' ' 4' ' ' THR . 33.1 m-85 -114.27 -116.74 0.32 Allowed 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.719 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.3 p -165.59 176.62 7.96 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.909 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.66 125.57 35.31 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.191 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.553 ' SG ' ' NE2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -59.84 165.59 3.09 Favored 'General case' 0 C--N 1.263 -3.168 0 CA-C-O 123.594 1.664 . . . . 0.0 111.897 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -142.31 13.32 1.99 Allowed 'General case' 1 C--N 1.239 -4.197 0 CA-C-N 110.595 -3.002 . . . . 0.0 105.338 174.198 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' C ' HD12 ' A' ' 30' ' ' LEU . 16.1 mt-10 -160.31 139.47 10.73 Favored 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.584 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.63 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -61.65 -175.62 0.06 Allowed 'General case' 0 N--CA 1.398 -3.061 0 CA-C-O 123.236 1.493 . . . . 0.0 111.15 177.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 69.47 -36.87 0.34 Allowed Glycine 1 C--N 1.231 -5.294 0 CA-C-N 111.278 -2.692 . . . . 0.0 112.524 177.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.553 ' NE2' ' SG ' ' A' ' 6' ' ' CYS . 0.4 OUTLIER -59.74 -171.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.555 -175.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.596 ' N ' ' ND2' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -171.77 40.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.659 178.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 24' ' ' GLN . 72.9 mt -143.02 1.32 1.26 Allowed 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.477 ' C ' HD23 ' A' ' 15' ' ' LEU . 3.3 p -100.48 171.45 7.73 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 113.617 -1.629 . . . . 0.0 109.604 -177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.785 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -81.48 78.83 8.19 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 123.664 1.697 . . . . 0.0 107.998 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.934 ' C ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -79.76 -61.32 2.03 Favored 'General case' 1 C--N 1.235 -4.382 0 CA-C-N 111.103 -2.772 . . . . 0.0 107.845 -178.724 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 11.4 mm-40 -73.99 72.17 1.61 Allowed 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.66 -1.616 . . . . 0.0 108.284 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.44 -113.4 4.07 Favored Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.085 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.3 p -99.91 -11.75 20.42 Favored 'General case' 0 CA--C 1.48 -1.732 0 CA-C-O 124.048 1.88 . . . . 0.0 109.197 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -75.04 119.39 19.14 Favored 'General case' 1 C--N 1.207 -5.628 0 CA-C-N 110.709 -2.95 . . . . 0.0 110.216 178.944 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 22' ' ' CYS . 25.4 t -63.41 147.11 12.39 Favored 'Isoleucine or valine' 1 C--N 1.215 -5.279 0 CA-C-N 110.956 -2.838 . . . . 0.0 107.713 175.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 23' ' ' GLY . 0.8 OUTLIER -77.93 -132.16 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.183 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 177.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.77 89.75 0.1 OUTLIER Glycine 1 C--N 1.224 -5.677 0 C-N-CA 115.942 -3.028 . . . . 0.0 112.36 177.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' ASN . 36.2 tt0 -23.67 142.74 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 113.782 -1.209 . . . . 0.0 110.743 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.62 -7.42 63.4 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -173.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 41' ' ' THR . 1.2 m-20 -111.11 -166.89 1.11 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.607 -1.297 . . . . 0.0 108.91 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -147.48 98.01 2.93 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 176.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 10' ' ' GLY . 51.1 t -75.68 154.84 36.26 Favored 'General case' 0 CA--C 1.435 -3.448 0 C-N-CA 116.55 -2.06 . . . . 0.0 109.918 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.57 HD11 ' CE ' ' A' ' 27' ' ' LYS . 32.3 mm -139.08 120.97 16.67 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.246 0 CA-C-N 112.769 -2.014 . . . . 0.0 109.633 175.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 9' ' ' SER . 18.4 mt -75.51 144.81 41.78 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 36' ' ' LYS . . . -61.83 61.04 0.02 OUTLIER Glycine 0 C--N 1.288 -2.116 0 CA-C-N 110.233 -3.167 . . . . 0.0 110.562 172.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.629 ' O ' ' N ' ' A' ' 34' ' ' GLY . 19.4 m -70.64 -124.96 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.552 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.573 178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.55 69.47 0.0 OUTLIER 'General case' 0 C--N 1.267 -2.981 0 O-C-N 125.377 1.673 . . . . 0.0 110.325 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 60.61 41.63 98.92 Favored Glycine 0 C--N 1.277 -2.739 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.49 -127.07 0.19 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.753 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 4.6 mttp -105.18 -118.04 0.23 Allowed 'General case' 0 C--N 1.268 -2.95 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -173.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.934 HD21 ' C ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER 119.7 36.76 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 111.994 -2.366 . . . . 0.0 105.76 -169.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -95.48 -173.36 2.88 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.56 -1.655 . . . . 0.0 108.629 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.59 67.12 1.53 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -91.17 136.02 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 117.011 -1.876 . . . . 0.0 114.829 -171.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.631 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 t -17.83 144.5 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.966 0 CA-C-N 110.008 -3.269 . . . . 0.0 113.127 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.26 -137.03 6.6 Favored Glycine 0 N--CA 1.484 1.878 1 N-CA-C 130.2 6.84 . . . . 0.0 130.2 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.73 98.5 0.88 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.601 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.61 -104.86 2.85 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.745 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.41 138.44 10.09 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.9 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -71.24 104.33 1.53 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.325 1.35 . . . . 0.0 110.715 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -44.71 102.61 0.3 Allowed Pre-proline 0 N--CA 1.495 1.82 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.905 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.03 126.85 22.22 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.959 1.106 . . . . 0.0 112.067 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.286 0 CA-C-O 116.298 -1.81 . . . . 0.0 110.396 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.8 t -80.1 167.26 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.966 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.651 ' CE2' HD22 ' A' ' 13' ' ' LEU . 22.0 m-85 -137.34 -111.15 0.18 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.655 0.741 . . . . 0.0 109.777 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 179.16 177.56 0.52 Allowed 'General case' 0 C--N 1.262 -3.229 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.64 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -78.07 131.68 37.4 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.812 -1.155 . . . . 0.0 111.387 -177.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.452 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 93.7 m -43.01 172.26 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.122 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.571 HG22 HE22 ' A' ' 11' ' ' GLN . 2.3 t -146.08 11.06 1.18 Allowed 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 113.342 -1.754 . . . . 0.0 107.727 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -168.86 123.73 0.88 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.461 -178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.95 149.71 1.77 Allowed 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.152 173.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 93.08 -0.58 69.28 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.17 -1.49 . . . . 0.0 111.613 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.571 HE22 HG22 ' A' ' 7' ' ' THR . 24.1 mt-30 -81.84 -173.6 4.55 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 118.75 -1.18 . . . . 0.0 108.695 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.566 HD21 ' C ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -167.69 30.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 116.689 -2.004 . . . . 0.0 115.348 -178.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.651 HD22 ' CE2' ' A' ' 3' ' ' TYR . 34.7 mt -146.07 14.56 1.32 Allowed 'General case' 0 C--N 1.263 -3.185 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -109.43 -179.98 3.98 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.725 -175.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.661 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 mt -76.27 70.22 2.87 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.291 -1.777 . . . . 0.0 108.142 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.621 ' C ' HD21 ' A' ' 37' ' ' ASN . 4.1 m -75.89 -83.06 0.07 Allowed 'General case' 0 C--N 1.249 -3.761 0 CA-C-N 112.44 -2.164 . . . . 0.0 110.387 -176.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -74.73 107.01 6.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 117.108 -1.837 . . . . 0.0 108.75 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.12 -137.54 33.6 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.148 -1.501 . . . . 0.0 109.901 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.65 5.06 47.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.585 1.183 . . . . 0.0 109.223 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -85.74 145.38 27.28 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 112.778 -2.01 . . . . 0.0 111.147 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 22' ' ' CYS . 17.7 t -79.3 143.15 12.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 118.667 -1.213 . . . . 0.0 110.94 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.655 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.27 -165.27 0.39 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -152.5 98.0 0.18 Allowed Glycine 0 C--N 1.288 -2.098 0 C-N-CA 116.02 -2.991 . . . . 0.0 112.261 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.0 tt0 -27.42 148.07 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.871 0 CA-C-N 112.207 -1.997 . . . . 0.0 111.008 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.28 -18.47 53.94 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 104.795 -3.322 . . . . 0.0 104.795 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 41' ' ' THR . 2.1 t-20 -105.16 -162.28 0.87 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 112.716 -1.742 . . . . 0.0 108.536 176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' N ' HD21 ' A' ' 12' ' ' ASN . 0.7 OUTLIER -149.41 104.6 3.39 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.923 ' O ' HD13 ' A' ' 29' ' ' ILE . 36.1 t -77.5 149.88 34.94 Favored 'General case' 0 C--N 1.269 -2.918 0 C-N-CA 117.095 -1.842 . . . . 0.0 109.746 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.5 mm -137.14 118.72 18.5 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.194 0 CA-C-N 112.695 -2.048 . . . . 0.0 109.859 177.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.442 ' H ' ' HB3' ' A' ' 9' ' ' SER . 93.1 mt -75.77 141.39 42.58 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 118.769 -1.172 . . . . 0.0 113.757 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.88 ' HA2' ' CB ' ' A' ' 35' ' ' GLU . . . -109.0 60.19 0.33 Allowed Glycine 0 N--CA 1.479 1.553 1 N-CA-C 128.25 6.06 . . . . 0.0 128.25 174.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 34' ' ' GLY . 11.4 m -53.76 -103.38 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.915 -0.642 . . . . 0.0 109.439 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.42 72.05 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.707 0 O-C-N 125.687 1.867 . . . . 0.0 109.052 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.741 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 45.81 36.99 6.9 Favored Glycine 0 C--N 1.269 -3.16 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.696 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.88 ' CB ' ' HA2' ' A' ' 31' ' ' GLY . 6.9 mt-10 -86.18 -136.93 0.08 Allowed 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 118.691 -1.203 . . . . 0.0 108.859 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.628 ' N ' ' CA ' ' A' ' 31' ' ' GLY . 35.6 mttm -96.12 -124.56 0.12 Allowed 'General case' 0 C--N 1.252 -3.659 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -175.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.621 HD21 ' C ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER 116.41 36.22 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 112.254 -2.248 . . . . 0.0 107.598 -173.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.652 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 1.9 tt0 -102.42 -164.33 1.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.615 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.652 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -135.62 73.26 1.46 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -92.21 120.07 40.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.986 -173.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.615 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -6.17 141.89 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.092 0 CA-C-N 112.668 -2.06 . . . . 0.0 114.437 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.96 -177.95 19.32 Favored Glycine 0 N--CA 1.488 2.166 1 N-CA-C 130.907 7.123 . . . . 0.0 130.907 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -108.78 90.78 3.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.799 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.63 -107.05 2.66 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.175 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.36 134.91 4.82 Favored Pre-proline 0 C--N 1.301 -1.53 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.725 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 47' ' ' LYS . 9.2 Cg_endo -75.87 97.23 1.09 Allowed 'Trans proline' 0 C--O 1.211 -0.855 0 C-N-CA 121.41 1.407 . . . . 0.0 110.648 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.0 tttm -35.91 95.37 0.09 OUTLIER Pre-proline 0 N--CA 1.512 2.632 0 O-C-N 123.543 0.527 . . . . 0.0 111.093 -178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.407 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.0 Cg_endo -71.41 162.33 42.71 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.135 1.223 . . . . 0.0 111.287 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.69 ' H ' HE21 ' A' ' 49' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.296 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.859 HG22 ' H ' ' A' ' 2' ' ' VAL . 12.1 p . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.859 ' H ' HG22 ' A' ' 1' ' ' VAL . 98.6 t -105.78 2.4 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.373 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.495 ' CE1' HD13 ' A' ' 13' ' ' LEU . 61.9 m-85 -139.4 -117.88 0.13 Allowed 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.013 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 179.52 177.33 0.59 Allowed 'General case' 0 C--N 1.253 -3.588 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.443 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.569 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.14 131.57 34.22 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.325 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 3.8 m -48.08 155.43 0.46 Allowed 'General case' 0 C--N 1.277 -2.547 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.939 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 t -134.18 7.15 3.65 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.021 175.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.679 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -163.29 138.64 6.58 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.898 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -55.47 146.43 20.06 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.628 ' HA2' ' HG2' ' A' ' 27' ' ' LYS . . . 97.84 -16.05 60.87 Favored Glycine 0 N--CA 1.497 2.715 1 N-CA-C 127.634 5.814 . . . . 0.0 127.634 -172.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.637 HE22 ' N ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -78.8 -171.47 2.58 Favored 'General case' 0 N--CA 1.511 2.622 0 C-N-CA 118.896 -1.121 . . . . 0.0 109.069 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.4 m120 -148.23 -53.29 0.19 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 117.562 -1.655 . . . . 0.0 115.413 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 3' ' ' TYR . 66.2 mt -73.22 14.29 0.33 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.094 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.6 p -102.58 173.88 6.14 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.42 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.9 mt -79.19 72.58 5.76 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-O 122.885 1.326 . . . . 0.0 108.283 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 88.1 m -75.29 -71.82 0.34 Allowed 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 112.254 -2.248 . . . . 0.0 109.224 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 90.88 2.99 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 117.987 -1.485 . . . . 0.0 109.448 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.48 -138.31 40.53 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.463 -1.351 . . . . 0.0 110.413 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -0.02 50.76 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.309 1.052 . . . . 0.0 109.996 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -88.98 144.16 26.36 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 113.243 -1.799 . . . . 0.0 111.668 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.0 t -85.46 143.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.743 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.682 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -75.93 -152.43 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.484 173.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -150.82 98.69 0.19 Allowed Glycine 0 C--N 1.27 -3.113 0 C-N-CA 116.738 -2.648 . . . . 0.0 111.122 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.4 tt0 -27.94 147.92 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.792 0 CA-C-N 112.413 -1.893 . . . . 0.0 110.379 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.67 -12.22 70.32 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -170.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 43' ' ' GLU . 28.0 t30 -111.64 -159.6 0.69 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.982 -1.109 . . . . 0.0 108.989 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 30.7 tttp -157.2 111.81 2.72 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 118.656 -1.217 . . . . 0.0 111.723 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.752 ' O ' HD13 ' A' ' 29' ' ' ILE . 5.3 m -78.62 157.77 28.61 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 117.871 -1.532 . . . . 0.0 110.409 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 28' ' ' CYS . 10.7 mm -133.52 110.03 14.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.321 173.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 8' ' ' GLU . 46.8 mt -83.2 112.6 19.99 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.784 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.46 -65.62 3.29 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 118.591 -1.766 . . . . 0.0 109.454 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 34' ' ' GLY . 3.4 t -134.87 -140.86 0.18 Allowed 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -66.96 62.42 0.05 OUTLIER 'General case' 0 C--N 1.263 -3.18 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.398 -176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 84.52 27.35 36.0 Favored Glycine 0 C--N 1.281 -2.5 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' A' ' 32' ' ' SER . 17.5 mm-40 -84.38 -103.16 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -73.9 51.23 0.38 Allowed 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.472 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m-20 -58.68 85.85 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.928 171.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.423 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 8.3 tt0 -78.0 175.33 10.17 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 117.687 -1.605 . . . . 0.0 106.884 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.423 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -138.77 74.51 1.48 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.071 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.615 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -120.12 138.91 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 C-N-CA 118.871 -1.132 . . . . 0.0 111.355 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 3.5 t -50.4 160.89 0.35 Allowed 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.22 -23.34 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.976 -1.465 . . . . 0.0 110.992 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -162.99 -150.6 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.485 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' H ' ' CD ' ' A' ' 43' ' ' GLU . . . 176.8 85.74 0.06 OUTLIER Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.189 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.84 139.3 29.93 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.032 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.0 Cg_endo -75.8 117.36 4.7 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.146 1.231 . . . . 0.0 110.203 173.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 46' ' ' PRO . 4.1 tmtt? -40.33 100.94 0.23 Allowed Pre-proline 0 N--CA 1.498 1.937 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.197 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.0 149.23 92.22 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.9 1.067 . . . . 0.0 111.53 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 C--N 1.306 -1.309 0 CA-C-O 116.252 -1.833 . . . . 0.0 110.412 179.497 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.0 t -107.89 170.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.88 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.472 ' C ' HG22 ' A' ' 4' ' ' THR . 2.4 m-85 -130.83 -99.48 0.32 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.538 0.685 . . . . 0.0 110.204 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.58 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER 178.07 -178.92 0.26 Allowed 'General case' 0 C--N 1.255 -3.543 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.027 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.58 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -94.91 134.99 36.96 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.092 -1.043 . . . . 0.0 112.103 -177.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -55.89 158.77 3.54 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.476 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -146.65 14.87 1.23 Allowed 'General case' 0 C--N 1.279 -2.499 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.003 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -166.37 137.16 3.44 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.715 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.613 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -54.64 152.33 7.05 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.838 176.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.39 -1.99 73.61 Favored Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.088 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.27 -165.98 0.76 Allowed 'General case' 0 N--CA 1.517 2.916 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.265 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.962 HD22 ' HA2' ' A' ' 44' ' ' GLY . 1.4 m-20 -164.04 -56.88 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 18.3 mt -74.87 12.99 0.72 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.592 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.2 p -105.13 178.98 4.4 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.841 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.1 mt -78.99 76.83 5.47 Favored 'General case' 0 CA--C 1.471 -2.078 0 CA-C-O 123.082 1.42 . . . . 0.0 108.936 -176.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 84.9 m -75.44 -84.83 0.05 OUTLIER 'General case' 1 C--N 1.243 -4.034 0 CA-C-N 112.027 -2.352 . . . . 0.0 111.123 -177.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.58 104.46 6.14 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.174 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.36 -111.38 3.46 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.916 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.28 3.99 7.79 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.472 1.129 . . . . 0.0 109.463 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -87.24 145.19 26.48 Favored 'General case' 0 C--N 1.257 -3.424 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.9 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.8 t -82.92 143.24 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.328 -1.349 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -96.84 -178.22 4.16 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.028 175.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 25' ' ' GLY . . . -121.24 116.78 3.25 Favored Glycine 0 C--N 1.278 -2.645 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.072 -169.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.735 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 2.4 pt20 -41.8 3.28 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.048 0 CA-C-N 111.345 -2.427 . . . . 0.0 114.11 174.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -102.62 16.01 55.23 Favored Glycine 0 C--N 1.262 -3.53 0 N-CA-C 105.935 -2.866 . . . . 0.0 105.935 172.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.849 ' C ' HD21 ' A' ' 12' ' ' ASN . 1.7 t-20 -138.61 -154.53 0.53 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.619 -1.29 . . . . 0.0 108.748 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -163.0 109.3 1.17 Allowed 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.084 177.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -84.64 139.36 32.1 Favored 'General case' 0 CA--C 1.46 -2.503 0 C-N-CA 118.386 -1.326 . . . . 0.0 109.435 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.634 HD11 ' CE ' ' A' ' 27' ' ' LYS . 29.7 mm -125.77 119.03 53.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.169 0 CA-C-N 113.713 -1.585 . . . . 0.0 112.123 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.613 HD12 ' N ' ' A' ' 9' ' ' SER . 21.6 mt -76.93 121.65 23.76 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.606 -1.238 . . . . 0.0 109.98 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . 72.65 89.28 0.14 Allowed Glycine 0 N--CA 1.499 2.89 0 C-N-CA 119.205 -1.474 . . . . 0.0 111.469 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -124.38 84.01 2.22 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t0 44.48 44.83 7.34 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.722 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.64 -1.31 18.06 Favored Glycine 0 C--N 1.295 -1.71 1 N-CA-C 124.351 4.5 . . . . 0.0 124.351 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 37' ' ' ASN . 6.1 mm-40 -121.31 103.35 8.9 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-N 113.169 -1.516 . . . . 0.0 109.265 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' GLY . 9.8 mttm -68.41 3.11 1.9 Allowed 'General case' 1 C--N 1.2 -5.935 0 CA-C-N 111.923 -2.399 . . . . 0.0 110.848 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.762 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER 175.85 89.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.138 -175.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 10.4 tt0 -89.05 -169.26 2.45 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.337 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.537 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -158.57 46.17 0.31 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.872 -174.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.5 m -114.39 158.44 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 t -12.65 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.084 0 CA-C-N 110.883 -2.871 . . . . 0.0 114.009 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 27' ' ' LYS . . . -179.77 -99.11 0.12 Allowed Glycine 0 N--CA 1.496 2.652 1 N-CA-C 132.148 7.619 . . . . 0.0 132.148 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -161.17 28.37 0.14 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.003 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.962 ' HA2' HD22 ' A' ' 12' ' ' ASN . . . 13.64 73.29 0.01 OUTLIER Glycine 0 C--N 1.3 -1.462 1 N-CA-C 129.598 6.599 . . . . 0.0 129.598 177.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.92 130.31 64.07 Favored Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 118.27 -1.372 . . . . 0.0 110.188 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -76.23 106.13 2.21 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 C-N-CA 121.392 1.394 . . . . 0.0 110.748 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -51.9 109.28 1.33 Allowed Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 118.746 -1.181 . . . . 0.0 109.607 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.37 153.67 75.55 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.803 1.002 . . . . 0.0 111.42 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.266 0 CA-C-O 116.348 -1.786 . . . . 0.0 110.482 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 1' ' ' VAL . 37.3 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 t -82.17 165.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.887 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.732 ' CZ ' HD22 ' A' ' 13' ' ' LEU . 9.3 m-85 -104.18 -112.57 0.24 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.419 0.628 . . . . 0.0 110.335 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.404 ' H ' ' HB3' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -146.94 169.18 19.71 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.661 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.4 127.24 35.8 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.103 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.7 m -46.86 155.37 0.26 Allowed 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.723 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.51 HG22 ' HZ3' ' A' ' 47' ' ' LYS . 1.7 t -147.97 16.68 1.09 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.822 175.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -163.06 131.82 3.97 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.08 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -55.41 153.3 7.54 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.4 174.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 90.42 -23.79 20.16 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 118.359 -1.877 . . . . 0.0 111.295 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' GLY . 13.1 mm-40 -54.76 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.254 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.866 HD21 ' C ' ' A' ' 26' ' ' ASN . 5.0 m-20 -176.67 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.166 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.732 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 6.0 mt -73.68 8.03 2.13 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.619 ' H ' ' C ' ' A' ' 12' ' ' ASN . 27.5 p -102.44 -179.97 4.13 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.622 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' N ' HD23 ' A' ' 15' ' ' LEU . 6.3 mt -79.41 71.61 5.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-O 122.739 1.257 . . . . 0.0 108.371 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 34.1 t -70.82 -77.58 0.09 Allowed 'General case' 0 C--N 1.255 -3.532 0 CA-C-N 112.531 -2.122 . . . . 0.0 109.428 -177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.02 89.61 2.43 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 117.76 -1.576 . . . . 0.0 109.019 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.21 -142.47 44.64 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.334 -1.413 . . . . 0.0 110.631 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -0.05 30.37 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.124 0.964 . . . . 0.0 110.35 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -87.63 143.59 27.1 Favored 'General case' 0 C--N 1.26 -3.317 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.849 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 22' ' ' CYS . 8.0 t -88.75 142.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.095 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.672 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -77.69 -160.56 0.19 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.015 175.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -143.83 96.43 0.19 Allowed Glycine 0 C--O 1.186 -2.895 0 C-N-CA 117.904 -2.093 . . . . 0.0 108.862 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.686 ' HA ' HD22 ' A' ' 12' ' ' ASN . 0.0 OUTLIER -30.59 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.537 3.922 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -82.51 7.09 66.06 Favored Glycine 1 C--N 1.238 -4.903 0 N-CA-C 105.741 -2.944 . . . . 0.0 105.741 172.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.866 ' C ' HD21 ' A' ' 12' ' ' ASN . 64.6 m-20 -121.97 -156.44 0.69 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.477 -1.362 . . . . 0.0 108.6 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.694 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -152.31 103.29 2.83 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.645 176.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.597 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 42.1 t -78.31 162.75 26.27 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 117.521 -1.672 . . . . 0.0 108.876 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.694 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 22.2 mm -149.88 121.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.386 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 9' ' ' SER . 12.3 mt -88.06 139.41 30.54 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.988 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 35' ' ' GLU . . . 57.19 75.77 0.24 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.084 -1.531 . . . . 0.0 111.805 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.616 ' OG ' ' N ' ' A' ' 33' ' ' ASP . 7.2 p -100.06 -141.73 0.33 Allowed 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.616 ' N ' ' OG ' ' A' ' 32' ' ' SER . 4.3 t0 -68.03 59.34 0.07 Allowed 'General case' 0 C--N 1.258 -3.393 0 O-C-N 124.794 1.309 . . . . 0.0 109.125 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 89.72 41.79 5.58 Favored Glycine 0 C--N 1.285 -2.292 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 -176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 31' ' ' GLY . 22.3 mt-10 -145.07 104.67 3.99 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 123.178 1.466 . . . . 0.0 111.745 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 31' ' ' GLY . 12.7 pttm -64.37 0.05 1.14 Allowed 'General case' 1 C--N 1.211 -5.417 0 CA-C-N 111.998 -2.364 . . . . 0.0 111.897 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.819 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER 175.83 113.28 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.436 -176.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.819 ' N ' HD22 ' A' ' 37' ' ' ASN . 9.9 tt0 -122.08 159.77 26.41 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -122.69 66.58 0.95 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -176.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -90.41 121.59 40.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 117.921 -1.512 . . . . 0.0 112.425 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -37.55 173.47 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 112.897 -1.956 . . . . 0.0 112.89 177.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' N ' ' HA ' ' A' ' 26' ' ' ASN . . . 126.44 -105.54 0.79 Allowed Glycine 0 N--CA 1.484 1.871 1 N-CA-C 128.411 6.124 . . . . 0.0 128.411 -176.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -165.01 88.9 0.47 Allowed 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.49 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' ASN . . . -102.23 -123.02 5.17 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 118.896 -1.621 . . . . 0.0 110.682 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.42 134.52 10.2 Favored Pre-proline 0 C--N 1.286 -2.179 0 CA-C-N 114.526 -0.837 . . . . 0.0 110.938 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -70.1 98.83 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 N-CA-C 109.683 -0.93 . . . . 0.0 109.683 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.51 ' HZ3' HG22 ' A' ' 7' ' ' THR . 26.3 tttp -43.99 105.35 0.43 Allowed Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.025 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.62 141.63 95.43 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.916 1.077 . . . . 0.0 111.711 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.357 -1.782 . . . . 0.0 110.494 179.269 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.03 161.46 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.082 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.534 ' O ' HG23 ' A' ' 4' ' ' THR . 58.3 m-85 -102.93 -116.53 0.2 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.507 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.5 p -160.13 165.78 31.03 Favored 'General case' 0 C--N 1.257 -3.429 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.928 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.21 129.54 34.56 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.992 -177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' OE1' ' A' ' 11' ' ' GLN . 13.7 m -46.58 169.8 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.573 0 CA-C-O 122.639 1.209 . . . . 0.0 110.436 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -150.08 14.36 0.8 Allowed 'General case' 0 C--N 1.258 -3.388 0 CA-C-N 112.415 -2.175 . . . . 0.0 106.783 172.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -164.96 123.13 1.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.196 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.611 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -51.37 153.92 1.95 Allowed 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.626 175.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 10.2 85.51 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 118.776 -1.678 . . . . 0.0 111.487 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' OE1' ' CB ' ' A' ' 6' ' ' CYS . 3.4 mt-30 -82.62 -166.45 1.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 14' ' ' CYS . 6.2 t-20 -135.64 -93.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 117.199 -1.8 . . . . 0.0 115.323 -177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 2.5 mt -75.13 40.32 0.15 Allowed 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.804 -173.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.57 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -94.59 -160.94 0.81 Allowed 'General case' 0 C--O 1.18 -2.593 0 C-N-CA 117.919 -1.512 . . . . 0.0 109.016 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.1 mt -109.04 81.2 1.41 Allowed 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 9.0 m -76.35 -81.71 0.08 Allowed 'General case' 0 C--N 1.249 -3.768 0 CA-C-N 112.944 -1.934 . . . . 0.0 111.209 -174.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 4.0 mm-40 -78.36 107.22 10.83 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 117.86 -1.536 . . . . 0.0 109.238 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.93 11.86 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.654 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 2.15 15.25 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.26 1.029 . . . . 0.0 110.056 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.61 149.32 25.94 Favored 'General case' 0 C--N 1.259 -3.353 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.931 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 35.5 t -88.2 148.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 118.491 -1.283 . . . . 0.0 111.049 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.2 m -136.62 -166.64 1.93 Allowed 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.591 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 93.21 -43.39 2.54 Favored Glycine 0 C--N 1.292 -1.915 0 C-N-CA 117.336 -2.364 . . . . 0.0 111.748 175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.532 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.8 tt0 -59.04 105.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.081 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.06 -10.16 28.47 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.591 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -118.89 -165.23 1.11 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.428 -0.886 . . . . 0.0 111.653 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.545 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -156.69 112.76 2.98 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.004 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 m -80.58 152.01 28.8 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 118.304 -1.359 . . . . 0.0 110.857 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.545 HD11 ' CE ' ' A' ' 27' ' ' LYS . 31.8 mm -139.53 104.7 2.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.455 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 9' ' ' SER . 10.2 mt -61.67 165.36 5.15 Favored 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 118.676 -1.21 . . . . 0.0 110.146 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.538 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . -153.46 -81.62 0.03 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 118.297 -1.906 . . . . 0.0 112.02 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.547 ' H ' ' N ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER 167.17 119.33 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.468 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.6 86.47 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.014 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.67 -49.41 4.04 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 37' ' ' ASN . 1.9 mt-10 -85.8 -2.88 58.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.679 1.228 . . . . 0.0 109.557 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' N ' ' H ' ' A' ' 32' ' ' SER . 8.5 tttm -50.74 -14.3 0.19 Allowed 'General case' 0 C--N 1.265 -3.073 0 CA-C-N 112.529 -2.123 . . . . 0.0 111.963 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 35' ' ' GLU . 30.0 m-80 -159.55 88.8 0.87 Allowed 'General case' 0 C--N 1.247 -3.869 0 CA-C-N 112.724 -2.035 . . . . 0.0 111.467 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -87.37 166.37 14.9 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 117.842 -1.543 . . . . 0.0 107.6 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.3 m -133.34 71.31 1.46 Allowed 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -91.37 137.71 21.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.507 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.8 t -34.83 168.01 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.815 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 122.48 -146.14 16.65 Favored Glycine 0 N--CA 1.482 1.706 1 N-CA-C 130.014 6.766 . . . . 0.0 130.014 -178.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -161.89 119.55 2.21 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.553 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.84 -91.3 1.11 Allowed Glycine 0 N--CA 1.486 2.032 1 N-CA-C 129.742 6.657 . . . . 0.0 129.742 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.8 122.14 4.25 Favored Pre-proline 0 C--N 1.302 -1.5 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.356 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.2 Cg_endo -66.71 95.26 0.34 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.07 1.18 . . . . 0.0 109.638 177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 46' ' ' PRO . 11.9 tttt -39.47 99.41 0.19 Allowed Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.211 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.89 158.33 29.65 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 120.855 1.037 . . . . 0.0 111.78 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.56 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 2' ' ' VAL . 1.2 t -90.65 163.68 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 4' ' ' THR . 5.8 m-85 -141.84 -114.01 0.12 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.967 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.0 p -163.79 176.51 9.46 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.272 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -89.48 132.48 35.01 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.733 -1.187 . . . . 0.0 110.584 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.33 149.26 7.62 Favored 'General case' 0 C--N 1.278 -2.531 0 C-N-CA 118.826 -1.15 . . . . 0.0 109.975 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 7' ' ' THR . 1.9 t -148.69 18.34 1.02 Allowed 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -161.54 109.37 1.46 Allowed 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.287 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.612 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -47.83 147.1 2.08 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.471 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 100.92 -5.82 56.59 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.684 -1.246 . . . . 0.0 111.791 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.634 HE21 ' HA ' ' A' ' 47' ' ' LYS . 61.4 mt-30 -85.57 -164.96 1.1 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.285 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.753 HD21 ' C ' ' A' ' 26' ' ' ASN . 35.5 m-20 -164.28 -43.08 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.806 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.581 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 51.7 mt -76.91 17.26 0.44 Allowed 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.051 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' H ' ' C ' ' A' ' 12' ' ' ASN . 28.2 p -108.43 176.93 4.94 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.457 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.2 mt -78.59 73.57 5.14 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 123.0 1.381 . . . . 0.0 108.16 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 32.1 t -67.79 -82.96 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.936 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.25 120.98 26.86 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 117.819 -1.552 . . . . 0.0 109.9 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.27 -115.94 6.36 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.036 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -127.93 5.59 5.99 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.753 1.263 . . . . 0.0 108.819 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -88.29 144.46 26.41 Favored 'General case' 0 C--N 1.262 -3.204 0 CA-C-N 112.342 -2.208 . . . . 0.0 112.256 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 22' ' ' CYS . 22.1 t -80.0 139.08 18.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 118.398 -1.321 . . . . 0.0 109.744 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.59 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -85.4 -140.64 0.08 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 118.416 -1.314 . . . . 0.0 109.371 175.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -157.65 111.89 0.5 Allowed Glycine 0 C--N 1.286 -2.233 0 C-N-CA 116.339 -2.839 . . . . 0.0 112.574 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.5 tt0 -36.21 152.06 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 113.482 -1.359 . . . . 0.0 108.448 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.88 -18.11 57.3 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.753 ' C ' HD21 ' A' ' 12' ' ' ASN . 5.3 t-20 -106.33 -161.83 0.82 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 112.989 -1.605 . . . . 0.0 107.081 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HA ' HD21 ' A' ' 12' ' ' ASN . 0.5 OUTLIER -160.35 101.96 1.39 Allowed 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.901 174.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.852 ' O ' HD13 ' A' ' 29' ' ' ILE . 22.2 m -78.64 155.71 29.4 Favored 'General case' 0 CA--C 1.46 -2.487 0 C-N-CA 118.027 -1.469 . . . . 0.0 110.424 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.3 mm -136.3 108.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.332 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.649 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 9' ' ' SER . 18.0 mt -60.29 113.04 2.17 Favored 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 118.155 -1.418 . . . . 0.0 108.394 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.584 ' HA3' ' H ' ' A' ' 36' ' ' LYS . . . -16.46 -36.52 0.0 OUTLIER Glycine 0 N--CA 1.492 2.402 1 N-CA-C 126.879 5.512 . . . . 0.0 126.879 -176.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 30' ' ' LEU . 5.1 t 170.51 99.74 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.778 -1.211 . . . . 0.0 108.39 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 54.51 47.49 22.63 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.163 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.88 6.24 63.72 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.468 -1.348 . . . . 0.0 112.24 177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HB2' ' N ' ' A' ' 32' ' ' SER . 3.4 mt-10 -64.73 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.819 -1.152 . . . . 0.0 111.143 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.584 ' H ' ' HA3' ' A' ' 31' ' ' GLY . 20.5 mttm -90.97 -134.74 0.13 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.3 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.601 ' HB3' HD23 ' A' ' 30' ' ' LEU . 2.8 p30 167.71 89.76 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 113.296 -1.775 . . . . 0.0 111.598 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.442 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 14.3 tt0 -83.46 -176.1 6.14 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.5 m -136.68 75.16 1.52 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -109.25 127.54 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 118.156 -1.418 . . . . 0.0 114.363 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.559 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 t -27.37 148.73 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 112.579 -2.1 . . . . 0.0 113.566 172.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.48 -101.37 0.19 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -98.61 -139.54 0.31 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.346 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 179.95 88.66 0.07 OUTLIER Glycine 0 C--N 1.28 -2.539 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.9 139.56 25.12 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 119.676 -0.81 . . . . 0.0 110.527 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -77.14 136.62 16.39 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.199 1.266 . . . . 0.0 109.16 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.634 ' HA ' HE21 ' A' ' 11' ' ' GLN . 16.4 tttp -51.79 -51.18 72.83 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 117.791 -1.564 . . . . 0.0 111.021 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 2.8 Cg_endo -67.3 108.79 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.803 1.002 . . . . 0.0 111.114 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.4 mp0 . . . . . 0 C--N 1.302 -1.491 0 CA-C-O 116.341 -1.79 . . . . 0.0 110.333 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 1' ' ' VAL . 52.0 t . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 3' ' ' TYR . 21.9 t -89.72 174.47 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.404 -0.919 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.623 ' N ' HG12 ' A' ' 2' ' ' VAL . 5.8 m-85 -137.99 -112.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.069 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -172.08 176.5 3.47 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.036 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.562 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.27 131.0 34.37 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.168 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.1 m -53.44 158.46 1.73 Allowed 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.734 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -140.16 8.99 2.29 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.125 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.501 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.7 mm-40 -161.0 143.98 12.84 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.52 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -62.03 147.92 45.64 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.658 175.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 27' ' ' LYS . . . 94.61 -7.44 71.14 Favored Glycine 0 N--CA 1.503 3.154 1 N-CA-C 126.736 5.454 . . . . 0.0 126.736 -172.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 75.9 mt-30 -83.67 -167.41 1.71 Allowed 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 114.283 -0.959 . . . . 0.0 111.09 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.746 HD21 ' C ' ' A' ' 26' ' ' ASN . 2.2 m-80 -156.38 -51.13 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 117.985 -1.486 . . . . 0.0 114.553 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 59.5 mt -76.09 13.69 0.84 Allowed 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.618 -175.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.5 p -110.13 177.8 4.6 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.73 -177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 15' ' ' LEU . 10.3 mt -77.77 75.92 4.31 Favored 'General case' 0 CA--C 1.468 -2.196 0 CA-C-O 122.811 1.291 . . . . 0.0 108.552 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.3 m -74.62 -80.43 0.08 Allowed 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.647 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.32 107.62 12.22 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.156 -1.418 . . . . 0.0 109.502 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.46 -144.02 48.74 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.176 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.26 5.06 48.76 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 122.38 1.086 . . . . 0.0 109.778 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -88.6 143.59 26.85 Favored 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 113.27 -1.786 . . . . 0.0 111.941 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 22' ' ' CYS . 11.4 t -83.76 139.28 17.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.277 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.625 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -78.47 -146.14 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.022 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.735 175.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.99 117.54 0.77 Allowed Glycine 0 C--N 1.278 -2.664 0 C-N-CA 117.451 -2.309 . . . . 0.0 110.67 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.5 tt0 -33.23 154.17 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.054 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.42 -6.31 82.36 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 106.959 -2.456 . . . . 0.0 106.959 -173.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.746 ' C ' HD21 ' A' ' 12' ' ' ASN . 8.7 t30 -122.25 -164.16 1.14 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.929 -1.136 . . . . 0.0 108.493 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 40' ' ' VAL . 36.2 tttp -162.22 112.35 1.53 Allowed 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.429 -1.308 . . . . 0.0 110.833 177.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 11' ' ' GLN . 1.9 m -83.04 153.63 24.83 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 118.544 -1.262 . . . . 0.0 110.64 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.58 117.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.491 0 C-N-CA 118.518 -1.273 . . . . 0.0 111.284 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.501 HD12 ' C ' ' A' ' 8' ' ' GLU . 19.1 mt -105.01 124.03 48.82 Favored 'General case' 0 N--CA 1.518 2.959 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.921 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.871 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . -175.99 42.65 0.11 Allowed Glycine 1 N--CA 1.516 4.022 1 N-CA-C 133.678 8.231 . . . . 0.0 133.678 176.217 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.809 ' H ' ' C ' ' A' ' 35' ' ' GLU . 26.5 t -106.07 -120.8 0.23 Allowed 'General case' 0 C--O 1.188 -2.165 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.11 55.05 0.04 OUTLIER 'General case' 0 C--N 1.269 -2.898 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 91.58 1.55 71.16 Favored Glycine 0 C--N 1.288 -2.084 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.809 ' C ' ' H ' ' A' ' 32' ' ' SER 0.252 15.0 mt-10 -170.68 90.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 118.087 2.625 . . . . 0.0 118.087 -174.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.871 ' H ' ' N ' ' A' ' 31' ' ' GLY . 21.2 tttm -100.86 66.52 1.18 Allowed 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 167.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -56.41 143.14 35.84 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.517 -1.219 . . . . 0.0 113.92 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 12.7 tt0 -153.46 170.89 19.62 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.052 -1.885 . . . . 0.0 107.206 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.426 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -145.31 79.12 1.57 Allowed 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.429 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -135.77 146.25 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 C-N-CA 117.776 -1.57 . . . . 0.0 114.879 -176.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -18.14 146.6 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 113.059 -1.882 . . . . 0.0 114.176 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.24 -120.94 1.02 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 7.4 mm-40 -78.67 -135.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.48 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 12' ' ' ASN . . . 162.03 97.44 0.12 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 144.83 55.16 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.422 -177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -76.23 126.07 8.93 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 121.356 1.371 . . . . 0.0 109.469 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -49.94 130.99 22.28 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 118.45 -1.3 . . . . 0.0 109.992 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.1 130.23 35.39 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 N-CA-C 110.293 -0.695 . . . . 0.0 110.293 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 116.41 -1.757 . . . . 0.0 110.651 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 2' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.792 HG12 ' H ' ' A' ' 3' ' ' TYR . 3.5 t -79.51 -178.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.183 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.792 ' H ' HG12 ' A' ' 2' ' ' VAL . 61.5 m-85 -106.06 -115.82 0.25 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.73 0.776 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -178.1 175.35 1.26 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.77 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.73 134.68 36.4 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.653 -176.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.428 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 92.7 m -47.8 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.662 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -138.05 3.14 2.4 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.725 -1.58 . . . . 0.0 107.992 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' C ' HD12 ' A' ' 30' ' ' LEU . 9.0 tt0 -171.16 136.55 1.07 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 113.741 -1.572 . . . . 0.0 110.424 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.661 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -51.27 157.88 0.89 Allowed 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.468 178.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.16 -20.97 46.7 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 118.663 -1.732 . . . . 0.0 112.629 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -174.48 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.15 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -161.65 21.9 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 115.668 -2.413 . . . . 0.0 115.285 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 3' ' ' TYR . 40.2 mt -146.71 25.88 1.16 Allowed 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -104.81 179.8 4.17 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.227 -176.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.635 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 9.4 mt -84.06 75.55 10.14 Favored 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.661 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 2.3 t -73.58 -68.99 0.46 Allowed 'General case' 0 C--N 1.254 -3.572 0 CA-C-N 112.581 -2.1 . . . . 0.0 110.472 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -84.32 89.32 7.34 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.708 -1.197 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.52 -133.22 25.47 Favored Glycine 0 N--CA 1.482 1.742 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.045 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 -1.66 58.21 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.144 0.973 . . . . 0.0 110.412 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -81.49 137.88 35.55 Favored 'General case' 0 C--N 1.26 -3.301 0 CA-C-N 113.597 -1.638 . . . . 0.0 111.48 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 22' ' ' CYS . 52.4 t -83.03 155.15 3.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 118.143 -1.423 . . . . 0.0 110.231 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' N ' HG12 ' A' ' 21' ' ' VAL . 10.9 m -145.19 -173.21 4.04 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 1.015 ' N ' HD22 ' A' ' 26' ' ' ASN . . . 99.31 -45.55 1.54 Allowed Glycine 0 C--O 1.206 -1.6 0 C-N-CA 117.547 -2.264 . . . . 0.0 114.611 173.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -63.48 115.89 5.07 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.786 -1.565 . . . . 0.0 109.586 -178.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.92 -10.56 39.41 Favored Glycine 0 N--CA 1.475 1.264 0 N-CA-C 106.6 -2.6 . . . . 0.0 106.6 -173.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 1.015 HD22 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -125.96 -158.24 0.84 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.919 -1.141 . . . . 0.0 111.417 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -154.82 124.36 6.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.527 176.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.0 t -78.82 155.13 29.35 Favored 'General case' 0 CA--C 1.479 -1.768 0 C-N-CA 117.54 -1.664 . . . . 0.0 109.5 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.581 HD11 ' CE ' ' A' ' 27' ' ' LYS . 15.2 mm -150.77 122.43 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.619 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.716 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 9' ' ' SER . 7.7 mt -94.88 129.79 41.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.186 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 76.58 92.44 0.22 Allowed Glycine 0 N--CA 1.502 3.079 0 C-N-CA 118.708 -1.711 . . . . 0.0 110.891 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -132.96 91.1 2.84 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' SER . 7.7 t0 35.57 49.91 0.55 Allowed 'General case' 0 N--CA 1.513 2.704 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.725 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.04 7.18 12.99 Favored Glycine 0 C--N 1.297 -1.626 1 N-CA-C 125.29 4.876 . . . . 0.0 125.29 -174.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 37' ' ' ASN . 36.4 mt-10 -142.8 108.16 5.02 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 113.767 -1.216 . . . . 0.0 111.036 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -66.31 6.18 0.46 Allowed 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.598 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.672 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -166.57 130.27 2.0 Allowed 'General case' 0 C--N 1.273 -2.753 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.751 -176.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.606 ' N ' ' ND2' ' A' ' 37' ' ' ASN . 40.2 tt0 -150.71 155.85 40.12 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 77.2 m -116.94 65.1 0.72 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -77.78 130.34 36.34 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.618 0 C-N-CA 117.709 -1.597 . . . . 0.0 111.515 -171.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.4 t -35.77 167.45 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.057 -1.883 . . . . 0.0 112.395 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 123.04 -133.93 9.28 Favored Glycine 0 N--CA 1.488 2.108 1 N-CA-C 130.387 6.915 . . . . 0.0 130.387 -178.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -161.99 116.2 1.88 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.595 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.95 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.42 -1.372 . . . . 0.0 111.511 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -158.85 152.58 19.32 Favored Pre-proline 0 C--N 1.31 -1.136 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.404 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -72.3 116.29 4.65 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 C-N-CA 121.212 1.275 . . . . 0.0 109.733 170.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.8 tttp -46.52 112.78 1.97 Allowed Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.702 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -67.87 133.0 27.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.457 0.772 . . . . 0.0 110.426 176.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.1 tt0 . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 116.387 -1.768 . . . . 0.0 111.461 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.27 165.39 2.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.146 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 4' ' ' THR . 2.3 m-85 -132.06 -111.84 0.24 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.813 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.7 p -162.34 177.31 9.69 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.809 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.55 134.02 34.32 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.678 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.7 m -52.54 155.48 2.16 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.052 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -140.54 9.73 2.24 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.688 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.668 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.0 mm-40 -163.33 139.85 7.11 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.838 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.435 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.87 156.92 6.08 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.496 176.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 85.18 0.66 88.67 Favored Glycine 0 N--CA 1.499 2.868 0 C-N-CA 119.475 -1.345 . . . . 0.0 113.086 178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.417 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 27.2 mt-30 -84.4 -177.37 6.61 Favored 'General case' 0 N--CA 1.514 2.768 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.175 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.819 HD21 ' C ' ' A' ' 26' ' ' ASN . 2.3 m-20 -151.81 -50.88 0.11 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 117.978 -1.489 . . . . 0.0 114.394 -177.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 87.1 mt -75.99 17.99 0.3 Allowed 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.299 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.528 ' H ' ' C ' ' A' ' 12' ' ' ASN . 29.7 p -110.35 178.92 4.23 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.136 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.45 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.6 mt -79.94 73.0 6.72 Favored 'General case' 0 CA--C 1.465 -2.289 0 CA-C-O 122.843 1.306 . . . . 0.0 108.552 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 94.4 m -69.94 -93.41 0.01 OUTLIER 'General case' 0 C--N 1.246 -3.915 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.28 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -73.09 116.55 13.76 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 117.711 -1.596 . . . . 0.0 109.394 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.28 -139.63 42.28 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.229 -1.462 . . . . 0.0 109.796 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 6.31 45.21 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.526 1.155 . . . . 0.0 108.992 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.88 144.7 28.23 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.305 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.9 t -85.12 138.93 18.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 118.154 -1.418 . . . . 0.0 109.556 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -77.33 -140.18 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 118.672 -1.211 . . . . 0.0 108.954 175.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.45 122.19 1.03 Allowed Glycine 0 C--N 1.275 -2.837 0 C-N-CA 117.303 -2.379 . . . . 0.0 111.056 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.603 ' HA ' HD22 ' A' ' 12' ' ' ASN . 4.4 tt0 -34.41 157.17 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 113.579 -1.31 . . . . 0.0 110.028 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -18.35 21.52 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 107.046 -2.421 . . . . 0.0 107.046 -174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.819 ' C ' HD21 ' A' ' 12' ' ' ASN . 13.0 t30 -104.19 -164.39 1.05 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.915 177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -161.67 102.77 1.19 Allowed 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 118.046 -1.461 . . . . 0.0 111.65 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 10' ' ' GLY . 2.4 m -79.84 153.6 28.97 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.45 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.631 HD11 ' CE ' ' A' ' 27' ' ' LYS . 33.4 mm -134.71 115.58 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.893 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.668 HD12 ' C ' ' A' ' 8' ' ' GLU . 10.6 mt -92.68 140.16 29.82 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.642 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . -149.11 -87.16 0.06 OUTLIER Glycine 0 N--CA 1.502 3.065 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.874 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.425 ' N ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER 175.64 120.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.656 -176.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 t0 52.42 88.39 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.476 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.31 -47.18 3.45 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 31' ' ' GLY . 1.7 mt-10 -91.43 -3.13 56.96 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.526 1.155 . . . . 0.0 109.788 177.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 12.1 pttt -55.4 -11.66 0.88 Allowed 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 112.831 -1.986 . . . . 0.0 112.029 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.682 HD22 ' N ' ' A' ' 38' ' ' GLN . 1.2 t-20 175.02 129.9 0.03 OUTLIER 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.274 -175.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.682 ' N ' HD22 ' A' ' 37' ' ' ASN . 38.6 tt0 -144.1 171.0 14.89 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.58 73.21 1.52 Allowed 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -113.11 130.3 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -172.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.9 t -22.71 155.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 112.54 -2.118 . . . . 0.0 113.573 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.35 -123.56 1.93 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -76.85 -131.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.393 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.574 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 157.2 80.09 0.03 OUTLIER Glycine 0 C--N 1.282 -2.431 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.933 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.36 131.52 42.08 Favored Pre-proline 0 CA--C 1.559 1.29 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.871 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.65 119.56 6.5 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.123 1.215 . . . . 0.0 110.928 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.4 114.25 8.91 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.539 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 49' ' ' GLN . 5.3 Cg_exo -56.67 -173.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 120.644 0.896 . . . . 0.0 111.558 -176.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 48' ' ' PRO . 29.5 mt-30 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.762 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 3' ' ' TYR . 20.1 t -83.7 170.53 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.452 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.598 ' N ' HG12 ' A' ' 2' ' ' VAL . 26.8 m-85 -103.82 -113.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.019 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.1 p -159.0 169.17 24.91 Favored 'General case' 0 C--N 1.261 -3.28 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.992 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.47 130.2 34.78 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 118.69 -1.204 . . . . 0.0 111.103 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.434 ' CB ' HD11 ' A' ' 30' ' ' LEU . 43.7 m -47.4 171.61 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.331 177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 t -144.33 8.1 1.37 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.704 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.746 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.6 tt0 -170.49 139.24 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.4 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.476 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -52.97 159.31 1.19 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.79 176.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.85 -20.61 50.01 Favored Glycine 0 N--CA 1.501 2.968 0 C-N-CA 119.037 -1.554 . . . . 0.0 112.461 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.47 -173.06 3.88 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.496 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 14' ' ' CYS . 69.6 m-80 -155.77 -45.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 117.72 -1.592 . . . . 0.0 113.937 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 3' ' ' TYR . 45.5 mt -76.59 16.24 0.52 Allowed 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.163 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.64 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -100.4 -170.1 1.82 Allowed 'General case' 0 C--O 1.181 -2.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.64 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 10.9 mt -91.52 71.38 5.94 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 5.8 t -64.2 -84.4 0.02 OUTLIER 'General case' 0 C--N 1.254 -3.554 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.929 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 tm-20 -69.88 88.0 0.55 Allowed 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.067 -1.453 . . . . 0.0 109.227 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.49 -130.9 18.76 Favored Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.399 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.96 0.75 57.45 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.184 0.992 . . . . 0.0 110.38 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -90.41 147.18 23.59 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.065 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 23.6 t -85.99 147.16 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 117.979 -1.488 . . . . 0.0 110.813 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.415 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -76.29 -129.91 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.36 115.45 0.57 Allowed Glycine 0 C--N 1.276 -2.751 0 C-N-CA 117.871 -2.109 . . . . 0.0 110.892 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 12.4 tt0 -34.44 149.22 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.279 -0.96 . . . . 0.0 109.905 177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.39 -10.89 65.07 Favored Glycine 0 C--N 1.292 -1.906 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 43' ' ' GLU . 20.4 t30 -108.09 -162.9 0.85 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.572 ' O ' ' O ' ' A' ' 40' ' ' VAL . 50.4 tttp -154.24 104.26 2.59 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 118.56 -1.256 . . . . 0.0 110.74 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 38' ' ' GLN . 52.6 t -77.4 159.57 29.36 Favored 'General case' 0 CA--C 1.462 -2.425 0 C-N-CA 117.01 -1.876 . . . . 0.0 109.284 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 28' ' ' CYS . 8.9 mm -137.23 115.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.132 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.746 HD12 ' C ' ' A' ' 8' ' ' GLU . 18.9 mt -101.24 109.18 21.0 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.575 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.961 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . -165.79 67.54 0.2 Allowed Glycine 1 N--CA 1.517 4.065 0 C-N-CA 115.569 -3.205 . . . . 0.0 117.617 179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.823 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 29.6 t -114.49 -139.49 0.38 Allowed 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' N ' ' OG ' ' A' ' 32' ' ' SER . 3.3 m-20 -47.94 -21.52 0.45 Allowed 'General case' 0 C--N 1.273 -2.751 0 CA-C-O 123.512 1.625 . . . . 0.0 107.858 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.579 ' N ' ' C ' ' A' ' 32' ' ' SER . . . -165.27 -4.14 0.04 OUTLIER Glycine 1 C--N 1.245 -4.512 0 CA-C-N 110.763 -2.926 . . . . 0.0 108.867 175.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.823 ' CA ' ' H ' ' A' ' 32' ' ' SER 0.267 13.8 mt-10 -177.28 101.13 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.961 ' H ' ' N ' ' A' ' 31' ' ' GLY . 16.4 tttt -98.15 69.28 2.01 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 171.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.557 ' ND2' ' CD2' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -49.41 136.94 15.43 Favored 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.603 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 15.7 tt0 -155.02 164.35 39.01 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -130.11 75.72 1.67 Allowed 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.572 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -119.32 130.42 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.569 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.419 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 8.1 t -51.09 154.56 1.52 Allowed 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.388 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.06 -24.32 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.117 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' ASN . 3.3 tt0 -162.89 -143.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.367 0.603 . . . . 0.0 110.265 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -179.2 85.47 0.07 OUTLIER Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.757 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.72 107.1 58.67 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 Cg_endo -68.68 92.9 0.43 Allowed 'Trans proline' 0 C--O 1.214 -0.681 0 N-CA-C 109.526 -0.99 . . . . 0.0 109.526 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 48' ' ' PRO . 4.7 tmtm? -40.39 118.19 1.44 Allowed Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.668 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.513 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 5.8 Cg_exo -59.48 108.46 0.46 Allowed 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.587 0.858 . . . . 0.0 110.833 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.61 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 116.244 -1.836 . . . . 0.0 111.094 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' H ' ' A' ' 3' ' ' TYR . 2.9 t -99.92 170.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.014 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.66 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 69.4 m-85 -139.68 -121.95 0.12 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.64 0.733 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 3.0 t 177.99 -177.77 0.22 Allowed 'General case' 0 C--N 1.259 -3.332 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.823 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.539 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.32 133.09 36.61 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.521 -177.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 86.7 m -46.14 169.1 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.089 177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.534 HG22 HE22 ' A' ' 11' ' ' GLN . 5.5 t -155.27 17.3 0.41 Allowed 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.921 172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 2.0 tt0 -167.31 124.14 1.18 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.905 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.598 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -55.78 151.64 10.9 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.646 177.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.86 -16.53 59.19 Favored Glycine 0 C--N 1.282 -2.439 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.25 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.534 HE22 HG22 ' A' ' 7' ' ' THR . 17.5 mt-30 -60.23 179.21 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.507 ' HB3' ' H ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -161.3 25.55 0.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 115.523 -2.471 . . . . 0.0 115.352 -177.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.66 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 34.6 mt -147.61 26.74 1.02 Allowed 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 172.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.644 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.46 177.74 4.7 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.373 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.644 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 mt -80.38 70.86 7.13 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.054 -1.884 . . . . 0.0 107.408 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 41.4 m -73.28 -61.9 1.66 Allowed 'General case' 1 C--N 1.239 -4.211 0 CA-C-N 112.353 -2.203 . . . . 0.0 110.541 -173.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.6 88.92 7.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.075 -1.45 . . . . 0.0 109.526 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.47 -105.37 1.77 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.112 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.42 -2.5 11.53 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 122.229 1.014 . . . . 0.0 110.485 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.77 139.99 30.17 Favored 'General case' 0 C--N 1.254 -3.583 0 CA-C-N 113.326 -1.761 . . . . 0.0 111.419 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 42.6 t -79.25 151.15 4.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 117.723 -1.591 . . . . 0.0 109.314 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 86.4 m -140.49 -173.75 3.77 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.555 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . 102.74 -49.87 0.95 Allowed Glycine 0 C--O 1.2 -2.002 0 C-N-CA 117.496 -2.287 . . . . 0.0 114.263 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 26' ' ' ASN . 9.7 tm0? -63.78 115.14 4.52 Favored 'General case' 0 C--N 1.285 -2.215 0 C-N-CA 117.493 -1.683 . . . . 0.0 109.493 -178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 -10.42 52.59 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -129.98 -163.7 1.33 Allowed 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 114.156 -1.022 . . . . 0.0 111.623 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.717 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -158.21 133.08 8.44 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.092 175.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.9 m -90.2 149.97 22.18 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.005 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.717 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 32.1 mm -140.35 111.86 4.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.795 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 9' ' ' SER . 8.9 mt -75.71 127.03 32.16 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.341 -1.343 . . . . 0.0 109.208 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 80.69 80.85 0.83 Allowed Glycine 0 N--CA 1.497 2.736 0 C-N-CA 118.728 -1.701 . . . . 0.0 109.95 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -132.63 79.58 1.86 Allowed 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.908 0.861 . . . . 0.0 109.42 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 0.8 OUTLIER 42.3 67.45 0.59 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.236 177.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.43 3.44 61.33 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.038 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 37' ' ' ASN . 2.4 mm-40 -131.96 95.55 3.72 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-O 122.283 1.039 . . . . 0.0 111.179 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 15.0 pttt -66.47 8.86 0.2 Allowed 'General case' 0 C--N 1.245 -3.958 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.119 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.761 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -178.87 69.95 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.62 -175.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -79.3 172.93 13.12 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.486 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.0 m -134.03 62.46 1.65 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -79.45 135.62 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 C-N-CA 117.913 -1.515 . . . . 0.0 111.931 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.7 t -38.8 165.13 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.332 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.02 -151.73 17.83 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 120.119 -1.038 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -143.07 124.48 14.72 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.524 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.3 -113.02 3.75 Favored Glycine 0 N--CA 1.482 1.753 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.775 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.507 ' H ' ' HB3' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -151.83 149.1 22.95 Favored Pre-proline 0 C--N 1.296 -1.748 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.056 -179.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.33 115.25 3.94 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.333 1.355 . . . . 0.0 110.546 173.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.522 ' HG2' HE21 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -55.24 113.66 5.88 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.632 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.64 134.12 60.97 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 120.653 0.902 . . . . 0.0 111.443 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 116.321 -1.799 . . . . 0.0 110.702 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.7 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 t -83.98 163.74 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.175 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.504 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 11.1 m-85 -142.59 -113.75 0.12 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.914 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 3' ' ' TYR . 1.3 p -159.31 173.42 16.31 Favored 'General case' 0 C--N 1.262 -3.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.506 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.56 132.18 34.14 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.564 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 m -52.1 155.12 2.0 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.218 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -148.13 14.92 1.03 Allowed 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.007 174.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.624 ' C ' HD12 ' A' ' 30' ' ' LEU . 19.9 mt-10 -161.52 127.04 3.63 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.619 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.586 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -53.5 158.24 1.84 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.088 177.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 79.67 11.21 84.96 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.582 -1.77 . . . . 0.0 110.435 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.793 HE21 ' CB ' ' A' ' 47' ' ' LYS . 1.8 tp60 -74.71 -164.63 0.29 Allowed 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.269 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 14' ' ' CYS . 9.8 m-20 -162.86 -69.36 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 117.914 -1.515 . . . . 0.0 113.93 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 72.0 mt -76.3 19.72 0.24 Allowed 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.538 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 22.7 p -103.55 177.99 4.68 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.372 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.3 mt -79.85 70.74 6.46 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-O 122.829 1.299 . . . . 0.0 107.765 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.623 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 39.5 t -69.21 -74.45 0.13 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.583 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.72 130.5 40.65 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.411 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 23.61 -91.26 0.01 OUTLIER Glycine 0 N--CA 1.503 3.155 1 N-CA-C 127.198 5.639 . . . . 0.0 127.198 -174.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.09 2.56 10.42 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.926 1.346 . . . . 0.0 107.864 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -89.73 143.01 27.15 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 112.131 -2.304 . . . . 0.0 110.882 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 22' ' ' CYS . 6.7 t -84.35 143.5 11.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.102 -1.439 . . . . 0.0 110.241 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -71.85 -142.43 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 175.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -172.06 115.44 0.57 Allowed Glycine 0 C--N 1.279 -2.619 0 C-N-CA 117.314 -2.374 . . . . 0.0 110.844 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 23' ' ' GLY . 11.3 tt0 -34.87 155.21 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.39 -0.905 . . . . 0.0 109.478 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.81 -16.33 55.02 Favored Glycine 0 C--N 1.293 -1.808 0 N-CA-C 106.452 -2.659 . . . . 0.0 106.452 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.817 HD21 ' C ' ' A' ' 39' ' ' CYS . 14.2 t30 -106.72 -156.55 0.58 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.081 -1.06 . . . . 0.0 108.776 176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.69 ' CE ' HD11 ' A' ' 29' ' ' ILE . 1.2 ttpp -159.63 103.54 1.56 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.152 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.538 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 42.7 t -78.28 156.98 29.38 Favored 'General case' 0 CA--C 1.462 -2.41 0 C-N-CA 116.808 -1.957 . . . . 0.0 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.69 HD11 ' CE ' ' A' ' 27' ' ' LYS . 24.3 mm -145.62 118.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.772 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.078 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.624 HD12 ' C ' ' A' ' 8' ' ' GLU . 12.8 mt -92.13 129.31 38.11 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.673 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 82.88 84.31 0.85 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 118.836 -1.649 . . . . 0.0 111.433 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' GLU . 2.5 t -137.98 80.23 1.79 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.725 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 32' ' ' SER . 49.0 m-20 37.68 69.95 0.21 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.68 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.78 4.73 57.84 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.431 -1.366 . . . . 0.0 110.808 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 37' ' ' ASN . 30.6 mt-10 -136.36 94.59 3.04 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.83 0.824 . . . . 0.0 111.061 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -72.17 10.92 0.65 Allowed 'General case' 0 C--N 1.251 -3.681 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.728 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER 179.75 107.48 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.966 -176.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.682 ' N ' HD22 ' A' ' 37' ' ' ASN . 9.0 tt0 -119.95 164.08 16.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.817 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.5 OUTLIER -123.57 71.48 1.09 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -101.3 124.72 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -171.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 40' ' ' VAL . 11.3 t -18.69 151.5 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 112.416 -2.174 . . . . 0.0 113.168 171.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.75 -155.73 20.74 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -127.54 98.32 5.18 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -91.93 -115.79 2.12 Favored Glycine 0 C--O 1.215 -1.042 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.653 -177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -164.84 150.96 9.03 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.565 -177.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -76.97 132.87 13.21 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.751 1.634 . . . . 0.0 110.057 170.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.793 ' CB ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -64.46 -40.02 46.86 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.775 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 47' ' ' LYS . 2.0 Cg_endo -65.88 146.28 82.6 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.357 0.705 . . . . 0.0 111.064 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.275 179.489 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 3' ' ' TYR . 15.5 t -113.91 178.7 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.896 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.732 ' H ' HG12 ' A' ' 2' ' ' VAL . 16.9 m-85 -140.3 -114.73 0.14 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.688 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 3' ' ' TYR . 11.1 p -158.13 175.25 14.03 Favored 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.211 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.18 132.05 36.94 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.273 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.07 151.09 2.81 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.082 177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 t -138.13 8.03 2.69 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.994 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.557 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.7 mt-10 -166.79 132.88 2.29 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.409 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.682 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -48.94 154.38 0.74 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.568 177.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' THR . . . 87.87 11.23 68.23 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.41 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -82.99 -170.09 2.85 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.91 -1.116 . . . . 0.0 109.786 177.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 14' ' ' CYS . 15.6 m120 -151.94 -73.51 0.15 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 118.406 -1.318 . . . . 0.0 113.365 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.552 HD13 ' CE1' ' A' ' 3' ' ' TYR . 51.8 mt -74.57 27.85 0.08 Allowed 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.176 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 20.9 p -105.55 177.29 4.89 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 119.186 -1.006 . . . . 0.0 109.598 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.4 mt -79.91 73.23 6.69 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.992 1.377 . . . . 0.0 107.629 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 76.2 m -69.52 -78.82 0.07 Allowed 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 111.864 -2.426 . . . . 0.0 110.869 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -77.22 107.36 9.55 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.544 -1.263 . . . . 0.0 109.867 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -115.05 6.83 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.95 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.93 0.6 11.93 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.361 1.077 . . . . 0.0 110.033 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -87.67 146.51 25.67 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.856 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 22' ' ' CYS . 22.1 t -82.75 140.29 16.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 C-N-CA 118.367 -1.333 . . . . 0.0 110.014 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.541 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -83.17 -138.8 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.95 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -166.31 121.25 0.97 Allowed Glycine 0 C--N 1.272 -3.008 0 C-N-CA 117.839 -2.124 . . . . 0.0 110.008 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 23' ' ' GLY . 4.9 tt0 -34.65 159.44 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.081 -1.06 . . . . 0.0 110.251 177.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.0 -16.4 58.67 Favored Glycine 0 C--N 1.292 -1.887 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 -172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.6 t30 -105.91 -161.22 0.79 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 113.873 -1.163 . . . . 0.0 108.864 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -160.95 96.42 1.11 Allowed 'General case' 0 C--N 1.28 -2.453 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.24 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 m -78.78 133.9 37.05 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 117.642 -1.623 . . . . 0.0 109.635 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -122.98 120.46 60.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.646 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 9' ' ' SER . 22.6 mt -81.94 139.06 34.83 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.162 178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.44 -74.64 0.27 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.698 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 34' ' ' GLY . 27.0 m -154.23 -127.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 67.47 0.0 OUTLIER 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.746 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 66.54 35.13 89.54 Favored Glycine 0 C--N 1.275 -2.827 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.581 ' HB2' ' H ' ' A' ' 32' ' ' SER . 58.8 mm-40 -78.68 -109.87 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.566 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 37' ' ' ASN . 3.6 pttt -93.1 -141.13 0.21 Allowed 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.457 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.949 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER 172.65 123.32 0.02 OUTLIER 'General case' 0 C--N 1.263 -3.162 0 CA-C-N 112.522 -2.126 . . . . 0.0 109.172 -169.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.949 ' N ' HD22 ' A' ' 37' ' ' ASN . 5.5 tt0 -117.2 -179.93 3.85 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' H ' ' HG2' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -145.55 78.85 1.56 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.508 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -114.74 131.51 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 C-N-CA 118.331 -1.347 . . . . 0.0 114.635 -175.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.563 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -9.41 143.77 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 112.505 -2.134 . . . . 0.0 113.263 171.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.03 -145.71 15.3 Favored Glycine 0 N--CA 1.489 2.225 1 N-CA-C 131.067 7.187 . . . . 0.0 131.067 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -146.87 84.77 1.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.719 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.57 -107.88 2.43 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.232 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -161.64 145.56 9.69 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.99 -179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -77.09 105.5 2.08 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.52 1.48 . . . . 0.0 110.496 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -43.78 106.18 0.49 Allowed Pre-proline 0 N--CA 1.497 1.888 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.714 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 125.32 15.26 Favored 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.709 0.939 . . . . 0.0 111.377 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 . . . . . 0 C--N 1.305 -1.338 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.585 179.452 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' H ' ' A' ' 3' ' ' TYR . 12.4 t -84.28 172.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.679 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.575 ' H ' HG12 ' A' ' 2' ' ' VAL . 60.0 m-85 -130.23 -118.29 0.23 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.67 0.748 . . . . 0.0 110.478 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.584 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -179.17 178.06 0.75 Allowed 'General case' 0 C--N 1.259 -3.367 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.643 -178.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.584 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -81.94 132.95 35.27 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.986 0.898 . . . . 0.0 112.119 -177.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -52.96 154.49 2.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.843 176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.683 HG22 ' HE2' ' A' ' 47' ' ' LYS . 6.9 t -139.38 11.27 2.54 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.979 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.687 ' C ' HD12 ' A' ' 30' ' ' LEU . 13.6 tt0 -166.34 125.39 1.54 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.272 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.713 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -45.14 155.58 0.12 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.819 177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.08 -18.71 56.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.185 -1.483 . . . . 0.0 112.53 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 22.4 mt-30 -79.71 -175.66 4.97 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 118.575 -1.25 . . . . 0.0 109.91 -178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 14' ' ' CYS . 65.8 m-80 -152.2 -48.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 117.68 -1.608 . . . . 0.0 114.126 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 46' ' ' PRO . 29.0 mt -75.35 17.73 0.25 Allowed 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.106 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' ASN . 25.8 p -103.25 175.73 5.38 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.962 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.1 mt -78.88 73.19 5.43 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-O 122.959 1.362 . . . . 0.0 108.284 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.61 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 35.8 t -72.8 -82.24 0.05 Allowed 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 112.11 -2.314 . . . . 0.0 109.816 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.71 97.76 3.3 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 117.452 -1.699 . . . . 0.0 109.129 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 20' ' ' ASN . . . 64.65 -148.78 51.38 Favored Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.217 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.86 3.54 16.61 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.358 1.075 . . . . 0.0 109.553 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -87.14 143.07 27.47 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 113.078 -1.874 . . . . 0.0 110.79 -178.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 22' ' ' CYS . 4.6 t -84.49 144.91 8.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.51 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -73.09 -137.33 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.13 109.11 0.35 Allowed Glycine 0 C--N 1.282 -2.457 0 C-N-CA 117.414 -2.327 . . . . 0.0 111.128 176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.467 ' C ' ' O ' ' A' ' 23' ' ' GLY . 1.9 tm0? -34.36 150.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.722 -0.739 . . . . 0.0 109.36 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.417 ' N ' HE21 ' A' ' 24' ' ' GLN . . . 89.45 -15.95 57.37 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 106.392 -2.683 . . . . 0.0 106.392 -173.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 16.3 t30 -106.5 -161.34 0.79 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 40' ' ' VAL . 49.0 tttp -155.42 105.82 2.5 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 118.711 -1.195 . . . . 0.0 110.357 175.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.609 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 51.9 t -76.34 158.17 31.72 Favored 'General case' 0 CA--C 1.462 -2.408 0 C-N-CA 116.845 -1.942 . . . . 0.0 108.718 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.1 mm -138.13 115.43 12.01 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.082 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.679 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 9' ' ' SER . 13.7 mt -91.74 123.95 35.51 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.215 176.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 78.92 86.87 0.51 Allowed Glycine 0 N--CA 1.503 3.135 0 C-N-CA 118.639 -1.744 . . . . 0.0 110.665 -177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.436 ' O ' ' OG ' ' A' ' 32' ' ' SER . 1.0 OUTLIER -135.53 82.5 1.96 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.949 0.881 . . . . 0.0 109.214 177.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 47.6 58.47 4.93 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.88 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.75 5.75 58.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.113 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 37' ' ' ASN . 42.6 mt-10 -125.64 94.8 4.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 122.246 1.022 . . . . 0.0 110.146 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -68.86 6.74 0.81 Allowed 'General case' 0 C--N 1.248 -3.84 0 CA-C-N 113.356 -1.747 . . . . 0.0 111.962 -178.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.78 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER 179.01 112.1 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.902 -176.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.78 ' N ' HD22 ' A' ' 37' ' ' ASN . 9.2 tt0 -128.78 166.43 19.02 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -126.04 72.24 1.29 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -115.45 130.68 69.63 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.167 0 C-N-CA 118.504 -1.279 . . . . 0.0 112.117 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 5.3 t -42.58 159.72 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 114.691 -1.14 . . . . 0.0 113.844 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.4 -103.26 0.22 Allowed Glycine 0 N--CA 1.494 2.534 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.854 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.522 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -79.15 -148.17 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.022 0.439 . . . . 0.0 109.949 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.57 80.57 0.06 OUTLIER Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.54 126.72 28.27 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.934 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.454 ' HA ' HD12 ' A' ' 13' ' ' LEU . 6.4 Cg_endo -73.39 115.67 4.42 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 C-N-CA 121.409 1.406 . . . . 0.0 111.734 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.683 ' HE2' HG22 ' A' ' 7' ' ' THR . 19.5 tptp -66.86 113.98 15.69 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.105 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 49' ' ' GLN . 3.9 Cg_exo -59.7 163.65 12.95 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.491 0.794 . . . . 0.0 111.348 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.422 ' O ' ' O ' ' A' ' 48' ' ' PRO . 3.3 mt-30 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 116.368 -1.777 . . . . 0.0 110.583 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 3' ' ' TYR . 8.8 t -101.18 172.69 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.747 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.574 ' H ' HG12 ' A' ' 2' ' ' VAL . 12.1 m-85 -115.77 -116.46 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.388 0.614 . . . . 0.0 110.709 -177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' TYR . 6.0 p -152.1 172.74 15.86 Favored 'General case' 0 C--N 1.259 -3.345 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.534 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.21 131.08 34.88 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.96 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -49.08 150.77 1.49 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.771 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 t -141.24 12.94 2.19 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -165.25 125.59 1.89 Allowed 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.572 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -46.77 159.8 0.09 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.237 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 82.77 -5.91 72.65 Favored Glycine 0 N--CA 1.505 3.288 0 C-N-CA 119.217 -1.468 . . . . 0.0 112.327 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -70.43 -176.48 1.24 Allowed 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.573 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.604 ' C ' ' H ' ' A' ' 14' ' ' CYS . 5.2 m120 -148.29 -64.22 0.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.274 -1.37 . . . . 0.0 113.562 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.475 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 9.6 mt -73.06 22.53 0.07 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.899 -177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' H ' ' C ' ' A' ' 12' ' ' ASN . 17.2 p -104.96 176.76 5.05 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.28 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.1 mt -82.65 70.82 9.7 Favored 'General case' 0 C--N 1.27 -2.884 0 CA-C-O 122.703 1.239 . . . . 0.0 107.859 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 43.9 t -67.51 -88.63 0.01 OUTLIER 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 112.288 -2.233 . . . . 0.0 110.258 -176.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -73.43 109.2 6.77 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 117.064 -1.854 . . . . 0.0 109.849 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.43 -132.19 24.96 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.51 4.91 36.42 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.741 1.258 . . . . 0.0 108.549 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -87.69 149.81 24.02 Favored 'General case' 0 C--N 1.262 -3.196 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.374 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.4 t -87.51 141.2 14.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.706 -1.198 . . . . 0.0 111.123 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.65 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -74.46 -141.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.381 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.866 ' CA ' HD21 ' A' ' 26' ' ' ASN . . . -164.23 101.98 0.19 Allowed Glycine 0 N--CA 1.504 3.175 0 C-N-CA 115.608 -3.187 . . . . 0.0 112.98 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' C ' ' O ' ' A' ' 23' ' ' GLY . 13.6 tm0? -27.45 114.63 0.07 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.519 1.152 . . . . 0.0 110.558 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.03 -16.82 5.48 Favored Glycine 0 C--N 1.28 -2.561 0 N-CA-C 105.263 -3.135 . . . . 0.0 105.263 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.866 HD21 ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -101.63 -171.41 1.98 Allowed 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.8 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 20.5 tttp -143.93 99.64 3.43 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.579 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 48.6 t -76.93 163.63 26.55 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 117.361 -1.736 . . . . 0.0 108.716 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.8 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 19.3 mm -147.36 118.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.257 -3.44 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.102 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.7 144.16 26.98 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.297 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.621 ' H ' ' N ' ' A' ' 36' ' ' LYS . . . -48.56 -80.63 0.06 OUTLIER Glycine 0 N--CA 1.499 2.842 0 C-N-CA 117.908 -2.091 . . . . 0.0 110.631 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.691 ' H ' ' HA ' ' A' ' 35' ' ' GLU . 5.2 t 138.84 -93.58 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.605 1.193 . . . . 0.0 108.359 -176.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.462 ' N ' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -79.2 40.52 0.42 Allowed 'General case' 0 C--N 1.255 -3.533 0 CA-C-N 112.831 -1.986 . . . . 0.0 107.967 177.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 32' ' ' SER . . . 152.35 33.42 0.03 OUTLIER Glycine 0 C--N 1.286 -2.225 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 -176.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.691 ' HA ' ' H ' ' A' ' 32' ' ' SER . 42.3 mt-10 -26.25 104.06 0.02 OUTLIER 'General case' 0 CA--C 1.462 -2.42 0 CA-C-O 123.698 1.713 . . . . 0.0 114.007 -177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.621 ' N ' ' H ' ' A' ' 31' ' ' GLY . 8.5 mttp -87.79 -141.38 0.12 Allowed 'General case' 1 C--N 1.24 -4.181 0 CA-C-N 110.386 -3.097 . . . . 0.0 104.077 170.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.864 HD22 ' N ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER 174.22 114.69 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.973 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.938 -176.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.864 ' N ' HD22 ' A' ' 37' ' ' ASN . 11.6 tt0 -124.76 163.36 22.27 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -124.05 65.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.1 t -89.44 131.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 117.914 -1.514 . . . . 0.0 111.816 -172.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.432 ' OG1' ' N ' ' A' ' 42' ' ' GLY . 1.9 t -44.83 170.45 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 113.925 -1.488 . . . . 0.0 111.55 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . 131.89 -111.64 1.08 Allowed Glycine 0 N--CA 1.494 2.502 1 N-CA-C 130.141 6.816 . . . . 0.0 130.141 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' ASN . 37.1 mt-10 -77.14 -144.53 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.092 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 173.2 96.3 0.1 Allowed Glycine 0 C--N 1.288 -2.123 0 C-N-CA 118.263 -1.922 . . . . 0.0 112.236 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.72 123.44 34.73 Favored Pre-proline 0 CA--C 1.566 1.571 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.82 176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.67 118.09 4.73 Favored 'Trans proline' 0 C--O 1.212 -0.796 0 C-N-CA 121.489 1.46 . . . . 0.0 110.561 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -47.14 105.97 0.54 Allowed Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 118.424 -1.311 . . . . 0.0 108.686 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.5 104.0 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.798 0.999 . . . . 0.0 111.323 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 C--N 1.304 -1.371 0 CA-C-O 116.456 -1.735 . . . . 0.0 110.171 179.548 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.26 169.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.249 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 HE22 ' A' ' 11' ' ' GLN . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.698 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 2.4 t30 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.698 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' SER . 11.3 mt -85.19 140.04 31.2 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 84.1 86.89 0.86 Allowed Glycine 0 N--CA 1.507 3.419 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.676 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -140.14 76.02 1.54 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.495 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER 42.25 68.24 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.911 -0.715 . . . . 0.0 111.126 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.8 0.28 62.38 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.441 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 37' ' ' ASN . 3.9 mm-40 -127.48 91.35 3.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.05 0.928 . . . . 0.0 110.383 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.501 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -72.07 13.06 0.34 Allowed 'General case' 1 C--N 1.243 -4.055 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.827 -179.951 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.763 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -176.13 107.99 0.08 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.095 -175.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.653 ' N ' HD22 ' A' ' 37' ' ' ASN . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.535 ' C ' HD21 ' A' ' 26' ' ' ASN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' C ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.97 106.98 0.51 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.7 Cg_endo -61.82 102.03 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.455 0.77 . . . . 0.0 110.771 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.798 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.701 HG12 ' H ' ' A' ' 3' ' ' TYR . 22.8 t -117.94 176.74 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.609 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.701 ' H ' HG12 ' A' ' 2' ' ' VAL . 19.6 m-85 -147.61 -114.68 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.461 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 3' ' ' TYR . 5.0 p -162.55 172.92 14.69 Favored 'General case' 0 C--N 1.258 -3.391 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.436 -178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.26 126.81 33.07 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.466 -1.294 . . . . 0.0 109.581 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 178.33 0.09 Allowed 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 122.781 1.277 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -151.96 18.32 0.68 Allowed 'General case' 0 C--N 1.258 -3.412 0 CA-C-N 111.923 -2.399 . . . . 0.0 106.311 173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.625 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.6 mt-10 -161.43 134.27 6.17 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 117.73 -1.588 . . . . 0.0 114.789 -176.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.469 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -63.59 154.23 33.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.507 172.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.25 -20.9 40.61 Favored Glycine 0 C--N 1.287 -2.143 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.953 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.793 HE21 ' HB2' ' A' ' 47' ' ' LYS . 4.2 mt-30 -82.59 -174.03 4.97 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.908 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.6 -36.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.623 -2.031 . . . . 0.0 115.609 -176.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 61.0 mt -76.11 11.5 1.46 Allowed 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.501 -1.28 . . . . 0.0 110.187 -176.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.498 ' H ' ' C ' ' A' ' 12' ' ' ASN . 5.1 p -104.08 174.58 5.81 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.07 -178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 15' ' ' LEU . 9.1 mt -78.07 74.77 4.61 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-O 122.855 1.312 . . . . 0.0 108.208 -177.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.829 ' C ' HD21 ' A' ' 37' ' ' ASN . 3.5 t -71.02 -83.95 0.03 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 111.803 -2.453 . . . . 0.0 110.076 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 3.9 mm-40 -76.04 121.46 22.79 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.709 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.33 -144.93 23.79 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 118.841 -1.647 . . . . 0.0 109.482 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.24 4.16 53.0 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.589 1.185 . . . . 0.0 109.139 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -83.31 146.55 28.45 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 112.742 -2.026 . . . . 0.0 111.403 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 22' ' ' CYS . 10.9 t -82.32 145.75 8.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.529 -1.268 . . . . 0.0 110.342 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -74.6 -130.43 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 174.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -168.37 109.93 0.36 Allowed Glycine 0 C--N 1.276 -2.793 0 C-N-CA 118.315 -1.898 . . . . 0.0 110.259 176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 10.8 tt0 -35.11 154.38 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.032 178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.81 -17.25 27.36 Favored Glycine 0 C--N 1.29 -1.987 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 39' ' ' CYS . 27.6 t30 -96.56 -157.96 0.62 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.549 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -159.07 98.67 1.47 Allowed 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.702 175.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.898 ' O ' HD13 ' A' ' 29' ' ' ILE . 53.2 t -78.23 166.03 23.21 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.199 -1.8 . . . . 0.0 110.541 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.898 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.6 mm -137.89 108.77 5.45 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.684 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.003 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 8' ' ' GLU . 96.1 mt -86.49 108.36 18.5 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.555 -1.258 . . . . 0.0 114.121 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 1.116 ' HA2' ' N ' ' A' ' 36' ' ' LYS . . . 0.42 67.91 0.0 OUTLIER Glycine 0 C--O 1.188 -2.761 1 N-CA-C 129.041 6.376 . . . . 0.0 129.041 173.629 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -23.69 86.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.958 1.034 . . . . 0.0 109.446 175.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 31' ' ' GLY . 32.6 t0 61.79 54.67 2.84 Favored 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 31' ' ' GLY . . . 84.48 9.37 81.7 Favored Glycine 0 N--CA 1.484 1.861 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.562 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 31' ' ' GLY . 5.3 mm-40 -75.24 -95.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.555 -1.258 . . . . 0.0 113.19 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 1.116 ' N ' ' HA2' ' A' ' 31' ' ' GLY . 19.9 mttp -82.25 -131.73 0.03 OUTLIER 'General case' 0 C--N 1.268 -2.956 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -173.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.829 HD21 ' C ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER 127.88 37.68 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 111.897 -2.41 . . . . 0.0 106.106 -169.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 8.0 tt0 -79.88 164.53 23.49 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.211 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -123.78 65.65 1.03 Allowed 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.604 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -105.3 127.57 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 C-N-CA 118.226 -1.39 . . . . 0.0 113.121 -172.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.428 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 5.5 t -53.98 156.41 2.96 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.25 -1.341 . . . . 0.0 113.505 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.63 -62.89 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.763 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.588 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 1.6 tt0 -121.93 -141.32 0.33 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.639 0.733 . . . . 0.0 110.728 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.588 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . -172.66 70.53 0.1 Allowed Glycine 0 N--CA 1.493 2.456 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.606 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.81 109.29 60.86 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.737 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -73.12 121.79 7.54 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 121.201 1.267 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.793 ' HB2' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -50.0 -48.5 78.51 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.268 179.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 2.9 Cg_endo -62.66 146.8 95.32 Favored 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 120.575 0.85 . . . . 0.0 111.352 173.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 . . . . . 0 C--N 1.305 -1.33 0 CA-C-O 116.417 -1.754 . . . . 0.0 110.603 178.689 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 1' ' ' VAL . 12.4 p . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.84 162.73 2.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.519 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.562 ' O ' HG23 ' A' ' 4' ' ' THR . 45.1 m-85 -131.54 -117.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 3' ' ' TYR . 3.0 p -161.45 166.54 27.1 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.821 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.74 127.74 33.72 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.558 -1.257 . . . . 0.0 110.029 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.9 m -44.91 154.09 0.15 Allowed 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.986 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.861 ' H ' HE22 ' A' ' 11' ' ' GLN . 0.1 OUTLIER -149.78 18.8 0.9 Allowed 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.591 174.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -164.73 120.07 1.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.967 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.482 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -49.21 154.15 0.87 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.147 178.143 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.93 -1.89 85.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.367 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.861 HE22 ' H ' ' A' ' 7' ' ' THR . 6.1 mt-30 -73.95 -172.29 1.29 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.115 -1.434 . . . . 0.0 108.28 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.729 HD21 ' H ' ' A' ' 44' ' ' GLY . 5.1 m-20 -136.77 -82.04 0.37 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 117.516 -1.674 . . . . 0.0 115.282 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 19.9 mt -73.16 34.64 0.08 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.347 -172.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 27.1 p -103.07 174.42 5.88 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.26 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.0 mt -84.81 77.69 10.03 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-O 122.839 1.304 . . . . 0.0 108.505 -176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 20.9 m -73.5 -87.45 0.03 OUTLIER 'General case' 1 C--N 1.243 -4.056 0 CA-C-N 112.413 -2.176 . . . . 0.0 110.442 -176.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.93 107.51 7.05 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.668 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.4 -147.29 50.62 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.055 -1.545 . . . . 0.0 109.909 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -87.52 4.69 42.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.278 1.037 . . . . 0.0 110.1 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.46 140.25 32.45 Favored 'General case' 0 C--N 1.259 -3.356 0 CA-C-N 113.268 -1.787 . . . . 0.0 111.642 -177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 36.7 t -82.91 155.04 3.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.334 -1.347 . . . . 0.0 109.91 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.535 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.5 m -141.41 -163.79 1.63 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.894 ' H ' HD22 ' A' ' 26' ' ' ASN . . . 105.61 -60.32 0.39 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 118.094 -2.003 . . . . 0.0 112.973 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.428 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 8.7 tt0 -66.8 110.32 3.24 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.131 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 -7.34 76.32 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.894 HD22 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -132.01 -171.19 2.56 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.47 -0.865 . . . . 0.0 112.919 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -155.4 114.01 3.5 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.028 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 10' ' ' GLY . 8.1 m -82.96 149.8 26.79 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.064 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' CE ' ' A' ' 27' ' ' LYS . 35.5 mm -138.5 118.3 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.858 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 9' ' ' SER . 13.7 mt -91.04 140.55 29.72 Favored 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.799 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 60.31 88.48 0.02 OUTLIER Glycine 0 N--CA 1.501 3.025 0 C-N-CA 118.643 -1.741 . . . . 0.0 111.315 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -137.08 79.64 1.76 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.723 0.773 . . . . 0.0 109.151 177.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 55.1 58.58 4.61 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.328 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.74 -6.56 70.33 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.696 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 37' ' ' ASN . 14.0 mt-10 -106.31 89.86 3.18 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.691 1.234 . . . . 0.0 110.007 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -67.27 5.08 0.79 Allowed 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 112.503 -2.135 . . . . 0.0 111.598 -179.199 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.696 HD22 ' N ' ' A' ' 38' ' ' GLN . 1.3 t-20 178.36 134.62 0.08 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.167 -174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.696 ' N ' HD22 ' A' ' 37' ' ' ASN . 8.2 tt0 -146.45 174.19 11.62 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.66 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 m -135.79 61.54 1.65 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -80.05 129.88 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.309 -172.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.9 t -25.91 156.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-N 112.833 -1.985 . . . . 0.0 112.875 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.97 -139.6 11.56 Favored Glycine 0 N--CA 1.492 2.423 1 N-CA-C 131.506 7.362 . . . . 0.0 131.506 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -153.56 109.51 3.28 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.729 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -107.07 -110.25 3.45 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.538 -1.315 . . . . 0.0 110.858 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.02 139.41 7.31 Favored Pre-proline 0 C--N 1.299 -1.596 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.473 -178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.0 Cg_exo -58.63 125.76 19.29 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 N-CA-C 109.41 -1.035 . . . . 0.0 109.41 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 46' ' ' PRO . 10.5 tmtt? -44.38 114.76 2.05 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.827 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.42 142.29 70.29 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.841 1.027 . . . . 0.0 111.945 -173.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 116.305 -1.807 . . . . 0.0 110.479 179.566 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' ' 3' ' ' TYR . 43.4 t -129.56 175.81 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.576 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.689 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.9 m-85 -108.66 -117.74 0.27 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.681 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 3' ' ' TYR . 6.7 p -161.21 174.29 13.84 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.897 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.33 131.74 35.68 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.842 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -48.85 158.81 0.29 Allowed 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.095 -1.411 . . . . 0.0 110.902 177.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 t -145.8 13.74 1.34 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.391 -1.277 . . . . 0.0 107.991 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -166.96 121.23 1.04 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.815 -177.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.475 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -48.55 156.6 0.43 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.266 176.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 92.27 -23.26 28.11 Favored Glycine 0 N--CA 1.497 2.739 0 C-N-CA 118.584 -1.77 . . . . 0.0 112.057 -178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' GLY . 11.1 mm-40 -54.07 -171.75 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.568 -179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.21 10.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 117.519 -1.672 . . . . 0.0 114.28 177.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.628 HD22 ' CZ ' ' A' ' 3' ' ' TYR . 19.9 mt -130.52 11.56 5.33 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 176.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 26.5 p -102.78 178.23 4.62 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.319 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.7 mt -77.09 73.09 3.68 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 123.057 1.408 . . . . 0.0 107.656 -178.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 31.7 t -77.14 -75.86 0.19 Allowed 'General case' 0 C--N 1.254 -3.558 0 CA-C-N 111.863 -2.426 . . . . 0.0 110.507 -175.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 117.816 -1.554 . . . . 0.0 109.415 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.94 -126.25 26.25 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -1.74 24.13 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.678 1.227 . . . . 0.0 108.703 178.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -83.26 151.7 25.5 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 112.449 -2.159 . . . . 0.0 110.865 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 43.3 t -81.21 149.21 5.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.301 -1.359 . . . . 0.0 111.273 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -73.74 -140.78 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 175.288 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -167.24 110.48 0.4 Allowed Glycine 0 C--N 1.281 -2.501 0 C-N-CA 117.488 -2.291 . . . . 0.0 111.135 176.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.687 HE21 ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -32.69 145.48 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.489 -0.856 . . . . 0.0 110.515 177.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.687 ' N ' HE21 ' A' ' 24' ' ' GLN . . . 96.17 -2.79 63.77 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 -174.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.713 HD21 ' C ' ' A' ' 39' ' ' CYS . 8.9 t30 -117.1 -157.91 0.68 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 113.952 -1.124 . . . . 0.0 109.188 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HE3' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -160.68 102.85 1.35 Allowed 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.665 176.55 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 10' ' ' GLY . 43.9 t -78.35 165.9 23.29 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 117.7 -1.6 . . . . 0.0 110.146 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.525 HD11 ' HE3' ' A' ' 27' ' ' LYS . 11.8 mm -149.12 120.25 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 CA-C-N 114.015 -1.448 . . . . 0.0 111.409 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 9' ' ' SER . 23.7 mt -78.18 77.24 4.68 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.442 177.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.919 ' HA3' ' CB ' ' A' ' 36' ' ' LYS . . . -17.18 -43.25 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 1 N-CA-C 127.735 5.854 . . . . 0.0 127.735 -177.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.07 89.25 0.08 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.572 177.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.04 41.37 8.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.133 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.43 8.97 67.5 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.678 -1.248 . . . . 0.0 110.42 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -74.69 -92.48 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.931 0.872 . . . . 0.0 112.831 -179.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.919 ' CB ' ' HA3' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -70.52 44.85 0.08 Allowed 'General case' 0 C--N 1.266 -3.064 0 CA-C-N 113.791 -1.55 . . . . 0.0 114.863 -174.526 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.512 ' ND2' ' SG ' ' A' ' 28' ' ' CYS . 0.2 OUTLIER -45.71 90.21 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.595 174.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 36' ' ' LYS . 7.3 tt0 -105.76 164.83 11.62 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.233 179.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.713 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.8 OUTLIER -121.2 71.67 0.96 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -177.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -96.55 120.85 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 118.194 -1.402 . . . . 0.0 114.78 -171.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.1 t -19.75 155.61 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.663 0 CA-C-N 112.456 -2.156 . . . . 0.0 113.781 171.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.24 -151.01 20.15 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -151.25 122.86 7.96 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.187 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.19 -95.56 0.19 Allowed Glycine 0 N--CA 1.478 1.493 1 N-CA-C 131.52 7.368 . . . . 0.0 131.52 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.0 104.48 20.59 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.529 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -70.41 103.36 1.26 Allowed 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.003 1.135 . . . . 0.0 110.484 177.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.17 126.28 15.01 Favored Pre-proline 0 CA--C 1.563 1.448 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.571 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.46 138.58 39.12 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 120.508 0.805 . . . . 0.0 110.324 172.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.614 -179.836 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.46 161.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.365 -0.934 . . . . 0.0 109.893 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.596 ' CE2' HD13 ' A' ' 13' ' ' LEU . 13.9 m-85 -140.63 -112.93 0.14 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.886 -179.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.54 171.85 17.48 Favored 'General case' 0 C--N 1.259 -3.351 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.003 -179.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -94.46 133.67 37.81 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.694 -1.202 . . . . 0.0 112.283 -177.55 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -56.4 156.59 5.79 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.007 -1.452 . . . . 0.0 110.84 176.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -143.08 9.38 1.69 Allowed 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.71 173.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.588 ' C ' HD12 ' A' ' 30' ' ' LEU . 12.3 mt-10 -164.95 145.96 7.58 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.502 -179.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.541 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -59.67 152.72 21.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.532 176.448 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 97.7 -17.65 58.55 Favored Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.137 -1.506 . . . . 0.0 112.376 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.437 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 10.3 mm-40 -61.41 -166.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.022 -179.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.776 HD22 ' HA ' ' A' ' 24' ' ' GLN . 1.7 m-20 -158.48 -68.18 0.09 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.136 -1.426 . . . . 0.0 113.748 -178.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.596 HD13 ' CE2' ' A' ' 3' ' ' TYR . 96.1 mt -75.63 18.26 0.25 Allowed 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.277 -176.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.4 p -100.39 175.96 5.52 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.731 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.449 ' N ' HD23 ' A' ' 15' ' ' LEU . 7.6 mt -79.87 73.53 6.62 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-O 122.793 1.282 . . . . 0.0 108.417 -177.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 43.4 t -72.32 -83.41 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 112.39 -2.186 . . . . 0.0 110.226 -177.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -75.2 110.82 9.86 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 117.928 -1.509 . . . . 0.0 109.341 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.04 -139.91 43.1 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -177.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -95.68 3.7 53.69 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.54 1.162 . . . . 0.0 109.276 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.55 147.08 26.6 Favored 'General case' 0 C--N 1.265 -3.104 0 CA-C-N 112.898 -1.956 . . . . 0.0 111.467 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.8 t -80.18 144.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -78.67 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.429 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . -146.31 96.01 0.18 Allowed Glycine 0 C--N 1.282 -2.463 1 N-CA-C 129.618 6.607 . . . . 0.0 129.618 179.074 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.776 ' HA ' HD22 ' A' ' 12' ' ' ASN . 35.2 tp60 -33.88 121.48 0.44 Allowed 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.658 178.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.06 -6.77 34.95 Favored Glycine 0 C--N 1.291 -1.968 0 N-CA-C 105.921 -2.872 . . . . 0.0 105.921 -172.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.599 ' C ' HD21 ' A' ' 12' ' ' ASN . 13.5 t30 -118.22 -167.61 1.38 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.316 -0.942 . . . . 0.0 109.292 177.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.637 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -142.1 106.41 4.8 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.267 176.206 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLY . 7.9 t -76.11 158.55 31.65 Favored 'General case' 0 C--N 1.283 -2.31 0 C-N-CA 116.413 -2.115 . . . . 0.0 108.262 177.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.637 HD11 ' CE ' ' A' ' 27' ' ' LYS . 14.6 mm -147.11 124.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.889 0 CA-C-N 114.309 -1.314 . . . . 0.0 112.274 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 8' ' ' GLU . 8.3 mt -95.67 130.45 42.55 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.402 175.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.598 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 64.69 92.55 0.03 OUTLIER Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.85 -1.643 . . . . 0.0 111.899 176.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -124.16 78.2 1.62 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.31 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.4 t0 51.17 45.23 28.15 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.01 178.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 3.63 28.09 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.704 179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 36' ' ' LYS . 41.3 mt-10 -125.26 99.06 5.9 Favored 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 121.953 0.883 . . . . 0.0 109.596 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.598 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -56.29 -123.72 0.0 OUTLIER 'General case' 0 C--N 1.247 -3.865 0 CA-C-N 113.838 -1.528 . . . . 0.0 109.803 -179.239 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -57.32 139.9 51.6 Favored 'General case' 1 C--N 1.229 -4.641 0 CA-C-N 112.979 -1.919 . . . . 0.0 110.528 177.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 24.0 tt0 -151.57 165.46 34.21 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.543 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.1 OUTLIER -125.38 66.75 1.14 Allowed 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.2 t -100.71 117.75 46.4 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 118.281 -1.368 . . . . 0.0 110.685 -175.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.2 150.48 3.29 Favored 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.25 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.23 -37.56 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.268 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 22.4 tt0 -157.29 -129.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.821 179.542 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' C ' HE22 ' A' ' 24' ' ' GLN . . . 157.75 97.41 0.13 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.616 -1.278 . . . . 0.0 111.314 176.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.23 107.96 60.7 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.492 179.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.25 101.54 0.2 Allowed 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 120.785 0.99 . . . . 0.0 110.262 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HG2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -42.35 104.5 0.36 Allowed Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.276 -178.778 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -59.99 113.14 1.52 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.597 0.865 . . . . 0.0 111.051 -177.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 . . . . . 0 C--N 1.305 -1.353 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.799 -179.448 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 t -101.26 169.77 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.249 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.502 ' CB ' ' O ' ' A' ' 13' ' ' LEU . 25.7 m-85 -135.54 -118.19 0.17 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.972 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 3' ' ' TYR . 2.9 p -158.07 170.88 21.3 Favored 'General case' 0 C--N 1.259 -3.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.241 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.72 132.64 35.3 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.218 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.7 m -50.77 169.79 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.862 0 CA-C-O 122.512 1.149 . . . . 0.0 110.58 178.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 HE22 ' A' ' 11' ' ' GLN . 5.0 t -149.74 12.72 0.79 Allowed 'General case' 0 C--N 1.266 -3.062 0 CA-C-N 112.844 -1.98 . . . . 0.0 107.092 173.194 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.86 135.53 3.37 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.017 -1.447 . . . . 0.0 112.034 -176.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.481 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -60.26 154.55 19.7 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.101 176.193 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 91.01 -28.11 8.31 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 118.79 -1.671 . . . . 0.0 111.921 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' GLY . 61.9 mt-30 -52.05 179.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 118.381 -1.328 . . . . 0.0 108.557 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -162.0 28.29 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 115.864 -2.334 . . . . 0.0 116.319 -177.278 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 20.0 mt -151.37 28.15 0.65 Allowed 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.7 p -104.91 -158.48 0.66 Allowed 'General case' 0 C--O 1.182 -2.482 0 C-N-CA 118.809 -1.157 . . . . 0.0 110.13 -176.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 16.2 mt -107.13 82.28 1.66 Allowed 'General case' 0 CA--C 1.476 -1.893 0 CA-C-O 122.456 1.122 . . . . 0.0 108.036 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 90.7 m -72.47 -83.04 0.04 OUTLIER 'General case' 0 C--N 1.246 -3.913 0 CA-C-N 113.153 -1.839 . . . . 0.0 111.903 -175.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.04 102.86 8.61 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.177 -1.409 . . . . 0.0 109.998 -178.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.69 -112.56 3.88 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.894 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -121.59 3.03 10.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.498 1.142 . . . . 0.0 109.66 -178.893 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -85.47 143.85 28.31 Favored 'General case' 0 C--N 1.258 -3.387 0 CA-C-N 112.954 -1.93 . . . . 0.0 110.654 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 55.2 t -84.91 155.58 3.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.915 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' N ' HG12 ' A' ' 21' ' ' VAL . 52.4 m -144.77 -172.76 3.89 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' ASN . . . 108.82 -57.65 0.42 Allowed Glycine 0 C--O 1.205 -1.666 0 C-N-CA 118.122 -1.989 . . . . 0.0 113.823 173.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -66.19 116.34 7.15 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 118.406 -1.317 . . . . 0.0 109.94 -177.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.34 3.85 88.39 Favored Glycine 0 C--N 1.301 -1.405 0 N-CA-C 106.612 -2.595 . . . . 0.0 106.612 -174.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.698 ' ND2' ' H ' ' A' ' 27' ' ' LYS . 2.4 t30 -148.49 -161.25 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.876 -1.162 . . . . 0.0 111.303 -179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.698 ' H ' ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -152.97 127.25 9.19 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.818 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -85.27 153.21 22.75 Favored 'General case' 0 CA--C 1.469 -2.152 0 C-N-CA 118.125 -1.43 . . . . 0.0 110.153 177.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD11 ' CE ' ' A' ' 27' ' ' LYS . 23.9 mm -149.67 113.82 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.256 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.471 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' SER . 11.3 mt -85.19 140.04 31.2 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.692 -1.203 . . . . 0.0 110.429 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 84.1 86.89 0.86 Allowed Glycine 0 N--CA 1.507 3.419 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.676 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -140.14 76.02 1.54 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.495 177.521 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER 42.25 68.24 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.911 -0.715 . . . . 0.0 111.126 178.321 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.8 0.28 62.38 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.441 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 37' ' ' ASN . 3.9 mm-40 -127.48 91.35 3.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.05 0.928 . . . . 0.0 110.383 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.501 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -72.07 13.06 0.34 Allowed 'General case' 1 C--N 1.243 -4.055 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.827 -179.951 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.763 HD22 ' C ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -176.13 107.99 0.08 Allowed 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.095 -175.333 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.653 ' N ' HD22 ' A' ' 37' ' ' ASN . 6.0 tt0 -122.43 -177.58 3.66 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.84 178.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.535 ' C ' HD21 ' A' ' 26' ' ' ASN . 76.4 m -137.64 75.34 1.52 Allowed 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' C ' ' ND2' ' A' ' 26' ' ' ASN . 1.1 t -94.28 121.26 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 118.195 -1.402 . . . . 0.0 114.097 -172.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 5.8 t -19.31 149.06 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.205 174.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.12 -151.59 20.31 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.893 178.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -146.21 114.39 6.62 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.6 -113.05 3.78 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.081 -175.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -153.34 150.38 23.51 Favored Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.942 -176.933 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.98 105.88 1.05 Allowed 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 121.138 1.225 . . . . 0.0 110.143 172.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.97 106.98 0.51 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.316 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.7 Cg_endo -61.82 102.03 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.455 0.77 . . . . 0.0 110.771 -178.022 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 48' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.798 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 3' ' ' TYR . 2.0 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.83 4.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 4' ' ' THR . 65.0 m-85 -132.76 -130.28 0.18 Allowed 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.651 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 3' ' ' TYR . 6.9 p -165.23 177.71 7.44 Favored 'General case' 0 C--N 1.256 -3.459 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.622 -176.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.76 129.93 34.76 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.422 178.13 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.8 m -43.69 158.16 0.04 OUTLIER 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.594 178.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 t -138.31 10.7 2.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.541 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -165.43 130.04 2.42 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.42 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.45 153.02 0.39 Allowed 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.608 -0.837 . . . . 0.0 108.754 172.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 80.35 19.38 69.2 Favored Glycine 0 C--N 1.278 -2.666 0 C-N-CA 119.994 -1.098 . . . . 0.0 112.45 -178.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 11.1 mm-40 -89.95 -166.32 1.56 Allowed 'General case' 0 N--CA 1.519 3.011 0 C-N-CA 118.443 -1.303 . . . . 0.0 109.919 178.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.0 m120 -153.5 -72.46 0.13 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.416 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 37.5 mt -71.82 17.16 0.1 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.566 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 26.7 p -103.93 176.48 5.14 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.218 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.1 mt -80.77 72.72 7.75 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-O 122.676 1.227 . . . . 0.0 108.156 -177.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.723 ' C ' HD21 ' A' ' 37' ' ' ASN . 99.6 m -70.93 -79.51 0.06 Allowed 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 112.555 -2.112 . . . . 0.0 110.315 -176.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 3.2 mp0 -74.36 91.97 2.26 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.061 -1.456 . . . . 0.0 108.788 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.78 -140.36 31.48 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.188 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -86.76 4.09 42.33 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.016 0.912 . . . . 0.0 110.65 -178.916 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -90.87 140.01 30.21 Favored 'General case' 0 C--N 1.261 -3.244 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.235 -177.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 22' ' ' CYS . 12.6 t -80.48 146.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.73 177.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -100.0 -146.96 0.34 Allowed 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.327 176.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 24' ' ' GLN . . . -157.18 123.05 1.24 Allowed Glycine 0 C--N 1.292 -1.895 0 C-N-CA 116.721 -2.656 . . . . 0.0 111.885 -177.158 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.577 HE22 ' CA ' ' A' ' 46' ' ' PRO . 5.2 tp-100 -35.25 160.76 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 113.036 -1.582 . . . . 0.0 110.052 175.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.2 -14.78 52.73 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 -174.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.562 HD21 ' C ' ' A' ' 39' ' ' CYS . 18.1 t30 -109.15 -163.43 0.87 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.249 -0.976 . . . . 0.0 109.23 177.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.39 96.75 1.19 Allowed 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.241 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -84.1 126.08 32.75 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 117.896 -1.522 . . . . 0.0 112.306 -178.413 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 37' ' ' ASN . 11.4 mm -99.32 116.56 42.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.275 -176.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' SER . 62.6 mt -74.54 135.55 42.15 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' H ' ' HB2' ' A' ' 37' ' ' ASN . . . -61.08 66.18 0.01 OUTLIER Glycine 0 N--CA 1.477 1.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.861 172.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.659 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.2 t -67.78 -123.12 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -56.3 70.36 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.088 0 O-C-N 125.295 1.622 . . . . 0.0 110.026 -179.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 56.67 41.97 90.48 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -178.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -96.39 -127.1 0.14 Allowed 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.384 -177.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 37' ' ' ASN . 5.8 mmtm -98.31 -118.69 0.14 Allowed 'General case' 0 C--N 1.267 -2.984 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.627 -176.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.723 HD21 ' C ' ' A' ' 16' ' ' CYS . 1.6 t-20 114.18 40.37 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.477 0 CA-C-N 111.992 -2.367 . . . . 0.0 106.675 -170.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.487 ' HG2' ' H ' ' A' ' 39' ' ' CYS . 5.1 tt0 -103.03 -165.28 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.029 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.562 ' C ' HD21 ' A' ' 26' ' ' ASN . 0.0 OUTLIER -147.98 89.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.268 -177.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -105.62 123.68 60.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 112.982 -1.917 . . . . 0.0 113.169 -176.7 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.3 t -6.35 144.05 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-N 112.534 -2.121 . . . . 0.0 113.824 171.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . 136.07 172.15 12.54 Favored Glycine 0 N--CA 1.487 2.095 1 N-CA-C 130.979 7.151 . . . . 0.0 130.979 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.47 94.76 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.477 -0.889 . . . . 0.0 109.953 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.17 -113.33 3.52 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.419 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.4 OUTLIER -164.07 134.18 3.18 Favored Pre-proline 0 C--N 1.297 -1.714 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.725 -179.898 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.577 ' CA ' HE22 ' A' ' 24' ' ' GLN . 9.5 Cg_endo -76.81 98.62 1.23 Allowed 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 121.458 1.439 . . . . 0.0 110.481 173.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' PRO . 13.4 tttp -43.15 105.27 0.41 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.203 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.53 -168.63 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 120.449 0.766 . . . . 0.0 110.993 -177.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.541 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 2.0 mp0 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 116.432 -1.747 . . . . 0.0 110.606 179.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 2' ' ' VAL . 46.7 t -82.48 6.43 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.856 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.83 -121.8 0.21 Allowed 'General case' 0 C--N 1.268 -2.942 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.709 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 1.8 t -170.71 178.86 3.42 Favored 'General case' 0 C--N 1.254 -3.56 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.251 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.555 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -95.12 131.22 41.37 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.155 -178.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 m -47.65 153.88 0.53 Allowed 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.8 177.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -148.57 18.03 1.03 Allowed 'General case' 0 C--N 1.274 -2.678 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.87 174.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -164.11 122.84 1.89 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.709 -179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.69 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -52.55 146.73 9.46 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.575 0.703 . . . . 0.0 110.663 178.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 98.96 -0.34 57.55 Favored Glycine 0 C--N 1.277 -2.749 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.66 178.112 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 20.4 mt-30 -88.39 179.17 6.38 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.653 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -148.0 -42.16 0.16 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 118.934 -1.106 . . . . 0.0 112.423 -177.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 46' ' ' PRO . 8.2 mp -75.76 22.88 0.13 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.608 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 12' ' ' ASN . 31.2 p -121.8 177.21 5.37 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.602 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.8 mt -79.5 74.73 6.14 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 122.672 1.225 . . . . 0.0 108.915 -176.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.8 m -69.89 -77.77 0.08 Allowed 'General case' 0 C--N 1.256 -3.465 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.03 -178.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -77.77 114.99 17.17 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.785 -179.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.42 -120.76 24.13 Favored Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.255 -179.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.71 4.59 18.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.486 1.136 . . . . 0.0 109.821 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -88.72 143.9 26.62 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.911 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 22' ' ' CYS . 12.8 t -83.03 136.73 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 118.773 -1.171 . . . . 0.0 110.342 177.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.632 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -82.35 -140.2 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.541 174.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -165.86 123.77 1.18 Allowed Glycine 0 C--N 1.27 -3.103 0 C-N-CA 116.58 -2.724 . . . . 0.0 111.58 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -33.94 150.78 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 113.009 -1.596 . . . . 0.0 109.078 175.687 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 96.99 -12.7 65.55 Favored Glycine 0 C--N 1.29 -2.007 0 N-CA-C 106.359 -2.696 . . . . 0.0 106.359 -173.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.546 ' OD1' ' N ' ' A' ' 41' ' ' THR . 5.5 t-20 -114.15 -163.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.904 177.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' O ' ' O ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -157.36 99.28 1.76 Allowed 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.395 176.148 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.811 ' O ' HD13 ' A' ' 29' ' ' ILE . 3.6 m -78.38 149.78 33.3 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 117.6 -1.64 . . . . 0.0 109.848 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.811 HD13 ' O ' ' A' ' 28' ' ' CYS . 7.3 mm -128.38 115.68 38.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.598 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 36' ' ' LYS . 29.0 mt -70.01 132.41 45.86 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.279 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . 63.64 90.18 0.03 OUTLIER Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.238 -1.458 . . . . 0.0 111.61 177.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.5 ' O ' ' OG ' ' A' ' 32' ' ' SER . 12.0 p -136.53 85.5 2.15 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.062 0.934 . . . . 0.0 109.225 176.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 t70 58.21 42.2 22.34 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.329 177.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.94 -1.25 31.68 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.671 -1.252 . . . . 0.0 111.319 178.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 37' ' ' ASN . 10.6 mt-10 -116.64 102.0 9.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 122.439 1.114 . . . . 0.0 110.38 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.713 ' O ' HD23 ' A' ' 30' ' ' LEU . 5.9 mttp -63.95 9.36 0.07 Allowed 'General case' 1 C--N 1.243 -4.036 0 CA-C-N 113.282 -1.781 . . . . 0.0 111.494 179.504 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 35' ' ' GLU . 1.8 p30 172.18 87.39 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.098 -177.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.516 ' CG ' ' H ' ' A' ' 39' ' ' CYS . 5.3 tt0 -78.77 -179.0 6.26 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 173.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.516 ' H ' ' CG ' ' A' ' 38' ' ' GLN . 0.8 OUTLIER -135.47 68.81 1.45 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.878 -1.129 . . . . 0.0 107.954 178.952 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -104.22 124.51 58.71 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.082 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.517 -175.692 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.546 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 10.2 t -55.03 154.59 5.28 Favored 'General case' 0 C--N 1.269 -2.91 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.53 -24.05 0.15 Allowed Glycine 0 N--CA 1.494 2.505 0 CA-C-N 113.744 -1.571 . . . . 0.0 109.762 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 26' ' ' ASN . 5.4 tt0 -159.46 -140.68 0.07 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' ' H ' ' A' ' 25' ' ' GLY . . . 163.8 102.06 0.16 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.196 -1.478 . . . . 0.0 111.267 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.6 139.98 32.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.633 178.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.641 ' HA ' HD13 ' A' ' 13' ' ' LEU . 11.7 Cg_endo -76.86 102.13 1.58 Allowed 'Trans proline' 0 C--O 1.216 -0.589 0 C-N-CA 121.773 1.649 . . . . 0.0 109.273 172.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -56.03 -62.79 4.1 Favored Pre-proline 0 C--N 1.305 -1.365 0 C-N-CA 118.3 -1.36 . . . . 0.0 111.732 -177.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 49' ' ' GLN . 3.3 Cg_exo -50.7 112.27 0.72 Allowed 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 120.824 1.016 . . . . 0.0 111.57 179.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 48' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 116.376 -1.773 . . . . 0.0 110.432 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 2' ' ' VAL . 2.7 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 3' ' ' TYR . 4.2 t -104.04 169.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.465 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.504 ' H ' HG12 ' A' ' 2' ' ' VAL . 9.0 m-85 -114.08 -110.25 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.559 0.695 . . . . 0.0 110.683 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER 177.2 179.22 0.24 Allowed 'General case' 0 C--N 1.261 -3.27 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.784 -179.097 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.572 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -82.84 130.88 35.19 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.459 -176.992 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 m -47.56 160.72 0.11 Allowed 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.729 175.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 t -141.78 9.43 1.96 Allowed 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.786 175.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -168.18 154.13 7.16 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.218 178.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 157.16 14.99 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.898 176.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 91.85 -22.56 30.61 Favored Glycine 0 N--CA 1.51 3.604 0 C-N-CA 119.336 -1.411 . . . . 0.0 114.147 177.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -78.52 160.95 27.39 Favored 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.719 -177.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 28' ' ' CYS . 6.8 m-80 -151.21 21.33 0.75 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 115.535 1.679 . . . . 0.0 115.535 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.746 ' H ' HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -123.65 8.29 8.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 173.159 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 21.9 p -102.53 179.97 4.14 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 112.307 -2.224 . . . . 0.0 109.226 -178.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.46 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.5 mt -79.75 74.88 6.44 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 122.95 1.357 . . . . 0.0 108.476 -177.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.0 t -72.14 -80.77 0.06 Allowed 'General case' 0 C--N 1.262 -3.216 0 CA-C-N 112.098 -2.319 . . . . 0.0 110.116 -177.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -78.31 106.86 10.51 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.957 178.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.58 -151.79 46.05 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.06 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.17 5.36 17.12 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.1 0.952 . . . . 0.0 110.332 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -89.63 142.2 27.9 Favored 'General case' 0 C--N 1.265 -3.086 0 CA-C-N 113.679 -1.601 . . . . 0.0 112.588 -176.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.455 HG13 ' C ' ' A' ' 13' ' ' LEU . 43.0 t -82.56 151.2 4.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.72 178.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -103.69 -143.26 0.36 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.71 176.26 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 12' ' ' ASN . . . -159.44 118.81 0.85 Allowed Glycine 0 C--O 1.203 -1.792 0 C-N-CA 116.782 -2.627 . . . . 0.0 112.469 -176.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.514 ' C ' ' H ' ' A' ' 26' ' ' ASN . 52.3 tt0 -35.3 162.02 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.699 -1.25 . . . . 0.0 110.179 174.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' N ' ' CG ' ' A' ' 24' ' ' GLN . . . 87.91 -24.29 11.33 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 106.006 -2.837 . . . . 0.0 106.006 -172.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 41' ' ' THR . 15.7 t30 -96.42 -167.17 1.53 Allowed 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -161.35 102.88 1.24 Allowed 'General case' 0 C--N 1.265 -3.103 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.61 177.567 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 97.3 m -78.29 158.98 28.71 Favored 'General case' 0 CA--C 1.442 -3.184 0 C-N-CA 117.372 -1.731 . . . . 0.0 108.86 179.19 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.605 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.6 mm -142.72 114.3 3.01 Favored 'Isoleucine or valine' 1 C--N 1.236 -4.355 0 CA-C-N 113.642 -1.617 . . . . 0.0 111.027 174.237 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.59 123.62 18.4 Favored 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 118.132 -1.427 . . . . 0.0 109.09 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . -102.25 -86.83 1.96 Allowed Glycine 0 N--CA 1.503 3.137 0 C-N-CA 119.323 -1.418 . . . . 0.0 112.877 -175.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER 168.05 115.64 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.523 -175.412 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 53.37 85.38 0.05 Allowed 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.035 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.22 -40.93 2.59 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.129 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' O ' ' O ' ' A' ' 36' ' ' LYS . 2.0 mt-10 -84.77 9.24 14.61 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.769 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.633 ' C ' ' H ' ' A' ' 31' ' ' GLY . 11.6 mttp -48.34 -117.94 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 113.729 -1.578 . . . . 0.0 112.267 -175.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.85 89.95 0.01 OUTLIER 'General case' 0 C--N 1.245 -3.942 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.326 -177.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -81.09 171.96 14.29 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -137.5 75.58 1.54 Allowed 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.644 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -110.97 131.02 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 C-N-CA 117.997 -1.481 . . . . 0.0 114.88 -174.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.572 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -9.15 153.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 CA-C-N 112.296 -2.229 . . . . 0.0 115.233 172.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.38 -136.21 8.53 Favored Glycine 0 N--CA 1.495 2.616 1 N-CA-C 129.937 6.735 . . . . 0.0 129.937 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.603 ' CG ' ' H ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -76.55 -131.13 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.46 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.603 ' H ' ' CG ' ' A' ' 43' ' ' GLU . . . 140.13 107.54 0.71 Allowed Glycine 0 C--N 1.281 -2.525 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.471 176.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.82 135.06 36.01 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.037 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.602 ' HA ' HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -68.07 100.72 0.65 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 120.512 0.808 . . . . 0.0 110.196 173.882 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.671 ' H ' ' CD1' ' A' ' 13' ' ' LEU . 12.4 tptm -38.63 104.89 0.32 Allowed Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.003 -179.157 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.37 129.93 20.1 Favored 'Trans proline' 0 C--O 1.217 -0.574 0 C-N-CA 120.793 0.995 . . . . 0.0 110.939 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 116.307 -1.806 . . . . 0.0 110.299 179.849 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.657 HG12 ' N ' ' A' ' 3' ' ' TYR . 33.4 t -115.06 171.27 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.673 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.657 ' N ' HG12 ' A' ' 2' ' ' VAL . 2.8 m-85 -118.4 -96.72 0.47 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.441 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -178.34 178.56 0.86 Allowed 'General case' 0 C--N 1.255 -3.512 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.9 178.346 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.554 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -86.44 132.11 34.02 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.51 -1.276 . . . . 0.0 112.559 -175.683 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 30' ' ' LEU . 2.7 m -48.88 160.13 0.21 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 113.932 -1.486 . . . . 0.0 111.362 176.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 7' ' ' THR . 5.1 t -152.8 14.77 0.55 Allowed 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.533 173.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.626 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.5 tt0 -166.2 117.97 1.03 Allowed 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.982 -178.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -45.81 160.99 0.05 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.709 177.441 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.99 -29.34 8.81 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 118.839 -1.648 . . . . 0.0 112.482 -179.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.431 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 33.2 mt-30 -67.6 -168.84 0.1 Allowed 'General case' 0 N--CA 1.514 2.766 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.615 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.709 HD21 ' C ' ' A' ' 26' ' ' ASN . 11.5 m-20 -166.0 -28.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 117.716 -1.594 . . . . 0.0 113.998 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 46' ' ' PRO . 26.6 mt -86.53 15.04 5.89 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.68 -1.208 . . . . 0.0 109.706 -178.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.5 p -105.63 177.11 4.95 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.992 -178.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 15' ' ' LEU . 8.4 mt -77.74 75.76 4.28 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.76 1.266 . . . . 0.0 108.726 -176.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 14.3 m -82.24 -72.68 0.43 Allowed 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.265 -2.243 . . . . 0.0 111.251 -177.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -74.03 87.88 1.87 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.505 179.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 -142.16 37.38 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 119.176 -1.487 . . . . 0.0 109.682 -178.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.3 0.98 43.34 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.187 0.994 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -90.64 150.39 21.71 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.413 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 14.2 t -81.3 150.27 4.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 118.288 -1.365 . . . . 0.0 111.335 -178.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -72.91 -136.24 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.542 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -169.67 111.46 0.42 Allowed Glycine 0 C--N 1.283 -2.395 0 C-N-CA 117.429 -2.32 . . . . 0.0 110.785 174.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 23' ' ' GLY . 34.9 tt0 -34.76 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.632 -0.784 . . . . 0.0 109.778 177.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' H ' ' HA3' ' A' ' 44' ' ' GLY . . . 87.12 -12.46 62.23 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 -174.104 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.709 ' C ' HD21 ' A' ' 12' ' ' ASN . 34.9 t30 -108.0 -162.09 0.81 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HA ' HD21 ' A' ' 12' ' ' ASN . 23.0 tttt -147.74 103.32 3.5 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.132 173.536 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.813 ' O ' HD13 ' A' ' 29' ' ' ILE . 38.0 t -75.93 156.92 33.77 Favored 'General case' 0 C--N 1.272 -2.77 0 C-N-CA 117.692 -1.603 . . . . 0.0 109.752 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 28' ' ' CYS . 9.0 mm -139.05 116.05 10.85 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.322 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.099 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 8' ' ' GLU . 20.9 mt -95.7 107.03 19.2 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.577 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.98 -40.5 9.83 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 117.535 -2.269 . . . . 0.0 108.304 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.36 89.22 0.15 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.51 0.671 . . . . 0.0 109.984 176.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 3.6 m-20 43.76 72.52 0.18 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.034 178.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' H ' HD22 ' A' ' 30' ' ' LEU . . . 85.41 -1.67 88.35 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.524 -1.322 . . . . 0.0 112.044 176.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 37' ' ' ASN . 8.7 mm-40 -71.74 -104.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.04 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -78.95 45.14 0.59 Allowed 'General case' 0 C--N 1.26 -3.321 0 CA-C-O 122.267 1.032 . . . . 0.0 110.253 -179.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' H ' ' C ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -42.61 130.42 4.03 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 113.215 -1.812 . . . . 0.0 112.814 170.685 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' HG3' ' H ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -133.25 175.48 9.36 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.669 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.635 ' C ' HD21 ' A' ' 26' ' ' ASN . 1.3 m -137.93 67.96 1.41 Allowed 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.561 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.1 t -107.19 128.18 62.34 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.809 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.04 -175.528 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.461 ' CA ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -52.94 151.35 4.71 Favored 'General case' 0 C--N 1.269 -2.907 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.6 -27.19 0.12 Allowed Glycine 0 N--CA 1.496 2.637 0 CA-C-N 114.306 -1.316 . . . . 0.0 110.404 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 26' ' ' ASN . 69.2 mt-10 -154.18 -135.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.432 0.634 . . . . 0.0 109.546 -178.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' HD22 ' A' ' 12' ' ' ASN . . . 159.71 97.93 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.684 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.15 144.45 52.68 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.249 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.549 ' HA ' HD12 ' A' ' 13' ' ' LEU . 18.4 Cg_endo -78.85 130.19 9.45 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.726 1.617 . . . . 0.0 110.678 173.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -60.92 127.57 87.78 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 118.401 -1.32 . . . . 0.0 108.673 177.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.13 155.57 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.536 0.824 . . . . 0.0 111.231 -178.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 116.205 -1.855 . . . . 0.0 110.514 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 3' ' ' TYR . 3.3 t -89.48 165.41 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.331 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.567 ' CZ ' HD13 ' A' ' 13' ' ' LEU . 72.3 m-85 -106.36 -114.17 0.26 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.304 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.538 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.1 OUTLIER -176.63 174.3 1.87 Allowed 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.532 178.856 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.538 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.43 133.77 36.54 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.888 -175.882 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.9 m -47.35 170.26 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.458 0 C-N-CA 118.331 -1.348 . . . . 0.0 109.457 176.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.38 10.23 1.45 Allowed 'General case' 0 C--N 1.262 -3.207 0 CA-C-N 113.406 -1.725 . . . . 0.0 107.276 172.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 30' ' ' LEU . 31.8 tt0 -169.94 128.82 0.92 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.512 -179.054 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.737 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -46.81 163.21 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.912 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.442 177.645 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 81.64 -15.46 24.96 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.011 -2.042 . . . . 0.0 111.597 178.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -58.64 -164.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.763 -1.175 . . . . 0.0 108.613 177.95 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -145.68 -81.48 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 117.345 -1.742 . . . . 0.0 114.348 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 ' CZ ' ' A' ' 3' ' ' TYR . 93.5 mt -75.32 36.72 0.12 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.831 -173.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -101.39 -176.69 3.22 Favored 'General case' 0 C--O 1.194 -1.821 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.337 179.758 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.615 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 11.3 mt -90.99 80.61 5.72 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.925 -176.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.6 m -71.59 -78.64 0.08 Allowed 'General case' 0 C--N 1.247 -3.884 0 CA-C-N 112.862 -1.972 . . . . 0.0 110.709 -177.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 37' ' ' ASN . 79.7 mm-40 -86.34 110.44 19.68 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.05 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.95 -119.19 9.47 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.683 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.47 1.44 12.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.476 1.131 . . . . 0.0 109.358 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -79.77 142.04 35.75 Favored 'General case' 0 C--N 1.259 -3.357 0 CA-C-N 112.798 -2.001 . . . . 0.0 111.06 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 38.7 t -86.31 154.29 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.42 178.71 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.3 m -142.46 -162.71 1.46 Allowed 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.011 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.97 ' N ' HD22 ' A' ' 26' ' ' ASN . . . 97.15 -50.37 1.48 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 117.412 -2.327 . . . . 0.0 113.518 174.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.538 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.3 tt0 -59.66 118.75 6.48 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 118.329 -1.348 . . . . 0.0 110.435 -177.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.84 -8.14 16.93 Favored Glycine 0 C--N 1.305 -1.166 0 N-CA-C 107.536 -2.226 . . . . 0.0 107.536 -176.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.97 HD22 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -122.97 -173.83 2.8 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.395 -0.903 . . . . 0.0 111.969 -179.43 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.587 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -136.25 116.58 13.61 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 176.695 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 10' ' ' GLY . 13.5 t -79.24 153.89 29.6 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 117.421 -1.711 . . . . 0.0 110.672 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.587 HD11 ' CE ' ' A' ' 27' ' ' LYS . 16.9 mm -148.36 124.59 2.51 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.479 0 CA-C-N 113.163 -1.835 . . . . 0.0 111.731 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 9' ' ' SER . 3.4 mt -99.67 135.13 41.54 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.615 176.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 36' ' ' LYS . . . 64.33 92.74 0.03 OUTLIER Glycine 0 N--CA 1.493 2.459 0 C-N-CA 118.546 -1.788 . . . . 0.0 110.884 178.582 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 35' ' ' GLU . 0.4 OUTLIER -129.14 84.63 2.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.633 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 32' ' ' SER . 49.9 t0 39.55 50.63 2.17 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.218 176.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.11 19.75 9.26 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.282 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 32' ' ' SER . 15.0 mt-10 -147.6 103.68 3.55 Favored 'General case' 0 C--O 1.198 -1.637 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.817 179.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 35' ' ' GLU . 1.1 mptp? -56.85 -121.28 0.0 OUTLIER 'General case' 0 C--N 1.255 -3.506 0 CA-C-O 122.761 1.267 . . . . 0.0 109.189 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.429 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -58.04 149.94 22.14 Favored 'General case' 1 C--N 1.236 -4.367 0 CA-C-N 113.445 -1.707 . . . . 0.0 110.696 176.584 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' OE1' ' A' ' 35' ' ' GLU . 11.3 tt0 -160.02 170.11 22.0 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.254 -1.339 . . . . 0.0 107.92 177.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 22.1 m -131.41 64.69 1.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -79.98 125.84 39.08 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.855 -173.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' VAL . 6.5 t -29.06 155.73 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 113.087 -1.869 . . . . 0.0 112.373 178.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.73 -154.3 16.99 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -142.11 124.73 15.85 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.472 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -103.09 -113.48 3.81 Favored Glycine 0 N--CA 1.479 1.527 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.887 -177.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.88 141.19 7.44 Favored Pre-proline 0 C--N 1.296 -1.736 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.746 -178.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.9 Cg_endo -67.43 111.8 2.41 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.881 1.054 . . . . 0.0 109.412 174.181 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HD3' HG23 ' A' ' 4' ' ' THR . 14.4 tttp -39.85 101.39 0.23 Allowed Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.613 -178.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.83 -169.2 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.986 1.124 . . . . 0.0 111.712 -175.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.409 -1.758 . . . . 0.0 110.558 179.752 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -92.14 170.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.688 -178.953 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -110.31 -116.69 0.3 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.657 0.742 . . . . 0.0 110.029 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -165.26 175.76 8.97 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.686 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -79.13 134.5 36.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.921 0.867 . . . . 0.0 112.723 -174.576 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.466 ' N ' ' HB2' ' A' ' 14' ' ' CYS . 3.2 m -48.81 158.07 0.34 Allowed 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.886 176.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.1 OUTLIER -140.69 7.07 2.08 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.253 174.088 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.62 126.7 0.9 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.288 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -50.51 157.54 0.72 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.489 175.765 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.15 -3.41 84.57 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.66 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' A' ' 47' ' ' LYS . 12.5 mt-30 -86.55 -166.19 1.49 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 118.886 -1.126 . . . . 0.0 108.502 178.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.589 HD21 ' H ' ' A' ' 44' ' ' GLY . 6.2 m-20 -139.83 -80.49 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 -175.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mt -71.63 41.67 0.08 Allowed 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.651 -172.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' N ' ' O ' ' A' ' 12' ' ' ASN . 31.8 p -107.75 178.75 4.43 Favored 'General case' 0 C--O 1.194 -1.834 0 C-N-CA 119.159 -1.017 . . . . 0.0 109.854 176.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -89.78 79.72 6.66 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-O 123.05 1.405 . . . . 0.0 108.286 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 33.9 t -61.99 -94.48 0.0 OUTLIER 'General case' 1 C--N 1.243 -4.024 0 CA-C-N 111.832 -2.44 . . . . 0.0 111.191 -176.47 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -80.43 122.29 26.8 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.421 -1.311 . . . . 0.0 109.592 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.63 -123.82 23.14 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.327 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -116.23 2.75 13.35 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 122.393 1.092 . . . . 0.0 109.652 -179.598 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.73 144.92 30.79 Favored 'General case' 0 C--N 1.26 -3.311 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.761 -177.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 22.8 t -86.67 149.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.645 178.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -136.64 -165.1 1.67 Allowed 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 174.529 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 1.103 ' N ' HD22 ' A' ' 26' ' ' ASN . . . 112.67 -68.52 0.23 Allowed Glycine 0 N--CA 1.484 1.893 0 C-N-CA 117.662 -2.209 . . . . 0.0 113.488 174.048 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' C ' ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -64.55 124.79 22.75 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.776 -175.065 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.6 -5.55 44.93 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -175.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 1.103 HD22 ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -133.82 -170.66 2.55 Favored 'General case' 0 C--O 1.21 -1.014 0 CA-C-N 114.565 -0.817 . . . . 0.0 112.674 -179.376 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 40' ' ' VAL . 19.4 tttp -156.27 105.95 2.34 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.292 177.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.832 ' O ' HD13 ' A' ' 29' ' ' ILE . 11.1 m -80.48 158.86 25.76 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 117.665 -1.614 . . . . 0.0 111.038 -179.151 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.832 HD13 ' O ' ' A' ' 28' ' ' CYS . 10.1 mm -139.5 106.87 2.83 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.101 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.288 -179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.47 ' H ' ' HB3' ' A' ' 9' ' ' SER . 0.8 OUTLIER -113.55 123.7 50.62 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.932 -178.104 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 1.002 ' N ' ' H ' ' A' ' 36' ' ' LYS . . . 176.75 80.85 0.05 OUTLIER Glycine 0 CA--C 1.568 3.393 0 C-N-CA 117.419 -2.324 . . . . 0.0 115.536 176.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.815 ' H ' ' CA ' ' A' ' 35' ' ' GLU . 67.0 m -102.26 -137.96 0.34 Allowed 'General case' 0 C--O 1.197 -1.668 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 171.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -19.25 0.36 Allowed 'General case' 0 C--N 1.272 -2.775 0 CA-C-O 123.513 1.625 . . . . 0.0 107.571 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' C ' ' A' ' 32' ' ' SER . . . -167.75 -5.6 0.03 OUTLIER Glycine 1 C--N 1.251 -4.174 0 CA-C-N 110.821 -2.9 . . . . 0.0 109.011 174.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.815 ' CA ' ' H ' ' A' ' 32' ' ' SER . 19.8 mt-10 -167.53 95.19 0.45 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -174.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 1.002 ' H ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -99.19 63.25 1.3 Allowed 'General case' 0 C--N 1.269 -2.893 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 172.278 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -51.37 131.73 28.82 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.351 -179.089 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 7.3 tt0 -147.56 167.66 23.95 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.097 174.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 2.3 m -131.74 73.15 1.52 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.2 t -91.24 125.79 43.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.898 -173.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' VAL . 1.3 t -32.99 159.18 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 113.173 -1.83 . . . . 0.0 111.476 177.604 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.51 -150.97 19.1 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.882 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -153.95 114.1 3.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.589 ' H ' HD21 ' A' ' 12' ' ' ASN . . . -104.92 -109.76 3.44 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.385 -1.388 . . . . 0.0 111.15 -177.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.16 148.27 11.91 Favored Pre-proline 0 C--N 1.3 -1.547 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.55 -177.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.27 129.07 29.83 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 121.11 1.207 . . . . 0.0 109.876 175.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 5.2 tmtm? -45.85 -50.95 32.74 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.861 -179.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 4.4 Cg_exo -51.38 117.43 3.44 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.515 0.81 . . . . 0.0 111.352 174.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.499 179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.7 t -92.59 161.8 2.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.264 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -145.19 -114.0 0.09 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.009 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.36 164.22 38.94 Favored 'General case' 0 C--N 1.26 -3.319 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.9 -178.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.86 131.92 35.26 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.555 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.75 150.35 4.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.578 176.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.829 HG22 ' HZ3' ' A' ' 47' ' ' LYS . 14.8 t -145.63 15.36 1.42 Allowed 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -162.46 113.67 1.57 Allowed 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.41 -177.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.449 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -46.87 155.41 0.26 Allowed 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.515 178.258 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 10.87 85.64 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.449 -1.357 . . . . 0.0 111.293 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -79.39 -168.52 1.55 Allowed 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.911 -1.115 . . . . 0.0 108.814 178.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' CYS . 28.7 t-20 -130.95 -91.18 0.44 Allowed 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 117.877 -1.529 . . . . 0.0 114.835 -177.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mt -74.35 37.58 0.11 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.857 -174.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 21.5 p -96.37 -178.85 4.43 Favored 'General case' 0 C--O 1.192 -1.922 0 C-N-CA 118.175 -1.41 . . . . 0.0 109.721 179.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -92.92 79.8 4.64 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 122.504 1.145 . . . . 0.0 108.577 -177.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 39' ' ' CYS . 44.9 t -66.97 -85.42 0.02 OUTLIER 'General case' 0 C--N 1.253 -3.593 0 CA-C-N 112.86 -1.973 . . . . 0.0 110.42 -176.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -80.77 120.3 24.47 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.168 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.71 -121.88 26.28 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.527 -179.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.99 2.9 14.36 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.635 1.207 . . . . 0.0 109.126 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.529 ' N ' HD22 ' A' ' 20' ' ' ASN . 1.4 m-80 -78.88 142.44 36.8 Favored 'General case' 0 C--N 1.26 -3.315 0 CA-C-N 112.481 -2.145 . . . . 0.0 111.518 -178.009 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.492 ' CG1' ' N ' ' A' ' 22' ' ' CYS . 39.2 t -85.7 153.05 3.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 118.379 -1.328 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.7 m -139.52 -166.93 2.16 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.183 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.794 ' H ' HD22 ' A' ' 26' ' ' ASN . . . 98.04 -47.04 1.53 Allowed Glycine 0 N--CA 1.483 1.824 0 C-N-CA 117.268 -2.396 . . . . 0.0 114.14 173.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' C ' ' H ' ' A' ' 26' ' ' ASN . 20.5 tt0 -60.49 103.21 0.22 Allowed 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 118.175 -1.41 . . . . 0.0 110.768 -176.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.42 -12.32 55.82 Favored Glycine 0 C--N 1.303 -1.27 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 -175.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.794 HD22 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -119.38 -164.45 1.06 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.884 -1.158 . . . . 0.0 111.102 178.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.693 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -159.81 134.78 7.97 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.668 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 t -94.73 159.5 15.04 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 118.188 -1.405 . . . . 0.0 110.438 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.693 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 31.1 mm -137.27 110.06 7.6 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.413 0 CA-C-N 112.942 -1.935 . . . . 0.0 110.786 177.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 9' ' ' SER . 63.1 mt -75.16 112.55 11.54 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.64 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.68 -44.49 12.31 Favored Glycine 0 N--CA 1.488 2.144 0 C-N-CA 118.985 -1.579 . . . . 0.0 109.876 179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.6 t -175.48 100.66 0.08 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.022 179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 1.4 m-20 54.82 51.35 13.87 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.68 176.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.437 ' HA2' HD22 ' A' ' 30' ' ' LEU . . . 88.17 11.41 67.2 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.132 -1.509 . . . . 0.0 111.561 177.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -78.34 -107.45 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.755 -179.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -80.0 62.67 4.27 Favored 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 122.702 1.239 . . . . 0.0 112.233 -175.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.548 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER -54.77 93.42 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 113.369 -1.741 . . . . 0.0 111.843 174.623 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 59.0 tt0 -82.7 162.71 21.71 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.087 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 12.2 m -123.9 67.74 1.04 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.2 t -85.18 131.18 34.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 C-N-CA 117.844 -1.543 . . . . 0.0 111.78 -172.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 40' ' ' VAL . 2.2 t -36.13 165.82 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.272 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.3 -129.95 7.13 Favored Glycine 0 N--CA 1.484 1.894 1 N-CA-C 129.596 6.599 . . . . 0.0 129.596 -178.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -161.07 115.4 2.06 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.199 178.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.8 -106.69 2.96 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.86 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.1 140.62 8.77 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.87 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.5 Cg_endo -61.85 96.6 0.14 Allowed 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 121.132 1.221 . . . . 0.0 110.227 176.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.829 ' HZ3' HG22 ' A' ' 7' ' ' THR . 32.3 tptt -39.32 104.81 0.33 Allowed Pre-proline 0 N--CA 1.491 1.595 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.754 -179.139 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.77 142.03 81.19 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.442 0.762 . . . . 0.0 110.943 178.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 116.397 -1.763 . . . . 0.0 110.539 -179.796 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.637 HG12 ' O ' ' A' ' 2' ' ' VAL . 22.0 t -142.61 16.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.171 -178.57 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.685 ' O ' HG23 ' A' ' 4' ' ' THR . 78.9 m-85 -104.66 -128.4 0.25 Allowed 'General case' 0 C--N 1.266 -3.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.359 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.677 -174.097 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.04 129.49 34.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.842 179.104 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.8 m -44.62 155.44 0.1 Allowed 'General case' 0 C--N 1.268 -2.957 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.17 178.238 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 t -140.75 11.48 2.26 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.978 175.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.65 134.31 4.48 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.01 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.531 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -53.47 155.25 3.02 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.317 176.59 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.812 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 77.62 13.56 83.37 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.485 -179.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.403 HE22 ' HG2' ' A' ' 47' ' ' LYS . 9.7 mm-40 -75.63 -168.65 0.88 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 118.589 -1.244 . . . . 0.0 110.014 179.047 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 14' ' ' CYS . 77.2 m-20 -151.14 -72.05 0.16 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.248 -1.381 . . . . 0.0 113.741 -178.842 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.502 HD13 ' CE1' ' A' ' 3' ' ' TYR . 24.0 mt -75.73 20.7 0.17 Allowed 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.19 -175.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 31.7 p -102.77 176.68 5.08 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.383 -179.342 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.497 ' N ' HD23 ' A' ' 15' ' ' LEU . 6.6 mt -80.62 73.31 7.57 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-O 122.934 1.35 . . . . 0.0 108.194 -177.018 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 71.0 m -72.38 -81.69 0.05 Allowed 'General case' 0 C--N 1.258 -3.376 0 CA-C-N 111.977 -2.374 . . . . 0.0 111.169 -175.82 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.99 112.13 12.1 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.033 -1.467 . . . . 0.0 109.55 -179.759 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.7 -121.76 12.97 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.97 1.91 12.67 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.593 1.187 . . . . 0.0 108.918 178.872 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -85.81 151.2 24.01 Favored 'General case' 0 C--N 1.264 -3.12 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.766 -177.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 22' ' ' CYS . 32.8 t -84.3 142.4 13.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.023 -179.888 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.593 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -84.81 -142.37 0.08 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.897 174.451 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -162.4 120.65 0.96 Allowed Glycine 0 C--N 1.282 -2.419 0 C-N-CA 116.88 -2.581 . . . . 0.0 111.683 -178.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 23' ' ' GLY . 2.6 tt0 -31.42 150.9 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.561 -1.319 . . . . 0.0 110.092 177.233 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.14 -15.01 63.72 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 106.381 -2.688 . . . . 0.0 106.381 -172.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.652 ' OD1' ' N ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -115.36 -170.84 1.84 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.625 -1.288 . . . . 0.0 108.461 177.185 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.82 ' NZ ' HD11 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -161.32 117.1 2.13 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.609 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.569 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -95.97 122.5 38.86 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.837 -177.189 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.82 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 26.3 mm -97.12 117.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 CA-C-N 113.097 -1.865 . . . . 0.0 112.698 -174.084 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 9' ' ' SER . 8.1 mt -79.42 123.29 27.38 Favored 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.422 179.654 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.656 ' H ' ' HA ' ' A' ' 36' ' ' LYS . . . -120.5 -89.58 1.12 Allowed Glycine 0 N--CA 1.507 3.396 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.33 -179.393 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.403 ' H ' ' N ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -179.28 106.67 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.979 -176.634 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 t0 45.45 85.01 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.812 174.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' LYS . . . 94.82 -51.89 1.97 Allowed Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.92 -0.73 36.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.468 1.127 . . . . 0.0 108.022 176.911 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.656 ' HA ' ' H ' ' A' ' 31' ' ' GLY . 23.8 tttt -53.53 -134.73 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 111.871 -2.422 . . . . 0.0 112.307 -176.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -64.65 85.99 0.05 OUTLIER 'General case' 0 C--N 1.249 -3.791 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.767 -178.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -77.12 173.98 11.21 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 173.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.13 80.64 1.77 Allowed 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.427 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -109.43 127.75 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.156 -175.231 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.652 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 t -16.71 141.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 113.053 -1.885 . . . . 0.0 111.696 172.391 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.17 -130.0 2.25 Favored Glycine 0 N--CA 1.484 1.856 1 N-CA-C 131.513 7.365 . . . . 0.0 131.513 -179.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -161.05 100.31 1.23 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.281 -179.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.812 ' HA3' ' O ' ' A' ' 10' ' ' GLY . . . -121.78 -97.03 1.44 Allowed Glycine 0 N--CA 1.481 1.648 1 N-CA-C 129.105 6.402 . . . . 0.0 129.105 177.122 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.82 129.57 2.46 Favored Pre-proline 0 C--N 1.299 -1.622 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.696 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.18 92.61 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.329 1.353 . . . . 0.0 110.441 172.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HG2' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -39.45 103.54 0.29 Allowed Pre-proline 0 N--CA 1.504 2.239 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.681 -179.525 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.68 -174.24 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 120.351 0.701 . . . . 0.0 111.027 -179.355 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.415 HE21 ' HB3' ' A' ' 49' ' ' GLN . 7.3 mt-30 . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 116.275 -1.821 . . . . 0.0 110.527 -179.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 3' ' ' TYR . 37.6 t -78.9 173.25 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.15 -1.02 . . . . 0.0 109.871 179.779 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.655 ' N ' HG12 ' A' ' 2' ' ' VAL . 9.2 m-85 -114.38 -112.65 0.34 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.555 0.693 . . . . 0.0 110.253 -178.565 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 5' ' ' ASP . 0.5 OUTLIER -169.22 -174.4 1.98 Allowed 'General case' 0 C--N 1.255 -3.51 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.305 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.594 ' N ' ' OG1' ' A' ' 4' ' ' THR . 0.0 OUTLIER -87.86 135.73 33.27 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.729 -1.188 . . . . 0.0 112.044 -177.301 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -48.76 155.38 0.58 Allowed 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.648 175.284 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -133.46 4.82 3.7 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.952 176.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.405 ' O ' ' OE1' ' A' ' 11' ' ' GLN . 7.1 pt-20 -168.51 132.55 1.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.757 179.585 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' HD12 ' A' ' 30' ' ' LEU . 0.8 OUTLIER -42.0 166.22 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.668 176.565 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 28' ' ' CYS . . . 68.17 20.48 73.12 Favored Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.806 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.485 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -85.58 -172.78 4.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.864 -179.463 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 14' ' ' CYS . 3.1 m120 -154.95 -67.29 0.13 Allowed 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 118.415 -1.314 . . . . 0.0 113.952 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 5.2 mt -74.07 22.9 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.455 -176.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 16.8 p -115.36 179.49 3.95 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.565 -179.708 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 15' ' ' LEU . 5.5 mt -81.04 72.15 8.06 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.444 -178.195 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 82.0 m -70.39 -83.22 0.03 OUTLIER 'General case' 0 C--N 1.255 -3.517 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.009 -177.145 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.696 ' HA ' HD21 ' A' ' 37' ' ' ASN . 1.3 tm-20 -77.45 122.62 25.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 118.336 -1.346 . . . . 0.0 109.93 178.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.18 -125.0 38.39 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.375 -1.393 . . . . 0.0 109.793 -178.361 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.02 4.61 15.77 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.893 1.33 . . . . 0.0 108.278 178.64 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.95 142.68 34.86 Favored 'General case' 0 C--N 1.261 -3.247 0 CA-C-N 111.965 -2.379 . . . . 0.0 111.877 -177.756 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 22' ' ' CYS . 5.0 t -84.22 135.43 24.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 C-N-CA 118.12 -1.432 . . . . 0.0 109.624 176.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.609 ' O ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -78.56 -143.33 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.726 175.439 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -166.91 119.32 0.84 Allowed Glycine 0 C--N 1.275 -2.857 0 C-N-CA 117.533 -2.27 . . . . 0.0 110.671 -179.141 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 23' ' ' GLY . 3.5 tp-100 -35.09 151.06 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.416 177.085 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.57 -13.3 67.83 Favored Glycine 0 C--N 1.292 -1.89 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -172.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 41' ' ' THR . 27.2 t30 -111.4 -161.75 0.77 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.198 -1.001 . . . . 0.0 109.208 177.166 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' CE ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.92 110.63 1.47 Allowed 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.18 179.055 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -105.26 125.28 50.81 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.004 177.7 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.555 HD11 ' CE ' ' A' ' 27' ' ' LYS . 37.0 mm -105.0 113.86 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.708 0 CA-C-N 113.15 -1.841 . . . . 0.0 111.209 -178.553 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 9' ' ' SER . 8.9 mt -76.61 120.92 22.48 Favored 'General case' 0 N--CA 1.529 3.507 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.673 -177.177 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.96 -57.13 21.32 Favored Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.398 -1.382 . . . . 0.0 109.954 177.575 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 m -168.16 90.47 0.29 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.76 179.338 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER 65.59 52.31 1.36 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.63 178.406 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.57 0.41 73.13 Favored Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.284 -179.889 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -61.2 -101.87 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.614 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -93.27 61.94 3.39 Favored 'General case' 0 C--N 1.257 -3.447 0 CA-C-N 113.924 -1.489 . . . . 0.0 112.057 -177.414 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.696 HD21 ' HA ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -80.32 146.3 31.67 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.262 175.707 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 39' ' ' CYS . 9.7 tt0 -119.82 170.63 9.06 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.161 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.488 ' N ' ' CG ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -139.86 82.56 1.88 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.267 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 41' ' ' THR . 1.1 t -125.08 141.31 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 117.915 -1.514 . . . . 0.0 114.354 -176.674 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.528 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -16.76 152.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 112.408 -2.178 . . . . 0.0 113.519 171.749 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.54 -143.26 12.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.73 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -160.91 111.51 1.76 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.818 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.85 -88.22 0.82 Allowed Glycine 0 N--CA 1.491 2.333 1 N-CA-C 129.77 6.668 . . . . 0.0 129.77 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -147.18 124.12 5.71 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.989 178.152 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.45 98.96 1.25 Allowed 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.474 1.449 . . . . 0.0 111.123 175.394 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -54.11 113.61 5.32 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.463 179.31 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.61 148.92 85.44 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.667 0.911 . . . . 0.0 111.218 -177.445 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.592 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 116.369 -1.777 . . . . 0.0 110.283 -179.645 . . . . . . . . 2 2 . 1 stop_ save_